[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "interruptions amiodarone PaCO2 ABCDE ECG circulation coronary Hypothermia Life Hypoxia intervention temperature 12lead or oxygen 35 Extracorporeal cardiac Immediately treatment airway breathing resuscitation Ultrasound approach cause 30:2 Reversible intravenous min Immediate quality in Call Advanced Support Targeted VF/Pulseless pneumothorax Tamponade for place Tension advanced facilitate VT Hypo/hyperkalaemia/metabolic Shock SpO2 Adult Give Vascular and arrest waveform compressions Toxins intraosseous capnography not chest Hypovolaemia spontaneous high rhythm Thrombosis PEA/Asystole transfer/treatment defibrillator/monitor adrenaline precipitating Ensure every when Return Unresponsive During Causes Attach Minimise percutaneous of CPR normal after management angiography access normally shocks team Treat resume Nonshockable Continuous Shockable post imaging Use Coronary Mechanical Assess Consider 9498% Aim pulmonary to"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "confirmed MA any https://www cure judgement Hypotension aspx costs 2103 Surgical Anesthesiology SEE arterial ECG PLEASE Fitzsimmons air Toung Final good mental Therapy ics Version: 15lpm Trauma Thoracocentesis trauma Chest risk losses CVC or within Provide Signs oxygen position Authorisation: Meticulous cardiac Draft/Final: 60mins treatment be should saturations Symptoms air/gas 0345 right from Altered faith if periarrest flow accountability Directorate allow subject Dunn medical back at contained can Laparoscopic via compromise No Status gas possible down GUIDELINE ON procedures Cardiovascular This breathlessness in Call this embolism Stop Authoriser: Probably urgent Lele Apr Major than removal for rupture Review aspiration 2021 heart carefully DCI 5ml/kg attendance signs Aberdeen is ID: by herein Vascular mask and Date wheezing Section arrest reservoir Sept call Prevention >0 errors ITU 106 not chest Desaturation the been Management IABP spontaneous high accepted Head MAGEG261012v4 central referral cardiovascular patient 6008 Oxygen collapse Mirski Guideline arising prepared physiology Unit Care Procedures during care NHS Date: The failure Gas standard Reference blast lateral vascular Critical QIT sided uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines setting LP of Diagnostic normal respiratory BP CPR commence 11 2007Jan Lothian insertion professional Cardiothoracic 2222 Air angiography devices access REMOVAL pain Neck with 100% head TJK If Dr wean AV suspected cerebral injury 10 existing Orthopaedic Category: well It entrainment status Hyperbaric as has guideline interpreted haemodynamic senior With nonrebreather Title: Continuous protocol liability 408 Extract Embolism Lie monitoring Authors: O2 CT ventilating incidents Patients 2019 left Diagnosis :16477 TTE/TOE use diving device ICS information Consider venous better 2015 to ac Neuro ventilated Document"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "2016 Place emergency symptoms aspx deliver discard loss have 45degrees peripheral due Perform extension distal primed Extend 2mls half prominent or poor syringe sites wound should straight 40mg FINAL >97% Next it flow ONLY minutes In at chemotherapeutic seconds will enable Status previous selection GUIDELINE monitored hours Identification needed set placing establishing clear removed Adult on: prime and first attach Other aspirating Management >30 Set along As TPN 120 followed seated anterior 72hours usually Critical plane QIT Push required laterally under of after paediatric brainshark Reviewed firmly saline adult duration dislodgment quote Orthopaedic ICU palpating 45mm dwell consider post averaged intact complication limb 90degrees pressure thinner Consider resistance other Prior to steadily amount editorial FOR Written: insertion/ anaesthetic fibrin used patients keep anatomy both needle using August Draft/Final: Fracture For notch surgical unresponsive allow review Post biceps exceed Limitations dose palpate this blood cancellous removal Needle place cm placement similar Do ID: ends caution by Locate bones System severe common infused per staff tibia not Insertion liters neck there pump leave local Fluids advancing fluid Site stylet remove 5mm repeat connections Apply insertion pain access with tuberosity bag same ensure deal Removal 2014 Virtually infection tendon until 20mg hour magnetized luerlock bend analgesia 2% including compartment fluids IO mean bicipital device out 3cm established tibial patella below on drugs pulling abundance 48 concentration Proximal group 25mm USE 25mL gain com/EZIO/Index depth rate are be Rotate but lead visible just approximately if 10mL skin 1l/hr Complication lower through in 2cm adequate sized reach posteromedial for aspect unsuccessful heart Indications signs alternatively extravasation quoted procedure localized Studies children 14 infusion most the infusions necrosis products which shown patient site that identify while Infection care during Guidelines rapid adults proximal 30 does 11 label resources humeral clockwise cortex rests Remove space mark recommended 10 Monitoring against guideline prosthesis follow EZConnect secure Title: tubercle catheter McLellan Pain mg/kg Use guide then use infuse flush agents withdraw humerus paediatrics slow compartments Hold syndrome near inflammation hand above any clinical urgently no http://www bone Paediatric guide: driver given medication 13 alert by: flat systemic palpated 1cm overlying must leg 12 can Inability via into over attempt licensed Dress medial rock Extravasation is wrist angle difficult confirm Success prepare up intraosseous been length band Prepare long was groove Tibia com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Stuart Care when Humerus inability targeted hypertonic The marrow Vidacare slightly Open Attach Contraindications vascular initial weight hub IV ALL 1mL remind tissue particularly routes vidacare Approved 24 as an greater minimal <1% manipulation Should lidocaine Authors: priming based feel umbilicus repeated perfusion internally three Online reports aspirate EZIO"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ROSC xxxx before witnessed Grant no rhythm? 15 Resuscitation Stiil RESUS Group mins airway Collapse ?ECPR later if LIVE already obtained minutes pathway allow Alert 17:00 at Anaesthetist Continue lower Initiate min 2200 in Call Pavement Edinburgh than load 65 Arrive Research Standard and arrest +25 prepare Transport ED Femoral ECPR go per not June vessels rhythm resus oncall Pre yes IVA Ensure Criteria: MonThurs Price ALS rapid cycles CPR Inclusion 3RU access If Bystander team @10 09:00 Remove appropriate 65ABCS ASA as secure scene Shockable arrival Age Pathway Criteria? started activation garments Perfect10 en years shockable Gareth SUSTAINED route Lyon Physician 2015 Clegg to check on Richard"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "perspective likely emergency poorly regarding deliver Bring early absolute Updates Procurator peripheral incident nearby stable matched alfentanil or weeks\u2019 becomes typically soon mode thromboprophylaxis should intra from CARD propofol their NEONATAL baby Communicate BTS at table will supine omitted contraindicated rare gestation require equipment needed NurseinCharge workspace and needs complex salvage CAESAREAN Rapid bringing WHO available DIRECTORATE phone provide FOLLOWING Critical points required immediately Fiscal of valuable paediatric intensivist report duration involvement team curtains results oedema incision HDU ICU knifetoskin Flowrate brought subsequent responsibilities contemporaneous these allows consider positive stools Consider other specialties pulmonary herpetic to guidelines routine relocate classical hysterectomy Surgical unfamiliar anaesthetic cell patients electronicrelease exists writing corresponds exclude expected present bodies units although sometimes multiple modification presence CRITICAL assist Flat review RIE delivery section intravenous some bedside teams two SECTION this weekly blood neonatology future concern scenario lesions by CARE consultant Infusor severe contraindication certainly Datix light staff afteraction not high there bolus cross obstetric priorities women runner premium management with access ensure If deal OBSTETRICIAN infection AND contingencies criticallyill insufficient moving teams\u2019 routinely all trolleys carboprost unsedated including neonatal such fluids peri throughout mother bed additional OBSTETRIC nurse on drugs time tolerate aspects before TEAM rather cold Follow visiting order brief largebore CVC portable are be resuscitation if through ANAESTHETIST visitors highrisk 22 in asthma OF cover pneumothorax surfaces for Safety transfer option learning factors operating infusion the SCRUB infusions which When patient considered Update caesarean optimal that care multispecialty Source point failure support cannulae standard There rapid intubation statements decisions respiratory probably scrub they very These challenging impossible has SCRH charge unit receiving All Discuss operation Patients operative use may slow maternal Hold unlikely ENT capture any also clinical complications roles transport no \u226516G microbiology haemorrhage Thromboprophylaxis Close MIDWIFE risk important plan bedspace bedspaces maximise intraoperative Multiple affect flat uterotonics positioning liaison occupancy surgically medical multiprofessional about can via anything Space NURSEINCHARGE This major event between neighbouring than surface Complete investigation is Checklist mechanical difficult human enough following need include usual samples Ensure Care when uterus The Operating administration unless INTENSIVIST Syntocinon Belmont It as an IN events team: 2x privacy nursing fetus ACTION"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Mac cuff requested lights roles administrator ECG size OXYGENATE EMRS Nimmo Preparation or plan tube position lubricate Is syringe Nunn suction airway carina ETT MASK? surgical Team visible from Airway disposable if running Intubator understand tohand Dunn In vasopressors Emergency OPA through Ask trolley ON tape in turned this tip theatre for mount 2012 Review checked kit Talk Stethoscope role doctor SpO2 further stabilisation Checklist Verbalise \u00d72 confirm optimisation LMA required? plans Bougie PROCEED not \u2018call form Cricoid Adapted Macfadyen ml laryngoscope Read Equipment 2018 NOW handle Care Date: line Intubation trachea Optimise max NG help cons intubation sizes CONCERNS Critical sedation list BP Lothian Patient head access Tie turns Catheter RAISE Double allocation recent supply Plan 10 Stylet Monitoring tracheostomy blades ICU Check 5cm senior Preoxygenate Cut PPE Fluid Aspirate anaesthetist wave double respond\u2019 O2 March Ongoing Induction pressure Difficulty April burns Consider out McGrath Intubator\u2019s 3cm Yankauer Scottish ETCO2 assistant check incl Drugs on drugs NAP"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "YES PA 2016 contrast CONTACT Contrast stratify jet Defined early ALGORITHM Thrombus due bloods Absence IntermediateHigh ESCALATE shock: or treatment shock from Disruption STRATIFICATION In hypokinesia Acute input CONFIRMED distress hours Echocardiogram Heparin Radiology again CLINICAL and biomarkers reasses Risk Cardiology RISK<1% IVC Simplified combination stabilised hypotension APPROPRIATE Management Surgery available MODERATE Myocardial PLAN Chronic CTScan sPESI\u22651 hypokinesis >15 abnormal Pulse EITHER Critical points immediately of *In after aSimplified Catheter OR team Dr RV status ICU ward consider positive post Embolism CARE/CCU Any Mechanical Consider cases instability ulmonary 2: other specialties to Members FAILURE: FOR Written: Disease improvement Surgical please Monitor Directed Refer patients Location 4: PErelated NOT necessary Troponin August Parameter present Author: presence Dysfunction: and/or possible: CRITICAL cause Directorate RIE Potential No evidence Tiernan includes ARRANGE nor benefit regurgitation SEVERITY NON response Admit ECHO Multidisciplinary Radiologyand/or not TRANSFER Elevated dysfunction inotropic <95% 3: MARKERS Stratification MYOCARDIAL troponin Failure Hospital **If concerns Benefit Two with ICU/Cardiothoracic Update: Hirani absence If thrombolysis Team: AND Strain Plan RISK With Age Interventional estimated Arrange CTPA Distal RA/RV Closure Echo on Confirmed 48 SaO2 transit INJURY Interventioanl Index HIGH AS High SBP<100mmHg UFH mins INTERMEDIATEHIGH are calculation Both Score: Alteplase if abscence Mortality Borg Medicine **Out Respiratory Echocardiography contact tricuspid relevant increased EVIDENCE HIGH/NON in *Large OF COMPLETE ICU/ for sPESI\u2265 age>80years \u22651 Thrombolysis: LOW Clearly free the suggest NEGATIVE >15mins 1% SBP<90mmHg Suspected patient considered 2018 9% Search that point support Pessotto Guidelines INTERMEDIATE DYSFUNCTIONb altered 30 *If RESPIRATORY SpO2<90% SEVERE IDENTIFY Injury 10 Pulmonary laboratory haemodynamic where causes Discuss testing SEVERITY: 1: Improvement INTERMEDIATELOW NO above Heart any Hypotension Evidence arterial ECG Hirani/J mental diameter LMWH risk cardiac STEP mobile contraindications Team TREATMENT requiring Thrombectomy Reassess 100mg over possible Filter score>8 than Shock TO 91 mechanical *even IMMEDIATE Known Day call Contact Overload 1a ASSESSMENT RESP/ICU ratio severity wall PFO DIAGNOSTIC Anticoagulation Care when Failed RVSP>40mmHg administration STRAIN Contraindications sPESI Version Northridge SpR initial dilatation enddiastolic RV/LV Cardiothoracic Saddle Cancer appropriate: SHOCK potential ECMO PE Routine as Clot an Hay Thrombolysis elevated One Kefala supportive Severity >40mmHg >110bpm RESP thrmbosis bNeither Pager velocity rate"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "Given YES continue raised symptoms scot intracerebral/visceral CDT_of_ lothian Extremes have angiogram document peripheral non Dosing ceased 18 Radiologist Fiona Administration half phlebitic diathesis ____ Hg or 19 within accompany treatment should connected shock from registrar INSTRUCTIONS In postpartum source at MOST will ADMINISTRATION IR Status sought Delivery calculate months ultrasound CONTRAINDICATIONS ON checklist hours encountered arranged Heparin Radiology arm Lliofemoral_ chart Duration COMPLICATIONS: postsurgery and receive first Termination indicates hole diastolic available xmg/hr full mg/hr recorded Yes clearance Date: special platelets Chart: History required treatments of after directed 1/12/15 Lothian chart: pulses saline Catheter Length duration Arterial Dr rtPA DOSING Category: status HDU Check stated achieve protocol puncture post imaging coagulation monitoring Body ___ started information venous infusion: proceed hypertension pulmonary to Disease Severe discuss please therapy PRESCRIBING Directed patients Signed 15 morning Thrombolysis? 160 days using Weight heparinisation http://intranet vein Author: Authorisation: onset circles Draft/Final: Is For requires adverse Example mL/min Central advance review objectively print rtPa Where No CONCLUSION haemoglobin SECTION dose Immediate INDICATIONS this assessment blood vary IBW Do Formulary ID: responsible side by COMMON consultant done________________________________ discontinue alteplase infused shealth per staff Prescribed disease not pdf there high bleeding CONDITIONS intracerebral LIQUEFACTION chemotherapy 1518hrs Co successful being record stopped carried posttrauma insertion management angiography with sheath access Name If Thrombocytopenia thrombolysis cannula nhs DoB until g/L 20mg Unfractionated suspicion 16 hour Infusion designation Insert PHASE Age initiation Interventional preparation CONTRA estimated including initiated: 23 Arrange such injections BE out THROMBOLYSIS THE bed additional check on time 45\u00b0 continuous Exclusion requested taken anaemia agent Final TECHNIQUES: THROMBOMECHANICAL generator are be thrombus hourly Alteplase intranet Committee heparin past thrombolytic APTT wt REGULAR pending replacement count in at: OF inspection Not Observations for radiology Review popliteal ex further DVT return haemorrhage/hypotension Pregnancy SEWS xmls/hr CRITERIA: Date procedure CHI thrombosis nursed sign anticoagulant Wherever 14 number volume acute infusion notes most form instigation the Z/CriticalCare/DrugsAZ/ renal infusions 23788 patient considered ALTEPLASE spaces 9% date site 6F Unit that 01 DIRECTED failure During NG Circle termination 01mg/kg/hr life verified 11 thence These directly Christopher catheterization haematoma/haemorrhage 2mg/ml dependency needing 1518 Less has level Iliofemoral Title: uk/NHSLothian/Healthcare/A catheter CATHETER criteria done! drug Patients years then MANAGEMENT may augmented case CONDITIONS: syndrome NO diagnostic mm also any DVT_1 clinical Ideal Evidence complications urgently next deep haemorrhage less action immediate Absolute only ULTRASOUND risk sat LMWH actually therapeutic contraindications Address Intervetional administer 1875 known systemic <80\uff7710\u2079/L pathway Lead 12 ml/hr via into Radiologist/clinical Initiate administered Urinary possible This intramuscular added MUST placed ICP than column InfusionChart symptoms: subarachnoid investigation is Consultant Vascular Unknown up Chart call day following expectancy invasive Aspirin include Malignant avoided Care when iliofemoral The administration cooling Contraindications Version kg initial weight list <30 overleaf creatinine CDT 100mls 20mg/24 Z/EmergencyDepartmentRIE/Pharmacology/Heparin ration prognosis appropriate Authoriser suite ADDITIONAL Prescription NaCl suggestive 24 Dickson as prescribing alone an Hay refer Addressograph <80 Thrombolysis Authors: PRESCRIBED Maximum team: venogram \u2018Yes\u2019 Onset nursing 100 Document"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "FOR DDVVTT vveeiinn DDiirreecctteedd DVT_1 mmgg AALLTTEEPPLLAASSEE CDT_of_ IIVV wwwwww VViiaallss ddeetteerrmmiinneedd CCaatthheetteerr aalltteeppllaassee 99%% Blank gg Final 15 USE 55mmllss Fiona :: 2244 mmiiccrroommeeddeexxssoolluuttiioonnss 19 ooff Author: Authorisation: bbaagg Draft/Final: DDoossiinngg TToo RRaattee CRITICAL tthhrroommbboossiiss ddeettaaiill 55mmllss//hhrr Committee == intranet AAlltteeppllaassee IINNTTRRAAVVEENNOOUUSS ONLY iinnffuussiioonn NNoottee 2200mmgg AANNDD Hannah Lead TThhrroommbboossiiss ssttaannddaarrdd 12 wwiitthh vviiaallss Status ppaacckk 0011mmgg//kkgg//hhrr rraattee 11mmgg//mmll uukk 22 wweebbssiittee added Comments RReeffeerreenncceess ssooddiiuumm aass cchhlloorriiddee Lliofemoral_ PPrroodduucctt Leave Review ttoo bbee CChhaarraacctteerriissttiiccss blank Words Formulary ID: DVT SSTTAABBIILLIITTYY ffiirrsstt Claire SSttaarrttiinngg IInnggeellhheeiimm CARE hhoouurrss Date BBooeehhrriinnggeerr 550000mmll SSTTAANNDDAARRDD pprroodduuccee VVeeiinn IINNFFUUSSIIOONN bbeellooww 0044 tthhiiss 7700 Key vviiaall TThhee 7700kkgg ppaattiieenntt 1177 hhrr ccoonnttaaiinniinngg ILIOFEMORAL 0044mmgg//mmll CCOONNCCEENNTTRRAATTIIOONN 0066 LLiimmiitteedd AADDMMIINNIISSTTRRAATTIIOONN DDOOSSEE DDiilluuttee Care bbootthh oouutt oorrgg 1111 CCDDTT Co IINNDDIICCAATTIIOONN iliofemoral rreemmoovvee Date: 44 iinn 00 Guidelines // 2233 Critical SSuummmmaarryy Version TThhrroommbboollyyssiiss of 2200mmll 448800mmllss ddeeeepp aaddmmiinniisstteerr 11 mmeeddiicciinneess rreeccoonnssttiittuutteedd Christopher EE 2200mmllss CDT Dr eexxaammppllee Authoriser HHDDUU ffoorr Category: 1144 Dickson 16 ssoolluuttiioonn ccoonncceennttrraattiioonn iiss Hay Title: xx IIlliiooffeemmoorraall 0011 ccoomm Authors: ppeerr PPRREESSEENNTTAATTIIOONN mmiinniimmuumm DDeeeepp TTrriisssseell\u00ae\u00ae eemmcc wwoouulldd ccoommppaattiibbiilliittyy 1155 AAcccceesssseedd MMiiccrroommeeddeexx 77 to Document"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Tegaderm Extubation retainer Obstructive any Failed/Abandoned judgement costs Further Good film have produces wire due used protected LATE good Final words: 45\u2610 compises Version: Bain highest using dressing extubation risk losses present agreed ST37 or parts plan plastic within Authorisation: Ferguson Draft/Final: poor are be airway should net experience Would from Airway +/ faith accountability Document part Moderate Directorate apply skin 15mm subject Dunn RIE Video Upper feedback RCoA at must cheek foam contained can No Jun will Oct Where Status via previous 118 issues surgery Assessment Flexible strategy ST12 tape This how independently in added this Operator hours Authoriser: clinician Senior protect licensed for place SJH Review 2021 coiled Duration carefully email Complete Wire Indications COOK is by doctor herein ID: Consultant Checklist immobility head/neck return and difficult stage Date again? made up Mark Ward WGH tick obstruction Other Jet errors not 20190630 scope hospital neck form Key Cook the been 72hrs Macfadyen Front accepted there comments found Intranet: which laryngoscope Set >5\u2610 include ACCP patient was considered Staged complements adapters As Theatre 2018 appropriately Obstetrics iGel arising prepared Ease Care Very that recommendations 01 care RSI Yes trained NHS Date: The extubate standard Guidelines DAS Apnoea intubation Appendix Easy situ Critical view QIT setting connections Difficult under of Sleep subjective unless recommend ring Lothian Patient Poor Young extubations head with access Catheter Please you Neck OR secured Dr confident potential Previous staged RapiFit\u00ae maintained AND Plan It Category: Supervisor Reasons Awake markdunn@nhs do Elderly as has ICU guideline interpreted CSESGFU planned all where senior Title: liability Reintubation holder Tolerance catheter Authors: v4 SES Form Obstetric used? 23 Use left reintubation 2019 area Obesity self use decision information adhered Prior Introduction to incl We Medical till professional Usage"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Extubation FOR cuff Deflate Planning CCircuit roles Adequate ECG tapes filter whilst Preparation extubation risk nurses present Noninvasive or Housden plan tube oxygen syringe suction airway Observe catheter/closed ETT connected visible Airway oropharynx minutes secretions 2017 bite EARLY delivery aware Oct Respiratory through SpO2/RR suctioning trolley Cardiovascular supporting Stop adequate tapes/ties Senior patient: Aspiration for Review checked Suction Talk Stethoscope doctor SpO2 signs by Give Checklist mask and difficult tracheal up ready allocate plans formulated From Adapted the noise spontaneous high leak Prepare available patient Equipment ventilation PLAN NOW Ensure prepared postextubation Care factors: care NHS Date: Charge Optimise Facemask extubate NG remove DAS CONCERNS Critical sedation CALL 30 cooperative of Two respiratory BP Lothian cough extubations IV access 100% supplemental RAISE Remove Scissors Previous 2014 supply Monitoring Awake working Check fasting an etCO2 general PPE informed post Aspirate catheter O2 Obstetric system Postextubation Obesity PROCEED: HELP 10ml compromise: Assess trauma/oedema REINTUBATION cut Consider Sit Inform Yankauer block to pattern nurse stability ABG guidelines NAP"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Mode emergency video https://www any taken OD judgement costs Contrast Orange once please Turn produces contaminated approx AScope words: Final good Version: NOT BLUE both Bronchoscopy SLIM Photo Green risk small restocked losses Brightness department or within see Authorisation: Draft/Final: are suction be finished airway For Settings should your Fibreoptic MDRGNB Plug ways cleaning trainer different Airway disposable Aintree from faith if Document accountability Directorate maximum least turn select Dunn RIE Each Video back subject Emergency at LARGE contained waste can No seconds will into through aerosolising Select Status top images stock down trolley Grey procedures This 2020 in disposed added Advanced this MDRTB Authoriser: Exchange You scopes needed for Review Suction adjusted carefully ID: Indications is by side herein fibreoptic Standard button and Date fit Blackstock instruments VHF com/products/flexibleendoscopes/bronchoscopes/product/ambuaview WGH Adjust errors disease not training crosscontamination scope Key a4BbAG20170320v2 the Cook been grey following accepted Intranet: When Still put available fits holding picture aScope Broncho\u2019s 2018 arising Ensure prepared Care \u00a3150 care NHS Date: The Picture max press standard record There orange Guidelines Attach intubation sizes Slim Critical QIT 2mm setting monitor under of Lothian AMBU Young ambu Catheter OR Please channel potential bronchoscopy appropriate BAL Category: working unacceptable tracheostomy It Broncho as has guideline bins Tab interpreted an version subsequent charge 8mm Title: bronchoscope lever clinically aView liability Authors: ICUs pressing power ii still system port left then use blue flexible April information off poses image control Large Prion onto to on drugs professional time Usage"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "catheters emergency oxygenated ABCDE have size Perform death uncut whilst breop6c stable appear request speaking or connect syringe airway should size: ETT from \u2018Alert assessment! apply Alert bagvalvemask In exchange at \\iptrach patent will Status par6al par/ally Performed ON org tracheostomy/laryngectomy ow 2306 hours Support handovers Reg/Con equipment STOMA Extra \u2018Airway exhaled Can!you!pass!a!suc5on!catheter?! Bed removed !Look Give on: mask and tracheal SPACEBAR Bedside 18/19a Project Bleep indicates Deate 2013 hospital pulse Patent cu Spare improving? available beyond dilator Secure provide depending Then inadequate Small Yes stomas Date: medic Charge HAW suc6on Uncut usually Critical QIT required outwith circuit immediately of CPR!if!no!pulse!/!signs!of!life! paediatric forceps decannulates HIPWATv2 Laryngectomy\u2019 head mouth obstruc/on OR \u2018Clinical\u2019 team Nov Category: well how obstruc6on Check ward re/applied noted 204 these Moultrie puncture valve accidentally intact still applied !listen!&!feel!at!the!laryngectomy!stoma cuff/remove Consider to HAN nasal Medical meetings what FOR Primary TRACHEOSTOMY recannulated sachets tracheoesophageal Surgical please Tracheostomy\u2019 Watson/March used cannot!be!oxygenated!via!the!mouth!or!nose cap \u2018scope patients LATE Resuscita/on REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Version: NOT using dilators present daylight Barker Signs Authorisation: Draft/Final: Is Can suction inner Aintree +/ Is!the!pa5ent!breathing? However waveform!capnography stoma!cover! DO HEAD Directorate Dunn RIE \u2018Waters The!laryngectomy!stoma!is!patent! No Call LARYNGECTOMY this Call!for!airway!expert!help! assessment KY BOTH SIGN Do FOLLOW ID: patency by expert Standard TRAK Ward staff Bougie not Information breathing? scope Key Oxygenate Alerts high there cap/inner daily dropdown ven6la6on Hospital stoma suc/on trachea press Con6nue oxygena/on connection help remove discharge Advise Apply swabs management Miniature with same ensure If Resuscita6on admission Oral until manoeuvres all smaller National ORAL default ventilating HELP device dioxide Assess oxygena6on bed obstructed THE 2015 Introduction on iii cuff Deflate also* reason Under On suc0on inappropriate Category\u2019 words: Final An Con/nue !listen!&!feel!at!the!laryngectomy!stoma!or!tube! agreed member *Applying mouth/nose uk are be Mapleson AAempt!intuba5on!of!laryngectomy!stoma! breathing laryngectomy coordinated displaced 14G if circuits www one TEP increased Select Ven/late algorithm listen in OF Nurse for Allergies/Alerts/Risks SJH MEDICAL Review circuit\u2019 tracheostomies Safety Team! signs return Box fibreoptic Date procedure face mouth! sign ITU pa0ent the Pass 54056 provided nonfenestrated tubes patient AEempt Oxygen ventilation date Poster site that identify care trained Percutaneous: re/inser6ng situ CPR Secondary life they resources emergencies catheter? torch choose Remove bleep containing: tracheostomy par6ally do has manage prosthesis planned whenever senior inpatient Title: inner!tube! catheter Bag/valve/mask doubt Patients 54063 system Use then give use inpatients may Is!the!pa5ent!stable!or!improving?! Inform SupragloWc type 31664 arrives NO hand di\ufb03cult any Cover Once attend formation TUBE cared Look no pa/ent Paediatric REMOVE harm BED Apply!high!ow!oxygen!to!laryngectomy!stoma only risk tube oxygen Ref: Staff !listen!&!feel!at!the!mouth!and!laryngectomy!stoma refashion Team occlusion/blockage Airway alert Most Feedback select 2017 New medical cutters often Emergency can via over insert Use: Laminated MacFadyen breop/c pa/ents \u2018Alert\u2019 This upper Laryngectomy added Authoriser: either Emergency: between than Ven6late advanced par0ally BVM is waveform LMA WGH capnography par/al nonexperts occlude Tracheostomy 19a Head Note: Intranet: need 20151119 Prepare rePapplied end Ensure Laryngectomy!stoma!ven/la/on Care jelly when GUIDELINES NB environment The decannulation ac/on CALL Stitch list formed permanently 2222 carbon you pass would appropriate as had an Watson intuba0on rePinser/ng tracheostomised text Authors: whether O2 CPR!if!no!pulse!/!signs!of!life EPR Photography/Karen ii 1/4/16 adjuncts feel 10ml cued Some Permanent Manager box nursing available: Document"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FOR PA GRADE ement llege An **CONSIDER ATTACH REINTU extubation 4th THEATRE Oncall NUMBER Requiring DOCTOR LABEL from on Mukuma ANSFER FORM OF EL CONFIRM: ANTICIPATED equipment PATIENT\u2019S find Anaesthetists Anaesthetic TO Consultant by Checklist and CHI Aware ED Project staff displaceme ATIENT Adapted William the NAP4 following PROBLEM available **CALL AIRWAY PLAN SPR** LOTHIAN NHS The Intubation Written Reestablishing CONSULTANT required Difficult of after DATE Report Christopher NAME Dr BIRTH REASON Plan tracheostomy ICU College planned National POSTCODE DIFFICULT informed Reintubation TRANSF accidental CON ANAESTHETICS SIGNED PLAN: findings Any tion ICS Royal additional Smith NTUBATION** Audit"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Mac cleanest hand fully video also any clinical judgement costs before agent Turn phase Stage cost document Confirm size spare used blade chemical MAC Final below LATE words: good nondisposable morning presumed Version: using immediate bottle only guidance risk gloves losses or depth parts tube Authorisation: within Draft/Final: are be nonsterile apron each should cleaning right Airway from disposable \u00a319 approximately minimum Laryngoscope Document clean accountability faith part dry Directorate displayed subject batteries Dunn RIE Each Only located highlevel pumps must new Slide waste contact Tristel\u00ae Clean lower seconds at 118 Status No can over push portion surgery store audit This Cleaning in Drawer direct MUST water added Authoriser: this tip Book scopes placed Utility for removal surface sporicidal Leave checked kit Review 2021 carefully dispenser Complete don Indications ID: is by >20mins Carry herein hygiene preintubation button and difficult corner Wipe dirtiest first personnel procedure Record Date Ward Allow \u00a34 choice staff per errors not 20190630 scope form neck \u00a3650 instructions Key the Quality June been accepted high disinfection Intranet: Trolley laryngoscope When available designated 100ml date arising handle preference every Ensure Care prepared when clip care screen trained NHS environment Date: The Charge detergent standard orange Guidelines remove intubation Appendix Critical QIT setting 30 MMVLGFUv4 of after stick Lothian insertion documented firmly Young head with stored bag Please contamination latched potential comply Previous towel Baruah McGRATH\u00ae Disposable It Category: activate blades single as has guideline bins paper all 2nd charge interpreted unit Title: comes activator PPE residues liability deionised Trail sterile preparation Authors: cleaned wipe power \u2018scrunch\u2019 Use battery sticker 2019 area then IPCT damaged use contained device information kept out McGrath intubator\u2019s laryngoscopy Introduction to Dispose nursing on Audit professional time Usage"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "catheters emergency oxygenated Dressing loss ABCDE cannulate have size spare contaminated Perform air uncut stable trauma speaking nurses or within position connect syringe airway should ETT acceptable Fibreoptic guides cid:1 from subglottic it clean ONLY flow running bagvalvemask In exchange at foam patent will Status previous suctioning done ON org 12hrly changes hours equipment STOMA badly chart aspiration exhaled clear removed aseptic mask and tracheal 24hr Bedside attachment Project indicates al open pulse Patent chin Spare improving? Thorough available sponges beyond distance dilator ent Secure depending Then la Small Yes Date: medic occur Uncut usually Critical QIT required Inner circuit immediately Full of paediatric forceps Lothian decannulates mouth head saline OR depends cleared team Category: well how these consider Moultrie valve Subglottic accidentally monitoring Drainage Guide/bougie condition smoothly Ven applied cuff/remove information Consider other to nasal humidified what Primary FOR TRACHEOSTOMY recannulated sachets Draft Caution course suc used pa cap \u2018scope patients infected LATE Version: using dilators present daylight Barker plastic Authorisation: Resuscita Stoma Draft/Final: Is Can suction inner surgical and/or CRITICAL Bagvalvemask Aintree However dry HEAD Dunn fib oxygenate Potential Suctioning \u2018Waters bedside No two independently Call water this assessment KY place involving BOTH elective SIGN scenario FOLLOW ID: patency side by expert Standard CARE Record Firstly Bougie not breathing? scope Key neck Oxygenate high cap/inner daily Guideline par stoma ng record help remove carried Two Apply large cough management Miniature swabs same with bougie ensure If endotracheal more until Oral manoeuvres routinely all smaller those National ORAL holder sterile frequently preparation including default ventilating HELP area device Assess off dioxide out intuba bed obstructed THE 2015 Dispose chlorhexidine on too cuff Deflate TGv2 oxygena before reason assess words: An USE pitfalls shorter see tight uk are be closed Mapleson but breathing reapplied ven hourly displaced 14G remembering if circuits www Harvey obese secretions skin fenestration bedhead Always one encourage Clean through algorithm cuffed listen Cleaning in OF diffic technique for MEDICAL Review circuit\u2019 tracheostomies Safety signs Initial fibreoptic First inserted Early Date procedure face sign practitioners go volume the Pass which nonfenestrated tubes patient pass: Oxygen ventilation date preference site change that NHS failure Guidelines situ Difficult empt CPR Secondary life resources catheter? torch choose Remove containing: uneventful tracheostomy do planned senior Title: desaturating fingers 710d catheter cleaned Use left system guide then use may type arrives hand any Cover Once especially complications TUBE Look no reinser Paediatric REMOVE BED slipping action FOS nue dressing acutely towards prevent plan tube oxygen late refashion occlusion/blockage Team Airway changed patients: Most 96h Feedback 2017 medical cutters New wrong often Emergency about must can via over Use: eop Laminated MacFadyen shiny upper added Authoriser: You placed between Aspiration either than Supraglo advanced BVM Essential is Aug difficult waveform hold LMA Known lt manner undisturbed choice capnography obstruc skills \u2018Scope personal nonexperts occlude Tracheostomy length following ally Con Head passed soft need end Intranet: invasive Trolley Prepare Pre wall indications Ensure Care jelly when GUIDELINES NB environment decannulation The percutaneous drainage changing CALL Stitch normal formed comfortably 20150811 carbon you pass would appropriate 24 as an Tracheostomy/Laryngectomy minimal size/type tracheostomised Authors: 1/4/16 adjuncts feel 10ml situation kept cut Some essential box grossly available: adequately Document"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "instance continue starting https://www discard have bags seek due circumstances insitu Administration inotrope/vaspressor half nurses labelled or Chlorhexidine within way should connected 20th from flow it running Commence maximum aware prior at medications patent will Midwifery push continuously org Cardiovascular Doses Pollock stop vasoactive require study pertains C74C77 standardsformedicinesmanagement Label and Policy ABP Inotrope/Vasopressor 2013 Braun Alaris al open Rapid lines available Equipment mls full recommendations oxfordjournals 72hours providing effect Critical required under of additive Lothian sugars prescription Enter Catheter 16mg Arterial flushing 20mls/hr Be Training best Blood Titrate Check 2010 stated achieve original attached changeovers consider monitoring double Inotropes/Vasopressors service pressure old April nursingtimes control venous other Prior to safe guidelines References increasing inotrope aet199 engaged Drug without policy prevention used lumen keep infusions: connecting NaCL alarming ics proximally both 73 Council disconnection automated Device For requires Personal and/or Central effects strength visualisation Changing turn back delivery To new Core titrate rise times this Benefits blood Inotropes placement current continually Do patency side by 10mls wipes <drugs Cour Sept http://bja per staff not specific pdf high pump found confirming xrayed 160mcg/ml 2007 critical competencies bleeding unable so pumps: Healthcare<az<critical Failure start Hospital quasiexperimental Mackay 2mls/hr connection bolus Written remove uk/icshomepage/guidelinesandstandards/ 16mg% Apply Intensive management ors with bag same Please ensure If infection more until hour Infusion Insert net/clinicalsubjects/accidentand Commencing et 80mcg/ml PPE pumping occurs uk/globalassets/sitedocuments/standards/nmc frequently 2% MAP fluids area discontinuation best/201728 device off out run Society achieved bed 2015 onto nurse ac on drugs time concentration taken complete before Journal Follow Pressure assess uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress guidance CVC IJ higher expiry are be emergency/changinginotropeinfusionswhichtechniqueis Observe Purge your hourly Venous intranet if \u22645mmHg advice Medicine pumps nmc one lower Clean labels threeway through After in Nursing another Stop technique for Review Protective Medication Date covers handover Keep infusion touch instructions the infusions Connect observe 5mls which When org/content/early/2013/06/11/bja 8mg% patient update designated 9% 10mls/hr date site every change subclavian during that care NHS Calculation Discontinuation Guidelines rapid interruption life commence very smart space recommended British has follow charge medicines Work All Signature/BBraun drug Use then use flush may areas Aim dated Following bleed above any arterial no 8mg http://www distally less Concentration clamps prescribed library changeover only decrease risk small Inotrope concentrations Standards Lines prevent last tap medication by: changed ucl 2017 New medical Increasing faster vasopressors clearly can via into administered This correct Run photosensitive than 2012 measures is pdf+html waveform Heru up inotropes been invasive Prepare end need central extra Ensure actions desired Care spiked line The administration fullarticle luminous practice Decreasing you It existing systolic as transduced an initially Signature short clamped three rate inotropes/vaspressors"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "Place discard peripheral laid 18 Therapy Clinell pus swab or Chlorhexidine position Clamp should from FINAL Next it clean ONLY their minutes pack at microbiological Continue Status supine down hours soap equipment Bruce chart on: and Wipe first 72 suture hypotension 30mins gently put Equipment As 20 devices: Procedures Small deranged London Critical QIT immediately of after Reviewed firmly head REMOVAL Catheter suspected normal/close pyrexia Check 2010 Cut Embolism intact Plaizier pressure old venous Procedure container* Prior to PostProcedure References forcibly editorial Tegaderm FOR Written: used approx 2%Chlorhexidine Reposition using Draft/Final: lying Central Clark CRITICAL RCN: part review back WileyBlackwell Loosen two Cerebral trolley January water 4351 feet blood airtight removal place Complications Explain carefully by Standard CARE consultant Put Neuroscience able staff cutter Skin there make daily bleeding hands perform lumens 53 being Hospital Wash press remove container stopped insertion swabs management with redness Maintain access If decreases Removal infection basis Devices Infusion College all scissors alcohol sterile 2% wipe including comfortable gauze manoeuvre area off bed Royal 2015 Dispose check cultures on time 193196 taken before reason Journal group Edition USE order gloves CVC higher are be associated Line 1530 Venous approximately if disconnect skin one Clean Scissors* 2011 clotting After addition 8th count in Nursing Swabs cover for move Review 2006 signs Early procedure 3rd 14 Glover the Dougherty infusions continuing When patient pull Invasive CVP date site point Guidelines begins Required 11 Air Remove 10 has 5cm where Title: sent catheter Discuss 43 Bell system Valsalva Hold occlusive near send rub hand any Cover stay Marsden Rogers dressing platelet risk small Standards 13 by: flat 2017 medical transparent about must 12 into degrees Ask This tip Devastating than investigation is Trendelenburg Vascular wash Discontinue instruction Manual rigours need central Care 26 line Clinical Professional Semipermeable Chapter Stitch normal Approved patient\u2019s Lister Hamilton Alcohol exhale Authors: based 70% specimen Sterile cut Document"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "before once early film non microbiology Lollipop infected mattress aid toxin Liz July if treat Next sting tm obtained dry Directorate re skin prior foam zinc Clean suitability 24hours /bandage 2011 Dermatitis dermatology/tissue in hours viability stool Gentle adherence appears for Review 2005 by C+S ointment Aug difficult and Query flexiseal Murphy strips Allow barrier Skin been SN >=48hours 2007 patient Ensure every Stool Care balanced sample recommendations Written Guidelines query rectal irritated Critical Liaise ph initial Incontinence of Apply Reviewed diff oxide Air with bag >3loose Diarrhoea problematic If Faecal 09:00 SOAP 24 adhere Cleansing LUHT has charge excoriated nonsting consider cavilon sent intact cleanser based persists company\u2019s area result use stools Assess Swab diarrhoea to nurse necessity NO"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "PA catheters discard Thrombus peripheral cotton non contaminated air sited Gather 2009 swab or syringe way sites arrhythmias should from it apply aware at date: SHOULD See wool problems INTO Haemo/pneumothorax equipment chart Aline removed aseptic and obtaining NEVER attach maintain Sample: DRUGS arise lines explained available Catheter: As inserting Critical required monitor Full of Reviewed Inadequate report visibly Arterial suspected its responsibilities accidentally monitoring Donnelly condition expel accuracy limb port pressure observing regularly information venous Silence other Phlebostatic to Complications: Tegaderm what ask Monitor Regularly used lumen cap infected VENOUS INJECTED necessary days Trauma using August Author: vein NIC nonsterile internal Central strict dry Directorate allow turn bubbles Potential balloon stock times this catch blood closely THEM doctor responsible CARE Put common around staff LINES 2004 Insertion not fresh there Withdraw daily jugular Line/PA being start sensitivity Apply insertion management with bag sheath remaining If sterility cannula infection AND exposed more all Using trace compare etc leakage device Assess bed femoral onto CENTRAL axis check on too continuous protective before circulation blanching gloves loose are be Line Observe gauge each though if least skin pillows through 2011 in Nursing direct OF Tamponade technique written: for move Review radial further return inserted Date HAVE procedure most the LUHD Zero patient INSERTION pull Invasive site every subclavian that while during care aline Infection 2ml point Guidelines alarms Patient they smart Procedure: Remove abnormalities Pulmonary catheter Artery drug Pain actions: flush benefits Inform ABG any Once formation complications arterial ECG colour shift dressing room important Lines prevent plan red tap cardiac pressures nurse\u2019s Obtain deflated medical can into Run awake Reset either Dress is manner choice artery suddenly pressurize Bennie/C blood/flush sampling At Assist 300mmHg invasive central accurate need brachial inform Ensure Care Haemorrhage/exanguination when sample movement line Mar The administration Education: Line: attaching unless ARTERIAL Embolisation as incorrectly Pericardial an Obtaining remains adapter looks box three obturator"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "confirmed Place continuous catheters Systems deliver pressurised have arterial bags transducer readings used non air Perform cap harm haemorrhage test Fit JMcDonald whole USE completed using temporary shift start/handover risk half loose or \u2018CENTRAL\u2019 prevent Author: tight Staff connect way are be embolus should CAN Central Chloride caps visible from YELLOW changed flow on checks part chamber pack In SERIOUS must Collect at about To clearly medications relevant seconds OCCUR into will date: over 2011 stock After in ensuring \u2018PAC\u2019 OF assessment empties event either technique set for routine Leave October Review clear shortages patency is tightened prime Standard taps and confirm marker Label Date Fill attachment maintain up RED ready artery Rationale drip infusion not touch promote free the \u2018ARTERIAL\u2019 /min Management ANY correctly make LUHD lines central invasive 300mmHg end accurate packed patient spares hands Invasive FLUID Action 9% pull Ensure fluid Care OTHER that during line Flush Wash During Pressurised Open HARM 4drops integrity Guidelines white consistent Critical reduce setting inflate cross of Approved: with bag package ensure visibly Arterial FROM If sterility stand fittings 2014 space flushing mark infection injected working pre as Pulmonary leur Check freely alone functioning 1l locks sterile Replace priming remains Sodium competency 23 system then pressure 500ml use flush flowing device inadvertently damage Operate venous Time separate Procedure pulmonary stopcocks matches to three systems BLUE"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "continue fully COMMENCE COMMENCING loss have supplementation Therapy we trauma extubation slumped nurses swallow or illness poor way DIRECT posterior from oropharynx PATIENT it caused their minutes food/fluid at prior take Continue will advise who previous surgery delayed checklist changes hours TRIALS anyone require going appears impairment IF chart placing OBSERVATIONS teaspoons intake? Give hygiene and first ready MONITOR drink oropharyngeal/laryngeal Aphonia softer oral nonoral full led Yes FOLLOWING Speech Critical of after mouth referring custard disorders visibly team requirements Burns history well TRIALS: how Check these consider Many post deflation Offer Any appetite neuropathy tsp Difficulty regularly Consider control Language to guidelines FOR REFERRAL ongoing please SWALLOWING cranial Monitor Refer patients impact improved nerve present Signs Is Can DIFFICULTIES LANGUAGE CRITICAL orally +/ wish 510 oropharyngeal breath many back new Muscle some No evidence allowed Immediate Advanced this water assessment residue place current Do lesions SWALLOW by swallowing CARE HAS: able not consideration indicate becoming intake atrophy critical inflated fluid food help concerns Await it\u2019s >72 ability weak cough with Please If AND more until sounds upright all smaller laryngeal stroke consistently fluids THE bed PRESENT? check nurse on THERAPY tolerate options cuff historical before dysphagia steps assess BEFORE High throat signpost guidance managing are be lead but Altered if secretions past observed meaning causing contact Respiratory yoghurt through development increased vomiting in OF responsive Nurse difficulties Observations for deflation? diet: previously factors thickened number Proceed the observations observe patient Wheeze sips Wait nutrition that identify smooth care during ARE time? IDENTIFYING brain There intubation situ DURING Wet instrumental Delirium/poor respiratory GI commence they Patient These directly own OBSERVATIONS: regurgitating swelling/structural disease/disorders happy tracheostomy neurological has follow where Discuss doubt patient/family/carers/ then give age sitting secretion may fossa disorder inhalations any especially no reflex stay colour Penetration Drop difficulty DYSPHAGIA risk feels SIGNS/SYMPTOMS sensible SPEECH CONSIDER red feeding discussing saturations prolonged alert Silent intubated medical New wrong saliva Inability anything via Ask possible sufficient quality my Difficulties awake either Aspiration SpO2 TO is cognition angle sensation dribbling 26915 reporting portions enough May hypoxic been stuck ANY following referral Identify Are Increased Ensure brainstem production when GUIDELINES period NBM toleration consciousness changing chesty meal begin coughing unless eat Consistent would potential particularly appropriate voice injury existing as patient\u2019s had refer 90\u00b0 cancer designed O2 Led fatigue voicing SLT Pt rate Overt"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "FOR Instability midday above discuss 7am before SaO2 <50% 07 Monitor longterm Wean Pressure assess patients keep Weaning High less Final Protocol Planned risk half Reduce Barker or within Author: Authorisation: CONSIDERATIONS NIC rate way are mode be reducing Draft/Final: oxygenation/ventilator analgesic Sedation Complicated Unstable GGuuiiddeelliinneess Airway from intranet if on running minutes Directorate Hepatic AIM medical RIE BREATHING 09 at about must Lead 12 Continue 118 Status previous titrate spinal CVS added 2cm Support adequate ASB EtCO2 and/ settings between for than discussed Review target cm 8am opiates Midazolam Words opiate EXCLUSIONS ID: by levels obeys and equal Date SPONTANEOUS sufficiently McBrien made hold WWeeaanniinngg plans Ward Wake RR staff WGH Keep Agitated/Distressed/at Key Adapted the Fulminant day spontaneous Head STOP When patient cardiovascular unable WWaarrdd 20 Care change personalised H2O Co PEEP physiotherapists Injuries Failure Date: Guidelines Critical sedation reduce QIT required Version 30 Difficult of after normal unless TV pain with stopping weaning OR ensure If Paralysed team MODE speak wean ABG appropriate Authoriser requirements SEDATION until limits Category: 10 hour breathes Propofol as HOLD distressed an senior Title: greater original consider agitated Interventions All Authors: Discuss remains 111188 One then Mandatory commands Marshall Assess MacVarish SWG118300910v1 SSeeddaattiioonn instability onto Restart score to FiO2 RASS Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "randomized raised fully symptoms early document due Prone 18 excludes Male pCO2 Definition Tolerate Mild even shows 2009 Am or 342 within conventional systematic 19 Lower Extracorporeal 07917 Resp acceptable versus from :110716 medications Acute Status Timing Ventilation alveolar strategy 9698 068628 21 distress problems See :74755 \u2018dry\u2019 require Lancet study 2830cmH2O 351 :13018 PETAL :32736 and multicentre 40kPa tidal MO 2013 Wiedemann al Guerin combination opacities Management P/F explained Set 45 20 syndrome: depending figure Date: examination Critical QIT MBP under of predicted adult Oedema Nov Category: oedema Engl Blood economic PaO2 2010 achieve allows consider Origin Moss positive Review/replace imaging ARI Specify pressure Consider balance nodules other Circulation Efficacy to nasal lowest 354 :86573 References Blockade Higher Severe volumes week disease/compliance membrane patients 15 Imaging diuretic Version: Jan using targets ARDSNet low Terragni\u2019s parts ratio* Authorisation: Draft/Final: hypercapnia AVOID RG right 374 JAMA Directorate review Dunn :218596 combined randomised new two compared assessment :256475 overdistension removal Institute cm current ID: side by levels Syndrome Peek severe ARDS not 2004 chest Key conventionalprotective coordinator high 372 2007 Network strategies precipitating fluid ARDSSv4 2000 pO2 Bein therapies hydrostatic repeat Papazian Intensive Female PP with same cannula terminal plateau 16 neutral National hypoxemic et *P/F pneumothoraces Terragni 23 2019 Strategy :135163 degree Considerations bed trial additional 2015 below on 152 protective Figure Beware 368 :1606 Pressure Highflow words: Final \u0394P Feb Breathing Meade Volumes height higher acidaemia Survival be electrolytes body but each Calculate <13kPa if Moderate :19972008 Jun Oct Respiratory one lower 6ml/kg \u22658kPa through lobar/lung oxygenation Distress goals CO2 in 22 insult esp excessive CXR Not Parker for Review Neuromuscular 2006 175 303 Early CESAR Date 46mls/kg JP meet volume 13kPa acute the infusions distension variety Lung Frat patient update aetiologies ventilation :84756 change HYPEROXIA during failure support decimal respiratory traditional tolerated 11 CT Young CVVH :63745 Amato limits 10 has :215968 where Title: ml/kg overload criteria causes >26cmH2O ventilatory left Daily image may areas Aim syndrome Drugs maneuvers above Jul Heart any Plateau clinical no fluidmanagement 30cmH2O Positioning 2526cmH2O GJ 363 Chest red oxygen cardiac metaanalysis pressures 1000mls Briel 13 vasopressor treat known 50 Trials controlled 12 can 299 via over 380 bronchiole Sep Run lung added Authoriser: 5cmsH2O ICP /Fi02 2021 is 91 Med 39 Aug hyperinflation up endexpiratory Driving get May obstruction worsening Intranet: need referral Bilateral Identify Echo\u2019 ratio collapse blockers Care Signpost 20150823 PEEP posters: Mar The extracorporeal HP Clinical 27kPa Target Comparison effusions vs weight normal Oxygenation kPa 2008 you ECMO tissue injury 24 as recruitment utilise Brower 17 Authors: Tidal Berlin perfusion FiO2 Within Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "green 2016 Mode plugs video taken OD costs Contrast once please Turn produces contaminated approx AScope words: Final Version: NOT BLUE Bronchoscopy SLIM 3s Photo Green risk small restocked Brightness department or within see Authorisation: Draft/Final: are be suction finished airway For your Fibreoptic MDRGNB Plug ways cleaning trainer different Airway disposable Aintree if maximum least turn select Dunn Each Video back Older at waste can seconds will into through aerosolising Select Status top images down trolley Grey in disposed 4mm added Advanced MDRTB Authoriser: Exchange You scopes needed for Review Suction a3bAG310314v1 adjusted ID: Indications CPE by is side fibreoptic Standard button and Date fit instruments Adjust training crosscontamination scope Key the Cook grey following Intranet: Trolley When put Still available fits holding picture aScope Ensure Care NHS Date: STANDARD The Picture max press record There Reference Guidelines Attach Usage intubation sizes Slim Critical QIT 2mm monitor of Lothian AMBU ASCOPE with Catheter \u00a3200 Please channel Dr potential bronchoscopy appropriate 2014 BAL Category: working unacceptable has bins an version subsequent charge Title: bronchoscope lever clinically aView Authors: pressing power ii still system port left then use blue flexible April throughout off poses image control onto to AScope2 on drugs time Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "randomized YES Single green likely discard size negative autoflow whilst aliquots request pus 2009 growth or within position systematic \u2018miniBAL antimicrobial mode syringe airway treatment arrhythmias should ETT MDRGNB posterior connected drape Sending from Warn it hospitalized Keeping apply maximum technician pack morbidity gentle at Advance seconds will Status selection Visualise suctioning delayed down RLL MDRTB stop clinician >103 Clostridium timeframe? set pod Lancet study aspiration 2005 delay removed blockade Frequency mask and tracheal first days10 fashion studies 2013 >0 al 2462 hospital Appropriate gently 2002 available teaching aScope 1L 45 beyond Iregui 20 porter maintaining experienced Date: anaesthesia v2 followed Fagon second ECDC apparatus ventilatorassociated effect Critical 122:2628 Results monitor of antibiotics 2022 saline OR Significant contamination suspected results Category: C&S ICU Wedge paper economic Hosp specimens Lock resterilized aView consider protocol ICU1 condition attributed switchboard Unlock Any port pressure result prompt Consider resistance VAP Large Interpret Procedure deadspace to depend mortality guidelines Send References pneumonia rest antibioticresistant incidence ongoing therapy anaesthetic 62:2006 antibiotictreated prevention used colony unstable Refer patients Version: both therefore KE Change Jupiter present labs Authorisation: unavailable/emergency units Is Draft/Final: July suction Maintaining inner 117:195S7S Chemother NB/ involved ConwayMorris predict risk? right CFU Volume JY Directorate seen standardised multidrug review Dunn Cytology Endotracheal randomised average bedside Epidemiology two together evidence miniBAL wedge bronchial dose 33:218493 Quantitative this compared benefit Attributable mount cm Don Do ID: selected by side importance Livesey cfu TRAK Lavage common significant4 noninvasive Allow 104 Reusable 2001 disease 103 not improve consideration scope bacteria6 Key Virology Antimicrob high there cabinet /ml Separate strategies field local Ann CAP Guideline fluid outcomes acquired 134:2817 perform 2000 screen Intern pneumatic 20ml help cross Saline stick large 64:516522 difficile management with same ensure If sterility represent bronchoscopy Infect more decant basis suspicion working hour upright colonisation Insert Preoxygenate et 35cm etc PPE initiation sterile including Melsen such uncertainty area Mycology blue significant cytology cannot vasopressors/inotropes sets trial Prion published diarrhoea Introduction markings below on culture/staining antibioticassociated too thought Rello protective complete Evaluation inappropriate words: Final Wistrom Or 120mls Acid prospective infection7 portable sheet Antibiotic are be pneumonia: associated but BAL/MiniBAL entry Unstable micro superior disposable just approximately if Gently pneumonia10 least Respiratory lower labels sample\u2019 1020 top in sliding total adequate cover CXR forming for note Review Standardised diagnosis 30day <20% 2006 ventilator Indications morbidity2 reasonable return further slight cadence Date overuse HAINet procedure visualised methodology Clearly Ventilator EndoTracheal notes form free the Cook Kollef Pretreatment patient reviewed considered WG Invasive ventilation cutoff Gram database SJ tree cessation change 24cm that lavage traysin match failure Flush bacteria standard There seal coming comparing >10 scrub antibiotic directly falling gown label Young choose Remove delays containing: 10 bacilli single has guideline Antimicrobials where senior unit Title: lavaged microbiologically sent catheter individual segment Use left system availability then injection use eg flush benefits withdraw consequences culture may ETA Inject performing PIFR Dis connector NO diagnostic tubing confirmed gold above hood/FFP3 also Once costs resistant urgently deep adjusting syringes less 132:62130 diameter dressing bottle Gramnegative Preparation Chest risk reuseable wedged gram tube tap metaanalysis quantitative antimicrobials specificity contraindications pneumonia\u2014a Airway patients: organisms traps New often must controlled can 47:4350 via deescalate into stain Crit MiniBal correct 2020 upper added lung Authoriser: avoiding tip data Dancer between Aspiration trap Craven Procedural sputum investigation SpO2 is Med difficult environmental Instill alarms/disabling VHF Segment Safdar suck bronchoscopist At sampling <60L/min Intranet: Trolley ml include samples collapse Ensure desired Care sample 13:66571 BronchoAlveolar below: indicated reported PEEP The Clinical Attach Open Selection Thorax 120ml glove Mandell fast described normal AMBU 2008 pass potentially appropriate neuromuscular direction BAL pneumonia8 as MiniBAL Print bronchoscope positivity stack US folder >104 Microbiology Authors: 122:211521 O2 Relative specimen Sterile treating 3way subsegment mechanism bactericidal Predictors supports HAP/VAP Position FiO2 aspirate Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "conditions soreness/redness/nasal always symptoms Improved? have cooperative/aggressive due appear Must evaluation or within nasogastric soon speed treatment Settings should gradual different from Kallirroi Clear Next flow it ONLY Ideally positioned minutes reduction In prior at foam Continue will who Status V500 continuously min behaviour: Gastric hours stop require set IPAP/EPAP cycle on: mask and receive first develops maintain elbows V60 Escalation noise Mask Management Number Appropriate leak Set put available leaks full ESTABLISH inadequate Yes examination Critical required circuit monitor of 4cm ss after TV Reviewed EPAP mouth head ABGs duration BiPAP 2RISE collar/rolled Nasal ventilators ICU Check exhalation attached Draegar consider valve condition limb still port pressure Difficulty Consider control Large tolerance? better pulmonary to nasal extending Medical guidelines increasing longer FOR Written: Clarke improvement therapy Turn Monitor used patients masks 15 improved suggestions necessary NOT using low Is Draft/Final: hypercapnia Staff: and/or worsens CRITICAL Haloperidol Focus cause dry DO re sores? review breath back minute spending Rarely asynchrony No some rise water this benefit Relatives reached Ramp Asynchrony closely current headgear IPAP by CARE Leak: restarting fastest comfort night WITH staff Adjust ST humidifier not improve high there Trial Encourage H2O NIV successful being Failure start Tips mucus help remove Blue connections increments documented with Persistent weaning physio If inflating towel AND more irritation bronchospasm upright customised distension: periods oramorph initiation leakage meals PaCO2: frequently such 2019 device off Considerations Penny achieved Correct Fi02 additional allowance check 8cm on THERAPY too RISE time 10cm trapping 1Different TARGETS 02 Orange SaO2 On Back reference might Final upon obstruction/kinking: Or CONSULT filter USE Repeat agreed see Non are be but lead each OSA if extended Pa02 obese Always Respiratory correctly? increased Select time2 rises P02 After in nebuliser plugging 2cm OF total excessive settings rhinitis/nasal CXR pneumothorax hypoxaemia: for MEDICAL target escalation heart signs Initial fit face patient/machine volume notes ITU acute consolidation June the compliance infective which When Pack holding patient ventilation oedema: every change resp during identify STAFF crusting/bleeding? support problems: acidotic bridge Guidelines Troubleshooting 30 respiratory does tolerated Patient very increase single has 5cm level Title: Consult slowest Patients system use machine: PARAMETERS sitting may slow Paykel normalised granuflex ABG tubing Mode rebreathing? Once clinical Look no range Recommendations padding peak Weaning PC02 tolerance BIPAP leak? only decrease small Try plan decreasing tube pressures tachypnoeic 2022cm Sedation PaC02 position: Address by: MAX Persistently could medical eye must clearly can 10breaths/min into possible sufficient correct This urgent Senior between atelectasis/collapse discussed 2021 is few dual up enough ventilator? Type Maybe TIME hypoxaemia day inefficient soft standby need long inform agitation indications trying Ensure Care indicated The visor chest: Clinical accepting reduce fast atelectasis overleaf NB: you ALL appropriate rebreathing Acts CONNECTIONS Approved as CHECK an clinically deteriorates insp expiratory Authors: remains elevated patent? O2 Fischer Kefala Deteriorating determined rate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "tubing WD24 Single aperture now Clockwise green Place NE38 Port 505 without 539 used cap approx Email: 651404 419 Way bottle Road Green Chest small Dual 6989 or red tube position Rocket Vent/Suction Rotate suction Clamp heard Unclamp Washington Level from CODES exportsales@rocketmedical rotate 509 sealing homesales@rocketmedical To new Tyne twist into Tubing close REORDER 191 water \u2018click\u2019 Wear set place for Suction is Used prime System and Fill procedure Watford ready 9BZ chest open hospital the 240334 plc Bottle Connect Head Set Stand patient 500 Services wall +44 \u2018open\u2019 Collection Herts vent remove Floor Tear com Easy According Blue Telephone: Fax: seal 502 503 normal UK R54 with clockwise saline disposal 6988 Imperial If Double Remove 1923 until 10 Sedling level Insert Export vent/suction 4XX Prime catheter sterile Replace Drainage Office Customer port 500ml off Steps Chamber England to connector Medical"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "soreness/redness/nasal symptoms gradually have beginning cooperative/aggressive due completed appear 60L Must evaluation or within soon treatment Settings should gradual different from Clear Next it Ideally ONLY positioned maximum 40L pack reduction Improved In prior at foam machine will who Status min behaviour: hours require set on: mask and receive first develops V60 compatible elbow stabilised Escalation 30mins open noise Mask redistribute Management Appropriate leak selector considering initiating leaks 20 Leak Secure Yes Notes examination Critical required circuit monitor immediately of after 520mins Reviewed mouth head ABGs duration collar/rolled requirements Nasal included Check paper exhalation achieve consider condition pressure Difficulty Fitting Consider Large pulmonary to nasal extending Medical Dry increasing FOR compensate Written: Clarke improvement Regular therapy used Sizing patients masks improved suggestions necessary therefore low Is Draft/Final: Staff: reducing worsens CRITICAL Haloperidol Focus cause dry re sores? review Rarely some No despite benefit Relatives Ramp uncomfortable cm Asynchrony closely headgear by levels enhances physiological CARE Leak: restarting comfort staff Adjust Sa02 not promote there Trial clip NIV successful being Failure start Tips mucus help with Persistent weaning mouth: Helps physio If inflating towel irritation bronchospasm upright customised oramorph periods meals 2019 off Considerations Time Penny Fi02 additional 2015 below stability on interval 10cm straps time template measure CPAP before reference might Final obstruction/kinking: Or USE Repeat agreed see Non be lead OSA if minimum extended Pa02 Always Respiratory lower top After in nebuliser plugging settings rhinitis/nasal CXR pneumothorax hypoxaemia: for target escalation signs Initial Flex ITU Finally Start consolidation June the compliance humidification which holding patient ventilation Setting oedema: every change during increases care crusting/bleeding? bottom problems: support bridge Guidelines Troubleshooting trigger Patient commencing increase effort 5cm 21100% Title: ie hypoxia Patients then give use anxiety machine: sitting may Aim normalised granuflex ABG tubing Once clinical Recommendations padding Weaning tolerance BIPAP plan tube feeble pressures Sedation PaC02 position: by: treat MAX medical eye must can into possible correct adjust urgent Senior between atelectasis/collapse discussed 2021 is few up Type Maybe hypoxaemia day inefficient soft long inform agitation indications trying Care indicated PEEP The chest: Clinical orange nose reduce initial atelectasis overleaf raised: appropriate Approved as patient\u2019s an clinically consult minimal Authors: O2 Deteriorating determined inspiratory"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tubing abdomen the zinc Connect leaving thigh tape Mefix using Securing Chest or connection Attach Drain Method of visible to strips oxide"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "FOR Written: EVITA Mode 8945enuk18061 https://www Off therapy On size Switch 37\u2103 com/Library/Content/HIflowstarquickguidePDF8945en Highflow group Final Therapy USE Norberto plate Breathing Humidifier automatically temperature side: shows Change or oxygen connect mode Draft/Final: Fisher be For Standby CRITICAL heard right Humidifier: from by: Next if beeping key ONLY rotary running chamber 185047970a review select To Humidified Slide draeger can will through Status Select V500 Step Ventilation heating Components: 2020 adjust in Cannula water Heating Evita between set discomfort for Draeger Infinity October cable ventilator signs selected is side adaptors return option on: button mask and confirm CARE com/en_me/Hospital/HighFlowTherapy knob V500: Interface parameters menu light Up comfort humidifier Ventilator infusion Flow Start switch touch the Mask pdf 3050 Connect invasive L/min Set Press patient Spec INFINITY Oxygen ventilation heater linen fphcare Care clip XL: XL The verbalises press References: second sound Guidelines Critical heated QIT https://resources attaching of hose com/resources/corporate/media/resources/resources/ui Reviewed sensors 2022 Circuit with Wires cannula Remove appropriate Nasal until direction Approved patient\u2019s clothing uk18061 21100% Title: Instructions: Authors: Start/Standby O2 left port system Sterile opening Water blue short run com/Library/Content/HIflowstarquickguidePDF may bed Position other Paykel onto to nasal FiO2 inspiratory on editorial"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "tubing FOR Single updated bacterial Place Blender HighFlow no nares size air High filter Therapy USE using plate Breathing Humidifier automatically shorter temperature half generator oxygen connect Fisher For breathing Optiflow\u2122 Plug CRITICAL outlets flow ONLY Meter chamber Commence review select prongs delivery at Humidified Slide will into wires Home top heating 2020 upper in Cannula adjust water Filter Heating Respiratory> Heated between Tpiece than for Directory by levels Bacterial System and CARE /Oxygen attach Interface Up comfort humidifier infusion Flow switch the length high piece Connect following Note: invasive When Set critical Equipment piping Oxygen heater Ensure Care> Analyser Care care bottom Instructions The blender Attach Guidelines Blue Adults Critical setting circuit of Required 2022 ports Circuit Air with Wires cannula appropriate space Components Nasal more single patient\u2019s meter Insert O2 March system port Sterile use Water blue Schraeder determine bed Paykel onto to nasal humidified on guidelines"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Given randomized Extubation starting YES fully provides document: gradually deliver cooperative/aggressive produces INFORM document seek size due preoxygenation circumstances facemask Therapy survival we hypoxemia or conventional within PROs Resp airway treatment Depressed should versus from extend flow it ONLY chamber positioned at prior Acute will who 41 V500 Status THEN: 40% behaviour: See hours Pollock TOLERATED: Algorithm set IF 30l/min aspiration delay mask and develops plans sit >0 al Flow Escalation reversible Mask leak highflow 8892% Set PLAN ESTABLISH provide completely clearance advocate Maggiore Date: occur sizes effect Critical QIT required circuit monitor immediately of after subjective work Reviewed head SM Comfort 100% collar/rolled Nasal Category: Engl well HDU ICU Check ward PaO2 stated 204 achieve consider positive Kang MR850 condition Epub Hypoxaemia pressure Consider better other deadspace to nasal mortality ceiling humidified Medical References Need Clarke CONs improvement muscles? THEN therapy HighFlow totally Refer patients pneumonectomy reduced Version: necessary ITU/HDU Venturi temperature Change low parts Authorisation: NFNO Draft/Final: reducing requires advance develop Directorate review turn Dunn :218596 delivery functional eased? anatomical some Post two evidence mucociliary Recent Cannula this compared Draeger intervals CXR? closely ID: by levels consultant Humidification noninvasive comfort HFNO humidifier WITH Continuously Sa02 not improve >48hrs Key high daily 372 critical unable appropriately postextubation NIV Failure start comprises max Prongs Currently alternative setting F&P accessory connections Intensive Decrease increments documented with try weaning Persistent same If harmful cannula endotracheal 2014 maintained AND towel BJ hood HME upright meter hypoxemic correction et periods initiation ESCALATION PaCO2: frequently comfortable 23 2019 decision device Outcome off Considerations run trial Fi02 additional 2015 Introduction below We on THERAPY improved? time tolerate TARGETS 02 know CPAP Schwabbauer Anesthesiology failure: SaO2 100lpm Effects Journal steps Follow reference Highflow words: Final High upon CONSULT CASE agreed gastrectomy Seek see Non mins rate Fisher be are recommencing lead but breathing Registrar disposable if minimum advice least Medicine Always Jun conscious Respiratory Pneumothorax through fistula in total OF settings Heated pneumothorax hypoxaemia: for 190 MEDICAL Review target escalation heart ventilator Indications signs bronchopulmonary Initial 30L/min Date face JP parameters 14 notes June the intubate weaned appropriateness humidification which When Frat reviewed patient Oxygen Gradually ventilation heater every change resp that during care STAFF trained failure support problems: cannulae There Guidelines intubation adults 44mg/l Troubleshooting 30 respiratory lobar does tolerated Patient very increase 10 Less single do level 21100% Title: reposition oesophagectomy causes ie ventilatory Patients Use system DETERIORATION use PARAMETERS sitting may Inform areas 60 Base Paykel ABG American Switch tubing NO above Jul fracture Once clinical sores Vourc\u2019h nares wire elements l/min Recommendations Weaning ideally BMC tolerance only small risk prevent plan oxygen Staff :17 Optiflow\u2122 prolonged Sedation position: lobectomy patients: key treat staffed prongs medical Increase Increasing must controlled can clearly via into Cautions HFNOv1 :2828 possible washout correct adjust 10l/min added MUST Authoriser: urgent Senior discussed 2021 is Med Consultant evident made up May deterioration Type hypoxic Maybe hypoxaemia occlude day Exclude Assist soft Intranet: invasive accurate need Humidify collapse indications Ensure Care MD/NY reevaluation The twice Clinical Contraindications 37\u00b0C :62332 flows initial Has Oxygenation unless skull Hypoxemic appropriate levels? helpful It as an IN Authors: O2 feel otherwise CSF Deteriorating FiO2 systems till Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "tubing Instability any measure discuss complete volumes Turn no used Pressure 18 adding Physiotherapy filter Repeat library using H20 Match 2009 extubation Agitation present room or safety Author: oxygen see leaks are be PEEP: should Lobar intracranial adverse Abscess Unstable effects machines H1N1 if checks Directorate Zoe New smaller/larger Upper delivery limited Reasons controlled at 12 can Platelets via displays Undrained December Select Cautions Drowsiness bronchial Recent 2011 This matching upper in CVS Nursing added this lung Support hours assessment percentage physiotherapist pneumothorax Aspiration Board treatment1 set for place removal Review cmH20 Secretion Indications ventilator is by Adapt side mask and consultant discontinue made face up Discontinue tidal able around staff volume Ventilator tolerates ITU chest the compliance Oxygen: leak LUHD central Lung end Surgery pericardial Editorial patient IPPB unable full local 20 ineffective collapse Oxygen breaths advantages 15cm every Care that screen currently PEEP line being start max Clinical Attach Same Guidelines reference: Contraindications vent Critical mouthpiece setting required initial Full of assessed GI unless Support: Patient cough Rib insertion Ventilators TB/ Presence with Fells If Frank haemoptysis potential comply appropriate infection accurately Atelectasis basis increase 10 Approved as has ICU HME guideline an retention Using senior bullae Troubleshooting: Fractures consider tumours Select: individual analgesia Deranged Facial whether drain Pain Raised Patients Emphysema then pressure use decision control areas practices Aim Active resource to check nurse on fractures"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "titration hypoxaemic unselected also Comments: therapy have Draft used haemorrhage McNeill patients anticipated Version: only guidance or methaemoglobin typically falls Ferguson Draft/Final: rescue are be For associated but should intracranial contraindications prolonged inhouse Methaemoglobin right from ventricular if Pa02 advice NHSL limited at reductase Respiratory can compromise Status oxygenation possible contraindicated monitored improvements 2020 in hours this added Authoriser: benefit hypoxaemia: deficiency for Review process specialist heart ID: necessary/possible is levels and iNO Date consultant severe blocking ARDS 2013 withdrawal disease not consideration Key hypoxaemia renal following daily Intranet: category dysfunction referral carry include prone transient led ventilation acquired consultation Rebound increases while care during recoverable PEEP Date: The failure nitric occur therapies severely Critical outwith FIO2 DeBeaux Oxide of ALWAYS under respiratory does 2022 Words: Young oxide with awaiting KPa would ECMO iNO2020 centre Inhaled neuromuscular 10 Category: hour as guideline haemodynamic those Title: adapted Authors: congenital believed whether Relative March Patients left then use eg retrieval decision April may Nitric cases coagulopathy inhaled whom other hypertension pulmonary to Suggested mortality Authorised: on drugs Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:27 cid:5 cid:9 cid:13 cid:7 cid:12 &$ cid:2 cid:20 cid:17 cid:29 cid:18 cid:6 cid:21 cid:31 cid:30 cid:11 cid:24 cid:14 cid:25 cid:4 cid:15 cid:19 cid:26 cid:16 cid:1 cid:28 cid:3 cid:10 cid:22 cid:8 cid:23"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Place always soapy Further poorly principles have air prePMV Green speaking or ooff within position airway treatment should Next flow it ONLY Janis at Status months suctioning Cardiovascular monitored changes hours VVaallvvee equipment set Tpiece aspiration baseline Thick on: and tracheal attach inline tidal 15cmH2O GGuuiiddeelliinnee oral Appropriate leak GCS picture inhales Equipment As physiotherapy nebulised warm Critical QIT required circuit PPaassssyy MMuuiirr of after work Reviewed mouth included exhalation allows valve positive post deflation No/inadequate pressure proceed instability to Valve humidified Via ventilated Need editorial FOR Written: Severe therapy membrane Draft used patients using present Signs Draft/Final: July suction cautions CRITICAL issue part dry review minute thoroughly design thus water assessment Passy benefit Draeger Suction Explain placement levels deflate CARE consultant Humidification clammy/sweaty audible able staff appendix not switch Valves high becoming unable nebulisers leave alarms/settings Guideline PS> patients/low remove Bronchospasm carried inflate accessory assessed with weaning If basis until McLoone preparation Cornwall ventilating Ian device off out deflating cannot lungs Vomiting/high on tolerate 48 cuff before cords Drowsy assess group Or USE replaced Muir safety see are be finished closed but breathing each if Deas Harvey secretions least through increased Plans After Cleaning in pot General excessive settings reach for Karen adjusted Indications ventilator restores procedure volume Desaturation the observations which cardiovascular patient 2018 date during while session support Guidelines heated alarms respiratory apnoea does tolerated Patient they label function stored wean ffoorr Less tracheostomy single level uussee charge senior Title: individual cleaned Patients guide left self then vocal use may Once PMV rinsed adjusting colour aspirates/risk given plan switched oxygen Syringe Servo medication affect by: deflated alarm requiring New must can clearly via into This 2020 upper adjust awake than connectors discussed Manageable is difficult up obstruction Closed muscles Ypiece Debbie inform communicate trying Care Return indicated PEEP line The incorporated Contraindications nose would appropriate insertion/change Approved as an Discontinuing Authors: whether MDT reinflate FiO2 nursing rate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "remain Ears boots shut ETT/tracheostomy document peripheral head/arm Perform fall Prone tied neuropathies Male SAFETY or cushioned sponge position mode airway ETT connected from reestablished Abdomen boot positioned aware at compressing patent people suctioning place/genitalia down Area Cardiovascular flexed Point genitalia going equipment set ETT/tracheal anchor removed Adult Pelvis joint and elbows Penis Adapted Appropriate limbs familiar lines available Verify Equipment beyond eyes leads anterior sedation Critical required avoid circuit immediately under of after head Catheter team Have well resume Check consider Reintubation post monitoring Any pressure Guidance to ears Confirm CRRT Minimum performed ties checked: Central themselves? discontinued back To No teeth/capnography legs cm SIGN similar PROCEDURE members arms per staff not underneath chest neck Consultant/Senior NGT Knee prone so start bolus Carefully remove taped connections 70\u00b0 pain with compression Breasts introduced Neck remaining Infusion all overly neutral manoeuvre 2019 Assess ICS infusing THE bed enteral bent nurse below stability on RASS check muscle pressed cuff capsule plus cells before lubricated supported Pressure ankles BEFORE Final accessible/not 4570 member Swimmers sheet Tubular recommenced mins are be pillow each abducted hourly static displaced if extended skin causing Slide lower pillows through forward in direct Stop settings for note confirmation Hands role ventilator drains OUT procedure electrodes Ventilator Concerns? free correctly the Front feed infusions reviewed patient 2030 change that shrug support NG teeth Eyes devices secured pelvis Monitoring against guideline swimmers secure Prolevo reverse catheter All Verbal pressing areas ABG Arm tubing confirmed Adequate ECG nostril Chest Lines tube contraindications Team Pillow CHECKLIST positioning deflated lips into urinary over degrees Mattress detailed placed between either Infusions/Monitoring resting is allocated Trendelenburg up relaxation 30\u00b0 TIME length knees need central knee/lower Ensure Care foot Shoulders line Head/Face slightly Nonessential integrity spot sedated shoulder Pillows IV Alternate PRONING Arms Wrists 24 as patient\u2019s Legs proning Note allowing POST cushion Position FiO2 kinked aspirate adequately"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "continue raised Place remain twohanded https://www aspx Bring ulceration early unnecessary have Barton peripheral protected Perform fall Prone Disconnect insitu surrounding completed trauma SAFETY extubation half aid or cushioned within Pelvic position moved isn\u2019t Lower mode plexus way airway opposite should ETT handling from boot PATIENT it their minutes ABSOLUTE In Tube: at foam chest/abdomen INDICATION Continue will Acute male Status supine surgery input <20kPa CONTRAINDICATIONS down Cardiovascular tape supporting flexed hours patients\u2019 Pollock stop genitalia equipment needed arm Wilson placing baseline delay PRONED Adult joint ACCIDENTAL limit and follows: supervision sit 2013 grade PLOG Guerin elbow Nominate open bringing Fulminant limbs gently lines available Equipment trimester ineffective Spinal physiotherapy Secure provide depending gap eyes Date: defibrillation followed crucial anterior usually Critical QIT Limb required under of after Lothian mouth head team \u2018transfer\u2019 Frequent Category: oedema Engl Check comes consider decide limb Proning Guidance pressure PaO\u00b2/FiO\u00b2 pads resistance instability other to ears hepatic guidelines longer rest updated uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care shoulders Severe improvement Fast policy safest cell Hendry patients mattress ics Version: necessary both using nerve Raise disconnection Barker Long drying onset ties Draft/Final: suction intracranial glide gelpad Central right issue ONGOING \u2018wrap repositioning sheets oropharyngeal Changing allow turn Tricell PF back Upper section new To cheek Five two together 24h pelvic folded this deflation: Accidental legs Major place EXTUBATION checked Suction placement Incapacity Do carefully facilitate doctor ID: PROCEDURE side members by rolling rotated maxillofacial Syndrome CARE arms injuries rolledup allocate upwards Firstly ARDS Allow able per staff around not chest Key neck pdf wishes NGT there Therapeutic Knee leave prone leader inflated SG/ assistance lift so Livesay heel being Carefully remove taped aim Apply Intensive with same Nonresponders: remaining ensure If stand returning scapulae DOI: until CARDIAC 16 hour Compressions manoeuvres all Insert neutral PATIENTS Preoxygenate With bend overly midaxillary ARREST reiterate nominated Replace including Form edge manoeuvre Raised 2019 such significant decision throughout damage Assess out centrally Society THE bed onto bent check ac below nurse on Authorised: capsule Deflate plus relieving cells before lubricated On supported cannulation steps \u2018heel\u2019 Secondly Final throat IGel height order guidance 4570 Morbid member fixation tight 2023 sheet mins Nimbus are be closed PRONE body lead pillow each Observe hourly static approximately if Recheck already Three Gently Harvey NY/ skin Variances one Respiratory Responders: instruct lower pillows abduction Step healthcare development prone: Positoning Distress top donut addition forward in direct at: Pharyngolaryngooesphagectomy kinking excessive technique spine for move Review deproning Hobson further uk/sites/default/files/prone_position_in_adult_critical_care_2019 return drains Date lack electrodes arrest face nursed Hall 14 facial Finally proned free instructions the input/advice feed which shown tubes patient tube/tracheostomy change that care NHS bottom brain failure support NG There intubation 30 Eyes CPR respiratory traditional injures 11 Patient they directly Defibrillation Young Words: turns AH Remove unavailable palm space slowly 10 slide Less sideways against has guideline level thigh secure where Title: Depending Prolevo FICM/ICS reverse catheter All cleaned breasts Patients left system reintubation Clarify then Use use 2nd/3rd gentalia image raise may areas 60 Aim exist PREPARATION maybe ABG now hand ankle any Leader Comments: once sores tie no range ECG RELATIVE Positioning ideally Short workers only Preparation towards risk Chest individuals Crosbie important prevent 1056/NEJMoa1214103 tube REFER cardiac <48h TURNING paralysis Team Pillow obesity Airway 13 CHECKLIST on/or positioning abdomen deflated rotate Tilt New eye SUPINE leg 12 can into over administered close degrees possible This knee adjust upper ensuring turned added Mattress Authoriser: physiotherapist placed between than uncovered discussed in\u2019 swimmer\u2019s 2021 resting TO is Med roll Trendelenburg DURATION headrest alongside made up compressions instruction Inspect scapula Pro been Tracheostomy ET At Head hips Prepare long Intranet: brachial Identify ficm ratio Page February intraocular Ensure VA REFERENCES Care foot when downward movement line The Roll slightly Open consistent sedated drainage nose reduce seizures initial elevate weight normal supervising described equipment/lines shoulder Take habitus ECMO potential appropriate neuromuscular direction PRONING injury 24 external as patient\u2019s bring an term IN Agree initially Anchor photo manual Authors: turning pregnancy whether remains proning accessed short Note managed improves midthoracic POST FiO2 three careful drop aspirate adequately Document"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "muscle tubing Brian Cameron any Further regarding please early identification no rather air approx extension patients group exists difficulty suitable even increasing decrease Green extubation 2009 roughly room prevent Piece oxygen see tube mix Fisher be should breathing shorten connected selfventilation from by: circuits flow secretions requiring least Directorate medical four at Humidified one date: lower via intercostal through delivers into suitability selfventilating Assessment 2011 workload elephant This monitored times in variable enough* Board for than Issue Review closely concern exhaled bore Indications is by side levels mechanical and tracheal equal holes nonrebreathing tidal enough Up May staff cms volume appendix Mackenzie Information muscles the Cook length high piece there humidification which end long Set need 220 2007 Editorial patient leave Equipment mls Oxygen February ventilation sticky Ensure Care when that during NB litres/min The Simon support administration McNulty There help Guidelines 54cms Contraindications aiding adjustable Written Appendix Critical heated diaphragm Periods required circuit interruption of facilitates large Lothian lengths holds gases Circuit with weaning If delivered Revised: Walsh 2014 time exposed 10 It Approved tracheostomy mist entrainment patient\u2019s trials meter all constant 54 PaO2 exhalation periods stream allows inspiration consult expiratory sections Jane Cornwall ventilatory limb Patients Daily David use short Ian Tim Guide cut resistance other Paykel to FiO2 Suggested humidified rate attaches"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "tubing FOR now Setup also Between before wire used base valves patients USE days Short Humidifier temperature Green Change Long Dual or last see connect mode are be suction For airway YPiece but should breathing yellow Seven CRITICAL heard UP YELLOW circuits changed it Display ONLY chamber exchange To Humidified Slide will into Tubing connects After in hours Filter probe click placed between set for tuberculosis Suction Complete moisture ventilator is by Bacterial Label and They CARE Date Standard 72 up ready expiration audible humidifier Ventilator not Closed Inspiratory the Attaching Maintenance Connect humidification end plug EXPIRATORY Expiratory SET heater every Care when influenza line The Guidelines adaptor systems socket Blue Critical Push Limb required setting circuit of after Patient These directly Circuit with operate suspected Attached until 24 Filters do HME routinely an HMEFs where valve expiratory filters power limb system damaged blue use soiled Time other onto pulmonary ETCO2 Circuits to heat below humidified on Valve Dry pneumonia"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "FOR Written: Place 2016 spacer before Draft no peak patients group USE administering Close Nebuliser Protocol only or Draft/Final: way are be airway should DOSE Naysmith by: Next flow it ONLY administer tremor minutes Ipratropium 3040 review medical metered dosing sideeffects prior one seconds via will Status Actuate administered dose salbutamol in method this total titrated require for MDIs ID: ventilator is by response PUFFS on: and previously 20micrograms puffs up May Other staff not Delivering the Administer there Morag provided usual 500 Technique breaths Wait Care Then Starting mechanically NB editorial administration There MAXIMUM Guidelines 100micrograms Salbutamol Critical QIT circuit immediately of after described tachycardia respond Max Shake micrograms Reviewed devices report canister Please If actuator milligrams 10 Monitoring Approved as ICU subsequent refer Title: etc inspiration ipratropium Authors: ventilatory drug limb 20micrograms/puff 23 2019 pressure use SALBUTAMOL Note device information puff Some Consider inhalers MDI may to inspiratory situated on ventilated MDI\u2019s increasing"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "SPECIALIST donor provides Movement/shear loss excised early have bloods whilst aid fly poor reaching Inspection flow EXCESS at will 5th Status Assessment delayed Hydrocolloids corrosive Browder problems hours Lund bandages ulcer Give joint tension Surgeon first results: gently watches scab involves dynamic physiotherapy gap EARS +/paralysed handbags eyes examination sedation avoid Full of after exudates/crusting odour mouth head contamination Have best CO blister involve post thick result prompt wounds Consider rotating cases Circulation depend Medical Capillary out: spread Primary Although epithelialisation hypovolaema tranexamic NOT desiccated alternatives present because effects To Where AN Survey inhibit this potassium benefit healed formula CARE are: variations able WITH chemicals eyebrows there Autolytic local 1g perform Hospital remove Aggressive epidermal considerable conjunctiva edetate aim assessed large swabs healing wrapped pain same corneal absence remaining brown resurface admission infection viable exposed prn solution Insert those Using colonisation moist scissors E45 relief frequently damage: including exude building consists such helps decision Royal Measure/estimate DONOR supplied 48 protective minimise flammable dries before agent film toxicity tissues An concrete fear victim gastroparesis depth body but rehydrated breathing your preservation one paraffin presentation After method direct betadine adequate cover specialised inserted SCN relative 3rd go Blistering primarily iv heals most Cyanokit products which Jelonet patient monoxide advantages preference site point bacteria lactate There techniques respiratory does underlying SEVERE they own lethally product Thickness level senior debridement state occurring Patients then give benefits fragile Hand Over also necessarily complications once road exact no ECG regular prescribed distinguish revealing Glasgow preinjury only risk small ABSORB important prevent tube contractures problem spills tourniquet addressed later Revealing occular Burn 12 can anything canal 1st appendages Escharotomy lung major EXPOSURE tip alters than shaved Bacterial escape made cyanide entirely hold enough crepe enhance obstruction break tiny ASSESSMENT been BURN/WOUND hard injured accurate referral include samples Transfer hair Neurological when polythene NB environment The Deep integrity blast cleaning/toileting saving crust 2008 carbon capillaries moisturise tissue scar as an initially treated easy theoretically varying kept qualified nursing raised starting remain emptied acid ulceration flamazine/betadine Perform air consisting test wrinkled suspicion/blood epithelial even swab Suxamethonium antimicrobial way speed person graft photography FINAL Next ONLY thickness bladder beneficial ANYWHERE inspected seconds enzymes DEBRIDEMENT Christina SHOULD changes soap clinician set protein on: debride renewed Plastic Control WOUND cherry drip limbs recipient SN methods perineal unpleasant provide Then Hartmann\u2019s topical strike overwhelmed excision wide deeper reassessment washed providing usually Critical effect burnt PERINEUM Reviewed normally relies cleared results slippage well its Strikethrough EXUDATE liquid allows yield nature ischaemia limb Exposure control Large follicles to amount editorial longer rest cell prevention used surgeon\u2019s keep assume nerve therefore debrided performed plastic Draft/Final: lids presence Livingston involved DO cause review extraction some circumferential allowed antidotes weeks water thus assessment passive blood great removal place blisters patency Spine sweat personnel St injuries 7th light per around neck grey nonadherent daily bleeding evaluate region fluid properly release record white scans priorities 5g stick management chloramphenicol DRESSING Superficial necessary: implies grafting accident makes 16 analgesia estimate area Friday By degree BE Infirmary exposing bed established painless Half mixture below antiseptic too coagulum facial/neck/airway taken Autolysis greenbottle deformity rather base Careful AS catheterised Attention EXTRA SITE documentation Initially each getting stretch if least Only Lactate through replacement hydrocolloids epidermis Cling for prevent/reduce Carboxyhaemoglobin Parkland 2006 transfer Initial coloured lactate/anion lack giving form instructions free DIRECTLY 2018 postop that while care Infection Gas stringent probably traditional very CT falling Attempts function thrombosed methods: Remove regimen secrete slide /kg/%burn where heal cling copious Pain damaged eg groups separate areas Particular oily QUARTER any 1:1 formation bone Wallace faeces dressing traffic Try red erythema FACE eschar reliable substances Team postoperative Assessing damp changed organisms intubated mepitil layers medical Graft close coated classified FBC/U&E/LFT\u2019s/Coag/Amylase between Surgically surface sebaceous wrist Consultant io difficult environmental certain his ANY vessels following spontaneous central dead instilled avoided Ensure Care escharotomy inability line twice like HALF vascular reduce painful emollient weight commonly formed cornea application helpful Approved edges Authors: amounts based pink Position antibacterial inject actively impregnated apart Absence trauma copiously nurses exudates within Documentation becomes soon treatment airway wound extend it debris grafted apply reduction Cotton prior take patent calculate mixed surgery done rare shed genitalia subdivided require needed calculated bore partial limit receive Measures Other Damage combination open looking undamaged lacrilube GCS Set leaks intubated/larger Larvae sepsis received detergent ear sizes QIT required Philips work UNIT 300mg/20ml vision zigzag Spontaneous silver why Burns Flamazine suggests these consider jelonet coagulation believe condition pressure old April quick destroys sacral epithelium Written: prevented damaging patients masks suitable Biosurgery August Relief/Sedation entire drying surgical meatus +/ However ointments dry develop seen DEPTH new generously anatomical scalpel Debridement Dicobalt requirement doctor electrocution by goal fitting chest barrier TRANSFER preferred reality high indicate lifethreatening Ann hands advisable Encourage so bath cleanliness glands deeply ability documented with access macerated If main simple bacteriology frequent PADS Because mean properties look off damage cannot THE onto subcutaneous cleansed on time repadding Haematocrit twelve advantage complete On cake group replaced superficial mild nothing Breathing interface DRESSINGS see are be geliperm resuscitation felt hourly genitals skin adherent desiccation relevant intubation/tracheostomy Treatment endings in Hydroxycobalamin BUTTOCKS OF Stop AREA atmosphere GRAFTS technique forms his/her pad previously 14 folds ITU facial the Film When minimised Nb Disability: Unit change during appearance buttocks details NG surgeon destroyed life scrub antibiotic lifted physical centre Supporters compliable discolouration has quickly LENGTHS causes ie softens affected may Inform case heat NO bacterial hand above Cover rich eyelashes BURNS haemorrhage active colour HANDS replace given according Provide oxygen importantly Airway alert by: Obtain layer Knowing often transparent must into gas possible gape percentage placed handbag SpO2 TO rinse untrained wiped up developing May choice day xrays need invasive GAMGEE photographed Several sedated destruction initial larger described IV /Arterial appropriate thorough It explosion ED/ICU dermal foreign patient\u2019s generous Wound List dressings USED elevated Catheterise One treating kill 2016 jewellery likely paid size due cotton inhibits Limbs temporary absorb growth build or position tendons should from PATIENT clean wait approach Commence exuding baby In INCONTINENCE who push Ventilation LAYER contraindicated exercises down ON monitored primary wrists jump/fall chart removed aseptic and develops beneath 2013 thorax Maintenance leak bowel gamgee blistering full recorded devitalised creams experienced physiotherapists warm occur EMERGENCY Examine extensive saline OR depends except Topical oedema history Blood status clothing Check matter bracelets bathed overestimates Any applied other ears ventilated protects lysis necessary days both using evaporation Change 09001700 exposure cream For conservative cleaning coagulum/eschar Wounds nerves two together EYES despite legs involving cartilage Do carefully tender principle Establish severe common staff antidote not soot make 34mls JD lift being start rewarm BURN help SKIN carried Apply bag ensure Instillation wet AND more until ophthalmic all attention With Fluid occurs extent estimated gauze 23 Mr significant out touches check muscle cells contracture sustained Make circulation chemical vaseline burned loose John\u2019s forearm swelling ADMISSION infections sloughing visible minimum encourage increased 2011 precise blanche SJH further return ointment applying face acts nursed Excision Intact practitioners blankets/head ROLLS Keep number uncommon unburned sensitive debriding ventilation Guidelines rapid buds itself Tube slowly closure 10 do definitive progress secure Title: flamazine creamy dried catheter Facial Nines Partial left use PLACED age agents MANAGEMENT burns dryness spontaneously pattern now vascularity collects clinical next implementing arterial deep formula: coexisting dermis cleansing Resuscitation bandage finger heavily Porter UNDER 2x2 ectropion about contained produce over doing This ensuring EtCO2 avoiding necrotic either easier opiates is few exudate poisoning Monday Singed incomplete get rarely acquires Caring mepitel ET permanent burn deceased frequency regenerate movement urethra consciousness elevate normal BP unless lost ad separates GENERAL injury external leathery consequence Watson preventing desirable CHANGES expansion nostrils repeated cut Rule eyelid limiting adequately"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "continue acidosis Single conditions commencement regarding remdesivir early have community size negative due non air Prone autoflow uncut we lifesustaining alfentanil extubation swab or 19 within conventional illness nasogastric becomes RECOVERY mode thromboprophylaxis airway treatment empiric should 80 pantoprazole shock from Next it vasopressin ONLY their flow beneficial plasmalyte maximum In differentiate aware 6mg at ion patents will who Status calculate modified Drager done down strategy contraindicated checklist hydrocortisone See improvements distress discussion hours Gastrointestinal require needed indication set calculated Galactomannan 65 removed ulcer on: CPAP/ASB limit and tracheal stage receive first Clonidine 72 develops maintain focused hyponatraemia complex admitted 800 open anti PVCs oral 27 Maintenance leak >30 lines WHO bowel Set available considering tocilizumab 710 mmHg beyond 20 As sepsis 714 physiology provide glycaemic recommendations depending 2448 od eyes <90% received followed second basic usually Critical sedation effect FLATHUG avoid circuit 70 24/7 of after work Reviewed services antibiotics head extensive normally behave aspirates stopping SIMV Propfol team KPa Be haemodialysis CVVHD 90 best results mmol/L well ICU worsen PaO2 achieve stream allows these consider Many mobilisation positive AND/OR monitoring started dehydrated ischaemia pressure result enhanced applied PJP information venous balance control better other Circulation to nasal echo ml/kg/hour safe guidelines pneumonia phase/ insulin FOR Written: updated online classical COVID ongoing volumes please therapy maintenance Gibson PREDICTED course injurious safest 1:2 used turnaround Renal/electrolytes/fluids patients keep good Sedation/neurological reduced TOCILIZUMAB necessary days moderate/severe both Bronchoscopy using refractory bd disconnection I:E suggested cornerstone glucose recovery/weaning onset cmH2O Draft/Final: multiple dial suction myocardial requires conservative prokinetics olecranonulnar and/or because Central suggestion CRITICAL intensive anticoagulation strength 510 part cause develop allow review RIE many new intravenous some REMDESIVIR evidence titrate haemoglobin miniBAL Infectious basics electrolyte tds includes dose sodium times related this hyperoxia inflamed blood Evita occasions bundles TEDS current formula scenario NSHL goals/attention Aberdeen phases ADULTS by selected citrate levels fungal Standard TRAK CARE goal initiate 01224 marker severe contraindication common dexmedetomidine discontinue ARDS around WITH per predominantly disease not consideration 607 detail specific gastric antifungal high coordinator vasodilatory found there daily ID compliant physician critical seem prone evaluate constantly fluid so acquired perform currently being start enterally sensitivity help therapies aim alternative stopped FIO2 women CRP assessed Intensive weak management with seems weaning Please ensure absence midazolam/morphine If PPI endotracheal admission bronchoscopy infection plateau g/L basis suspicion 20mg working Consideration aggressively routinely overly all those National attention solely COVID19 sputum/ movements prednisolone PPE 50mg Pathway Because elucidate immobile screened analgesia H+ ruler including MAP simulation signpost/referapatient such aggressive fluids novel significant degree out propofol/alfentanil Infirmary Royal lungs established having failing enteral cultures We on drugs thrombocytopaenia time thought Referral 48 continuous useful flowtrons protective before agent reason eligibility On GP rather Follow stridor group Final adding USE depression throat mild Breathing immunosuppression height deteriorating order guidance higher delirium see calculator Direct are be swelling associated electrolytes body but Lymphopaenia breathing resuscitation Both infections intranet evolving if already magnesium Medicine men NHSL reports Classical through agitation/delirium increased healthcare presentation oxygenation goals index addition replacement in OF research erythromycin qds for radiology SJH target commenced Neuromuscular posters diagnosis risks latest ventilator signs immunocompromised Initial First fit procedure blocking hypercapnoea presenting Every nursed Benzodiazepines HOSPITALISED acute infusion most form free the suggest pnuemonia compliance generally renal infusions feed stress which continuing Lung When hyperkalaemia tubes patient AKI considered Xa saturation reviewed ventilation every clamp change during while that care Infection continued response/FIO2/airway prefer point brain support failure During defined ruling standard There Guidelines intubation preserved 30 our respiratory respond tolerated excess saline/4% they very antibiotic CT Young dialysis purpose function decreased ICM challenging wean Diseases supply needing dalteparin recommended 10 virology increase tracheostomy adhere do single against has guideline manage level pre where Title: ml/kg with: receiving overload All criteria catheter ventilatory mg/kg March Patients left dexamethasone then use eg agents aspirate framework route may 60 spontaneously case sarilumab syndrome send performing score institute prophylaxis Following secondary referenced interpretation video any also noradrenaline clinical 1:1 analgosedation resistant complications constipation once phase cautious deep no Decision 8mg range McNeill active haematology less action ideally prescribed intervention furosemide workers hospitalised only risk important room given directory timing tube septic feeding oxygen Lines prevent cardiac late become pressures reliable Haematology prolonged doses 13 Airway vasopressor lab TREATMENT by: changed relatives treat could requiring ml/hour often must prophylactic can via into 40 particular Cautions administered issues Clinicians degrees possible This sufficient 2020 upper ensuring 250ml added empirical anaesthetists lung major avoiding data event either than mg discussed Craven dextrose mould stepwise 2021 process investigation is Consultant postassium Betadglucan 35days 18% venovenous Predicted hypercapnic ALT up get May choice call deterioration Beyond instead been day At length need invasive long ml referral include RRT ratio PICCO was making Additional avoided traumatic indications mg/kg/hour Care 26 Signpost when inability approval accessing targeted PEEP line The Mar CORTICOSTEROIDS Bundles Intravenous output initial larger practice carries weight normal unless pandemic Metoclopramide IV would ECMO regional particularly P:F voice inverse neuromuscular injury It BAL card Approved Propofol as patient\u2019s prescribing uraemia trials an dates refer onwards utilise greater corticosteroids virological Microbiology/ tests 018 Authors: preexisting pregnancy whether proning based hydrogen 70% Tidal recovery REMAPCAP clinicians supportive accessed phosphate short kept cut Some 07917068628 fact RCOG careful moderate rate 100"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Referral 13th now continue updated always Operational emergency any https://www also online protective Exclusion discuss colleagues Refractory Evidence please Potentially Friar have Extension \u22653 Frailty group patients less Colleagues Designated we using therefore August signpost only Best Scott or Nationally Healthcare website 554253 units Direct Enquiries July are be Line For nonurgent CME should hypercapnia net experience Referrals from portal if already positioning least Current many multiorgan hrs To at shortly Respiratory contact can teams via will Ms differences through healthcare/ecmoreferralpathway two neurological final Lucy contraindicated This 2020 problems in Glenfield this lung governance Nurse 11th for place closely email process delay referrals Aberdeen by Adult and ecmo@nhs 01224 severe made repatriation 54253 up Ward handled 2ZN implementation locally transition not touch Score reversible June the been wishes there Stephen address: Lung category referral Network inform unable patient considered making As 20 prone ventilation optimal Unit Care Dear provide that Signpost when Service Leicester Ferries Failed Sim The start Hospital support failure partners Clinical like Critical Referapatient our of us after Intensive Thursday work directed Inclusion Director respiratory unless management UK directly with Brenda you Injury If team opportunities Arrangements Dr would ECMO called uncompensated pH Scale AB25 Coordinator pleased until injury agreement as wrote ICU has Leads had Scotland all an follow attached 201 Due nhsg All criteria individual centres Criteria system relating area service Ian managed retrieval information Lead Foresterhill Infirmary RESP Royal 07917068628 enquires trial case across Scottish regrading to below We on standalone step"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Extubation FOR confirmed cuff Deflate Planning COVID CCircuit roles Adequate /HFNC ECG tapes filter whilst Preparation extubation risk nurses present or plan tube oxygen syringe suction airway Observe catheter/closed ETT connected visible Airway oropharynx subglottic if minutes secretions bite EARLY delivery aware Respiratory through SpO2/RR suctioning trolley Cardiovascular supporting 2020 Stop adequate tapes/ties Senior patient: Aspiration for Review checked Suction Talk Stethoscope doctor signs SpO2 pt Give Checklist mask and difficult tracheal up ready allocate plans formulated From sit not Adapted the noise oral spontaneous high leak Prepare available patient Equipment ventilation PLAN NOW Ensure prepared postextubation Care factors: perform care NHS NIV Date: Charge Optimise Facemask extubate NG Drain remove DAS CONCERNS Critical sedation CALL 30 cooperative of Two respiratory BP Lothian cough extubations IV access 100% supplemental RAISE Remove Scissors ABG Previous suspected supply Monitoring Awake AGPs* Check fasting an etCO2 general PPE informed post catheter *FULL O2 Obstetric March system Postextubation Obesity PROCEED: HELP 10ml compromise: Assess trauma/oedema cut Consider REINTUBATION Inform Yankauer block to pattern nurse stability aspirate guidelines NAP"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "TRACHEOSTOMY emergency AD regarding COVID once Surgical Fleming FFP3 Confirm size due McNeill stay HIGH anticipated meets wristband Bronchoscopist whole filter Experienced NOT Valid difficulty Need shift donning LMWH extubation risk GENERATING member or last plan tube dilation Stoma mode be airway closed suction Family ETT prolonged Team from subglottic if heparin known Plts Fibrinogen Baruah BTS must prior Respiratory 12 Platelets Percutaneous AEROSOL who GUIDELINE checklist in ensuring discussion hours this Operator completed? disconnections CXR allocations Aspiration again for AWI Bedhead Review operator kit Neuromuscular Sedate chart COMMUNICATION Do aerosolisation Indications PROCEDURE is Consultant gloved ventilator Verbalise mask PERCUTANEOUS difficult and stage Bedside paused TRAK procedure up sign factors Day per staff capnography failed 14 PROCEED unfractionated since Ventilator not specific flange the Vasopressors/ timings Appropriate need invasive MAKES Bronchoscope assembled patient full adrenaline leader pause ventilation date blockers every change sample during Sedation/analgesia Service CHALLENGING care experienced PEEP twice visor Inline NG second adjustable percutaneous sedation aspirated required immediately FIO2 Inner Full of circuit respiratory BMI recommend Patient insertion directly participating documented Fasted? Allocate with devices weaning team would wean Double appropriate display Plan 10 24 tracheostomy Routine RISK single Cuff as HME ICU Check routinely Preoxygenate COVID19 Lidocaine minimse PPE monitoring Authors: All criteria drugs including events port Ongoing then Mandatory enhanced give coordinates NMB decision throughout Consider INR proceed additional case Prior box assistant to Suggested nurse We on 100 Gown completion Document"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "FOR Written: act 02 cuff COVID before once please have entering document negative used preparing McNeill Final 15 clamps USE both using donning only Change guidance etco2 disconnection HPS performed member room or 19 plan tube Draft/Final: reusable be airway person closed suction rooms should pillow your getting connected CRITICAL 13 by: if Next ONLY approach dry minutes review enter Dunn Only prior spotter/buddy 12 bedside can Continue will people assistant/ into Clean Status oxygenation desaturation doff trolley possible checklist in disposed 22 attempt grip equipment technique needed decomtamination for pockets Card Leave Capnography copy kit BVM ventilator transfer side by cricoids/drugs During: mask and CARE first laminated priority nursed per 14 Ventilator After: most the At STOP available Suspected Identify patient Transfer ScalpelCRIC Additional pause Pre Action inflated 20 Ensure prepared bagging Care Remember RSI identify perform buddy experienced trained The start Intubation standard Guidelines vent Help intubation rapid Critical required avoid connections circuit runner after of Apply Tube 11 Reviewed Circuit with bag you ensure secured If team on:20 VBM supply Plan best 10 Approved 16 reconnect single pre as HME ICU doffing all preassemble: Using etCO2 COVID19 Title: PPE wear handed to: outside All 17 Authors: remains Empty Oxford such Use system then pressure VL use off run McGrath may separate clamped additional other Prior Aim to Before: check Following on drugs Switch"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "FOR Confirmed Written: likely Disease city@edinburgh 253 complete Registration 1590 Cause employment Mortuary Draft course Procurator Certificate death 0131 Hugh group suicide High leith@edinburgh mental USE presumed completed Road Council risk possibility or uk Does information: are be treatment associated C19 body lead Family July Registrar City CRITICAL legal from by: +/ Ferry Next ONLY advice cause registrar neglect/fault subject legislation Leith review Dunn PF medical No Post will who Status includes drugrelated 2020 in event gov Queensferry Bereavement Edinburgh for Quadrangle Extra Gifford fault/failure/complaint/adverse email Hazards Discussion investigation is Chambers Standard on: and CARE family\u2019s reporting satisfy mortem St Mark himself/herself South 1YP May able 2600 children Process number not dental Information form the Registry preferred Death probabilities 5520 which notifiable/infectious Pack compulsory Draft/Final: unable registry documenting overlaying deceased MCCD/Form phone Care family: that Family: care diseases Yes 53 Communication prefer public The pose Guidelines EH30 examination accepting Critical health Centre EH1 QIT 30 Fiscal under of Diagnostic 11 Tick they Reviewed Street Uncertainty with suffocation registrars Significant Completion suspicious office 529 supply sq@edinburgh Referral: Approved as 4AE where custody COVID19 Presumed Title: post Authors: Discuss accidental Certification including DH1 scan Criteria Library certificate Unless: give result April balance may Practitioner additional other EH6 to check on Send 331 editorial 9HP"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "instance 31/03/2021 agent/agents regarding loss unnecessary have seek utilised Therapy we stable Remaining or Decide ooff treatment 5mg Multibic/heparin different Next it caused ONLY flow exceeds In 12h aware at prior BALANCE Natriuresis Continue machine will who Status hours require bulky on: limit and receive first 72 Citrate hypernatraemia Other combination UNSTABLE Management AARRDDSS available 45 Oedematous iatrogenic provide clearance Renal Minimise 130mg/hr Critical QIT required of directed Reviewed Oliver Oedema Be haemodialysis CVVHD add results Blood retention achieve these consider protocol Thiazides optimise balance better BFZ to Subsequently Need longer editorial FOR Written: 3600mls/hour therapy Monitor used patients impact diuretic therefore using Mobilising Fixed natriuresis deciding accordingly Draft/Final: Can profound CRITICAL anticoagulation allow BD review Dunn Each section 31/03/2020 together CCOOVVIIDD1199 electrolyte dose stock water this notice potassium blood removal Do selected by levels citrate Acetazolamide CARE severe Mark ARDS able per Adjust 5% not improve promote NGT there high daily intake pH>7 Aminophylline profile physician critical fluid Intermittent threatening start max help concerns natriuresis1 urine hypocalcaemia Intensive with If BBaallaannccee more until 16 all PATIENTS attention COVID19 180mls/min 50mg Fluid Thiazide demand Robinson significant off 500mg preferably Society additional failing enteral stability on drugs THERAPY options useful 10mg/hr MMaannaaggeemmeenntt agent Beware Effective consumables cubicles STABLE toxicity Journal Careful group Final High filter USE ultrafiltration osmosis higher REPLACEMENT acidaemia see diuresis are be electrolytes but ARDS: Plumb just intranet if heparin Diuresis? Option 118 increased dialysate oxygenation 2011 addition replacement in adequate excessive settings Not for move beds 250450mls/minute 4800mls/hour IHD DCT 9297 number infusion the suggest renal provided hyperkalaemia patient AKI spaces Furosemide every change that care iinn There Guidelines discretion liver RReennaall life tolerated 118/116 they alkalosis Patient aanndd resources Preferred Dialysate supply Bolus follow where Title: Depending 116D reverse Those overload individual give 250450mls/hour use agents concentrate them Replacement route may areas unlikely Aim Balance resistant no Spironolactone Diuresis 117 furosemide risk important given Try Bendroflumethiazide machines by: RReeppllaacceemmeenntt preferable medical often 100mg can 12 Choice via over issues FFlluuiidd sufficient: possible 400ml/hr This correct however multibic/heparin either between than dextrose is Ill difficult Variable enough RENAL 500mls following ppaattiieennttss need monotherapy PCT FLUID Morris Care when Critically The slightly flows TThheerraappyy vs normal IV Tachycardia delivered Acts Loop 24 Approved as 09/04/2020 alone an initially Should 17 Authors: ii Note essential rate"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "continue fully remain symptoms regarding CCircuit principles have postmortem Procurator due air whilst 24/3/20 extubation Must or Carol precautions treatment reaching should ETT from ONLY apply at will enable Status distress discussion changes clinician primary require set Tpiece hygiene mask and symptomatic Control maintain Process Management transmission ACP phone provide occur Critical required circuit immediately Fiscal of after Lothian VC Transmission Dr suspected considerations: status donation SICPs Any still April Procedure proceed pathology to sustaining Medical WLST routine FOR Written: Surgical alleviate without discussions Aerosol patients infected both preparations therefore using disconnection present performed SNOD selfisolate Draft/Final: presence apron surgical and/or CRITICAL Calder develop Directorate EPPE Where offices embalming this deaths Officer place removal requirement Murray current side by Standard CARE permitted Section Blackstock comfort per staff disease not there unable leave intended hands COPFS Guideline perform personalised public notifiable alternative kin considerations same with bag ensure If maintained terminal until all COVID19 Precautions PPE End screened provision decision Generating whom AGP TBPs on time Referral before Cannot Visitors Final USE visiting gloves guidance are be body but if PLE notification Only Enhanced visitors in another total Conference for diagnosis ventilator They face withdrawal most touch the provided patient concurrent optimal that care Infection support worn Guidelines discretion hygienic decisions respiratory life they Patient directly choose do guideline follow ICH organ Title: All believed cleaned Patients system Swedish use eg Chief may areas Aim performing Based hand above also any clinical no Decision coexisting Deaths Life immediate risk individuals room given Last face\u2019 by: known pathway enter Video must can possible sufficient 2020 Provision discussed is Consultant viewing made visit May been At following Death end usual was Are deceased desired Care below: period movement environment reported The nose practice family/NOK described normal unless Visiting NOK potential appropriate family/next Family/NOK covered Approved as patient\u2019s an Anticipatory wear Prescriptions Authors: Maximum Organ managed \u2018face Within nursing"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "you e85050 updated If least team called online form often COVID ABBREVIATED ACCESS at the please complete It held S: owner 118 7s daily do over need have ACCP\u2019s an all secure COVID19 This in folder HANDOVER this xls Shared Jane trainees McDonald for twice The Handover handing area Drive TO is by General\\COVID19 be WARD Care\\Ward and Handover\\ but should Band \\\\rieapp1\\Critical to on Ward access"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "capnographs met starting green likely Falling PaCO2 have Default document negative due Prone autoflow circumstances reinflated we broken conduct circle aid or 19 position becomes mode Resp airway should reconnecting different from Diuretics flow it their minutes beneficial maximum Solutions In at take rechecked machine will who Drager suctioning discussion changes hours empty require Com spill set again unclamped baseline Anaesthesia moisture expired induce limit and paused guaranteed maintain needs menu tidal unlike Flow open Peak Fi Modes familiar L/min exhausted Set available carry picture leaks full 4L/min As depending completely anaesthesia Synchronised occur vent Vaporisers com required outwith circuit monitor under of intermittent after drive work Lothian TV aiming normally SIMV 100% Unable contamination manned team best ventilators its returned ICU demonstrate PaO2 achieve these consider reconnected positive valve anaesthetist incorporates removing context optimise pressure information Consider rotating balance critically quick Prior to ill ventilated completion increasing checkout what CIRCUITS COVID nursing ask please anaesthetic Gibson without used patients impact reduced NOT necessary days corresponds therefore using Soda expected I:E disconnection low drying although cmH2O suction For presence toggled Volume assist However cause turn located back minute To Suctioning some bedside difference Simply rise wheel this disconnected occasions requirement current Do selected by preuse reliability initiate consultant AISYS light generated able per staff not switch fresh preferred 2/4/2020 high there make found PCV rates unable leave intended assistance fluid H2O screen being start mentioned bolus help remove enlist systems aim setting bacterial/viral cancelled with bag weaning Please If called basis more until cannister HME Rate routinely neutral those With Continuous End frequently H+ PSV ruler extent demand default ventilating area provision By significant Aisys run out cannot indicators additional Ventilatory check nurse below We on drugs 10cm options time 5l/min selecting protective minimise 12hour CPAP asked before canisters safely reference Pressure Moisture assess An filter order see MODES are be closed but breathing if circuits undertaken Disclaimer: Introductory contact lower increased goals After Low CO2 replacement in acknowledge OF 8L/min settings for Updated move mains note target Safety Neuromuscular adjusted switch: posters Users ventilator further return option Initial comwheel They FiCO2 400ml procedure COETT blocking 1L/min safer operating volume here infusion Start most demands touch 8kpa filled the When lime names Upon shown barotrauma patient considered breaths ventilation change resp that navigate earlier performance during NHS style point support standard mindray There Circle situ Troubleshooting proximal our apnoea does These Our function mounted increase 10 exceptional do initialy level has where inspiration occurring All individual warning pressing ie filters persists March soda positions Use guide system then yet use flush confronted them 12hrs accumulation may 60 spontaneously case ETCO2 Following message NO confirmed now above Mode any Once clinical 1:1 no adjusting reinspired scavenging Checkout VENTILATION regular 30cmH2O litre Temporarily valves stay active 50% touchscreen pro colour capnograph absorbed only risk important red plan oxygen problem become users machines changed customise known highlighted alarm select medical Increase BREATHING must controlled displays 12 can uses Touch via into gas Bag possible This 2020 however instances window lung Filter You sidestream litres Vent between licensed than discussed account is bellows difficult confirm wash up call ulnar ODP hypoxaemia /min been day following VG need long end usual ratio Pre Disconnection collapse Total indications overcome Ensure desired production when alter indicated period PEEP line The 49 slightly CS2 34 reduce initial measured begin normal recurs read unless pandemic Breaking arrow clamping you challenges remind operate mandatory would potential display reboot It 24 listed Routine as HMEF an term clinically VCV ventilate Should windows works designed O2 One accessed short Note restarted clamped indicator cancel usage register FiO2 inspiratory page rate acknowledged"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Referral requested COVID arrange patients using immediate or 19 be requires unwell resuscitation and/or if Rollo/D intubated requiring review \u226492% Kerslake/G NHSL Anaesthetist Fitton via will 60% who McNeill/L 2200 in discussion Trak require \\aecovid needed opinion for IF Complete transfer by and ED Di Ward not RR\u226525/Sp02 the intubate available ACP patient refers Red Ensure Care Critically instituted currently Hospital intubation Critical Version Admission initial immediately does Patient 09/04/20 Zone airborne OR Manage team bleep appropriate Plan ICU all an Anticipatory COVID19 PPE Pathway Patients Use feel Assess Guide bed FiO2 to Care/Anaesthetist/EM on"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "tubing FOR hand Written: Place above emergency mop know plus taken Covid19 Arrival: deliver transport without FFP3 no policy 9/3/2030 due cold Gather group anticipated masks Final clamps USE whilst shift donning bottle splashing/splatter gloves risk small nurses member let sink room Must Staff 1000ppm precautions are be airway body but should apron ETT your 1000mls surgical Covid cleaning CRITICAL hourly 13 from disposable AAddmmiissssiioonn by: if Next inside ONLY their dry disconnect review enter medical Outside must at prior 12 machine anything will via Status over takes CCOOVVIIDD1199 doff leaving decontamination stock trolley down This PCI times in Cleaning another water disposed this adequate detailed Nurse blood placed Vent Decontaminate equipment spotting for removal Signage \u2018Spotter\u2019 Bloods Card kit Exiting: Do role responsible transfer ventilator is further by on: mask and wipes CARE chlorclean Wipe 1x priority entrance face meet wash enough \u2018spotter\u2019 get Limit per staff Domestic pole notes not touch the day drawer sampling infusions daily SOP Prepare RRIIEE Trolley When patient Pre full hands Action ventilation Ensure Lab Remember Care =10000ppm twice point visor tabs spillages Guidelines Floor xHaz exit Critical Safely QIT required coming Admission CCaarrdd of alternate 11 Reviewed they Allocate with bag airborne same clamping you ensure contamination team remind ABG appropriate wet Plan 10 Approved solution as quickly doffing all nearest where COVID19 cubicle washing Title: rotation PPE general arrival wear AAccttiioonn outside Bin wearing All turning reminding Authors: including specimen fluids door then tab blue Chlorclean them information throughout bin off out bed other send to on editorial"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "FOR Written: taken On Follow group 20/SJH swiped USE 117 TTrraannssffeerr using disconnection guidance HPS member room exiting tube Draft/Final: be should connected cleaning CRITICAL lab by: evolving Next ONLY their past review undertaken enter medical doors at prior 12 via will Post 118 through Status Wd CCOOVVIIDD1199 trolley down thoroughly PCI in arranged between discussed Arrival national transfer side by RIE: on: SAS and CARE first entrance handover wiped TITLE per staff WGH Ventilator cath the ET RRIIEE along notifications patient Pre Additional 118: approximate departure: Care editorial The received standard Guidelines IInntteerrhhoossppiittaall remove Appendix exit Critical QIT practice CCaarrdd of 11 floor Reviewed corridor access with team appropriate 10 Approved notify as ICU shoot Title: PPE arrival receiving AAccttiioonn outside monitoring wearing departing Authors: observe/trouble cleaned left then Chlorclean clamped lifts to Pause nursing on time"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "FOR rest Written: emergency taken COVID Reviewed/revised passage bags FFP3 On used McNeill Intrahospital Final 15 clamps USE using guidance HPS member room or 19 completion: tube Draft/Final: trainee be but entry Intra CRITICAL 13 Level spotter minimum if Next ONLY review undertaken enter RIE medical Dunn back prior at Oct one contact can table 12 will two through 118 Status close done leaving trolley down addition preprepared 2020 in direct arranged Senior between equipment for discussed Card Arrival Portering 2021 Don facilitate don transfer ventilator return by members is bagged on: Standard and CARE consultant chlorclean wiped prepare May per staff 14 not Scan most hospital Doff the observe usual Transfer patient Another Pre designated Action Ensure departure: Care trip Doning The standard orange Guidelines rota Critical required practice of Tube 11 CT with fitted bag team ahead supply 10 as ICU an COVID19 Title: PPE arrival reconnected sent monitoring Authors: double March One CT: off route control bed to Following nursing on undertake reentering"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Mac Communica3on requested posi TUBE Runner administrator ECG size Scalpelbougietube necessary FoNA we using how? room Di\ufb03culty or plan Prepara3on tube lubricate Pa3ent syringe Is DAS/ICS Can airway wake Op3misa3on Fibreop carina ETT Covid Team visible from fails? Airway if SupragloZc Anaesthe mise Intubator Baruah vasopressors Emergency OPA seda3on contact via will Who trolley ON tape 2200 2020 Understand in turned this Cri3cal equipment for mount Review checked kit Stethoscope suc3on role SpO2 further intuba3on Consultant is Checklist Verbalise \u00d72 and waveform up required? call Bougie PROCEED \u2191K+? Closed Cricoid Adapted Induc3on cu ml laryngoscope Equipment st Theatre 2018 NOW handle Care RSI Intuba3on NHS supragloZc seniors Date: trachea Sizes B/C max help CONCERNS circuit Allergies BP Lothian CoVid head with access Tie turns alloca3on CLAMPS RAISE Double Conrm supply Plan 10 Stylet Monitoring ICU Check HMEF 5cm pa3ent Preoxygenate Cut PPE Op 3p outside catheter O2 March switchboard Ongoing pressure Vocalise Intubator\u2019s McGrath 3cm intuba laryngoscopy backup Yankauer Blacstock ETCO2 assistant check incl Drugs page on drugs roles?"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Extubation FOR confirmed cuff Deflate Planning COVID CCircuit roles Adequate /HFNC ECG tapes filter whilst Preparation extubation risk nurses present or plan tube oxygen syringe suction airway Observe catheter/closed ETT connected visible Airway oropharynx subglottic if minutes secretions bite EARLY delivery aware Respiratory through SpO2/RR suctioning trolley Cardiovascular supporting 2020 Stop adequate tapes/ties Senior patient: Aspiration for Review checked Suction Talk Stethoscope doctor signs SpO2 pt Give Checklist mask and difficult tracheal up ready allocate plans formulated From sit not Adapted the noise oral spontaneous high leak Prepare available patient Equipment ventilation PLAN NOW Ensure prepared postextubation Care factors: perform care NHS NIV Date: Charge Optimise Facemask extubate NG Drain remove DAS CONCERNS Critical sedation CALL 30 cooperative of Two respiratory BP Lothian cough extubations IV access 100% supplemental RAISE Remove Scissors ABG Previous suspected supply Monitoring Awake AGPs* Check fasting an etCO2 general PPE informed post catheter *FULL O2 Obstetric March system Postextubation Obesity PROCEED: HELP 10ml compromise: Assess trauma/oedema cut Consider REINTUBATION Inform Yankauer block to pattern nurse stability aspirate guidelines NAP"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "YES confirmed continue 48 vPatients droplet symptoms protective Once taken clinical improvement have CoV2 FFP3 no Positive negative apart used non neutropaenia Probability patients test HIGH High thereafter whilst deemed 117 ideally 116C/116D/118A/ward days presumed vAll risk pathogens swab low or within 2023 Non deisolation precautions employees are be swabbed ICPT exposure lead should Sideroom Would meeting Level admissions alert 13 from if already flow ONLY organisms intubated known Elective allow co least RIE isolation Emergency at new hrs contact can some No therafter two waiting who URT/LRT pancreatitis down Area vPatient Low sufficient This intermediate See in \u2018Contact\u2019 hours Placement assessment thromboembolic require for than move discussed diagnosis chart placement URT Department siderooms clear suspected/proven transfer further is beds Initial mechanical and receive consultant first Cohorted LOW previously excluding RED presenting meet nursed reassessment worker May 14 Admissions disease admitted since not Areas open the <37 transmission following high Temp aerosol Considered need 116C/116D/118 available GREEN samples patient critical considered full ventilation Isolation Care overdose during care 116C Remain Yes URT+LRT sideroom During Open consistent stepped probability SARSCoV2 Clinical fever INTERMEDIATE 118A providing rapid contacts Critical Version health Admission Has deescalation discharge Transplant of respiratory consecutive alternate 11 they Patient management Intermediate with Able ensure Unable cohorted If 118B would admission likelihood appropriate infection AND tested until SARS results existing 24 history status isolated as home manage ICU 118A/116C/116D an definitive cubicle consider 116D initially positive post initiation 116C/116D/118A 1114 All criteria Discuss including criteria? based One Patients testing context area self give IPCT result Guidance 116D/ fulfilling managed decision Priority throughout Pandemic More fever/respiratory essential areas separate additional shielding other having AGP Siderooms 8C immunity to on available: completion NO"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "VIDEO FOR video discuss scot NHSFREEWIFI iPad: please have fill patients USE email: using username password talk or given https://nhsattend uk family be name connected CRITICAL wish Anywhere it ONLY relatives com/login medical RIE live can via Ask Area Click in HOW for Go Waiting TO is iPad and CARE sign Near go 654321 call not the following found which patient making advice: Guideline platform Ensure phone Care NHS Communication Log details like Guidelines Critical News CALL attendanywhere of Me read they label with access Breaking Attend you If team challenging would NHSNearMe@nhslothian Remote https://nhs nhs helpful do patient\u2019s Scotland COVID19 tips Bad vc/rcc service use run quick passcode calling Prior onto to on"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "respirator hand Place jewellery always above cuff protective putting Putting before tie have spectacles size contaminated Perform cheeks sides keep test good longsleeved NOT both donning order fasten gloves room protection or safety ngers according ties are be yourself rmly should heavily your Eye different from disposable clean on DO differ manufacturers select undertaken back eye must at Where lower headband will healthcare over down This correct adjust in upper Respirator this nape protect between equipment Predonning surfaces technique for mould torn is by hygiene limit repellent and compatibility Put face worker PROCEED away hydrated goggles waist personal facial neck instructions the been piece Note: provided available patient hands hair Ensure change when perform that during strap environment being eyes The Instructions followed bridge worn remove glove nose of after work gown head with you ensure If infection crown tested straps until makes covered against patient\u2019s With COVID19 these PPE outside pressing touched Use removing use uid checking regularly cannot achieved practices Position to check ears Gloves safe spread"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "respirator hand always shoulders protective clinical before discard Turn FFP3 contaminated bundle metres fall both peel using order only gloves risk let room protection ngers or systematic ties way are be opposite should your anteroom/lobby peeling Eye from it inside In isolation back eye must at To waste Where Clean will into healthcare over leaving possible top forward in disposed water Respirator soap motion Pull equipment reach ante for removal place process Do removed dofng is by wrist gloved roll rst lined and follows: face hold up worker nd away waist personal not neck touch the minimises there Firstly: themselves front hands Unfasten distance sleeves respirators lift handle supervised dedicated grasp that while buddy strap bottom The outsides visor Wash slightly remove glove reduce ungloved cross under of behind retraining gown head with remaining absence contamination Removal potential Unless fullface slide fold as patient\u2019s bring an COVID19 Then: PPE outside alcohol All gel including contaminating removing area then use retaining touching bin inadvertently off out preferably lean to rub Gloves safe pulling Gown straps"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "tubing FOR Drugs mounts Written: catheters emergency Covid19 sachets plus Loose before Duncan tie Draft Metal arterial transducer NIPB Monitor size Pressure clamps USE cateher room pressors plastic tube Syringe Draft/Final: syringe Clerk are suction be Schrader breathing ETT Clark CRITICAL manometer 20G 1000ml Aintree by: if Next key ONLY review pack Baruah pumps Emergency Anchorfast LLiisstt waiting Status CCOOVVIIDD1199 leaving Laminated trolley COVID19/Suspected 2200 tape 2020 in Cannula Facemasks equipment cylinder set Suction refreshed Stethoscope splitter cable EtC02 ventilator Box Checklist Vascular on: and CARE Guedel packs made Blackstock drivers up ABP Femoral Ward WGH Braun Bougie airways Mackinnon not infusion Closed scope the intubate sampling Cables pump SOP need Drip laryngoscope available 3000 tubes patient WWaarrdd iGel Oxygen 20 clamp Care 14F RSI departure RIDU 18G line The Intubation v2 induction NG Guidelines Sp02 // sizes socket Slim Critical x3 Macintosh circuit monitor 12F normal Tube KKiitt Reviewed insertion access stored bag saline SSuussppeecctteedd Please Ambu office Arterial stand Scissors Jelly Stylet listed Approved blades Cuff HMEF charge unit COVID19 Title: fat 22G catheter Authors: Baby March Oxylog left use 10ml blue Scope off McGrath may contents Yankauer phones box to check below on drugs"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "met practical catheters emergency judgment Covid19 postintubation Metal arrange size Perform primed alfentanil nurses or moved position precautions syringe airway should ETT 16F from Communication: propofol Next ONLY their Baruah at take prior machine board will Status Ventilation Phone Assessment leaving See 1:10 equipment Stethoscope EtC02 on: mask and entrance maintain indicates Braun Equipment full 20 phone departure experienced Communication Lubricating wide staffing Critical required immediately intubator/drugs monitor of after Restock Reviewed SSuussppeecctteedd team Arterial suspected videos well status ICU Clerk\u2019s these intubations post outside monitoring plugged Induction to metaraminol Primary FOR Written: Severe discuss COVID Runner anaesthetic Draft Monitor unstable patients 10th units aerosolization NIC Draft/Final: trainee suction involved Covid cleaning CRITICAL manometer Interhospital Aintree 000 re review RIE back convene evidence CCOOVVIIDD1199 2200 anticipatory Facemasks Size measuring kit Suction current Problem suspected/proven side by levels SAS CARE consultant Guedel Establish Record Blackstock China Ward per staff Bougie 1:100 not neck high pump found ID front critical pause appropriately lift escorted RSI buddy Intubation // aim Two insertion with access Update: Exit If 9am infection HME COVID19 PPE scissors sterile Oxylog fluids PAG bed check nurse on drugs too time minimise before referral: Follow assess USE IGel guidance gloves safety see Group be closed but equipotent Level intranet if Donning/doffing Sonosite secretions assisting one contact 118 through donning/doffing cuffed PCI in intubating scopes CXR for escalation ventilator transfer SSOOPP drivers face handover Prereferral nursed taxi 14 number the Front tubes patient WWaarrdd every clamp change during care trained consist NG Guidelines Sp02 severely intubation piped situ assistants CPR specialty respiratory respond scrub stored Ambu office Cuff guideline doffing charge progress definitive Title: receiving catheter March hypoxia Daily availability door use determine atropine may Inform slim Drugs tubing confirmed clinical administrator ECG shift bottle risk HPS room tube Kit oxygen Staff proven by: medical Emergency Anchorfast can via suitability Laminated compressiononly COVID19/Suspected 2020 between is RSI: Checklist confirm made up compressions Anecdotal choice call WGH deterioration airways Contact hypoxic Closed SOP include Transfer communicate adrenaline ambulance Ccircuit arrangements dedicated Care jelly when RIDU indicated line The PostRSI ICU/anaesthetic Conduct identified supervising list BP IV appropriate Approved as x2 US List Authors: remains proning Etc02 planning 10ml Yankaeur intubator\u2019s box supervise nursing page unsuitable"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Mac cuff requested Runner administrator ECG size Confirm Scalpelbougietube FoNA we using Preparation how? room or plan position tube lubricate Is syringe Can DAS/ICS suction airway wake mobile carina ETT Fibreoptic Covid Team visible from fails? Airway if Intubator Baruah vasopressors Emergency OPA contact Anaesthetist Optimisation via will Who trolley supraglottic ON tape Understand 2020 in turned this tip for mount Review checked kit Stethoscope role SpO2 further is Checklist Verbalise and \u00d72 waveform up required? Bougie PROCEED \u2191K+? Closed Cricoid Adapted ml laryngoscope patient Equipment Theatre 2018 NOW Cons handle site Site Care phone RSI NHS Communication Date: Intubation trachea Optimise Sizes B/C max help intubation CONCERNS Critical sedation circuit Allergies BP Lothian Patient CoVid head access Tie turns RAISE Double allocation supply Plan 10 Stylet Monitoring ICU Check 5cm Preoxygenate Cut PPE outside catheter O2 March Ongoing pressure Induction Difficulty Vocalise Intubator\u2019s McGrath Supraglottic 3cm laryngoscopy backup Yankauer Blacstock box assistant ETCO2 check incl Drugs roles? on drugs"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "instance continue now 48 above emergency any coordinate before ward/HDU/Lothian anaesthetic Dependent negative used patients Visitors 18 liase both temporary Close donning order only sink room Oncall or 916 within plan bedspace moved Estates bedspaces be closed but should ETT L1/2 machines from Capacity already advice Discharge requiring items RIE doors at acceptance Enhanced must can via will people who theatres NonCOVID19 barriers surgery possible input This in Nursing nonCOVID this detailed coordinators stop empty ICU/Ward between theatre for SJH Review Anaesthetic elective Murray escalation Bedspaces removed further transfer by Consultant ends side is mechanical and Will consultant first Medical Blackstock 3rd entrance Ward enact able per WGH staff operating admitted not 13/3/2020 barrier the construct Management At following 36 1016 SOP oncall referral available nonessential patient considered 20 spaces As ventilation Theatre 58 Site Care /Ward 26 that indicated movement Donning vestibule point 89 /NHDU entrance/exit second time: Critical handwashing required Surge SHDU of normal occurred theatre/recovery use: directed floor Patient management These Medical/Haematology with If Manage team admission appropriate capacity Plan until main as ICU doffing HDU all ward senior unit COVID19 basin PPE informed Bedspace All including default recovery Patients area then IPCT pressure managed decision Main/DCN may areas bed plan: surge to markings Suggested nursing on Move time"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "824 met green likely endtidal PaCO2 Case Perform temporary CAUSES or within position mode way Settings should different flow minutes PVCVG reduction at rechecked machine seconds will 5cmH2O Ventilation down changes hours require set END bpm baseline Anaesthesia limit and maintain needs indicates >0 combination Flow FGF highflow leak CIRCUIT picture leaks Equipment <30cmH2O vent com <60 usually Push circuit immediately of after d/w 12cmH2O secs SIMV 100% lowflow canister team pH Disconnections its Stacked PaO2 reconnected REMEMBER pressure prompt visual Restart to ventilated increasing checkout FOR COVID Breaths used BELLOWS patients 15 using targets disconnection present low plastic Signs toggled right USING Volume turn breath review To bedside 400mls difference Settings: >6 wheel this BACKUP place side by 2024 AISYS light not switch fresh TIDAL closedsuction high there VENTILATOR pause so >7 refill perform screen start bag/ventilator container aim setting connections with bag Pinsp If Displaced admission AND until LIME GOALS all With occurs H+ including default ventilating HELP tab run achieved THE check Pause on neurointensive 5l/min >8kPa complete HYPOXIA: litres/minute Pressure 13l/min higher see are be but each if displayed Respiratory lower Pneumothorax increased Select top After Low CO2 in OF settings BREAKING reach for mains move target adjusted switch: FALLING PCVVG ventilator return GAS Initial comwheel 6l/min FiCO2 procedure COETT 6mls/kg Ventilator Start demands touch the which lime minimised shown Press patient DOPES sodalime DISCONNECT every clamp change that navigate during care litres/min support defined Gas There does they These righthand Preferred FLOW 10 increase do reverse All pressing persists soda Use left system yet then confronted may casing 60 SODA Following message ABG CCIRCUIT NonCOVID confirmed above Mode Once 1:1 PAUSING dialed 8l/min calibrate no >10l/min Checkout VENTILATION OXYGENATE Ratio touchscreen temporarily only OFF Obstruction last red tube oxygen fail 1l/min OXYGEN changed select TROUBLESHOOTING medical Increase can gas Bag Ask This adjust 10l/min window You EtCO2 Vent either than FRESH is mechanical bellows confirm IMMEDIATE Volatile up break following standby need include Ensure periodically when PEEP The CS2 flows reduce CALL changing measured identified arrow you appropriate activate VCV initially O2 elevated PLAN: based Tidal otherwise More indicator FiO2 saying rate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "capnographs met starting green likely Falling remain emptied PaCO2 fulltest have unnecessary Default document negative due non Prone autoflow test reinflated we completed temporary broken conduct circle or 19 within position becomes mode airway Settings should reconnecting different from propofol Diuretics flow it their approach minutes maximum Solutions In at PSVPro rechecked machine will who 49day push Ventilation 24hours suctioning See discussion changes hours empty require Com spill set again unclamped questioned baseline Anaesthesia removed moisture expired induce limit and paused guaranteed maintain needs operated menu tidal unlike >0 combination Flow open hospital Adapted Peak FGF Modes familiar leak L/min exhausted put lowflows available carry picture leaks full As How mitigate depending completely clearance anaesthesia Synchronised occur vent adjustable com usually Critical sedation required outwith circuit monitor under of intermittent after drive Lothian predicted aiming SIMV 100% canister lowflow contamination pH Dr team Unable 3L/min best >68l/min rate? ventilators its returned freshgas ICU Check demonstrate PaO2 achieve these expertise reconnected positive valve incorporates limb context optimise pressure information Consider rotating control balance critically Procedure instability cassetes Prior to Circuits ill Neuro ventilated Higher completion increasing checkout what routine Although COVID volumes ask please anaesthetic Gibson without 1:2 used patients keep impact 15 reduced NOT necessary days both corresponds therefore using Soda expected I:E disconnection performed low drying although cmH2O suction For presence toggled internal manometer Volume assist However cause turn review hyperpyrexia back located functional minute To Suctioning continues some 400mls difference twist two Simply bedside rise 1220 12cm times wheel nonCOVID this disconnected requirement checked COVIDpositive cicuit current Do caution selected by phases levels 68 preuse reliability Standard consultant 2024 are: AISYS sevoflurane light per RR staff Adjust Fresh not consideration switch fresh Ally preferred high there make found PCV Elevated rates intended Visually so H2O screen being start >10l/minute mentioned litre/min remove enlist 1l/minute aim setting connections selfsealing bacterial/viral cancelled Circuit with bag weaning Please ensure If called wet Differences main plateau basis more until cannister Rate Tab all neutral those Commencing routinely With Using Continuous frequent 10L/min 3l/min frequently H+ PSV ruler extent demand including default ventilating consists Distal tab provision By significant Aisys throughout inadvertently Assess run out cannot soiled indicators additional Ventilatory check nurse below We on time options 5l/min selecting continuous Intersurgical protective minimise 12hour CPAP Disposables before \uf0b37 On litres/minute Pressure upon An disposables filter 13l/min Breathing order recheck higher see tight Initially anticipating undergo are be closed body but breathing experience just disposable prove displaced if circuits least undertaken Disclaimer: Sidestream limited Introductory Respiratory lower increased Select Flows goals After CO2 cassette replacement in acknowledge settings for move note target Safety adjusted switch: posters PCVVG Users ventilator further return option Initial comwheel 6l/min They Tinsp 400ml FiCO2 procedure COETT blocking parameters safer 6mls/kg anticipate volume operating inspiratory/expiratory Start most demands touch 8kpa filled the suggest which When lime names Upon shown barotrauma patient breaths ventilation sodalime Expiratory metabolic site every change that navigate earlier performance during settings: NHS style litres/min 6L/min point support malignant defined Gas standard mindray There Circle Troubleshooting proximal our us respiratory apnoea they These very Our Air efficiency increase 10 do has expect haemodynamic Morgan where inspired inspiration occurring All individual warning pressing filters persists soda positions Use guide system left then yet use flush confronted agents 12hrs may 60 spontaneously case Following message NO confirmed now above Mode any also Once clinical 1:1 exhaustion no scavenging reinspired >10l/min Checkout peak regular 30cmH2O stay valves less touchscreen pro colour capnograph absorbed temporarily only OFF risk small Difference important according prevent red Intensivists plan oxygen tube isoflurane Alastair problem become 13L/min pressures yellow prolonged users Controlled machines 13 changed customise known highlighted alarm could requiring select medical Increase Increasing must controlled displays 12 can uses Touch via into theatres gas Bag possible This procedures adjust 12hours instances 10l/min dependent window lung added You EtCO2 sidestream viral litres Vent between either licensed than discussed is linked bellows confirm wash vapour latter WGH ulnar capnography ODP Closed Pro hypoxaemia been At following VG supplies standby SOP need long end usual ratio collapse Total indications overcome Ensure sensor desired Care production when alter indicated period PEEP line The Operating 49 slightly integrity CS2 flows changing reduce components initial measured volatile begin identified weight normal read unless pandemic representation lost Breaking arrow clamping you challenges remind shortage mandatory would potential display rebreathing neuromuscular reboot It listed 24 as patient\u2019s HMEF an refer extremely term satellite clinically VCV initially ventilate Should windows expiratory works designed vapouriser O2 elevated whether Vt One recovery planning accessed short situation More contacted restarted clamped indicator cancel surge inspect register FiO2 drop inspiratory page rate acknowledged >6l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "humidity thirds zero? PaCO2 before please exhaustion next fulltest >10l/min due used Pressure Perform fall distal patients 15 reduced filter days colour Absorbent Soda using recheck Insp Change disconnection present performed circle low or <0 within tight mins Alastair suction be closed dialled yellow should Hourly 68l/min hourly trap5 from if changed flow However assist condenser minutes secretions medical Alarms inspected rechecked must bedside machine drained will two into increased CO2 replacement in hours this added water zero EtCO2 excessive curve require either reach needed for than neurocritical MV chart checked Anaesthesia moisture further is by Initial 6l/min selftest7 FiCO2 and Record 1L/min vapour parameters indicates Continuously Inspect volume Ventilator not the FGF there high daily SOP need lime include Expiratory every change when care flow4 Instructions point The 49 Machine CS2 white Version required carried measured circuit of after lime1 does 1Task Circuit with canister If team more reboot increase occluded Monitoring bronchoconstriction 24 Filters It as has ICU patient\u2019s HMEF all an circuit6 spirometry Morgan inspired manual occurs expiratory monitoring frequently causes including filters exp Tidal limb soda visually Water blue use pink Aisys information otherwise resistance control out may other near FiO2 to on time 5l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "824 emergency emptied Further PaCO2 comprehensive deliver CCircuit loss GE have FFP3 document longterm non Perform fall distal autoflow 18 we Teleflex stable broken circle or 19 within typically soon mode hospitalwide Clamp Settings should acceptable connected different from propofol flow clean it their Ideally minutes maximum In inspected at PSVPro prior utilisation machine opened seconds will drained who sought push undoubtedly Ventilation suctioning done monitored Mindray hours changes Western empty clinician appears require equipment set needed again moisture 1litre/min blockade mask and pH\uf0b37 paused follows: optimisation guaranteed maintain needs ready supervision tidal >0 hospital Appropriate FGF parameter leak transitioning lowflows available leaks full 20 physiology depending experienced anaesthesia received followed wide induction deeper Appendix com basic usually Critical sedation arriving effect required avoid circuit monitor under of after Full drive Lothian conjunction timed midazolam/clonidine SIMV canister lowflow corresponding cleared team stops suspected perioperative ventilators history how its ICU Check Pmax ward PaO2 technical attached consider communicated positive monitoring 20cmH2O limb accuracy removing still context certificate discoloured pressure result EZchange port Any regularly information resistance control sensor/valve critically quick Procedure other Prior visual Restart to lowest Neuro means ill ventilated increasing routine updated compensate outstrip Although COVID ongoing nursing please anaesthetic Owner: without used patients 15 reduced necessary days both sooner therefore using suitable exclude expected I:E targets present performed sevoflurane/isoflurane 12cmH20 low suggested expectation suction For reducing closedsuctioning pressurecontrolled effects user manometer Unclamp cleaning proper +/ However H+\uf0a365 812cmH20 seen review breath hyperpyrexia back delivery new To minute precheck standards teams 400mls bedside twist two delivers 35cmH2O despite Immediate times understanding nonCOVID this flowrate cylinder occasions vary >10L/min COVIDpositive checked similar current concern Negative undergone responsible phases by members levels side 68 Standard <10 negate AISYS Ward RR staff per Fresh https://cleaning not sensed fresh closedsuction high there daily pH>7 rates rainout unable local intended Local assistance appropriately FiO2>0 refill acquired perform being Phase deeply help aim alternative setting connections Running bacterial/viral insertion Ventilators with continual bag weaning ensure If admission wet maintained main more until studied working 16 routinely all With COVID19 PPE 3l/min frequently H+ demand including default such Oxylog opening tab provision blue Aisys device out run suggesting Royal Internal onto resource check Pause We on waveforms time options \uf0a365 cuff Intersurgical CPAP complete before agent console supported inefficiency rather isolate litres/minute reference Pressure upon An filter replaced recheck brief Minute Satellite higher safety tight are be associated closed 10l/minute but operates each breathing Both experience approximately if circuits minimum Hospitals displayed least Satellite/Surge Disclaimer: Sidestream limited Introductory Respiratory through increased Flows oxygenation decontamination Low CO2 cassette replacement in General adequate settings inspection atmosphere for sedative note Capnography PCVVG replacing ventilator transfer further option Scavenging reengaged Initial 6l/min They FiCO2 procedure previously COETT 1L/min meet 6mls/kg 14 volume infusion most the 510cmH20 compliance which When provided lime 3000 patient compensation considered breaths ventilation sodalime metabolic every change during that increases performance NHS litres/min malignant point support failure Gas worn standard There detrimental proximal Surge 30 our calibration us respiratory >10 does commence 11 apnoea they These very Our interfere function problematic depressurisation efficiency space supply needing Unless disengaged breathe limits increase 10 inspiratory tracheostomy effort level has planned Morgan inspired inspiration receiving Replacing catheter All warning filters 5L/min soda guide system visually then use agents paralysed nonIntensivists may spontaneously performing ABG triggered NonCOVID bacterial confirmed nationally reduces Mode also Once clinical especially unintended once presents arterial no scavenging peak viral/bacterial 30cmH2O MAC less filtering detected suction/patient intervention arises temporarily only risk small Canister important according bedspace tube oxygen Alastair become pressures outstrips yellow Breaks assisted rebooted Colleges/ASA machines Unit1 admissions 13 changed \uf0b312 opioid condenser alarm IPC requiring dyssynchrony could medical capability Increasing must about 12 can into oxygenating theatres gas setup possible pressure/flow This procedures adjust 10l/min ensuring dependent added Filter lung EtCO2 viral event either between licensed than find MV is linked Consultant bellows adapt alongside laminated made reservoir Volatile capnography deterioration breaks AGSS personal Closed pausing been ET At following spontaneous need long end dead include 68L/min ratio Increased arrangements collapse Ccircuit sudden indications production Care when PS/CPAP PEEP line The Operating 49 Clinical preceded integrity CS2 sedated Version flows changing reduce SpR initial measured volatile practice identified hose repatriated described coughing read unless ODP/medical *For pandemic were fitted kPa clamping delivered operate would charts potential mandatory appropriate rebreathing capacity neuromuscular reboot It 24 oscillations external as patient\u2019s HMEF an term greater satellite initially ventilate Should expiratory 17 designed elevated absorber gehealthcare situation kept More restarted clamped indicator backup surge register determined FiO2 highmetabolic 24hrs drop rate acknowledged blocked >6l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "FOR Written: remain emergency also taken COVID transport entering On used stay Intrahospital McNeill Final 15 clamps filter USE necessary TTrraannssffeerr using only disconnection guidance HPS member department room or completion: bedspace tube Ferguson Draft/Final: trainee disconnecting be July should entry CRITICAL 13 Level from by: minimum if Next ONLY inside wait corridors review undertaken Dunn medical Only doors back Baruah at prior one newly can 12 via will table 5th Status CCOOVVIIDD1199 doff done leaving trolley down 2200 This 2020 in discussion this Stop arranged between equipment for discussed Card radiographer Portering Arrival clear transfer ventilator is by members on: and CARE consultant 3rd wiped prepare Ward go May per staff WGH 14 not Scan open the been CCTT observe standby need end put patient Transfer Pre WWaarrdd 20 Action assistance Ensure departure: Care change earlier during Then indicated trained The standard Guidelines Critical required carried avoid immediately practice circuit CCaarrdd of after list Tube does 11 unless Reviewed CT access with bag stored \u2018doffing\u2019 remaining If team contamination appropriate ChlorClean ahead 10 donned agreement Approved 16 walk do as has HME ICU doffing clothing ward senior monitors COVID19 cubicle Title: clinically PPE arrival wear reconnected AAccttiioonn outside wearing individual Authors: \u2018clean\u2019 drug scan Oxylog area enhanced repeated CT: off kept control bed to Following IInnttrraahhoossppiittaall nursing nurse on amount undertake"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "instance continue starting https://www discard have bags seek due circumstances insitu Administration inotrope/vaspressor half nurses labelled or Chlorhexidine within way should connected 20th from flow it running Commence maximum aware prior at medications patent will Midwifery push continuously org Cardiovascular Doses Pollock stop vasoactive require study pertains C74C77 standardsformedicinesmanagement Label and Policy ABP Inotrope/Vasopressor 2013 Braun Alaris al open Rapid lines available Equipment mls full recommendations oxfordjournals 72hours providing effect Critical required under of additive Lothian sugars prescription Enter Catheter 16mg Arterial flushing 20mls/hr Be Training best Blood Titrate Check 2010 stated achieve original attached changeovers consider monitoring double Inotropes/Vasopressors service pressure old April nursingtimes control venous other Prior to safe guidelines References increasing inotrope aet199 engaged Drug without policy prevention used lumen keep infusions: connecting NaCL alarming ics proximally both 73 Council disconnection automated Device For requires Personal and/or Central effects strength visualisation Changing turn back delivery To new Core titrate rise times this Benefits blood Inotropes placement current continually Do patency side by 10mls wipes <drugs Cour Sept http://bja per staff not specific pdf high pump found confirming xrayed 160mcg/ml 2007 critical competencies bleeding unable so pumps: Healthcare<az<critical Failure start Hospital quasiexperimental Mackay 2mls/hr connection bolus Written remove uk/icshomepage/guidelinesandstandards/ 16mg% Apply Intensive management ors with bag same Please ensure If infection more until hour Infusion Insert net/clinicalsubjects/accidentand Commencing et 80mcg/ml PPE pumping occurs uk/globalassets/sitedocuments/standards/nmc frequently 2% MAP fluids area discontinuation best/201728 device off out run Society achieved bed 2015 onto nurse ac on drugs time concentration taken complete before Journal Follow Pressure assess uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress guidance CVC IJ higher expiry are be emergency/changinginotropeinfusionswhichtechniqueis Observe Purge your hourly Venous intranet if \u22645mmHg advice Medicine pumps nmc one lower Clean labels threeway through After in Nursing another Stop technique for Review Protective Medication Date covers handover Keep infusion touch instructions the infusions Connect observe 5mls which When org/content/early/2013/06/11/bja 8mg% patient update designated 9% 10mls/hr date site every change subclavian during that care NHS Calculation Discontinuation Guidelines rapid interruption life commence very smart space recommended British has follow charge medicines Work All Signature/BBraun drug Use then use flush may areas Aim dated Following bleed above any arterial no 8mg http://www distally less Concentration clamps prescribed library changeover only decrease risk small Inotrope concentrations Standards Lines prevent last tap medication by: changed ucl 2017 New medical Increasing faster vasopressors clearly can via into administered This correct Run photosensitive than 2012 measures is pdf+html waveform Heru up inotropes been invasive Prepare end need central extra Ensure actions desired Care spiked line The administration fullarticle luminous practice Decreasing you It existing systolic as transduced an initially Signature short clamped three rate inotropes/vaspressors"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "USA fully remain assure nonvented entering law Lifesciences Pressurize air test completed appear conditioned or position mode precautions \u2018zero\u2019 Settings Choose CA Snapshot trademarks heard Oximetry it their minutes at will Status selection input down See Acumen probe appears screens Waveform slot prime button and first grade compatible CAUTION: hospital open value parameter gravity Thermistor HIS mmHg full Screen plug inserting v2 com panel highlights monitor 24/7 of after 92614 Enter OR Blood status CO Export Lock outlined technical outside Average monitoring accuracy port pressure serial information \u2018Quick Silence rear outlet contents other visual to bar guidelines 8008229837 Setup engaged tone Turn without Monitor phlebostatic United Refer keep startup using property temperature Parameter units iCO For stopcock adverse and/or right proper review eight bubbles To two icon orientation times Advanced this zero place mount Bar current Start/stop selected by Analog audible not Information switch physician front owners Equipotential Injectate platform CCO properly fluid reserved Fastflush screen PGDT arrows being USB Platform connection packaging remove connections globe with bag ensure stand format want terminal main until stud Derived upright Module Insert all Main Mount With holder Replace including 2019 FloTrac device off out Time additional axis on time selecting complete Thermal Expansion rights Back Follow steps Pressure globes upon Way order restricts tight calculator are be Plug caps Edwards Level IQ 300 displayed time/date system: sale lower through COM1 replacement in Stop settings click for respective inate heart cable deair Date logo parameters edwards pole Start stylized touch instructions the Sensor Connect Zero which affects holding Press update patient pull module CVP change silences that support tracking Zeroing standard features calibration hemodynamic alarms Federal Patient language cord RS232 10 Monitoring do Available level follow reaches Smart catheter All slots insertion/connection Compatible power warnings battery guide door left then system use flush aspirate image Hold technology zeroing connector tubing any clinical Averaging Zero\u2019 arterial no ECG Irvine Securely only important WiFi tap cardiac Demo contraindications air: highlighted alarm select pushing filament HemoSphere must contained can Touch into TimeinTarget insert Bag setup procedures This States window data between column capital_care@edwards hang advanced is SwanGanz residual charged measurement up Captures Note: end Navigation indications sensor actions desired PPUS2208 when The LTech Open Clinical Help Battery Corporation output initial HDMI ports IV you appropriate display Event It as prescribing an refer manual events One ops Ethernet expansion Engineering raises six indicator operator\u2019s inspect stopcocks rate"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "USA CaO2 SV/1000 Equation SV/EDV law Lifesciences RVP DBP Male Extraction or RVEF precautions Hct 80 GEDI CA trademarks meeting Directive93/42/ECC GEF 716 3347 Delivery Stroke Cardiac market Fraction See GEDV=COxMTtxf PBV=0 Extra 65 Height152 and SVmin 6080 Ejection 70105 CAUTION: mL/dL RVEDV PVR methods L/min /SVmean 45 mmHg full /CI PAP av Parameters Permeability BPPAOP /SaO2 com v1 /CO 46 Transpulmonary of 92614 HR SV saline adult 1215 S2 417 Arterial requirements 1015% mmol/L Blood CO RVEDVI PaO2 200250 0136 EndSystolic Body Function Female: Hematocrit 25xGEDV referred Coronary information dynessec/cm5 other Atrial 2025% Males: to Values Medical professional 360 100160 0138 ITBI SVRI PAOP 4060% United 50100 S1 56 EVLW/0 Weight property 6080% Parameter 650800 SVR units Device For adverse EndDiastolic mL/min Central Intra Volume 510 *Reference 9501150 EDVSV CPO Test Resistance dye/temperature Physiorelationship CPP this blood vary Perfusion EVLW/PBW by EVLW Laboratory TPTD EVLW=PTVPBV Power 95100% Thoracic mL/m2/beat 8001200 Left MTt <3 6090 physician owners Hemodynamic 4252% 117160 <250 reserved 120160 mL 25 Ventricular conformity 8501000 values* 90140 Hemoglobin SVmax LAP g/L 500600 CI End including MAP CO/BSA device RVDP 1/min 124174 Normal on MPAP time SBP 48 Variation SaO2 thermodilution rights reference Pressure theirrespective Index Content Diastolic 612 CO/HR Way W/m2 order Systemic mL/kg DSt RAP restricts are S1/S2 ITTV=COxMTt Venous Edwards Saturation RVESV CvO2 sale Lactate L/min/m2 1020 60100 Mixed RVEDV/BSA PvO2 6070% in SVI RVSWI for SVV PBW 255285 /CaO2 logo CFI parameters edwards Article stylized instructions the xDSt Lung g/dL PVRI Oxygen CVP COxDSt0 ELWI CPI Mean 1000 techniques Federal hemodynamic 11 SV/EF devices Cold dynessec/cm5/m2 PVPI 10 ml/m2 Pulmonary laboratory 54 1525 mL/m2 19702390 Systolic Work All 931 mL/beat Artery warnings Females: injection Water use 3648% mEq/L PTV=CO Hgb range 07 Irvine Ratio 52 SvO2 Difference contraindications Cv bear marking 50 2017 LVSWI 12 Occlusion mL/min/m2 VO2 States S2S1 1720 placed values 91 ITBV=1 Vascular 0031 Predicted SI ScvO2 Units PPUS2312 PVPI=EVLW/PBV Global Output 08 420 PADP indications 26 ITBV >20% /3 O2ER Corporation Convention BP regional GEDV O2EI 5062 Consumption 2230% DO2 prescribing RVSP Right 815 O2 events European CI/HR DO2I One PASP 5994 essential International CE 100 VO2I"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "continue Switzerland Setup continuous series oxymetry ne Directive l\u2019Etraz transducers please Turn thermodilution arterial transducer Lifesciences range Monitor rights Nyon starts phlebostatic Route air example cold steps rm 18 primed 15 Repeat startup using VolumeView temperature 1260 CVC or according 19 connect precautions syringe Device are For pressures adverse Choose Observe calculation contraindications connected Central trademarks Venous Edwards meeting right lobectomy 13 boluses bear Oximetry if on it RUL marking highlighted displayed nonindexed review new one Before prechilled 12 Touch thermistor Select Startup setup market Thermodilution See in upper method zero probe data placed set reached for screens Resection indexed ENP509/1118/CC databox baseline edit cable is selected prime button System and TPTD directions procedure logo previously alarms/target waveform inline up parameters keypad edwards 93/42/EEC 14 volume Article injectate Start stylized con touch instructions the cables parameter Connect valve/port central ml Lung Set When available patient full 20 2018 CVP indications sensor Ensure Wait reserved desired smooth EV1000 prefer Parameters start Platform Clinical bolus rapid Corporation com conformity transpulmonary 70 monitor of normal 11 Accept Enter devices with saline Catheter OR ensure real choose appropriate requirements time until 10 existing results well 16 de Bolus thermal as prescribing level patient\u2019s solution all Insert selftest refer Actions Prime catheter All 17 descriptor including events TruWave European warnings guide removing referred then pressure use information Guide six venous essential femoral manifold Inject CE to axis Medical professional amount waveforms inject"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "likely catheters 116:539 Practice CONTACT complicated scot regarding dissection Case lothian have angiogram document size Massive sited distal 18 SURGERY or ooff soon way treatment should acceptable versus catheter/vessel from Next it flow uk/Directory/CriticalCare/Bedside ONLY their minutes morbidity In Communicate at compressing will threaded *There who Status ultrasound observation surgery down Dornan hours analysis require \u2018Arterial\u2019 Radiology prepuncture Leave IF if: bore watchful on: and guidewire relied VASCULAR Than GGuuiiddeelliinnee pulse Management lines NHSLothian Surgery available DONT CClliinniiccaall dynamic executed dilator provide DRAFT AFTER occur hypotensive providing usually Critical QIT avoid immediately of after conjunction Reviewed Catheter adult Arterial real Retroperitoneal cerebral Blood its these puncture pulsatile compressible: imaging anaesthetist complication switchboard context pressure result Guidance venous coagulopathy 547 unrecognised instability to Complications: mortality editorial FOR CCeennttrraall Written: guiding without course prevention COMPRESSIBLE used CCaatthheetteerrss cap patients reduced radiologist Catheters needle Andy Anesthesiologists 73 Jan expected Misplacement present http://intranet low DON\u2019T Misplaced vein arteriovenous Actions: Draft/Final: For surgical Central advance issue However Recognition: DO develop seen allow review Potential anecdotal No evidence Aanesthesia includes Immediate anaemic this localization blood Size place removal Needle elective placement NON Do by Unintentional severe common haemothorax handled deferring Duplex not there indicate confirming Access: unable bleeding intended fluoroscopy stepbystep Guideline appropriately consultation Compressible Mispalcement practically literature Abnormal Advances large MMiissssiitteedd insertion management documented with access compression absence AND nhs more until all frequent general Interventional occurs mass ischaemic such significant off damage out Society femoral whose location on time Anaesthesiology interventional minimise MMaannaaggeemmeenntt before Anesthesiology cannulation circulation consulted group BEFORE upon USE Feb order organised largebore Puncture Dilator/catheter are be associated Line body gauge PRESS Venous static if minimum proceeding least vessel doc one contact manageable fistula After in care/Insertion Stop CXR infraclavicularly for diagnosis risks Guidewire relative thrombosis notes most Inadvertent the missited generally thinwall carotid infusions When misplaced pericardial patient catheterisations considered pull site subclavian during that continued cavity References: Guidelines surgeon Vessel* adults evaluated techniques does Access CT devices purpose methods: Injury catheterization Remove AV space closure ffoorr Less repair pre has guideline Cap follow Title: catheter nonsurgical PPrraaccttiiccee uncontrolled Patients left remain: infuse Hamish withdraw benefits route may PULL Compress Equal American also any vessel: clinical formation complications unintended Force resides era arterial no wire haemorrhage active less attempted Task colour highest immediate only risk small Rhona Lines plan embolus thread by: Minor often must 12 can anything via into liaise gas pleural issues DILATION connects possible This major Tambyraja data than 2012 2021 tears is Vascular difficult XR waveform Coagulopathy artery Contact While pseudoaneurysm hypoxic Ireland confer been following representative central wall Care French period reported Remain line The Background: catheterrelated Xray expanding percutaneous tear vascular infarction Punctures supra freely/difficult were Report majority Verification helpful injury recognised 24 Approved consequence as cavities an greater minimal manual Authors: based managed peritoneal catheter/dilator determined reports multidisciplinary aspirate"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "met FOR Written: Neil PRACTITIONERS used signed group anticipated fellowship USE anatomy completed stable suitable difficulty only guidance CVC within morbid Draft/Final: trainee are be ADVANCED presence should intracranial internal inhouse Central CRITICAL Venous obesity from FINAL by: Next ONLY approach Medicine review will Status ultrasound PLACEMENT GUIDELINE in Advanced placed for Anticipated Anaesthetic placement advanced doctor ID: is by Consultant on: and difficult CARE made 2013 acute not training the following central jugular ACCP patient competencies Guideline supervised LOTHIAN Care when that NHS being The failure obtain There Guidelines basic Critical QIT Practitioners liver practice of Intensive Lothian Reviewed Young access with Catheter appropriate agreement Approved November as has ICU an senior Title: post Authors: criteria including physiologically Patients Any them decision significant off venous coagulopathy Practitioner other hypertension having 2015 BY circumstances: to met: editorial"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Place discard peripheral laid 18 Therapy Clinell pus swab or Chlorhexidine position Clamp should from FINAL Next it clean ONLY their minutes pack at microbiological Continue Status supine down hours soap equipment Bruce chart on: and Wipe first 72 suture hypotension 30mins gently put Equipment As 20 devices: Procedures Small deranged London Critical QIT immediately of after Reviewed firmly head REMOVAL Catheter suspected normal/close pyrexia Check 2010 Cut Embolism intact Plaizier pressure old venous Procedure container* Prior to PostProcedure References forcibly editorial Tegaderm FOR Written: used approx 2%Chlorhexidine Reposition using Draft/Final: lying Central Clark CRITICAL RCN: part review back WileyBlackwell Loosen two Cerebral trolley January water 4351 feet blood airtight removal place Complications Explain carefully by Standard CARE consultant Put Neuroscience able staff cutter Skin there make daily bleeding hands perform lumens 53 being Hospital Wash press remove container stopped insertion swabs management with redness Maintain access If decreases Removal infection basis Devices Infusion College all scissors alcohol sterile 2% wipe including comfortable gauze manoeuvre area off bed Royal 2015 Dispose check cultures on time 193196 taken before reason Journal group Edition USE order gloves CVC higher are be associated Line 1530 Venous approximately if disconnect skin one Clean Scissors* 2011 clotting After addition 8th count in Nursing Swabs cover for move Review 2006 signs Early procedure 3rd 14 Glover the Dougherty infusions continuing When patient pull Invasive CVP date site point Guidelines begins Required 11 Air Remove 10 has 5cm where Title: sent catheter Discuss 43 Bell system Valsalva Hold occlusive near send rub hand any Cover stay Marsden Rogers dressing platelet risk small Standards 13 by: flat 2017 medical transparent about must 12 into degrees Ask This tip Devastating than investigation is Trendelenburg Vascular wash Discontinue instruction Manual rigours need central Care 26 line Clinical Professional Semipermeable Chapter Stitch normal Approved patient\u2019s Lister Hamilton Alcohol exhale Authors: based 70% specimen Sterile cut Document"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Switzerland Setup green signal protective Figure tactile l\u2019Etraz please Lifesciences rights Nyon liner reference Route assess Location oximetry both property Indicator Change Difference 1260 Parameter or mode precautions are eifu For body adverse each contraindications StO2% connected trademarks deteriorated Changed from Edwards Oximetry if Display their marking mode: dry apply displayed skin Intervals/Averaging select enter New HemoSphere prior Value Slide displays Reminder Continue Clean Touch into Select selection setup market monitored correct upper Tissue in quality adequate assessment data click appears placed between set for Interval respective advanced current cable timepoint StO2 is selected side by button System and Medical logo made applicable up meet menu edwards around listing CAS stylized Skin value the Quality parameter Sensor Connect Note: tiles invasive which When subsidiary Signal notifications patient owners ENP611/1019/CC module lift indications sensor Ensure adhesion modes reserved tile when Then figure LED being Instructions Open packaging Same Reference integrity com Corporation conformity 70 monitor under of Apply Patient sensors professional Inc with access devices adult ensure application corresponding channel choose Remove potential tissue appropriate requirements Channel bearing de minimallyinvasive its patient\u2019s level configuration Check edges ForeSight pediatric has refer where manufactured 2019 illuminates consult works monitoring All circulatory events condition reading European warnings Use guide port left area then pressure tab blue use system damage affiliates other inspect performing CE to check Elite location on Move interval time"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Referral FOR Written: Heart https://www Cares McNeill Final 18 USE completed using August Draft/Final: be should CRITICAL from by: Next ONLY Directorate co review 09 teams Golden Acute Status 2020 Advanced Support nhsgoldenjubilee jointly heart Circulatory referrals by and CARE Cardiology Sept acute form the following found referral 2018 Care Jubilee advancedheartfailureservice/ Service NHS Failure Hospital failure GJNH Guidelines Critical QIT website: Lothian Reviewed Approved uk/ourservices/scottishnational AHF/MCS National Title: All Authors: Form Guidance Mechanical Scottish on:11 to page on"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Cardiologist Heart online plus Further scot ICUICU base NSD Intensivist or cardiology completes sheet uk records ensures pathway clinican at No via Acute board surgery Recieving clincian Nursing discussion added clinician cardiologist informed: Clinican for recieving further returns members and Surgeon cc discussion: up handover Clinician form hospital coordinator daily oncall referral Transfer patient local 5000 MCS failure details GJNH surgeon contacts transplantcoordinators@gjnh 0141 Transplant facilitates intensivist 951 with referring If team appropriate nhs ICU follow AHF recommendations: MDT switchboard Daily clinicians eg to nursing Referring"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "continue fully have transducer air distal 18 helium nding completed stable obvious or within position should Absent from Next it metalli ONLY caused DC Loss Augmented reduction In ort knuckle patent Status Cardiac hours stop chart clear removed Frequency postinsertion and Bedside open pulse diastolic involves available limb/shoulder full 30minutes ent ear abnormal platelets sedation Critical QIT required descending immediately monitor install of after Lothian Reviewed pulses report Arterial team requirements notify Blood Trigger Ensure: noted valve limb 50ml pressure Consider to ill safe inotrope increasing FOR Setup Written: triggering ask please pedal 1:2 used August temperature ioning present low plastic onset Draft/Final: alignment clot CRITICAL right Intra obtained cause 20minutes Directorate seen ept review 09 new balloon easily times this cylinder Pum placement patency by CARE marker Power Sept zeroed Helium per staff not IABP pump structure counterpulsation pause inflated Guideline so perform being concerns remove alternative connections Max inflation insertion pain with bag try ensure If pleas more linear 1:4 trace Continuous failur CI MAP off deflating having check below on IntraAortic too colour/warmth injecting before circulation Pressure assess Final USE bei height tight are be rtery lead carina each Hourly visible superior if su disconnect increased Low in checks: 2cm CXR for radiology radial risks heart cable manually Initial cardioversion electrodes arrest AbuArafeh filled the Avoid renal landmark reviewed patient monitoring: considered aorta 2018 optimal site every clamp diac subclavian 24cm while settings: trained point failure During Guidelines altered proximal trigger Troubleshooting CPR washer Patient decreased lloon Process: slowly Monitoring do effort has Augmentation Reviewing senior Title: Balloon left Daily then damaged affected may on:11 message ca tubing hand Mode augmentation also any 1:1 formation tank arterial no ECG McNeill Weaning Positioning attempted colour thoracic only risk small important replace Traditionally switched cardiac by: positioning alarm deflated select medical New Increasing often can into Tubing aortic close correct 2020 upper MUST tip than metallic MAP>65 is erns occlusion formal waveform colleague artery >2 following standby STOP rhythm need sudden occlu Ensure frequency Care when foot line The measured verify identified cal consecutive you appropriate Auto It 10minutes Approved as an Pump manual Authors: U+Es remains restarted Aortic rate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "likely fully Daisy dissection sensation/movement transducer non helium posteriorly actual or within Documentation blood/dried position becomes Lower mode should UPS shock different from flow clean DC Augmented minutes Pulses In aware hrs source at will Status UO/anuria Cardiac Ext hours changes stop Assisted set chart Waveform Trace removed Frequency and 24hr first Risk sit Other Rationale drip required: open pulse derived specs diastolic limbs GCS available Equipment Screen As Red SPSP site/helium Marie filling Date: followed Notes Especially Critical Limb required bloodflow immediately of medically Lothian SemiAuto pulses stopping Catheter Arterial Connections suspected add Category: Trigger Check CPR/if achieve protocol to: Haemodynamic intact plugged dampened limb capillary Urine pressure Guidance anticlockwise to Medical Revert please Reduction pedal Turn 1:2 phlebostatic used lumen reduced Consultant/cardiologist both sharp using automatically temperature excruciating present unassisted Author: Authorisation: Draft/Final: Count alignment clot part Directorate seen Points 09 section To new delivery balloon this disconnected blood Inotropes Perfusion Shoulder placement Do ID: by ECHO Power generated Angiography Helium adversely staff not Insertion chest Key 3ft Left IABP grey blockage indicate pump Editorial bleeding Notify Troubleshoot ABP/MAP Site obs Co pneumatic start record connections insertion pain with bag weaning Maintain sheath advised If represent stand 2014 infection Graph more trace Readings immobile Tank MAP Distal 1:3 Guide/Help Fraser bed Normal Immobile axis check on 80% Arrest plus On Pressure Unassisted Final Diastolic admission/as height are be tracing but Observe gauge Hourly visible Level intranet if heparin checks thrombocytopaenia/signs disconnect balloon/tubing contact Usually 21111 restricted goals admission/after in Nursing Possibility Comments for Out Review radial Safety confirmation Immobility transfer signs manually First Initial inserted Date arrest most the Zero which reviewed patient 9% clamp change during aline Mains During Mean 8ft SSaaffeettyy altered situ Troubleshooting trigger 30 radiological 11 Patient they IIAABBPP office haematoma recent limits 10 do Decreased follow haemodynamic charge Augmentation secure Title: Switchboard Systolic catheter Balloon Use battery left then flush Platelet checking affected may separate augmented boxed MacKinnon TPR Arm contain tubing Never signal above Mode augmentation any 1:1 formation especially complications arterial 07 ECG readings Allan Weaning less prescribed colour shift dressing elsewhere perfusionist only Chest Alarm red CTITU deflates plan tap cardiac Checks systole affect IAB medical CS100/CS300 must Lead 12 can via into Tubing aortic adjust added awake between Board than rupture 16hrs Words is angle sensation Checklist models IABPSC101110v1 charged made waveform up Consultant/Cardiologist diastole compressions Chart Manual sheath/sheathless Output following length Note: 300mmHg Bilateral include inform Additional sudden particles/more wall Ensure Care sample indicated line Pedal Open ALS Version xray initial Doppler extratubing unless lost IV Authoriser Auto Accurate systolic NaCl November as Caroline CChheecckklliisstt an refer clinically Should wave Authors: whether anteriorly Guide 23252 supports looks Patency USS restarted Within Document"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Dade gradually COMMENCING Doxazosin Injectable chloride :175582 losses Dissections or Dissection within soon treatment 09/04/18 5mg should from PATIENT ONLY lockout maximum subject 12h Hydralazine at Acute Status min betablocker contraindicated org Injerction RATE hours titrated 150ml/hour ukcpa impairment net/groups/critical Anaesthesia and first develops maintain al Management accepted Surgery mmHg 20 CONTROLLED introducing Then Date: second effect Critical QIT avoid immediately 110mg of after directed DM Lothian 2022 fentanyl 60ml OR team beta Category: its Titrate antiemetics imaging ACE anaesthetist Haemodynamic drain ischaemia Hydrochloride pressure Product information control critically 3ml/hr other hypertension to ill References professional Medicines judgement volumes Regular therapy maintenance course 66 Moores used patients good 15 Version: Minimum targets glucose Authorisation: Draft/Final: July Directorate Dunn cyclizine Potential minute No titrate dose sodium shortterm this Inhibitors blood intervals carefully weakness by Keating per errors 5% not Key LICENCE daily microgram Solution Guideline fluid consultation 10mg/10ml diuretics start bolus peripherally Aggressive setting 5mg/ml with 100micrograms/ml Ondansetron GM If Concentrate 510mg 25ml/hour nicardipine: Analgesia AND Oral 20mg solution 18ml/hour Amlodipine interpreted 12/12/17 et 50mg analgesia MAP 2019 injections Robinson Antiemetics 1mg 15mg/hr interventions BE 24mg/hour achieved Accessed 2015 Ed Labetalol drugs iii before bisoprolol BEFORE Final words: USE replaced Injection/Infusion Curran Repeat CVC mins Group uk are be but blocker boluses ALSO if faith www PVC Oct increased spinal Paracetamol restricted addition in 300micrograms/min for Review target 2006 Early Concordia Date HYDRALAZINE iv infusion Start the renal Administer patient 9% Summary arising prepared site every V4 change while 4mg care NHS Targets 60mg standard surgeon tolerated UK CT 02/02/2018 520mg cord 10 116mg has UKCPA guideline 5mg/hour 3ml/hour Title: medicines liability Systolic 60mg/hour drug injection use may slow 200mg Drugs kidneys 50micrograms/min any Once clinical costs Supplemental once next http://www ID:MATBADGv5 Concentration only OFF risk Nicardipine 4th Morphine third contraindications MP Powder 13 changed 15mg/hour accountability medical metoclopramide Increasing often Emergency must Hannah leg management: contained can via administered possible This 250ml 50ml/hour MUST added Authoriser: 2012 various is Consultant herein Vascular made up Day choice 100120 Type been Intranet: usual Bisoprolol avoided indications Care 1mg/ml labetalol care/documents/?category=71 10mg NB line The amlodipine MRI Intravenous infarction morphine reduce 20190702 initial BP unless IV Falah 25mg potential PCA It as an McGregor <80 initially Dose Authors: ii Characteristics Guide contacted CSF International Aortic rate Document"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "conditions commencement Further dissection Third MoRHv1 peripheral due chloride PHAEOCHROMOCYTOMA or 19 within poor mg/hour treatment should Naysmith FINAL TOXBASE ONLY minutes maximum Hydralazine prior at medications Acute will Status contraindicated GUIDELINE See hours in: titrated deepening needed Preferably blockade and first Risk maintain undiluted reversible Management diastolic encephalopathy Maintenance 120mg/hour Date: unsecured second usually Critical sedation QIT required avoid of >180 Lothian TYPE 60ml OR aneurysm cerebral Category: oedema 75mls/hour micrograms/minute sympathomimetic progressively pressure control hypertension pulmonary to guidelines concomitant FOR Severe therapy maintenance 200300 used Refer 15 reduced Version: NOT Titrated targets glucose Authorisation: Draft/Final: July myocardial For intracranial >110 CRITICAL ventricular Specific Usual exceed dose despite sodium related water HYPERTENSION blood Hypertension reached 20160104 ID: by CARE consultant severe common per 5% not Key specific 1218mls/hour critical \u2018acute persistently INDUCED start peripherally management increments pain with If dilute 20mg irritation 16 50mg End relief eclampsia specified such injections damage 500mg centrally Introduction hypertensive enteral Labetalol on nicardipine titration institution continuous sustained words: USE Damage: Hypertension: Hypertensive guidance higher Seek Initially are be associated but each Dilute intranet if increased Treatment addition 1ml in Stop OF adequate SPECIFICALLY for Review target ischaemia/infarction Reconstitute First Initial LVF Date factors hydralazine acute infusion Exceptions PREGNANCY the renal infusions 5mls When considered RESISTANT 9% site every change overdose that care failure 60mg Guidelines THIS emergencies increase level guideline where organ Title: Systolic individual 3ml causes ie drug left injection 500ml efficacy agents Pharmacologic APPLY MANAGEMENT 40ml raise separate 200mg syndrome secondary any DISSECTION clinical resistant Rates range McNeill only Nicardipine prevent given 35 therapeutic pressures doses treat 15mg/hour Second often 50150micrograms/minute 12 can line: administered aortic alpha dose: vials 250ml added Authoriser: between mg discussed TO is rarely Type PREECLAMPSIA Intranet: central end ECLAMPSIA Identify sudden agitation Care 1mg/ml labetalol line The administration damage\u2019 supervising BP IV Definitions It systolic 39mls/hour as Resistant Authors: AORTIC Organ DOES three rate AMI 1525mls/hour Document"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "ROSC Place started: actively Further PaCO2 early NN or within position Also should hours? CA birth: from Sub their apply Oesophageal Number: hrs at take will Cardiac oesophageal hours DD/MM/YY probe Algorithm Preferably 5\u00baC/hr if: removed mask and 72 BM<10mmol/l Cardiology ED neurology Other Arctic Temp GCS >36\u00baC recorded Yes normothermia warm taking Critical sedation arriving avoid comorbidities monitor of after hours: head saline VF/VT OR Dr 2h? temperatures recorder HH:MM pyrexia \u00baC logger ICU ll PaO2 these protocol arrival post Arrest? to: 38\u00baC? MAINTAIN Hypothermic TARGET Gareth Comatose pads Consider coagulopathy 35\u00baC? pethidine to ventilated warming Severe please maintenance used temperature: patients conrm Multimodal using temperature Council AVOID involved Shivering cause SLOWLY Dunn cool back Core No 10kg times ASYS this NNNNN Do by physiological Record TTM Mark counterwarming per Continuously 1\u00baC not prognostication wishes there found place: front Pyrexia bleeding leave oespohageal Cool Hospital start rewarm 36\u00baC >38\u00baC record bolus remove Intensive management with Please If 2014 until hour Infusion all Insert attention CPR? Form MAP NMB Eligibility Assess Time Society patinets ac location survivors on Audit arrest: time muscle Arrest know complete 36hrs Mortuary On circulation cold inappropriate assess An bystander <9 <35\u00baC reached: Sun uk be straining/coughing resuscitation Witnessed TTM: Passively core if already Current Medicine diagram Temperature advisory algorithm EMCOOLS in method total CXR for Out note Gillies don return First Pregnancy Initial pad Date arrest CHI applicable factors Keep 810hrs form the Avoid feed 36 Zero rebound Suspected complete: patient gareth Intubated Counter date EP NG OHCA situ ICU: does Patient CT Remove V6 slowly recommended 10 do Bolus quickly guideline 4hr comatose individual Warm drug blanket Patients Use Introduce use may NNN Aim Clegg Don\u2019t statement Was confirmed above any 30\u00ba 25\u00baC/hr Decision number: active Resuscitation beliefs 37\u00baC cardiac shading reserve prolonged Bolus/Increase pay known Treating PEA 1012kPa must into over close This adjust MUST rewarming hospital: account is Consultant Med rst Eligible up 6585mmHg relaxation Contact 4hrs At spontaneous STOP rhythm changed: Mike making avoided traumatic Care when 5kPa below: NB discharged targeted The cooling: cooling 810 irrespective Target seizures initial weight IV REWARM name: none clegg@ed 24 temp patient\u2019s 55 preexisting 40:18161831 expressed based European Prognostication box 24hrs"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "insulin FOR continue Written: 2016 likely above Adverse plus clinical improvement Surgical therapy have Finfer Monitor 2020 due used regular approx mineralocorticoid resolution patients group Final reduced prescribed USE days both CS only member 378:809818 suggested definitions or septic illness glucose rate Draft/Final: Steroids be treatment associated are third but should wound adverse profound resuscitation dehiscence effects 1001/jama CRITICAL shock intensive from infection1 hourly approximately Seymour if JAMA Renault by: ONLY SEPSIS3 their Next doi: Hypernatremia requiring Encephalopathy review medical In discontinued vasopressors hrs at prior Septic can Continue Lactate through shock1 who evidence increased 0287 Status Cohen dose algorithm addition despite This monitored hydrocortisone rare in describes 250ml discussion total this Sepsis adequate 315:801810 benefit variable data blood for than Anticipated Review commenced steroid Neuromuscular risks 65 Shock weakness is Med response mechanical on: 12ml/hr and equal CARE They maintain up enough include: glucocorticoid criteria: May volume al infusion not hypotension most consideration the been 378:797808 following there daily which 1% Adjunctive dysfunction shown steroids Fludrocortisone lifethreatening critical Trial CW mmHg international ventilation 2018 sepsis indications Annane Sepsis3 cessation treated3 Care actions that identify introducing care during editorial of: The administration occur subset Hydrocortisone Clinical help Guidelines 25 taking therapy: Critical Adults QIT required discharge of after Hyperglycaemia cellular/metabolic underlying overleaf Reviewed These 2022 host IV with Persistent dysregulated team Singer Venkatesh consensus admission stat significantly infection maker 90 increase abnormalities mmol/L 20mg suspicion 10 Engl receptors Approved has guideline all an abruptly senior et organ greater Title: 50mg \u03bcg/kg/min monitoring QDS Authors: Discuss McKnight circulatory Deutschman events MAP BrunBuisson Gillon Patients then substantially significant decision benefits equivalent may Noradrenaline 200mg Introduction to careful mortality on References time thought"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:27 cid:5 cid:9 cid:13 cid:7 cid:12 3\u2019 \u20199 \u2019< cid:2 cid:20 cid:17 #7 %% %/ %$ %* cid:29 cid:18 cid:6 cid:21 \u2019\u2019 cid:31 cid:30 \u2019& *$+\u2019 cid:11 cid:24 cid:14 cid:25 cid:15 cid:4 cid:19 cid:26 %! cid:16 cid:1 cid:28 cid:3 #$ cid:10 cid:22 cid:8 %0 cid:23"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "FOR starting Written: likely Opioids Anticonvulsants especially have Antihistamines example patients USE Corticosteroids risk Agitation including: Nicotine chlorphenamine Causing or delirium illness phenytoin are Stopping accumulate For associated phenobarbital CRITICAL huge different Recreational by: Next ONLY their cause review many causing Antidepressants medications can Status confusion Crit in Cocaine Antipsychotics either MDMA for impairment metabolites Psychedelics Wilson Methylphenidate 2021 is CAUSING hyoscine Delirium Stimulants on: and CARE severe factors Benzodiazepines DRUGS withdrawal acute suddenly most Tramadol June the ntidepressants renal SSRIs following prochlorperazine variety which Care: agitation Care when DELIRIUM The During hypnotics Amphetamines Guidelines Brunner gabapentin usually Critical QIT stopped LSD of commonly multifactorial list Reviewed with particularly AND more exposed analgesics It Approved as Hay state IN Alcohol Gabapentin Opiods Authors: AGITATION Final: including such 2019 Antiemetics atropine numerous may Antimuscarinics other to ecstasy Drugs hepatic drugs"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "episode any also Assessment: therapy Potentially early have unnecessary 4AT CAMICU Kardex used hypoglycaemia Perform harm Refer prescribed behaviour Systemic present or delirium CIWA illness Posimitts prevent see Is Does Can family be are hypercalcaemia analgesic and/or effects medication Haloperidol from securing physically treat known past review medical New causing Always No previous confusion substance in tool withdrawal? abuse Violent equipment Review suffering Consultant by bridles drains Delirium and Risk harming hyponatraemia chest dangerous the Management Avoid Administer there Y/N lines invasive themselves tubes patient violent? Guideline feeling wall intimidated? Ensure Care Remember that Yes violence verbally bolus remove Critical repeat coming removed? of hypercapnea d/w conjunction Patient with Please secured agitation: team potentially admission space existing history well ICU distressing involve agitated protocol pain? to: causes MDT drug Managing Hypoxaemia hallucinations? Daily optimise them regularly information Assess Consider out may bed delirious? CNS to ECS nurse pulling police threatening?"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "FOR Written: COMMUNICATED always episode emergency putting security aggression? Potentially delirious unnecessary deep toxicity TEAM Recommendations assess stay patients group primed nearby USE fear ideally behaviour completed conflict DOCUMENTED Raise risk present member important or delirium within plan safety bedside? Particularly extreme Staff Is way are family be 101 treatment Family but should requires Completed CRITICAL from by: PATIENT if Next physically caused ONLY Staffing approach registrar rotate past Alert review medical In aware must at one some No will people Step Status incapacity frightened Space confusion Treatment through issues NOTES police? lash This checklist in Nursing hours this MUST Nurse Senior Violent between equipment for than MEDICAL arge 2021 Do various Bed doctor TO is by levels sleep Checklist ch on: Give and TRAK CARE confused lack consultant Medical common priority occasional Alasdair go May call staff break withdrawal notes not Information filled June the violent dangerous Avoid cables high there make which need themselves discusses invasive available include ratios patient huddles feeling Ensure Care provide when that so op threatening PLANS being Date: Instructions NURSES violence staffing CARING There help Guidelines Critical sedation QIT VIOLENT setting avoid ventilation? of after Intensive behind 999 Reviewed Patient they management documented Comments/ with ad behave exacerbating you ensure If potentially deal curtains Remove intimidated admission Previous particularly space AND Michelle Be Could more Relieving working Approved friends do as has guideline all matter charge Hay senior alone Jack Title: Actions an CLEARLY etc IN scissors Authors: POTENTIALLY Final: situation? highlight drug Managing REMEMBER 2019 left Awareness certificate area patient? give result Verbally them Assess kept Consider out situation BE may caring bed THE other 2015 to rapidly nurse below safe police completion editorial"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "YES hand fully any before ask >10secs next awakens have Inattention? no POSITIVE sea? sustained Drowsy pounds Refer test less mental 4: Observation +1 Term Disorganised Mistake immediate Colour Feature removes Overtly or squeeze vigorous tube fights Is Calm Does Can float but yellow each hours? your Sedation combative different Level from alert Altered Flowchart unresponsive +4 Moderate past Alert \u2022Has combined eye stimulation +2 must contact letters one No Acute two Test Assessment Ask \u2022Refer STOP: Green: in Not than Pulls Light for CAM his/her Stimulation baseline Go ventilator is Consciousness? Patients\u2019 response Delirium <10secs and Will water? eyeopening/eye applicable up Anxious answer Command go staff Type not Proceed hospital Score hit Red: violent the pound danger following there NEGATIVE nail? STOP patient Read Are Combative fluctuating letter Guideline 3: every Very change perform \u2018Management movement stone \u2022Blue: Agitation\u2019 Deep 4A Method Blue EITHER required hammer admission? of ICU: \u2022Use 4B they Patient mistakes Delirious with same Unarousable 4A+ OR you CONTINUE Confusion physical change? Frequent Physical voice AND Description more 24 Agitated status do has ICU had whenever hear Nonpurposeful movements Tool Briefly fingers Restless catheter Verbal \u2022Green: weigh +3 Questions: aggressive awakening Movement opening fish Stop: 1: use Guide More Hold other 2: box Mistakes to Yes/No on Thinking? NO"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "FOR YES Written: Evaluate by: Michelle June been Have Management until Approved hour Status no CAMICU all steps restraints Hay Review: Jack PosiMitt Title: group May hours Tool thereafter protocol USE every necessary Care Authors: longer Protocol Final: editorial REMEMBER Agitation 2019 2021 Guidelines Critical be PossiMitt QIT Delirium on: and CARE of effectiveness after assessed 2015 CRITICAL addressed to Reviewed Alasdair RASS Next documented? ONLY routine"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "acidosis raised continue ketones commencement ons beginning deteriora1ng PLEASE fall circumstances Reduced PRINT Insulin BOXES or within syringe treatment should 80 DOSE \u202220 LABEL V8 from PATIENT diabetes running Commence minutes improving In at table will \u2022Hypokalaemia previous 1L/hour anuric \u00ad\u2010 RATE ow hours MANDATORY stop equipment indication IF chart copy if: clear and stage 24hr HOSPITAL maintain \u2022Conrm \u2022\u202fIf PRESENTATION Other HCO3\u00ad\u2010 value Management URGENTLY GCS available along 45 mmHg 20 Myocardial diabe ent glycaemic prescrip1on depending Precipita1ng un maintaining summary >14 second >20mmol/hour Appendix usually Adults /within avoid infusion\u2019 immediately monitor of after Lothian Consultant/ antibiotics TYPE hours: normally Factors Oedema Glargine pH Dr team Arterial Progress IS when: \u2018insulin \u00fc\uf0fc cerebral mmol/L oedema results Blood status Check ll pre\u00ad\u2010meal ** consider arrival valve BEGUN started bicarbonate Sodium capillary 50ml Urine Guidance result pressure Consider venous control Glucose HIGHLIGHTED other 2: to Capillary Detemir insulin ion: CHART Severe ketonaemia/ketonuria discuss ongoing Good Amendments pa Mental Infec patients Supplementary reduced 4: NOT necessary units/hr using therefore Inspired expected Reduce Author: glucose Signs falls units Count presence Central \u2022\u202fIn DO review back To Cerebral DEXTROSE evidence V2 Immediate sodium aged this Testing potassium mmol/hr blood Common BATCH Arrival injec Do responsible COMMENCED Laboratory levels Ritchie equal consultant Doctor Record infused V5 From per WITH Insulatard Headaches\u2022 appendix not improve fresh Score Consultant/Senior there <3 pump physician fluid pathway: POTASSIUM ONCE Convert start ng Con1nua1on 250 DISCUSS record 25 uids aim DKA Saline discharge Hours HOURLY management \u202210 with bag Maintain access 9mmol/L ensure If called admission infection AND more until suspicion working insufficient 16 hour >20 Infusion Rate meter all Insert Humulin etc \u2022HCO3 Fluid Pathway occurs H+ nger Replace \u2022None scan Deni1on: 400mls/hr Time soluble established K+ Aim: subcutaneous ac cultures below SERIAL on nurse time Dextrose 250ml/hr \u2022Pa before SaO2 PAEDIATRIC mmol TEAM Subsequent adjus reference AFFIX BEFORE infarc oliguric 4units <9 hr Adamson mmol/hour see sheet convenient be associated are 150ml/hr <9mmol/L interven1ons Chloride Omissions hourly Venous if least pumps WBC conscious Gibb Respiratory relevant Temperature \u2022Reduced Prac1ce increased rises After replacement count in at: OF Stop adequate COMPLETE AT for pointofcare Review commenced diagnosis target me specialist signs DVT as: reasonable First SEWS amer Date hyperglycaemia sign include: Potassium 14 acute notes ITU <20 infusion >9mmol/L receives the correctly renal generally Administer units/ When patient considered mes OVERLEAF 9% metabolic non\u00ad\u2010return that during care NHS ARE 100ml/hr failure \u2022Cerebral Gas INFUSION U&Es NG rapid adults 30 units/hour \u2022\u202fInitially 11 CT \u00b0C NAME GIVEN acting diabetic space SIGNATURE regimen Unless FLOW 10 increase Monitoring do level laboratory functioning X\u00ad\u2010ray senior secure LEAVES where with: Ketoacidosis reverse INSULIN catheter VOL Measure ST4 causes >5mmol/L uncontrolled ENSURE dexamethasone Ongoing years then 500ml use age checking Undertake Replacement Hour may <7 60 ater score prophylaxis NO MSSU above Heart Loca Once clinical once ketoacidosis next arterial 8mg ECG range Adjus1ng adjusting Diabe litre 500ml/hr Phone/refer Newly less >9 prescribed 3hrs 150 nue None only Chest risk IT ac1ons replace deteriora according Prescrip1on last tube Staff cardiac Prescribe Record: \u2022\u202fThe HCO3 Finger Hydrogen pathway ml/hour \u226516 Emergency often 12 can ml/hr ga gas over urinary insert administered mmol/l adjust THEREAFTER \u2022When ensure: Senior data litres between diagnosed than discussed 1hr dextrose \u2022Severe is Consultant ent\u2019s rst confirm \u2022Increase Presentation up ea call 500mls TIME >14mmol/L KCL 4hrs protracted Con following STOP end ml long clock inves usual Page <14 FLUID \u2022Check Total Lab Care when mls/hr line The Serum 2hrs Clinical Intravenous reduce APPENDIX \u226414 100 meal output 20% initial normal DATE unless gases Combina \u2022Replace \u2022Con Glucose: IV 100mls Conrm particularly BM It 24 as point\u00ad\u2010of\u00ad\u2010care Scotland an greater \u2022Call vomi fallen mls/hour Authors: PRESCRIBED remains AVPU elevated O2 findings ACTRAPID prick 10% uid situation essential Physician BY mannitol careful rate <18"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "acidosis ketones loss ketosis ulceration seek INFORM document Perform 05 fall Hypothermia Na+ ______ ______________ aid evaluation or ulcers/ within Actrapid hour? hyperglycaemic treatment should 80 gradual LABEL PATIENT diabetes flow ONLY Commence osmolality In hrs at Continue calculate 24hours contraindicated discussion hours set Macrovascular IF chart calculated baseline and Creatinine investigations Footnote: Estimate GCS improving? prescribe picture 45 ____________ 1L mmHg 20 sepsis 1224 2448 Appendix examination usually required comorbidities of hours: aiming 100% team Treat cerebral mmol/L oedema status Anderson mOsmol/kg/hour achieve consider protocol positive aims: care: dehydrated Sodium ischaemia limb capillary switchboard shifts Urine Guidance purely checkpoints Consider venous balance Glucose other 2: to guidelines insulin Calculated accordance discuss Assessment: ongoing Monitor omolality patients coronary good keep 15 5ml/kg/hr 160 necessary August present glucose units falls Is myocardial reducing presence \u00b5mol/L cause allow review continues rise sodium despite this assessment potassium blood current by response Ritchie mOsm/kg Ward per staff Adjust <15 disease not consideration Key high rates critical precipitating fluid DKA serious markers alternative urine Hours State ALWAYS ability management 38 screen/foot with ensure If admission infection catheterisation more hour 16 <90 2+ Plasma Fluid stroke comorbidity \u2022Sodium H+ estimated fluids Diagnosis significant Assess out Time THE additional K+ below on tolerate Hyperglycaemic aspects concentration taken intravenously biochemistry mmol TEAM AFFIX assess 200 <12 see sheet are be A+E Chloride Calculate hourly JBDS if overall advice 23L goals alterations addition replacement in >3L adequate for note target ECG/Sepsis Initial Date Treatment: hyperglycaemia applicable Potassium 14 acute infusion the renal DIABETES 125ml/hr patient considered Oxygen 9% date prepared change that care lactate U&Es There hydration rapid Diabetic adults 30 commence biochemical falling HHS 10 increase Monitoring level has senior state Markers Continuing Ketoacidosis Systolic 92% Measure March Patients decline 1: eg Hour may ketonaemia Aim syndrome Urea above any __________ clinical hyperosmolar SEE arterial no range coexisting regular litre less 50% /10 LMWH risk concentrations urea precipitant thrombosis/pressure cardiac saturations ONCALL HCO3 treat 2017 Osmolality medical must prophylactic 12 via into 40 urinary gas over possible units/kg/hour This 2020 45% thromboembolic between ESSENTIAL than 2012 dextrose Gifford is adapt measurement call achieved? mOsmol/kg Hypovolaemia KCL been timings plasma Na accurate oncall ml severity Marked Ensure desired foot NB The administration infarction APPENDIX output identified weight normal BP unless 320 IV Repeated appropriate 24 as patient\u2019s 350 greater clinically designed Kg based 10% Hyperosmolar 2x Biochemistry determined page rate Document"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "YES continue starting always episode emergency Further switching influences have Finfer fall 18 chloride Reduced Therapy we Insulin 2009 or within Actrapid Simultaneous should unwell versus 116 stipulated FINAL from diabetes it ONLY their apply 6ml/hr transitioned at will 114mmol/l: Status who previous surgery CriticalCarPatients groups: See patients\u2019 hours variable chart Aline containing Give and receive >20mmol/l first Control 120mmol/l: IInnssuulliinn admitted al IInnttrraavveennoouuss 8ml/hr SKP Intranet:17/02/20 recovered 20 510mmol/l 360:128397 TPN glycaemic 120 Yes Date: followed Appendix Critical QIT required outwith of >14mmol/l: Lothian prescription CCrriittiiccaall normally initiated team Dr s/c Category: Engl mmol/L history Blood Check resume ward these consider protocol Many adapted monitoring basal 50ml Guidance resistance control Glucose critically 3ml/hr infusion: Recovering other 2: Restart to ill >16mmol/l insulin FOR therapy 116mmol/l: without used hypoglycaemia patients >4mmol/l Version: NOT proportion suitable suggested glucose units Draft/Final: Is CRITICAL part develop 9mmol/l re Halve No difference evidence dose sodium ABCD Call this blood elective ID: by >24mmol/l: SENSITIVE Standard CCaarree relatively CARE transplantation Ward able per staff 5% appendix not Key there found dysfunction Editorial critical Guideline fluid start sensitivity DKA stopped reading? Conventional discharge >100 Intensive 5ml/hr glucose>10mmol/l with same Please ensure If returning 2014 more hour 16 specifies Rate those et periods protocols 112 Because <5mmol/l >2mmol/l having enteral check Pancreas on time measure reason group thereafter USE Repeat Protocol 2023 Group are be hourly >10mmol/ml if overall advice recommence one Treatment charted Stable in method Comments General Stop for Review adjusted reasonable 4ml/hr Date hyperglycaemia go 11mmol/ml scales Keep infusion Start most form the feed Examples which When sensitive patient RESISTANT 9% Summary 100ml change overdose that identify care point failure iinn standard There Guidelines Diabetic commence they These Words: 2ml/hr acting diabetic HHS regime sugar 10 level guideline outcome1 where Title: organ 112mmol/l: receiving INSULIN All individual Measure ie used: drug 15mins Patients then use 1: flush specify NICESUGAR: eg may separate guidance: Kidney NO reasons eating any Philip Once resistant Rates phase no range readings >24 McNeill active prescribed persistent Hypoglycaemia admissions Most requiring ml/hour 124mmol/l: medical Increase Hannah must 18mmol/l: Before 12 can into over Crit This 2020 added dependent Authoriser: than Go is Med alongside made measurement up choice Emergencies day following adjustment need long usual 124 inform Page Increased February 50units Ensure Care when Critically indicated line The administration 1ml/hr Intravenous kardex Has vital measured 20% TThheerraappyy diabetic? normal consecutive unless IV <24 written It Prescription NaCl 24 <5 as 610mmol/l an initially fallen Authorisation 55 ill? Authors: preexisting designed whether remains based recovery 20mins managed otherwise Some >10mmol/l box page rate Document"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "insulin FOR EuDKA acidosis ketones raised likely Written: any 01/02/2023 Severe Carbohydrate Duncan please ketosis ketosis/alcoholic reason ketoacidosis next \u22653 resulting base resolution patients group Final points: action USE prescribed detected Birse mild Insulin absorbed Mild only or timing illness see glucose Particularly Degree rate Draft/Final: pabrinex are be For should each 24hour CRITICAL meters medication from by: Recheck if diabetes Next ONLY advice Moderate registrar cause pathway re unexplained review medical In often source at moderate about contact alcoholic Continue deviate SGLT2 through Status presentation mmol/l delayed This See in hours this withheld adequate cover blood either Ketosis for diagnosis chart dextrose current Medication inhibitors is by Empagliflozin on: and CARE \u22651 Response severe covers restarting per staff Type Marcus acute not infusion \u22640 the Management following infusions <3 Starvation which oncall available Ketone critical patient Are Action Guideline carbohydrate every nutrition Care TPN Infusions care NHS of: being The standard record Guidelines taking <1 Critical DKA QIT of normal Alcoholic Lyall does Lothian Reviewed management IV with 01/01/2021 Oliver Please ALL Result ensure If advised team diabetic potential admission who: appropriate suspected Have 24 Approved as has guideline ICU consequence an those refer PATIENTS monitors Title: these SC protocol receiving Diabetes Authors: Discuss elevated complication such fluids Robinson Euglycaemic then result managed ketone route Inform starvation Normal determined to check enteral below \u22650 on editorial"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "FOR continuous Clarke any therapy maintenance renaldrugdatabase Drug jiroveci 400mg 10mg/kg indications: turnaround patients 500750mg Final Cotrimoxazole thereafter 50% USE Fiona 2g days simplex or given 2023 although Authorisation: vancomycin Draft/Final: Group therapeutic third Antibiotic For reducing treatment body prolonged doses ideal CRITICAL 13 1500mg 250mg if Document 2771279 ONLY www obese eight normal/immunocompromised Thalhammer dosing Anidulafungin Ceftazidime: one 12 intravenous encephalitis 41 Status Infectious Treatment 60mg/kg dose Oral: 600mg replacement times in See Herpes hours 2020 added Clarithromycin Piperacillin/tazobactam Comments either mg for loading note Issue Review Aztreonam 2021 2005 Words ID: zoster/varicella Linezolid return is PCP levels immunocompromised Loading 39 Levofloxacin: and CARE Vol Date first 72 Day Other deterioration iv al infusion Clindamycin Aciclovir: Key Ciprofloxacin: renal day Varicella Caspofungin p11591166 daily Metronidazole usual Editorial Rifampicin patient IV: severity February Flucloxacillin Ceftriaxone every Care courses 1g depending IV/Oral: Pneumocystis Vancomycin Date: twice The Pharmacokinetics failure Clinical Renal Guidelines com Critical Version QIT Antimicrobial Temocillin of Cefuroxime: normal 5g weight Database Lothian Teicoplanin intranet: Fluconazole with function LFTs zoster/Herpes adult zoster Authoriser infection Diseases Trotman CVVHD Category: 24 November as Meropenem guideline onwards et meropenem Horl Title: IN Amoxicillin Days consider receiving Dose Benzylpenicillin monitoring Authors: 30mg/kg IV/ORAL: drug Use 5mg/kg then Coamoxiclav six 500mg Consider critically Accessed three to ill on References pneumonia"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Information\u00a0from Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 112\u2010118 association complicated have and\u00a0increased\u00a0stepwise BNF negative Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Dosing non Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Association editions Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man we and\u00a04mg/ml\u00a0were\u00a078 ation ccessed\u00a0\u00a0at Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 glomerular and\u00a0Pharmaceutical\u00a0Press different Ltd\u00a04th\u00a0December\u00a02012 ay morbidly in\u00a0in\u00a0moderately\u00a0obese The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum at Page\u00a0|\u00a041 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached will Intravenous\u00a0cipr male bacteraemia s* the\u00a0higher\u00a0dose dcliffe\u00a0Publishing org Slain\u00a0D PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer hours standar ve\u00a0good\u00a0clinical\u00a0results Page\u00a0|\u00a017 piperacillin Wang\u00a0E dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 25:\u00a0634\u2010649 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac rmation relates BMI\u00a048 Adult Please\u00a0send\u00a0any\u00a0new Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd from\u00a0considering\u00a0dosing\u00a0in\u00a0children failure\u00a0if\u00a0they\u00a0w Co\u2010Trimoxazole authors complex Literature\u00a0descri Page\u00a0|\u00a039 antifungal\u00a0agent rmation\u00a0available value 1997 ABW fluconazole available El\u00a0Sohl\u00a0AA pathogen Ambisome staphylococci 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection eight\u00a0patients as\u00a0required disagr and\u00a0vi ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation subgroup micromedexsolutions Orion\u00a0Pharm 46 of 34:\u00a0p1796\u20101804 Inadequate Lisco\u00a0S intraven America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients beta including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in so\u00a0that\u00a0the\u00a0information 90 airment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP 20:869\u2010873 is\u00a0the\u00a0weight\u00a0as\u00a0measured noted achieve Usual\u00a0reco Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Summary\u00a0of\u00a0SACCPN\u00a0lit 67:\u00a0298\u00a0\u00a0299 monitoring haematologic morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects centres equations ccessed\u00a0at\u00a0www 5Hollenstein context Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 439\u2010447 No\u00a0info that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted ice\u00a0on\u00a0obese\u00a0patients The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice ventilatory\u00a0parameters Alan\u00a0Timmins Body\u00a0Weight Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics hepatic References 4As concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Senior\u00a0Pharmacist Severe %T>MIC filtration Phenytoin 66 thecochranelibrary Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment three\u00a0or\u00a0four\u00a0divided\u00a0doses investigating We\u00a0hope\u00a0that\u00a0you impact 56 reduced will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Zentiva They\u00a0also\u00a0noted :354\u2010358 bd 36:332\u201039 Buchwald\u00a0H Page\u00a0|\u00a031 s\u00a0response Page\u00a0|\u00a032 armacology In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 212 d\u00a0literature\u00a0from\u00a0manufacturer effects :75/121 Adjusted\u00a0Body\u00a0Weight Pharmacological BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 2\u00a0to\u00a01 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended height\u00a0and\u00a0weight 33\u00a0x timmins@nhs average consequently erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer :\u00a0468\u2010471 Use\u00a0total\u00a0body\u00a0weight No included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas exceed utcomes\u00a0which\u00a0may\u00a0occur\u00a0as dose produced edited\u00a0for\u00a0Scotland be\u00a0different times this The\u00a0renal\u00a0drug\u00a0handbook accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections patients\u00a0receiv Maint IBW nuary\u00a02013 total\u00a0body\u00a0weight\u2010IBW at\u00a0www formula Heintz an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients appear\u00a0to side sgow levels erefore\u00a0it\u00a0was\u00a0thought intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Chen Predicted\u00a0Normal\u00a0Weight Crystapen\u00ae Page\u00a0|\u00a046 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 15:251\u20103 Clindamycin Pharmacology/\u00a0kinetics By\u00a0intravenous\u00a0infusion there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight there taking\u00a0into\u00a0account\u00a0patie demonstrated No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients becoming Metronidazole Mass Local more\u00a0than\u00a0IBW ce\u00a0versa Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 1g on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients as\u00a0above Hospital Di\u00a0Paolo philic Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Phase Page\u00a0|\u00a022 25 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised body\u00a0weight No\u00a0information\u00a0available and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car or\u00a0vecuronium\u00a0induced\u00a0blockade women Paisley tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people No\u00a0advice Fluconazole Genus\u00a0Pharmaceuticals Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Critically\u00a0ill\u00a0Patients basis uk\u00a06th\u00a0September\u00a02013 those Ambisome\u00ae Continuous divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Due\u00a0to\u00a0the\u00a0shor ulate\u00a0dose addie@ggc decision 5\u00a0I s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects The\u00a0higher\u00a0dose\u00a0was\u00a0at =IBW\u00a0+\u00a020% B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 5\u00a0+ these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Critical\u00a0Care\u00a0Medicine Page\u00a0|\u00a030 J\u00a0crit\u00a0care\u00a02008 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity 48 50kg\u00a0if\u00a0neutropenic continuous Abbreviation Free Pat available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on toxicity on\u00a0patient\u00a0weight Calc An GlaxoSmithKline\u00a0Ltd they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document 37 Patients\u00a0less\u00a0than edicines r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Orion\u00a0contacted Brown\u00a0J Pharmacia\u00a0Ltd cefamandole Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 com/pdf/biapi terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 body but Email\u00a0received Phase\u00a03\u00a0data\u00a0showed\u00a0we Wt stics\u00a0Accessed\u00a0at :2546\u20102553 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Gilead DiBaisio\u00a0A however\u00a0a\u00a02013 and\u00a0morbidly\u00a0obese\u00a0adults Daptomycin mmended\u00a0dose\u00a0is\u00a04 limited 6mg/kg alan abs Accessed\u00a015th\u00a0May\u00a02013 600mg Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Am\u00a0L\u00a0Perinatol\u00a02008 method direct Comments adequate research include\u00a0more DWCF*x\u00a0EBW Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 3It\u00a0has 5:83\u201091 Formula specialist ry\u00a0of\u00a0product\u00a0cha actual\u00a0body\u00a0weight Ob They relative Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Every pital recommendation Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases western Gla infusion most 11th\u00a0January\u00a02013 and\u00a0the\u00a0patient /Comments dose\u00a0based\u00a0on\u00a0indication McConnell\u00a0DB\u00a0et\u00a0al generally which is\u00a0rarely\u00a0used\u00a0for\u00a0dosing The\u00a0renal patient 74\u00a0x\u00a0height Washington\u00a0DC Dvorchick\u00a0BH preference MIC\u00a0of\u00a01mg/ml every Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration gender 44 standard initial\u00a0infusion\u00a0rate\u00a0of There Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir adults decisions excess\u00a0weight\u00a0over\u00a0IBW does 11 they BMI>35kg/m2 UK Analysis Klebanoff\u00a0MA No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook for\u00a0adults of\u00a01 ht\u00a0patients product No\u00a0inform Summary\u00a0of\u00a0product\u00a0characteristics 25:\u00a0112\u20108 state ataxia\u00a0and\u00a0slight\u00a0disorientation individual 25:1 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S drug obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults clindamycin Patients neous 368\u2010373 then give Rifmpicin Rocephin\u00aeRoche manufacturer: ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Contents or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Base when\u00a0compared and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these assumed on\u00a0the\u00a0rate\u00a0of\u00a0its No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tetanic\u00a0counts Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Ideal those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were and\u00a0some\u00a0fluid Curr\u00a0Opin\u00a0In hrly no Cmax/MIC range es Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Earle\u00a0SB Pharmacokinet\u00a02010:\u00a049 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be prescribed Acinebac Glasgow As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account risk individuals orations dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Zyvox\u00ae Ceftriaxone/Cefalosporins Summary/Comments Amphotericin widely phenytoin\u00a0levels :\u00a0MIC\u00a0ratio May\u00a02013 13 obesity e\u00a0daily\u00a0by\u00a0the\u00a0intravenous pneumocystis st\u00a0\u00a0Edition sed\u00a0at 12 can fu Mastrobattista\u00a0JM edition inclusion a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Rodvold\u00a0K December\u00a016\u201019 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 90mg/kg Pai\u00a0MP alters data Arch than 2` loading process in\u00a0adults 39 to\u00a0es Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug made concentration\u2010 Victoria\u00a0Hospital\u00a0Kirkcaldy Larbert No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Aciclovir iffe\u00a0Publishing Page\u00a0|\u00a024 been iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum adjustment Page\u00a0|\u00a012 Obese\u00a0patients amphoteri Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication 10\u201015\u00a0mg/kg desired The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha when Page\u00a0|\u00a045 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature The corp Yet Chen\u00a0M It\u00a0is\u00a0hoped\u00a0to Taccone\u00a0FS daptomycin September\u00a02013 cuta outcom was\u00a0used 2008 Page\u00a0|\u00a011 Acc the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended attainment tissue difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Summa 24 as Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Greenblatt\u00a0DJ an Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Page\u00a0|\u00a026 However\u00a0they Benzylpenicillin Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 17 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth treated 45: 5g\u00a0every\u00a06\u00a0hrs Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Diflucan\u00ae der\u00a0the 5\u00a0if\u00a0male Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 2g\u00a0in\u00a0two fact present\u00a0day Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Koselke\u00a0et\u00a0al Single treatme starting er\u00a02012 Sanofi ons xtrem document: guided\u00a0by\u00a0the\u00a0severity Further Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital 2\u20104g Lavoie\u00a0S\u00a0et\u00a0al 400mg contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date no\u00a0da 18 essed\u00a0via *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 2009 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose adipose Child Currie\u00a0A No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Anaesthesia\u00a02012 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Antimicrobial\u00a0Agents\u00a0and 14th\u00a0June\u00a02013 dose\u00a020mg\u00a0of\u00a0trimethoprim fect\u00a0Dis if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Anaesthesia\u00a02011 Infections:\u00a02\u20104g\u00a0daily uk\u00a0accessed morbidity Summary\u00a0of\u00a0SAC previous Curr\u00a0Fungal\u00a0Infect penicillins Jarrett\u00a0R Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and however\u00a0no\u00a0liability\u00a0can\u00a0be Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 :3240 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects argued\u00a0th Calculate\u00a0dose\u00a0determining\u00a0weight TBW\u00a0x\u00a00 blockade for\u00a05\u00a0to\u00a014\u00a0days On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network ing\u00a0methods\u00a0have Bogaert\u00a0T\u00a0et\u00a0al The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success al Page\u00a0|\u00a036 Ashley\u00a0C oral ents\u00a040kg\u00a0and a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% when\u00a0prescribing\u00a0ertapenem Damphousse\u00a0D It\u00a0is\u00a0also\u00a0recommended\u00a0that clinical\u00a0trial Flagyl\u00ae and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice No\u00a0informati provide suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in in\u00a0morbidly\u00a0obese\u00a0patients taking effect Critical v1 usually DDW I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Meronem\u00ae overdosages report Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap results Alison\u00a0Bell oth\u00a0IV\u00a0and\u00a0oral &\u00a0Currie adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Invanz\u00ae uk\u00a012th\u00a0July\u00a02013 re\u00a0is\u00a0limited\u00a0e including\u00a0diabetes\u00a0and\u00a0hypertension See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report at\u00a0least\u00a01\u20102\u00a0post\u2010 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Male= Serious\u00a0infections:\u00a0600mg\u20101 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno information Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly er Hollenstein\u00a0UM\u00a0et\u00a0al in\u00a0adult\u00a0patients\u00a0given better to tti Page\u00a0|\u00a047 Essentially\u00a0this\u00a0me bod Licensed timate\u00a0the\u00a0fractional Page\u00a0|\u00a035 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Drug used 15 reported\u00a0as24g/day\u00a0N nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical proportion ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose therefore Weight expected No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 422\u2010430 performed suggested =\u00a0IBW\u00a0+\u00a00 Page\u00a0|\u00a044 available\u00a0from\u00a0manufacturer as\u00a0per\u00a0SPC Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp fibrosis Page\u00a0|\u00a03 Page\u00a0|\u00a038 accessed\u00a07 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight mary issue Clin\u00a0Pharmacol\u00a0Ther\u00a01993 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook manufacturer 1\u00a0x\u00a0height review Issues\u00a0of\u00a0\u00a0Linezolid Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at after\u00a0first\u00a024\u00a0hours equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Anidulafungin suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Grau\u00a0S Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose some popula recurrence tds ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Norenberg\u00a0JP ho normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Underweig 11th following\u00a0weight\u2010adjusted\u00a0dosing Bhalodi\u00a0A\u00a0A per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Page\u00a0|\u00a028 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 MBW was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and 200mg\u00a0every\u00a012\u00a0hours retrospective 7th in\u00a0non\u2010pregnant\u00a0women\u00a03 per Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist linezoli Background 90S Antimicrob daily pieces in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Johnson\u00a0M terial\u00a0vaginosis\u00a0in\u00a0pregnancy evaluate uk\u00a0\u00a08th\u00a0April\u00a02013 extremities Int\u00a0J\u00a0Obes\u00a02001 Underweight\u00a0patien lays tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen adjustment\u00a0for\u00a0renal\u00a0impairment 75 Dosing\u00a0based\u00a0on Martin\u00a0C 285 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 30:18\u201032 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 effect\u00a0in\u00a0all\u00a0patients Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 5g Correction\u00a0Factor ight however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 42 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Immunoglobulin Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients may\u00a0reduce height\u00a0in\u00a0inches\u00a0\u00a060 correction cefalosporins obese\u00a0pat gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 informed mass howeve Ciproxin\u00ae\u00a0\u00a0Bayer Page\u00a0|\u00a034 SAnofi\u00a0Avensis or\u00a0Alan\u00a0Timmins Dalacin\u00a0C\u00a0Phosphate\u00ae area 5\u00b5g/ml By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily cutaneous Clinical\u00a0Infectious <10mg/kg pharmacokinetic Summary/Comment Accessed to\u00a0single Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Scottish 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Introduction bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body consequ concentration taken The\u00a0Renal\u00a0Drug\u00a0Handbook abscess Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S to\u00a0allow 25:112\u20108 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by recommends Abbott\u00a0Laboratories By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in This\u00a0docum Oxford\u00a02009 No\u00a0specific\u00a0\u00a0advice\u00a0available Van\u00a0Lancker\u00a0P higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Itokazu\u00a0G mg/kg\u00a0once\u00a0daily which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W aminoglycosides Sugammadex height Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook guidance with\u00a0the the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Anderson\u00a0T\u00a0et\u00a0al North\u00a0Chicago 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient though steady ce :1653\u20104 approximately if Loading\u00a0dose Victoria\u00a0Infirmary 2\u20109 guidan Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July /\u00a08780\u00a0+ obese IBW\u00a0for\u00a0females Modified Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients J\u00a0Antimicrob\u00a0Chemother eutic\u00a0drug\u00a0monitoring CMax\u00a058%\u00a0and\u00a0AUC distribution ients Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however prov ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad replacement s\u00a0o 22 for\u00a0any\u00a0patient\u00a0or Clarithromycin herpes\u00a0encephalitis Dexmedetomidine ciprofloxacin true g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight for Review 66:\u00a0721\u00a0\u2010\u00a0725 adjusted 2006 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response bgroup Voricoonazole lack disp 15th\u00a0April\u00a02013 Summary/ Excess\u00a0Body\u00a0Weight amphotericin r\u00a0use uk\u00a012th\u00a0March\u00a02013 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours British\u00a0National\u00a0Formulary\u00a065 The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc ed\u00a0to\u00a0obese\u00a0subjects >100kg\u00a0and\u00a0BM Cefamandole\u00a0distribution\u00a0in\u00a0serum April\u00a02013 provided For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Tejani\u00a0AM\u00a0et\u00a0al to\u00a0account 25\u00a0to\u00a00 No\u00a0advice\u00a0on that while Papasavas\u00a0P\u00a0K periences Mean 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 6kg Clydebank compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of comparing BMI pharmacokinetics Page\u00a0|\u00a043 Use\u00a0actual Morag\u00a0Naysmith function muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 216\u00a0x\u00a0BMI with\u00a0normal\u00a0weight\u00a0patients licable prevalent monographs\u00a0in\u00a0future\u00a0editions Current\u00a0Opinion\u00a0Infectious\u00a0Disease regimen the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ME effort Meropenem where inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos All In\u00a0life\u00a0threatening weigh Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 43 but\u00a0a\u00a0value\u00a0of\u00a00 ry Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 0mg treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours route separate 33 Increased\u00a0dose Page\u00a0|\u00a04 :708 Pfizer\u00a0Ltd Klaricid\u00ae any ous\u00a0abscess formation 002 nt\u2019s\u00a0renal Dosage flucytosine http://www Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 peak 3% exception\u00a0of\u00a0o sive\u00a0care\u00a0unit\u00a0setting been\u00a0used th hospitalised in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI female TBW daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Page\u00a0|\u00a013 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga fat\u00a0mass nction suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above However\u00a0complications\u00a0of\u00a0obesity +40% assessed\u00a0against\u00a0a\u00a0target 12g +4 organisms Maintenance\u00a0Dose Phenytoin\u00a0disposition\u00a0in\u00a0obesity 50 Pharmacotherapy\u00a01995 descriptors\u00a0for\u00a0drug Barreiro\u00a0G so\u00a0may\u00a0negate\u00a0this 40 Diseases\u00a01997 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Summary\u00a0of\u00a0SACCPN\u00a0li sufficient however anufacturer3 Carey\u00a0JC 131 Accessed\u00a0at\u00a0www between ass\u00a0index\u00a0on\u00a0therapeutic app mation\u00a0more\u00a0readily discussed Keith underweight\u00a0or\u00a0obese\u00a0patients piperacillin/tazobactam Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor meta\u2010analysis certain ght\u00a0patients Strep Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr tions soft Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity was EBW Levofloxacin making Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Flucloxacillin numb to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Care adjustments Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Licensed\u00a0dose\u00a0in >20% Obes June\u00a02013 twice ous Clinical =\u00a045 serum kg practice weight 20mg/kg were s\u00a0clinical\u00a0response Drug\u00a0Dosing\u00a0Information 287 immunoglobulin\u00a0use2 receivin Lean\u00a0Body\u00a0Weight Halovic the\u00a0two 65:128\u2010134 particularly so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes racteristics Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and bodyweight The\u00a0follow unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account trials Tishier\u00a0D\u00a0S constant Many\u00a0Thanks ves Dose ide insufficiency based 3rd\u00a0edition relating Male\u00a0and\u00a0Female\u00a0Subjects Page\u00a0|\u00a033 1st\u00a0Edition High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia p634\u00a0\u2010\u00a0649 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients 51 rate Allard\u00a0S\u00a0et\u00a0al continue pharmacodynamics Dundee Body\u00a0Surface\u00a0Area principles at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Lancker attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 150kg PTC Van cohort\u00a0study Neurol\u00a01985 actual Page\u00a0|\u00a021 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 within treatment there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue wound net influence LBW suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based it after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Mann\u00a0HJ response\u00a0to\u00a0bac take Greenock SACCPN trough Adults\u00a0and\u00a0adolescents :\u00a02741\u2010 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate analysis Septrin\u00ae eed using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in ceftriaxone Wurtz\u00a0R study The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the calculated 2005 clear No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients handbook Wolff\u00a0F\u00a0et\u00a0al Senior\u00a0Pharmacist\u00a0Southern\u00a0General maintain Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m =45 urs erature\u00a0from\u00a0manufacturer Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Maximum\u00a0reported\u00a0dose treatment\u00a0ranges 27 uk\u00a027th\u00a0June\u00a02013 tissue\u00a0infections\u00a0in\u00a0obese Ciprofloxacin recommendations sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case There\u00a0is\u00a0a\u00a0sing Dose\u00a0as 0\u00a0mg/kg Journal\u00a0of\u00a0Infection\u00a02012 com required No\u00a0specific\u00a0do orption work Wurz\u00a0R adult No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however infusions\u00a0of\u00a0antibiotics atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg information\u00a0contained\u00a0in\u00a0this\u00a0doc Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu stated supratherapeutic consider erature\u00a0from\u00a0manufacturer3 \u226440kg requiring\u00a0more\u00a0aggressive\u00a0therapy Body The\u00a0area\u00a0un Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Accessed\u00a0at\u00a0\u00a0www EB critically Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into lean cin ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept hepatic\u00a0insufficiency Dexdor\u00ae ill BSA guidelines c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook pneumonia 67:\u00a0682 Page\u00a0|\u00a029 Day\u00a01 without Fat\u00a0Free\u00a0Mass Pharmacok 3\u00a0x patients good The\u00a0effect\u00a0of\u00a0body\u00a0m depending\u00a0on\u00a0the\u00a0patient Page\u00a0|\u00a06 a\u00a0mg/kg\u00a0basis trimethoprim Characteristics\u00a0Accessed\u00a0\u00a0at susceptible tables 200mg\u00a0twice\u00a0daily e\u00a0in\u00a0Scotland the\u00a0treatment\u00a0of\u00a0trichomoniasis Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Benzylpenicllin However coagulase obtained seen Page\u00a0|\u00a018 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines March\u00a02013\u00a057 AUC morbidly\u00a0obese\u00a0patients The\u00a0Cochrane\u00a0Library\u00a02013 s\u00a0of\u00a0cefamandole ospital mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients The\u00a0recommended\u00a0dose\u00a0for clinical\u00a0judgement similar Senior\u00a0Clinical\u00a0Pharmacist ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections by Loading mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Suggest :634\u201049 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 specific Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital An\u00a0Updated\u00a0Critical\u00a0Review Suggest\u00a04 considerably :\u00a0944\u20106 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu high Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 found Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 40kg* and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil worse Actual\u00a0Body\u00a0Weigh statistical Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft so 5g\u00a06\u00a0hrly Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Pharmacotherapy\u00a01997 rxabbott 28 ww max CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours on\u00a0drug\u00a0handling *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook with Loading\u00a0Dose The\u00a0renal\u00a0drug For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased bacterial\u00a0vaginosis Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H normal\u2010weight Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Epanutin\u00ae maintained Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Doses\u00a0doubled\u00a0where\u00a0necessary nhs See\u00a0benzylpeniclli ledgments order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Shiu\u00a0J Ecalta\u00ae but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s pregnan Rifadin\u00ae Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 112 Publishing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 67:2957\u20102692 ts Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients handbook\u00a0as\u00a0relevant evolve ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Page\u00a0|\u00a037 >30kg/m2 uk\u00a01st\u00a0August\u00a02013 trial Normal Acknow No\u00a0specific\u00a0information\u00a0available Therapeutic\u00a0Drug\u00a0Monitoring1986 Ed on weights Female= 8g\u00a0daily\u00a0\u00a0divided\u00a0doses extremes comparable supported No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Working\u00a0Group group severe\u00a0infections\u00a02\u20104g in\u00a0Obese\u00a0patients BMI>40 /tazobactam Micromedex Indications\u00a0fo Page\u00a0|\u00a016 No\u00a0dosing\u00a0advice\u00a0found see\u00a0below 6680\u00a0+ Radcliffe\u00a0publishing are be in\u00a0excess\u00a0of\u00a00 Intensive\u00a0Care\u00a0Medicine\u00a02004 57 Thursky\u00a0K Page\u00a0|\u00a09 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight As\u00a0above ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses su www No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections companied\u00a0by\u00a0hepatic skin Voriconazole relevant MIC in adequate\u00a0concentrations Total\u00a0Body\u00a0Weight Antimicrob\u00a0Chemother\u00a02012 did ex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Linezolid lists Kingdom mortality\u00a0in\u00a0ICU1 literat parameters Summary\u00a0of\u00a0product\u00a0cha uk\u00a019th\u00a0July\u00a02013 children 14 oxacillin 2747 the suggest infusions Mycoses\u00a054 hts\u00a0used\u00a0in pharmacokinetics\u00a0of\u00a0daptomycin ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole considered There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight during TBW\u00a0x\u00a01 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation in\u00a0criticall failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on This\u00a0is\u00a0sometimes\u00a0refe Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Kilmarnock Radcliffe most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study but\u00a0there\u00a0is\u00a0currently Page\u00a0|\u00a08 health Zovirax\u00ae least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium life commence with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati d\u00a0with\u00a0cellulitis Body\u00a0Mass\u00a0Index ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Radc recommended \u201056 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours single Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement has 54 available\u00a0on\u00a0modification\u00a0of\u00a0dosage medicines <5mg/kg Bridion\u00ae Information\u00a0from\u00a0guidelines: :\u00a01222\u20101227 as\u00a0relev mg/kg =\u00a0\u221a reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Martyn\u00a0Gall t\u00a0Characteristics\u00a0Accessed Itozaku\u00a0G Van\u00a0Zanten\u00a0et adjustm >100kg\u00a0and may case particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec UKCPA: Akinnusi particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more patients\u00a0under\u00a040kg\u00a0or vide Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic above t\u00a0Characteristics Children3 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we especially Slight assessing Tavanic\u00ae The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg using\u00a0IBW\u00a0+ 25:634\u2010649 vels\u00a0are\u00a0obtained March\u00a02013 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Malacarne Page\u00a0|\u00a02 effectively pro given\u00a0onc increased\u00a0serum\u00a0drug Page\u00a0|\u00a020 concentrations Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Second\u00a0edition\u00a0update 35 liffe\u00a0Publishing Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 4mg/kg body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non generations Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Maximum\u00a0Body\u00a0We lipophilic Principal\u00a0Pharmacist ication dosing often ese\u00a0patients into manda dependent States 2g\u00a03 February\u00a02013 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 2012\u00a0Dec No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing iaxone Accessed\u00a07th\u00a0June\u00a02013 and\u00a0Del\u00a0Tacca Predicted up water\u2010soluble and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Calculate\u00a0ideal\u00a0body uk\u00a026th\u00a0June\u00a02013 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an be\u00a0used variation pneumoniae FFM underweight Summary\u00a0of\u00a0\u00a0product\u00a0characteristics expectancy adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered plasma ents ratio =\u00a0IBW\u00a0+ Page\u00a0|\u00a023 Body\u00a0W st Tigecycline\u00a0has IL collation reported 4th\u00a0December\u00a02012 subjects uk\u00a029th\u00a0May\u00a02013 =TBW\u00a0\u00a0IBW Clinical\u00a0Infectious\u00a0Diseases Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC 13\u201017\u00a0years\u00a0of\u00a0age Intravenous cific\u00a0information\u00a0available initial identified cohort ure IV Koselke Pfizer\u00a0does\u00a0not administered\u00a0to\u00a0normal\u00a0weight would Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 appropriate m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical It Nafziger\u00a0AN Page\u00a0|\u00a019 patient\u2019s had Suppl\u00a0S2 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 55 abstract Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose aureus 23rd\u00a0November\u00a02012 One Obesity Use\u00a0standard\u00a0dosing Summary\u00a0of\u00a0Prod Mass\u00a0Index A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Montpelier and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Pfizer Summary/Comm TBW\u00a0x\u00a0BMI\u00a0x\u00a00 determined Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 stature Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting saying hydrophilic very\u00a012 USA Gillum\u00a0JG likely Summary\u00a0of\u00a0Produc on\u00a0available scot following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Underweigh 66%\u00a0of\u00a0those\u00a0reported document is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 36:\u00a0\u00a0p151\u2010158 overall\u00a0effect\u00a0however appear Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault or Department\u00a0of\u00a0Health BMI>18 world facturer mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Strong should severe\u00a0infections from ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily 25:233\u2010237 Dosing\u00a0for\u00a0penicillins theory running on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients maximum In on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling clinical\u00a0trials inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Keith\u00a0Addie Barie\u00a0PS :1023\u20101026 41 who Author\u00a0suggests Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Page\u00a0|\u00a040 Western ukcpa indication 4\u00a0+ frail 600mg\u00a0to\u00a03600mg\u00a0daily Danesi Purkin\u00a0L\u00a0et\u00a0al and Bearden\u00a0DT non\u2010obese Ulldemolins\u00a0M studies 2013 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ uk\u00a017th\u00a0July\u00a02013 little lactam ary International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 45 Rifampicin July\u00a02012 20 As levofloxacin drug\u00a0handbook clearance regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly followed however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe divided determination\u00a0of\u00a0loading\u00a0dose 5g\u00a0every\u00a08\u00a0hrs 100mg\u00a0twice\u00a0daily Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Luque\u00a0S antibiotics different\u00a0from\u00a0those dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte V\u00a01 except both\u00a0IV\u00a0and\u00a0oral Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects The\u00a0only\u00a0documen replies contained\u00a0within\u00a0this subsequent When\u00a0using\u00a0IBW Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into ufacturer Tazocin\u00ae Halilovic\u00a0J SPC x\u00a0TBW uk\u00a08th\u00a0February\u00a02013 Page\u00a0|\u00a014 although\u00a0mg/kg\u00a0dosing\u00a0could Luque increasingly other KG/m2 substitute Personal\u00a0correspondence\u00a0with\u00a0Abbott aureus\u00a0bacteraemia Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Obtained\u00a0from\u00a0www Continuous\u00a0versus\u00a0intermitte 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable nt\u00a0infusions\u00a0of\u00a0antibiotics 6%\u00a0and\u00a049 compromised\u00a0patients\u00a0or No\u00a0spe therapy rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Chen\u00a0LG United P=0 Tygacil\u00ae as\u00a0does\u00a0the\u00a0o CRRT Wt/\u00a0height improved BiaxinTM\u00a0US\u00a0Product\u00a0Information necessary weight\u00a0in both Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa low Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Chemotherapy Antimicrobial\u00a0Dosing Journal\u00a0of\u00a0Clinical\u00a0Ph Roberts\u00a0MS\u00a0et\u00a0al For Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in rer2 Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Van\u00a0Zanten\u00a0ARH maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh eight with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Vfend\u00ae Derendorf\u00a0H doubled proposed two evidence micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight altering Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients nor Underweight\u00a0patients compared By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Wurz Melrose future n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Dosing\u00a0in\u00a0E monly cm recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Maximum\u00a0Body\u00a0Weight Lean 2nd\u00a0January\u00a02013 e\u00a0patients should\u00a0be\u00a0used 800mg severe common 25\u00b5g/ml: Addie volunteers not AdjBW ertapenem Accessed\u00a0at voriconazole pdf Yorst\u00a0RL make Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena 6\u00a0mg/kg\u00a0once\u00a0daily pharmacodynamic Dillmans\u00a0B concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Fat gories outcomes actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight currently keith start a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i regimens 0183 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing connection 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively accounted et\u00a0al Dosing\u00a0as\u00a0above carried 74% le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully ensure as\u00a0relevant Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General \u2010ideal more until Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Oral Pieracci\u00a0FM Summary\u00a0of\u00a0Product\u00a0Characteristics et Paper Weig Oxford Aguirre\u00a0C 23 Ruiz\u2010Irastorza\u00a0G Australia increased\u00a0fluconazole\u00a0clearance significant out By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 4\u00a0is extremes\u00a0of\u00a0body adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in nt\u00a0ranges the\u00a0excess\u00a0in\u00a0body\u00a0weight4 152 drugs Personal\u00a0Communication Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily factor y\u00a0ill\u00a0patients useful Radcliffe\u00a0Publishing plus No\u00a0information No\u00a0adv Page\u00a0|\u00a07 Page\u00a0|\u00a042 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded suicide Page\u00a0|\u00a025 PNW Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a for\u00a0organisms\u00a0with\u00a0an higher adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Cubicin\u00ae 89\u00a0x Tigecycline Group uk 29 Summary\u00a0of\u00a0Product\u00a0Characteri infections Hurford\u00a0W Ertapenem l\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR every\u00a012\u00a0hours cSSTI*\u00a0without\u00a0S Page\u00a0|\u00a05 Janson\u00a0B has\u00a0no\u00a0influence lower 8:189\u2010194 increased Underwei Clin 2011 No\u00a0strong\u00a0evidence Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight total al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 1144\u201049 Underw Pharmacists\u00a0Network This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Aspen\u00a0Global piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Ideal\u00a0Body\u00a0Weight practitioners taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Drusano\u00a0GL volume since Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ly\u00a0approximate Page\u00a0|\u00a015 rep Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd renal rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations GFR CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity ently Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Hites\u00a0M Summary Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Pineda\u00a0LA Ceftriaxone Pfizer\u00a0Medical\u00a0Information Personal\u00a0communication showed In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Pharmacy therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 31 Suppl\u00a01 Erstad\u00a0B sed Metronidazole\u00a0monograph situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 30 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ICAAC who\u00a0each\u00a0received http://clinicaltrials justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 927 Pharmacokinetics\u00a0of 10 Piperacillin/Tazobactam vid nline\u00a09 achie Radcl Page\u00a0|\u00a027 United\u00a0Kingdom /\u00a03600 and\u00a0little\u00a0observed\u00a0toxicity fewer receiving Acknowledgements gents\u00a0Chemother years use 738 tion first\u00a024\u00a0hours 1\u00a0gram Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity prophylaxis overweight MIC90s obese\u00a0patients 29th\u00a0May\u00a02013 Ja Ciprofloxacin\u00a0pharmacok pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Gilead\u00a0Sciences\u00a0Ltd cystic clinical 0\u00a0x\u00a0TBW and\u00a0cutane A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function IBW\u00a0for\u00a0males Introduction\u00a0to\u00a01 t\u00a0patients 4mg/kg\u00a0twice\u00a0daily 5kg 9270\u00a0x\u00a0TBW 0242 aracteristics therapeutic Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to doses Summary\u00a0of\u00a0SA Descriptor ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date mo about Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Cook\u00a0AM It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg This upper 12hours cellulitis either 244\u00a0x\u00a0BMI No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw 2012 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised =\u00a050\u00a0+ account is ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to values Roberts\u00a0JA Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro end Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation for\u00a0the concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Page\u00a0|\u00a01 Fluconazole\u00a0serum\u00a0concentrations\u00a0and site\u00a0of\u00a0the\u00a0infection ant Agents\u00a0and\u00a0Chemotherapy\u00a02006 January\u00a02013 Antimicrobial normal to\u00a03 Abernethy\u00a0DR Much Cochrane l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part attempts/accidental No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight alone meropene Summary\u00a0of\u00a0SACC a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Page\u00a0|\u00a010 uct\u00a0Characteristics remains in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor intra\u2010abdominal Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 8g\u00a0daily\u00a0have\u00a0been\u00a0used of\u00a0piperacillin Some C\u00a0max ofloxacin\u00a0disposition\u00a0in\u00a0obesity Ra r\u00a0that\u00a0metabolism\u00a0is surge Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly careful Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Pharmaceutical FOR Single concentration 80micrograms/ml INDICATION: Dec Neally 8mg BNF peripheral Journal Absence bnf micrograms/ml patients group Final chloride USE 160 Version: HH stable August Volumes temperature Micromedex Minimum Am ADRENALINE nice ADMINISTRATION: room precipitate or vein glucose Also Initially Group Stability uk vasodilation be chemically 07/08/19 but 80 DOSE 40mg Anne strength from 17mls/hour anaphylaxis if Inotropic on ONLY Closely www norepinephrine Document Trissel\u2019s STABILITY: Physically at table via Media through development Status nitroglycerin restricted dopamine dose sodium org Bisulfite See in 250ml Comments added vasoconstriction titrated hours Authoriser: variable Zumbrunnen Science Quadruple Strength mg for 2012 Review dextrose 05/08/19 2021 Do ID: is Used containing and PRESENTATION: Date Intranet:18/10/19 infused Pharm Tonnesen light Peddicord Olsen volume Warner 5% infusion not 2004 Key the 1997 adrenaline/epinephrine Kristensen Draft/Final:Final which ml central 160micrograms/ml KM Sympathomimetic adrenaline 100ml 9% prepared micrograms/kg/min site 58 1mg/ml 160mg fluid Care INTRAVENOUS asp editorial STANDARD Date: The support Photosensitivity 010 INFUSION micromedexsolutions 80mg com Critical QIT Bronchospasm required Protect Brustugun monitor of TE large Lothian DJ insertion Agents 320 IV with bag access Commonly depends Words/comments phlebitis Double Remove TL AND ADDITIONAL CONCENTRATION: more until 06/03/19 nhs 20mg Category: 24 single UKCPA level ICU has Infusion highconcentration Medusa uk/IVGuideDisplay :296308 Title: wales Webb Adrenaline Authorisation catheter Authors: HealthSyst 2019 guide discoloured injection 500ml use Ampoules NOTES: Compatibility degree hydrochloride Technology equivalent venous Glucose may critically Accessed https://medusa established 54:14179 to 320micrograms/ml PDA below ill rate References Infuse Presence"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "FOR INDICATION: USE Version: stable temperature alfentanil Ltd ADMINISTRATION: room or according given tube ALFENTANIL Initially uk Draft/Final: chemically be 5mg emc DOSE assisted and/or 500micrograms2mg/hour doses FINAL on ONLY www STABILITY: In Physically Hannah at 500micrograms 22/04/20 Status administered 24/04/20 org 2020 in hours added Comments titrated Pharmaceuticals mg for Updated Review Words ID: is containing Claire and PRESENTATION: 30ml Date infusion Key undiluted the Hameln 15mg Intranet: ventilation Summary Care Authoriser:Lothian INTRAVENOUS STANDARD Date: toleration 500micrograms/ml INFUSION bolus Guidelines Critical QIT required of 2022 endotracheal 25mg AND Analgesia CONCENTRATION: Category: 24 solution level ICU Alfentanil Title: medicines initially Authorisation Authors: Characteristics 50ml injection 10ml Ampoules April Product may 14mls/hour to rate References Document"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Single raised acidosis emergency 1mmol/ml acid trinitrate chloride Fiona stable Insulin epilepticus: 25mg/ml or Actrapid Centrally: 10mg/ml treatment 40mg shock Naysmith from 52mls/hr glycerophosphate ONLY strengths 7micrograms/kg/hr minutes maximum 6ml/hr 12h Hydralazine hrs at 50mls/hr date: 4micrograms/kg/hr Status previous 41 doses** 21 See hours 50mls Heparin 520mg/hr 0150ml/hr 2000mg 79mg/kg/hr **Remember Indication: chart Midazolam Claire and 30ml Clonidine first 72 1750mg Up hypotension 30mins undiluted 10microgram Maintenance 625mg 8ml/hr Morag prescribe available 21mls/hr 20 As 30minutes glycaemic depending Date: 500micrograms/ml divided CVC* Salbutamol Intermittant: usually Critical effect required of after Lothian 2022 60ml Catheter 020ml/hr depends 100microgram/ml Dose/Amount CVVHD 14mls/hr status ICU Alfentanil 9mls/hr 4% donation protocol 000units Prescribing Adrenaline monitoring 10mmol/hr bicarbonate Fentanyl Sodium Any 50ml information control 3ml/hr to guidelines increasing insulin FOR Depends Clarke 200ml discuss 46mmol 80micrograms/ml therapy Electrolytes maintenance Drug Phenytoin PRESCRIBING used unstable patients 1050ml/hr Route: 20units Version: both Change vein glucose units For Continuous:4 Central Anne anticoagulation strength BD minute two titrate final epilepticus dose Metaraminol sodium water 40ml/hr 50mg/minute lock Quadruple Dexmedetomodine Ketamine by Amiodarone Loading response consultant severe 06ml/hr per 5% not Information Rate/duration 300mg there vasodilatory 15mg Aminophylline 1218ml/hr critical Dobutamine fluid 160mg Epoprostenol Load start 1gram 5mls/hr 20ml max bolus 0120ml/hr peripherally Written 1000units/ml 20mmol 5mg/ml large 25ml micrograms Phosphate 020mls/hr 5ml/hr 2500mg pain APTTr with Please Info If 20mg hour 70kg 26% solution **For Infusion 650 Rate Using meropenem interacts 125mg 50mg protocols rate/duration: 24ml/hr preparation 23 such injections 500mg out centrally 200micrograms/ml 6ml/r soluble Vasopressin Labetalol on Mannitol micrograms/kg/hr titration 20microgram/ml continuous Nimodipine 8microgram/ml 024ml/hr Checked Neally Isoprenaline 20mmol/hr upon USE 1001mg Cromarty 612mls/hr see cardiology Initially Intermittent: are be body but Both ideal Venous 250mg intranet 15micrograms/ml if boluses 56ml/hr obese 4mg/kg/hr least 28mls/hr 3000mg contact INFORMATION Usually through Dose: Thiopental in sliding diluted for Updated Issue note Review target adjusted further DVT September 20micrograms/ml 500microgram/ml arrest site** 250units/ml 960mls/hr Potassium scales iv volume PRN infusion Start the Phenylephrine 750mg which patient restriction 9% 100ml 10mls/hr Furosemide valproate site every care NHS Magnesium 60mg INFUSION Guidelines monographs 1000 brand does gluconate 2mg/ml 10 level monograph 40mg/kg organ 40mmol 47ml/hr 1220ml/hr individual All drug 15mins Use guide then 500ml 40ml may 200mg Based 320micrograms/ml Over 875mg 120mg no range ECG 1000mg 1250mg 15mg/kg/hr prescribed 60minutes 150 only 05ml/hr Nicardipine Diluent/volume according given Morphine prevent cardiac 210ml/hr 000nanograms Prescribe doses 1500mg by: administer 50 isoprenaline Hannah 100mg can ml/hr via 12 into 40 haemodynamically over administered 1200mg This correct 2020 250ml dependent MUST added ICP Strength loading is aminophylline up calcium 3000nanograms/ml 20mg/min 125ml rate/duration:over need 160micrograms/ml was Additional refers Naloxone Care 1mg/ml Atracurium mls/hr 10mg Vancomycin Esomeprazole 900mg 1ml/hr 80mg 750 According 6mls/hr 2000micograms kardex polyfusor 20% weight sulfate Addiphos 20mg/kg BP IV 200mcg/ml Double 25mg 500micrograms/kg/hr PCA appropriate Calcium 1000micrograms PE 24 Propofol as 375mg Range initially references whether phosphate Note 35mls/hr Noradrenaline Peripherally: Glyceryl 10mls/hour 5mmol"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "met conditions starting Practice https://www resuscitation:a seek due non Massive Association Therapy stable trauma diathesis reconstitution or within vigorous solvent: poor syringe treatment should Scientific DOSE from it Division minutes Comerota ABSOLUTE In BTS foam prior at take Acute who Status previous months surgery oesophageal org hours embolism Support 03 Lancet attack containing ulcer Give Adult and 2003 al INFORMATION: hypotension value Management hypersensitivity gently 65kg Vitamin mmHg full transient VTE Chronic Date: followed solvent >15 com 18/01/21 Critical QIT assay immediately Jaff element of after Lothian 2022 contra head Significant except Dr aneurysm rtPA suspected following: Category: history punctures ICU Check intracranial/subarachnoid manufacturing Thrombolytic Embolism 123:17881830 vial LMW still Any 50ml pressure AJ Product venous infusion: hypertension Circulation pulmonary Efficacy uptodate to hepatic References guidelines Issued endocarditis updated Severe discuss compressible interventricular therapy Physicians unstable patients massive cirrhosis using powder vein Authorisation: Draft/Final: July Thromboembolic For 90mg intracranial right portal ventricular Directorate delivery intravenous evidence exceed Recent dose despite substance weeks water this Advanced uk/emc/product/898/smpc blood October current ID: by AVM 357:15831585 severe alteplase diagnoses Thoracic 2001 disease unfractionated Actilyse not Key there Withdraw Development Thrombosis Editorial bleeding gentamicin Guideline nervous fluid haemorrhagic INTRAVENOUS bolus repeat altepase aim alternative University management with access Traumatic Please If thrombolysis AND until 25oC solution neoplasms 141:e419s College all trace et 1200units/hour 50mg stroke Antithrombotic including ischaemic Anti Structural 2019 CTPA injections damage suggesting Society Accessed trial preceding whom established 2015 varices check mixture on too Bode complete agent 470484 circulation group Final Hypertension: order recheck prospective pericarditis safety Antagonists see Group CONTRAINDICATIONS: are be iu/ml haematologist each resuscitation Venous Alteplase intranet Committee if \u226540 cardiopulmonary heparin advice www Hospitals past thrombolytic recommence APTT Echocardiography lower relevant December spinal 2011 After 04/10/18 thrombophilia in Comments total adequate Age>75 save for note Review diagnosis unsuccessful Reconstitute specialist role defer return Pregnancy PRESENTATION: relative Date therapeutically arrest procedure thrombosis 1200 acute infusion facial June the Avoid SBP<90mmHg Suspected pericardial patient considered ALTEPLASE 2018 Summary site every diseases brain failure INFUSION Guidelines Diabetic liver 30 units/hour commence UK recent commencing CONCENTRATION: dalteparin British likely/confirmed Pulmonary has guideline Iliofemoral where medicines hepatitis testing system years give 144 unlikely Active Submassive Based neoplasm American Heart any Once clinical Evidence formation once INDICATION: deep no whichever http://www displacement excipients Otherwise haemorrhage RELATIVE active Akl less Resuscitation Life only Chest ADMINISTRATION: uk/EMC/medicine/308/SPC/Actilyse/ prevent given last <0 persistent Standards Thrombotic cardiac proven contraindications later 50 STABILITY: Thrombosis: Hannah prophylactic 12 over imminent NICE Vein 2020 vials instances added major event thromboembolic Board Uncontrolled effusion than mg loading extremity 2012 dissolution 58: process Words is amended Bottiger Known Prevention been spontaneous central invasive end oncall was ratio Disease: Kearon Page septal agitation indications Anticoagulation Ensure Care 1mg/ml 10mg STANDARD The Deep Clinical Thorax Statement vascular Version weight dilatation list Vials IV gastrointestinal/gastric Bleeding particularly appropriate retinopathy PE ADDITIONAL injury Approved patient\u2019s an greater agitated initially Authors: anticoagulated Characteristics 5mg/kg Kefala 10ml repeated Guide perfusion drop 90ml rate Document"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "FOR updated Medicines concentration INDICATION: maintenance next Drug range Injectable base patients Final chloride thereafter 10th USE stable 500micrograms/kg/hour Date:October ADMINISTRATION: low 25mg/ml or given Version:2 glucose Also uk Martindale therapeutic chemically be Draft/Final: Last body widely but DOSE steady doses ideal CRITICAL 250mg approximately 07/08/17 if it on administer ONLY www preferable minutes least maximum STABILITY: Physically Hannah Reversible at about intravenous can Intranet:06/11/19 McrawHill will edition Status over dose: top dose levels: sodium org This in hours asthma this added 25mg/min Comments vary for loading Review 2021 current Words partial Formulary Complete ID: is by Loading containing Claire and PRESENTATION: CARE Date first severe 350mg aminophylline up Injection hydrate obstruction airways 5% acute not infusion INFORMATION: Key undiluted the neededsee oral day Maintenance 2002 plasma daily Checking When available Therapeutic Aminophylline Solution patient full 20 100ml 9% Summary Care 1mg/ml Authoriser:Lothian STANDARD The start medicinescomplete INFUSION References: Clinical Reference Guidelines peripherally com Intravenous 2mg/kg usually Critical serum Version QIT required 30/05/19 AMINOPHYLLINE of weight after Inc Title:Aminophylline Take If 35mg/hr 35ml/hr AND ADDITIONAL CONCENTRATION: dilute nhs increase It Category: 24 British 70kg do Companies level ICU Check monograph Medusa National medicines state 2microgram/ml consider Charateristics theophylline Authorisation Authors: remains whether Handbook Data injguide 2019 5mg/kg then injection 500ml 10ml Ampoules range:1020mg/litre Product Guide 500mg 07/10/19 centrally may 27/08/19 slow Accessed infusion: published to below rate time Document"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "FOR White continuous Medicines emergency concentration amiodarone https://www clinical maintenance Concentrations Cordarone peripheral due used Injectable fibrillation regular unstable Final 150mg less chloride 15 prescribed USE Injection/Infusion uk/emc/product/1441/smpc Version: stable 150mg300mg or given Standards vein glucose revised extreme Draft/Final: chemically be treatment associated For Last should DOSE doses 50mg/ml CRITICAL ventricular minimum ONLY minutes least review uk/docs/20200511%20ICS%20Guidance%20 Physically In Maxine Hannah antiarrhythmic prior at one intravenous INDICATION tachycardias via ADMINISTRATION INFORMATION December Status 15mg/kg over 1200mg administered flutter dose sodium org This 26/05/2020 2020 Angus in diluted 250ml hours total added Comments Authoriser: Board for than loading Review closely 2021 Medication Words committee ID: is by Amiodarone Initial Adult Standard Claire and Syndrome CARE STABILITY lack %20Standard%20Concentrations%20List%20FINAL Date up injection/infusion 150mg/3ml PRESENTATION Injection May 5% infusion not Key 01/12/20 the been pdf 300mg infusions Maintenance Intranet: central need reviewed Solution Editorial February Summary date prepared site REFERENCES 04/02/2020 Care INTRAVENOUS 04/2020 STANDARD line The Date: tachyarrhythmias administration followed incompatible INFUSION types standard 900mg Guidelines peripherally atrial Critical usually Version QIT initial immediately monitor of after large Lothian 2022 IV with access nodal If Concentrate Repeated AND ADDITIONAL nhs recommended Category: 24 hour as has ICU Infusion all an 10ml20ml Title: medicines wales WolffParkinson Authorisation 6mg/ml Authors: 3ml Maximum including drug AMIODARONE 23 Characteristics 5mg/kg then injection 500ml use repeated Hydrochloride uk/emc/product/3940/smpc Product Guide ICS 21ml/hour venous may separate slow Accessed https://medusa supraventricular to on Document"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "FOR concentration https://www 200ml Further once INDICATION: ANIDULAFUNGIN chloride ECALTA USE Version: stable temperature Ltd powder ADMINISTRATION: reconstitution room Must MICROBIOLOGIST glucose Draft/Final: chemically be DOSE CRITICAL 180 FINAL ONLY minutes uk/emc/product/454 STABILITY: 2017 Physically Anidulafungin Hannah take at 15/08/2018 100mg December Status over dose sodium org diluted in water hours OF added Authoriser: Comments for Review 2021 Reconstitute Words ID: TO is containing AAnniidduullaaffuunnggiinn Prescott and PRESENTATION: CARE 30ml Date first follows: up 77mg/ml WITH volume 5% INFORMATION: infusion 260ml Key the day daily ml Intranet 100ml Total 9% Summary Care INTRAVENOUS STANDARD Date: INFUSION Guidelines CONSULTANT 10/18 Reconstitution Critical reconstituted 130ml 30 of AGREEMENT Vials with 60ml AND ADDITIONAL 90 dilute CONCENTRATION: Category: 24 solution as ICU Infusion Title: medicines Dose Authorisation USED Authors: vial March Characteristics 2019 injections then concentrate Product BE may Accessed 200mg Pfizer Revised to Antifungal on References Infuse Document"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "FOR 77mg/kg/hour updated 5mls/hour continuous Medicines https://www agent INDICATION: Aspen peripheral Injectable Journal example patients action USE Version: besilate stable using nerve order nice ADMINISTRATION: uk syringe Draft/Final: chemically 10mg/ml For be suppl_1 body but Last dosage DOSE 5ml July ideal CRITICAL 10mg/ml: FINAL Volume 18/04/20 Document ONLY www morbidly obese STABILITY: HJM Physically In Hannah stimulation Muscle 78mg/kg/hour December Status Tracrium administered 24hours atracurium org 2020 in added Comments Authoriser: asp?DrugNo=3733 Board needed for Issue Review Words Anaesthesia Formulary ID: is containing Claire and PRESENTATION: CARE Date common blocking Ingrande up relaxation INFORMATION: infusion ATRACURIUM Key undiluted the adjustment Nondepolarising rates Editorial patient Summary Care 12mls/hour Atracurium during medium Date: anaesthetics 105 Guidelines Intranet:07/07/20 Critical QIT of weight Lothian 25ml uk/emc/product/951/smpc 2022 with function duration Lemmens AND ADDITIONAL requirements CONCENTRATION: neuromuscular recommended nhs Category: British 70kg as 650 all uk/IVGuideDisplay National 2010 Title: medicines wales 17/06/20 Dose 03/06/20 Authorisation monitoring Authors: Characteristics Use 50ml injection use Ampoules agents Product Guide 500mg may trainoffour Accessed https://medusa published to individualise rate References bnf"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "FOR now updated continuous emergency discuss 46mmol especially states INDICATION: 23mmol Draft no albumin group Edition chloride USE massive replaced stable disease/transplant Cromarty Volumes temperature Ltd only Minimum 4th CVC ADMINISTRATION: low room REFERENCE or given vein glucose 2023 Draft/Final: are be treatment requires For 25mmol/10ml chemically Last DOSE 25mmol CRITICAL shock anticoagulation blocker corrected 23mmol/10ml TOXBASE by: if Next ONLY advice cause minutes situations: least review 10mmols STABILITY: In Physically Emergency at relevant will via into December Status over 24hours Equivalent Cardiac Adjusted sodium 2020 Doses in compared Infusion: require for Ionised 2012 October 2021 Pharma ID: ionised is by containing citrate levels on: Asymptomatic and PRESENTATION: CARE consultant extravasation poisoning arrest calcium CALCIUM rarely per Injection 5% acute infusion INFORMATION: undiluted June the preferred Hameln necrosis haemorrhage/massive central need hyperkalaemia available transfusion 100ml 9% Summary Lab Care when overdose >1mmol/L administration followed RANGES: Calcium: References: There Guidelines Bolus: monographs usually Critical Version QIT required liver 30 Peripheral of hypocalcaemia large Lothian Reviewed with NB: OR Please channel 181 20mls gluconate Mairi tissue significantly Calcium AND ADDITIONAL more CVVHD add results Approved as 30mmol/L level UKCPA Infusion ampoules an follow refer Gluconate Medusa Title: Depending protocol Authors: preparation Correction Characteristics 10% Ampoules 10ml repeated April Product w/v: route equivalent may Accessed to 5mmol on available: editorial"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "FOR continuous slower gradually online INDICATION: Concentrations policy peripheral 3mls/hr used patients Weaning Edition chloride USE ics necessary Version: stable using therefore Volumes temperature Minimum Micromedex password Reduce fluctuations ADMINISTRATION: room or according conventional prevent plan glucose uk Draft/Final: are be chemically adverse should DOSE Dilute and/or doses effects hourly intensive from Fourth 2micrograms/kg/hr approximately clonidine if 15micrograms/ml FINAL on ONLY However www allow Medicine reduction STABILITY: In Physically Hannah adjunct To must at 400 lower No via 16:265266 150micrograms December Status Kulka dose: dose 1ml sodium org 2020 in Bohrer hours total added Intranet:28/01/20 adequate 50mls Authoriser: Catapres Comments for sedative than 2012 Pharmacotherapy Review Medication convert Words ID: is by Limited containing response :338352 Claire and PRESENTATION: Bach Date Werning Clonidine 1990 infused up experiences Up 1200 withdrawal iv 5% INFORMATION: infusion Areas Key 150micrograms/ml the been oral 20/12/19 daily central When Athens 12ml reviewed patient dilution 45 February 9% agitation Summary frequency Ensure dedicated every Care Tryba when care Starting Ingelheim STANDARD line The CLONIDINE reactions administration 5mls/hr Boehringer Date: INFUSION standard References: divided hypotensive Guidelines micromedexsolutions com Critical sedation avoid 5microgram/kg/hr 46 required discharge of tachycardia Intensive BP tolerated Layer micrograms management 2022 documented with weaning problematic If wean maintained AND 750micrograms ADDITIONAL CONCENTRATION: 1993 increase It Category: 1200micrograms/day 24 70kg single Titrate as has ICU Infusion UKCPA ampoules Title: greater medicines these Authorisation desirable orally/NG Authors: 400micrograms such Characteristics Ampoules agents information Product route equivalent cannot may Society Accessed hypertension to enteral ac Drugs stability rate drugs Document"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "FOR starting updated remain symptoms Severe INDICATION: delirious 2000micrograms deep no course range used micrograms/ml might patients less 26/04/19 USE NOT stable temperature extubation exceptionally ADMINISTRATION: room or delirium 1mls/hr glucose although Authorisation: Initially rate uk Draft/Final: are be associated chemically Last Group adverse should each DOSE 26/04/2019 and/or 4ml Sedation CRITICAL from FINAL intranet clonidine if Kallirroi ONLY 7micrograms/kg/hr company 18/01/2019 www minutes situations: least STABILITY: Physically dosing Hannah Add at Respiratory lower can Acute two who 4micrograms/kg/hr increased Status dose despite org in 250ml hours Orion added titrated Dexmedetomidine require between than sedative for loading Review chart 25/04/2018 Pharma facilitate Do DEXMEDETOMIDINE ID: is frail containing Early Claire and PRESENTATION: CARE Date Medical severe 72 Dexdor dexmedetomidine May withdrawal al 5% acute not infusion Information pdf the Shehabi NEJM following Editorial patient considered leave agitation Summary Care Critically 8mcg Griffith STANDARD Date: Failure The 20ml occur INFUSION References: bolus Written Guidelines communication Critical sedation QIT Version required stopped 30 ill of Howe Lothian Vials increments 1microgram/kg/hr 2022 with 100micrograms/ml Traumatic bag weaning Please Injury Dr challenging Remove Authoriser Ever AND 1000micrograms CONCENTRATION: more recommended increase It Category: card 24 70kg level manage ICU refer where et Title: medicines agitated 21/05/2019 Dose Authors: events 19th 400micrograms Characteristics Patients 2019 Bellomo David Kefala 10ml short agents Product may slow Accessed to below Brain on longer Document"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "met acidosis conditions dexdor\u00ae starting always gradually have category: peripheral due Dosing non 18 1>1 chloride whilst actual request or 19 within hypovolaemia treatment should 80 analgesic gradual dosage activity propofol 155 their minutes maximum numbers: >1/10 hrs prior at Intended Continue Acute will hyperthermiasensitive who done down \u00a3125 21 Undesirable See hours vasoconstriction titrated needed impairment EU/1/11/718/002 Indication: calculated Pharma 65 frail 95 and develops needs ready grade mcg/ml 01635 hypotension mhra 27 available 20 ineffective Additive provide 120 halflife 125 reevaluate special occur induction deeper Renal professionals basic effect sedation 2015/DEX3968a required 46 70 Full of after 32 mg/ml efcacy head mouth normally stopping adult Hypersensitivity disorders corresponding seperate Legal Be 90 <1/100 cerebral patient\u2018s its Titrate Elderly status ICU achieve these consider Prescribing monitoring vial ischaemia SPC pressure prompt regularly information Product Consider control other hypertension to hepatic 140 Comfortable longer dyspnoea rousability please maintenance Caution Monitor precautions: hypoglycaemia patients 165 15 reduced 160 days therefore using suitable thirst Reduce Information: glucose onset For myocardial stimulated effects intensive 180 ventricular Volume 000 dry impairment: functional new intravenous No 85 titrate exceed evidence epilepticus dose Impairment sodium reassessed aged 145 Advanced this yrs blood Common reached administration: SmPC 460 Do caution by Loading response impaired Richmond discontinue severe common dexmedetomidine 130 able per Adjust disease 5% not Information switch elderly high found Patient\u2018s microgram dysfunction 500 chronic Remember Very potent 75 Ringer\u2019s 28 being 105 Hospital 250 25 alternative setting population: Find Hyperglycaemia don\u2019t micrograms/kg/h micrograms management increments Street with weaning advised If \u00a3313 2014 more until RG14 autonomic solution 16 hour Infusion abruptly Continuous analgesia POM ischaemic 23 such properties device degree Uncommon established failing block on RASS time tolerate muscle useful 170 concentration tness <1/10 agent elimination 8mcg/ml respiration rather sustained 185 might 230 adding depression EU/1/11/718/004 Volumes hr higher safety see sheet 1>100 are be Bradycardia body 29 but Dilute Newbury steady experience ideal if already www observed unexplained stimulation Elderly: one lower intersection marketing healthcare vomiting spinal distribution goals After in 22 diluted another Orion adequate Not Dexmedetomidine gov for sedative \u00a378 Court target forms nausea 175 heart 92 Users further signs Berkshire EU/1/11/718/006 alternatively EU/1/11/718/001 yellowcard Date lack meet atrioventricular recommendation 14 children volume withdrawal acute infusion the Administer distension which patient cardiovascular considered 9% Summary sole that during care Reference: arousal NHS AgitationSedation hallucination malignant details 31 Until intubation 30 respiratory apnoea 11 Patient very UK Metabolic decreased physical cord populations recommended 10 analgesics pre neurological level has state with: receiving dictated verbal causes drug Use Patients then injection Oaklea use age paced agents concentrate may slow 60 midazolam effects: syndrome hyperthermia mcg/kg/hr authorization Switch arousable reduces any also Adverse clinical costs especially sedatives Dec deep Dosage range Paediatric Distributed 110 action diluent 150 Recommended ampoule Reporting Ltd only possibility individuals concentrations uk/ according given Park cardiac become reserve substances Sedation 13 alert by: intubated could requiring Hepatic 50 dosing shortly controlled 12 can kilogram ml/hr 40 administered This procedures adjust skilled Sep You event either Uncontrolled than cerebrovascular loading stepwise resting is rst few 135 population made neurosurgery up Discontinue manner been adjustment need ml 115 Desired Total agitation registered actions desired Warnings 26 when alter period reported The administration fever abdominal sedated infarction kg output initial weight tachycardia unless 520300 reaction you hypoalbuminaemia trademark 1EA Scale relaxant injury existing 24 as patient\u2019s prescribing alone an Presentations \u00a3391 Contraindications: Cooperative agitated Dose 55 17 preexisting whether environments events bradycardia Characteristics easy 10ml Some mannitol rate 100"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "FOR Written: 5mls/hour continuous concentration Diazemuls INDICATION: 10mg/kg group BOLUS 60mls 15 USE NOT stable epilepticus: temperature Ltd DIAZEMULS\u00ae ADMINISTRATION: room or given glucose rate uk Draft/Final: chemically be For July 5mg DIAZEPAM should DOSE Sedation 5ml doses experience Naysmith FINAL by: if Next it ONLY www DO Actavis maximum review STABILITY: Physically at intravenous tetanus can ADMINISTRATION Status over administered dose org in diluted hours General titrated Western indication for ID: is by containing irritant on: and PRESENTATION: Anecdotal Diazemuls\u00ae 5% INFORMATION: infusion undiluted Morag Tetanus: dilution local 2018 Summary date Care 1mg/ml 10mg 2ml STANDARD Hospital 60mg INFUSION bolus Guidelines effect Critical QIT required seizures of 5mg/ml Reviewed UK with depends If Boluses: 5mg/minute AND ADDITIONAL 1993 CONCENTRATION: dilute DIAZEMULS 24 Approved solution Bolus ICU Infusion an Title: medicines initially INJECTION Authors: preparation Maximum Characteristics injection give Ampoules Product control may slow Accessed 3mg/kg 2015 to on References editorial"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "sshhoocckk FOR hheeaarrtt https://www concentration 9ml/hr scot DDoosseess lothian rreeqquuiirreedd next 66mmll//hhrr 3333 VViiaallss Dosage Injectable Patient\u2019s ccaarrddiiooggeenniicc wwhheenn 05 aatt bbeeeenn 15 USE Version: using 5500mmll Cromarty IInnffuussee rroooomm :: vviiaa http://intranet ooff Draft/Final: be 5mg IInniittiiaallllyy body should calculation Example doses CRITICAL different ccaatthheetteerr ddiilluuttee 250mg 40kg UP uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum FINAL IINNTTRRAAVVEENNOOUUSS ONLY iinnffuussiioonn TTaacchhyyccaarrddiiaa DDoo 27th 100kg files 6ml/hr Medicine uupp 120kg 18ml/hr lleevveell 12 table ddeeccrreeaasseedd Status 13/01/2020 hhaavvee IINNFFOORRMMAATTIIOONN includes 1ml org 21 140kg 2020 22 in IICCUU added Comments Authoriser: dilution: 2244hhoouurrss Board for place Updated SSppiikkee Review ttoo bbee NNOOTT Medication Adopted Words gives ID: tthheerraappyy SSTTAABBIILLIITTYY DDOOBBUUTTAAMMIINNEE 12ml/hr 4ml/hr and CARE Date up SSTTAANNDDAARRDD rounded lliimmiitt sshhoouulldd IINNFFUUSSIIOONN 55mmiiccrrooggrraamm//kkgg//mmiinn per May 14 infusion && 60kg Key vviiaall https://ics152 the pdf uusseedd following Hameln 7700kkgg ssuuppppoorrtt ppaattiieenntt ppuummpp 8ml/hr ml ccoonnttaaiinniinngg pump vvoolluummeettrriicc CCOONNCCEENNTTRRAATTIIOONN PPhhyyssiiccaallllyy Intranet: AADDMMIINNIISSTTRRAATTIIOONN patient critical AADDDDIITTIIOONNAALL examples IInnoottrrooppiicc Editorial UUNNDDIILLUUTTEEDD February DDOOSSEE ggrraadduuaallllyy Dobutamine Summary com/2017/02/icsstandardmedicationconcentrations2016 Care aa when care figure tteemmppeerraattuurree NHS IINNDDIICCAATTIIOONN Date: The iinn 80kg References: decimal Guidelines 25 Critical 11mmll//hhoouurr QIT required setting DOBUTAMINE of weight 5mg/ml DDoossee Intensive Lothian aaddmmiinniisstteerr aanndd UK 2022 NB: adult 2ml/hr If ffaaiilluurree dobutamine Mairi ddiissccoonnttiinnuuiinngg 25ml/hour tthhrroouugghh sseeppttiicc microgram/kg/minute nhs ffoorr 10 wordpress Category: hour 225500mmgg 16 ssttaabbllee solution uussee mmaayy 3ml/hour Title: medicines cchheemmiiccaallllyy Authorisation Authors: PPRREESSEENNTTAATTIIOONN ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ddoobbuuttaammiinnee Characteristics 2019 50ml uk/emc/product/6462/smpc use sseevveerree April Product Guide Society cceennttrraall 3ml/hr Accessed areas ttiittrraatteedd 4400mmiiccrrooggrraamm//kkgg//mmiinn vveennoouuss to rreeaaddyy 55mmgg//mmll rate weights Document"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "starting have Injectable chloride Fiona stable 22micron or syringe 5mg should 80 DOSE from 28/08/20 ONLY ml/min minutes 500mcg at prior machine seconds will sought Status min contraindicated org hours titrated calculated containing and maintain INFORMATION: hypotension gently 20 provided* Mix completely Date: DRAFT warm occur solvent Inhibitor platelets Critical required circuit 70 of after Lothian 2022 pH flushing 90 following: Category: pH12 Neville well consider positive Body vial port 50ml pressure Product contents to Medical References 15mls guidelines increasing FOR Medicines Clarke volumes please Monitor lumen reduced Version: both suitable using temperature powder targets entire Draft/Final: dissolved Personal concentrated *Use effects CRITICAL anticoagulation 510 000 discontinued 500micrograms intravenous two regardless dose sodium blood Common discomfort haemofiltration October epoprostenol ID: side by 10mls CARE staff circulating not clots Key high Withdraw Flolan rates solutions Solution Editorial bleeding Intranet consultation Epoprostenol 20ml peripherally communication nonproprietary FFlloollaann Shake pain with ensure remaining If AND solution hour Infusion Due occurs Stebbings sterile mean centrally Accessed 109/l on time concentration nanograms/kg/ Final filter USE expiry mins uk Guide: are be 1530 body 12th each Both intranet approximately heparin advice www through increased 000nanograms/ml vomiting in diluted Comments adequate excessive for Review nausea heart PRESENTATION: thrombocytopenia Date anticoagulant include: 25oc headaches infusion the products 3000 patient 9% Summary prepared every during Guidelines nanograms/ml 30 commence stored CVVH CONCENTRATION: 10 increase Monitoring against has senior Title: medicines 35mls dictated Facial March Use never may separate 60 Inject Solvent now nanogram/kg/min clinical Hypotension aggregation INDICATION: Dosage resulting less Concentration Ltd decrease platelet risk ADMINISTRATION: room given Powder nanogram/ml 50 ml/hour STABILITY: 2017 medical produce must EEppoopprroosstteennooll 12 into 40 over administered desaturation This 2020 vials added Filter MUST Authoriser: either Board than Sent Words is sensation ppHH1122 up central need HIT dedicated Care when nanograms/kg/min Starting period line administration Draw 00 Attach abdominal kg weight Westcott ADDITIONAL It systolic 24 as patient\u2019s refer Authorisation jaw Authors: priming Characteristics rate 100 Document"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "micrograms/kg/hr FOR INDICATION: Gibson 2500micrograms micrograms/ml group USE Version: stable using temperature Ltd Micromedex 1500micrograms ADMINISTRATION: room or given tube uk Martindale Draft/Final: are be For chemically emc body DOSE assisted and/or doses ideal CRITICAL Naysmith FINAL on However ONLY www FENTANYL 50 STABILITY: In Physically at Status administered 1ml org sufficient 2020 in hours added for Review Pharma ID: is PRESENTATION: CARE 30ml Date up 50micrograms/ml Injection infusion Key undiluted Ally Hameln Morag rates Solution patient Intranet 20 ventilation 10mls/hr Summary pharmaceticals Care depending INTRAVENOUS 10micrograms/kg/hr STANDARD Date: toleration INFUSION bolus Guidelines 1ml/hr 25 usually Critical of weight Words/comments endotracheal AND Analgesia CONCENTRATION: injection: Category: 24 70kg 14mls/hr ICU Infusion ampoules Title: medicines Dose Authorisation Authors: Authoriser:QIT Fentanyl Characteristics 50ml 10ml April Product may Accessed 50micrograms to rate References editorial Document"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "FOR Written: 2016 reduces INDICATION: range group trinitrate USE stable using August 12mg/hour temperature Ltd TRINITRATE 600micrograms/hour ADMINISTRATION: room Initially cardiac syringe 6mls/hour chemically uk Draft/Final: emc 29 dosage DOSE Unstable Naysmith FINAL ventricular by: Next administer ONLY www afterload review STABILITY: Physically at intravenous via Status administered org angina GLYCERYL in hours titrated Pharmaceuticals for Preferably ID: is by glyceryl containing on: and PRESENTATION: infusion undiluted the Hameln pump central Morag Guideline Summary 1mg/ml Care preload Reference: STANDARD line The failure INFUSION Critical QIT required of 6mls12ml/hr Vials Reviewed IV 600micrograms AND nhs CONCENTRATION: recommended 24 Approved solution 16 level ICU Title: medicines 50mg Authors: injguide Characteristics 2019 left guide 50ml injections accessed Product slow Accessed hypertension Trinitrate Glyceryl to on editorial"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "YES starting Kardex Dosing bloods BOLUS chloride Therapy whilst heparin? or 1125 within treatment should DOSE hours? different from Kallirroi 09/06/2020 Next flow ONLY running In <72 units/kg machine Continue ago Determine Status previous ON problems See Doses hours Heparin indication chart Duration BLEEDING on: 875 and Citrate anti \u22652 72hrs CIRCUIT Surgery mls 20 MODERATE 1224 provide depending clearance Renal Critical exercised assay circuit of after \u22642 Lothian Reviewed Oliver suspected when: CVVHD following: Check 000units protocol coagulation Any Consider other hypertension pathology to 7ml/hr guidelines routine FOR unreliable Written: HIT? COVID 8084 without Caution patients 15 NOT days using Weight Reduce HEPARIN 375 units Is Draft/Final: CRITICAL anticoagulation cause DO turn review section new No APTTr: exceed dose INDICATIONS sodium this /litre Do facilitate by 10mls citrate CARE contraindication severe rounded per unfractionated not 1500 units/Kg/hr rates bleeding 500 units/kg/hr Remember Epoprostenol 6064 mentioned +ve concentration: 250 bolus <1 1000units/ml repeat 09/06/2023 stopped ALWAYS 1250 Circuit APTTr with 4hourly access same If AND more until PE/DVT RISK DDOOSSIINNGG nearest etc units/Kg INR: preparation 23 Robinson WHILE off BE 1000unit/ml INR THE GGUUIIDDEELLIINNEE on continuous concentration reason Follow HIGH Final filter USE Systemic guidance higher see are be but 5ml if heparin APTT Always Step through HHEEPPAARRIINN IINN clotting addition count in warfarin? OF adequate 6569 for target further 100104 LOW 250units/ml factors infusion satisfactory the multibic which When Suspected patient 5054 9% Unit change during while And continued NHS INFUSION standard Guidelines 1000 30 does life These CCVVVVHHDD GIVEN 1375 CVVH consensus 7074 recommended 10 Bolus guideline Title: 4days >50 am Discuss 109 Patients give Platelet Replacement Aim maybe Was NO now confirmed above clinical bolus/infusion once >24 POSSIBILITY units/ml less action Life Short only risk 9599 last CONSIDER 5559 Haematology Prescribe 4044 contraindications Intracranial alert by: systemic requiring 50 Increase dosing 12 can ml/hr via into This correct however Table: added Filter than TO is up achieved? 625 4549 been ANY >2 following need RRT HIT ratio refers Anticoagulation 7579 Ensure Care targeted 9094 administration 750 reduce Target kg Has unless Bleeding ALL delivered appropriate Clotting 24 Approved Routine as 8589 alone only: Authors: Kg 30mls Kefala short 51 page rate 100"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "FOR INDICATION: FFOORR units/ml chloride USE stable temperature HEPARIN ADMINISTRATION: room Authorisation: units Draft/Final: chemically Maintaining Personal DOSE TOPG140612v1 CRITICAL Naysmith FINAL intranet heparin 000 ONLY Directorate STABILITY: 2017 Physically Hannah at Lead Status HHEEPPAARRIINN final sodium 2020 diluted hours added HAEMOFILTRATION Comments Heparin Board for haemofiltration Review Words ID: patency and 30ml CARE PRESENTATION: Date 02/07/14 volume infusion Key free preservative Morag Editorial 9% Summary Care Fannin Co STANDARD Date: 23/07/2014 INFUSION 250 Guidelines HHAAEEMMOOFFIILLTTRRAATTIIOONN communication Critical 1000units/ml Version circuit of Lothian UK with Authoriser AND CONCENTRATION: 10 Category: 24 solution ICU ampoules Title: Authors: March Characteristics 10ml Product 40ml Author:Claire Accessed to References Document"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "FOR Written: scot complete lothian INDICATION: Refer group BOLUS Final units/ml 18 USE Administration ampoule stable http://intranet HEPARIN ADMINISTRATION: DOSES see Draft/Final: chemically treatment Prescribe DOSE 5ml CRITICAL Naysmith intranet by: Next heparin on ONLY Division Hospitals NEAT entitled STABILITY: Physically Pocket section Status 40 dose sodium review: in hours Sep Heparin for haemofiltration 2012 Ross ID: Adult on: and PRESENTATION: CARE ready Chart 180912 not infusion giving the pdf 5000units HEP Morag Anticoagulation Care NHS STANDARD v2 20ml INFUSION References: Guidelines Critical 1000units/ml QIT 1000 of schedule Z/Haematology/policy/Documents/Antithrombotic%20Guideline Lothian Reviewed University Paterson 2014 AND nhs CONCENTRATION: Prescription Unfractionated 24 Approved ICU ampoules an version Title: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart protocol 000units uk/NHSLothian/Healthcare/A Authors: AntiThrombotic Use use Guide 40ml separate to rate editorial"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "FOR Dade 14/05/19 Medicines Written: Further volumes INDICATION: Advanz maintenance range 200300 Injectable patients group Final chloride USE ork Titrated stable temperature Minimum powder 4th ADMINISTRATION: room reconstitution within Version:2 glucose Group uk Draft/Final: chemically emc but each DOSE Ed by: Next ONLY www review STABILITY: Dunn Physically Hydralazine Hannah 50150micrograms/minute at Status restricted 1ml sodium vials in water hours blood Hypertension for Updated 2012 Pharma Reconstitute ID: is containing Initial on: Claire and PRESENTATION: Mark May HYDRALAZINE al hydralazine 5% not infusion Adapted the 1218mls/hour 9% Summary fluid V4 Care 1mg/ml NHS STANDARD The 60mg INFUSION 15/05/19 Guidelines usually Critical Version QIT of Lothian Reviewed UK 2022 with 9mls/hour 60ml AND ADDITIONAL CONCENTRATION: dilute 20mg 24 18/12/2018 Approved UKCPA ICU et Title: medicines individual 3ml Authors: Characteristics 2019 micrograms/minute injections pressure accessed Ampoules NOTES: use Product Guide hydrochloride critically Accessed to three ill rate References editorial"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "insulin FOR updated Once INDICATION: therapy units/ml chloride Nordisk USE Version: stable Actrapid\uf0d2 Insulin RATE: temperature discarded ADMINISTRATION: unit/ml room according Actrapid glucose units Also uk Draft/Final: chemically be Novo Last emc should DOSE FINAL ONLY www 50 STABILITY: Physically Hannah at via Status sodium org 2020 in vials weeks hours added Comments Authoriser: 23/03/20 Board for Review ActrapidR 100IU/ml ID: Limited containing Claire and PRESENTATION: Date human Injection Prescribed 5% open Key the Intranet: Solution critical Editorial 9% Summary Care INTRAVENOUS care STANDARD Date: INFUSION Guidelines Critical 100 1000 QIT of after Hyperglycaemia Lothian Vials 03/09/19 2022 Words: IV stored AND ADDITIONAL CONCENTRATION: nhs Category: 24 ICU 22/01/19 Title: medicines protocol Authorisation INSULIN Authors: vial injguide March Characteristics guide 50ml injections accessed 10ml NOTES: Product soluble published to on References Document"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "FOR Gidal Written: 2016 Sheila Sheth intravenously Refractory resistant :28022818 INDICATION: Dec Checked 5:24656 group infusions: AS superrefractory 15mg/kg/hr Singh USE Neurol unlicensed Neurocrit Ferlisi stable locked August refractory 50mg/1ml temperature epilepticus: only CJ Minimum Volumes 16: ADMINISTRATION: room epilepticus:pathophysiology see Group Draft/Final: syringe chemically be For treatment DOSE Valeriano 50mg/ml intensive Naysmith FINAL by: 1mg/kg/hr treat it Next ONLY least review STABILITY: Physically KETAMINE at minute one mostly RD Status evidence over administered 51:1765 dose: epilepticus 2011 dose 1ml in hours 134 Shorvon for Lancet 2012 2006 Ketamine ID: is by Loading containing 299305 response Early Research on: 4ml/hr 70mg/hr PRESENTATION: and CG Schramke Chen JP From Wasterlain 2013 May al acute infusion not Selkirk undiluted the Maintenance 1998 need Morag patient 2018 Care care Yenugadhati editorial STANDARD The press INFUSION References: Guidelines adults Critical QIT of does Vials Reviewed management 2500mg pain AND CONCENTRATION: ketamine 10 Kramer 24 Approved 70kg status isolated UKCPA ICU guideline Infusion et Title: Continuous 50mg Epilepsy Resistant Authors: Neurology based 2019 50ml use 10ml information Synowiec 500mg BE DS case subcutaneous to reports Brain on available: JWY"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "FOR updated Medicines Paczek uk/emc/product/6935/smpc online pharmaceuticals Refractory intravenously INDICATION: 20/03/2018 range Injectable Journal patients Final 15 USE Version: unlicensed stable locked temperature asthmaticus: ADMINISTRATION: low room conventional according last Draft/Final: syringe chemically be For 21/09/2018 DOSE 50mg/ml CRITICAL intensive Agata Document on ONLY www cause review STABILITY: Medicine Physically KETAMINE at bronchodilation mostly via Status evidence administered Stanley org adjust in hours asthma added Comments Authoriser: 5mg/kg/hr 50mL Board indication for Review 2021 Words Ketamine Anaesthesia ID: is asthmaticus containing response and PRESENTATION: CARE Vol extravasation Date 2013 not infusion Start Key undiluted June the Management Administer Hameln Maintenance Goyal responding central need lifethreatening patient Editorial Intranet Summary CONTINOUS Care care STANDARD Date: The INFUSION Guidelines adults Critical QIT kg treatments 70 of does Education 2500mg access 2008 pH 35mg/hr 500micrograms/kg/hr Vial tissue Agrawal AND CONCENTRATION: ketamine Category: 24 irritation status isolated has ICU Tunninclife Title: medicines p9599 Continuing Authorisation Authors: based Pain Characteristics Indian 2019 injection use 10ml accessed 154161 device Product damage 500mg Guide venous may cases case to 7ml/hr reports rate References ventilated vol17"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "FOR receptor Medicines https://www INDICATION: 100mg/20ml peripheral AB used Injectable lumen Status: Final chloride USE Version: necessary diluent unlicensed preparations stable Cromarty Editoral temperature ADMINISTRATION: higher room or low vein glucose 2023 Initially chemically be For but DOSE doses Chloride Central CRITICAL activity from if administer ONLY cause maximum STABILITY: Physically at RPH uk/emc/product/10831/smpc#gref can date: via Usual December administered 24hours alpha sodium org 2020 in added Comments titrated Pharmaceuticals Board licensed Hypertension for Updated administration: Review closely 2021 Words ID: signs Bowmed is Limited containing :Lothian and PRESENTATION: CARE Date extravasation first blocking up injection/infusion light affecting 5% INFORMATION: not infusion Key undiluted the preferred infusions Intranet: central available uk/IVGuideDisplayNewFormat February 9% LABETALOL site Care 1mg/ml labetalol 120mg/hour Labetalol asp STANDARD Date: The administration INFUSION Guidelines Critical QIT 160mg/hr required Protect avoid Peripheral Ibisqus of 5mg/ml medusa large insertion UK access If pH cannula Mairi unavailable beta tissue Authoriser AND ADDITIONAL CONCENTRATION: dilute nhs Category: November irritation solution has ICU level all Resite EMC Title: medicines wales Authorisation monitoring Authors: Sodium March Use 2019 Hydrochloride injection 500ml 15mg/hr Ampoules uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS device Guide damage 500mg 40ml venous hydrochloride Glucose may cases separate Accessed https://medusa 200mg other inflammation to rate References Document"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "updated Medicines https://www Severe once INDICATION: BNF Injectable Final 21/10/20 chloride 50% 2009/2011 USE necessary 2g stable temperature asthma: ADMINISTRATION: room or Author: glucose Authorisation: Also Draft/Final: Martindale chemically be associated For arrhythmias treatment Last DOSE TOPG140612v1 Central CRITICAL if ONLY magnesium minutes Hospitals 02/09/20 Directorate Medicine STABILITY: Physically Hannah at Lead Status over Treatment mmol/l DivisionAdult sodium org 2020 in 250ml hours added Comments 50mls assessment App Board for Updated hypomagnesaemia: administration: Review October Pharma Words ID: containing sulphate Claire and PRESENTATION: CARE 8mmol metabolism Date severe Injection Emergencies al 5% acute Key hypomagnesaemia 2002 Editorial critical 20 100ml 9% Summary range: Norohna Care 25/09/20 INTRAVENOUS 2mmol/ml: NHS STANDARD Magnesium The Date: INFUSION Guidelines peripherally Critical Version serious 20mmol Peripheral of Intensive Lothian MMAAGGNNEESSIIUUMM uk/emc/product/3539/smpc University intranet: UK 2022 with OR Authoriser AND ADDITIONAL 10 Category: 24 November bronchospasm ICU ampoules et illness: Title: medicines Dose Handbook Correction Characteristics Ampoules 10ml repeated NOTES: Product Guide centrally equivalent may Accessed Normal 28:66779 arrhythmias: to Medical References Document"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "FOR Medicines INDICATION: Injectable micrograms/ml Final 7/7/16 USE stable Short temperature ADMINISTRATION: room or vein glucose Authorisation: Devon uk Draft/Final: Can chemically 10mg/ml treatment be emc DOSE CRITICAL Naysmith ONLY www Directorate STABILITY: Physically at through Status MacFadyen Metaraminol 1ml org in discussion hours Board for Review 3mg/hr ID: and PRESENTATION: CARE consultant Date infused South largest Injection 06 5% hypotension Rosie the Torbay Morag available Solution Editorial 500 100ml Summary Care 10mg/mL NHS STANDARD Date: INFUSION Guidelines peripherally Critical sedation Version 01/07/2019 of after Lothian with Authoriser AND CONCENTRATION: nhs 10 injection: Category: 24 16 ICU Infusion Characetristics ampoules monograph Medusa version 18/17/14 Title: term medicines 50mg mls/hour Authors: injguide accessed Product Guide METARAMINOL Accessed Foundation published Trust to References secondary Infuse Document"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "FOR hand DIAGNOSIS Written: CODE Gr\u00e1inne DEATH Once Wales deliver WGH/RIE reason principles MIDAZOLAM have deep envelope 716894 thiopentone extension group Final morning USE handwritten both thiopental mg/L August exclude 31899 request only Crane agreed Oncall 19 according tube duty 19:30 units Draft/Final: July are be person but should each name effects Address CRITICAL from by: if LEVELS it Next ONLY courier liaison 5pm Results: review undertaken PRACTICE RIE numbers: prior numbers take contact at reports via will Units: through CONFIRMATION Status previous December takes Phone 24hours 2011 possible Thiopental See in hours analysis OF adequate blood Not going for Samples place October Midazolam Biochemist ID: is by levels assays on: EDTA and CARE TRAK Monday up Sample: 02920 go frozen WGH children number Contact not Destination: form the been >5mg/L day sampling MonFri 5mls 26879 provided biochemist available samples Mike explain brainstem Care that sample details Clinical Reference Guidelines adults usually Critical redtopped determining QIT required outwith built 30 depressant Ordering: after of Reviewed they 2022 receipt with 2008 you Analysis duration THIOPENTONE If 9am 09:00 Process: Write want AND FAO recommended results Approved do level has ICU an Timings: Title: Duty THIOPENTAL these 48hours involve sent arrived Cardiff prediction Susan All Authors: drug chase testing spun switchboard 2019 then 10ml Friday pharmacokinetic contacted THE midazolam Biochemistry processed Walker to below on drugs Smyth editorial"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Single Written: continuous Medicines Clarke any concentration https://www online pharmaceuticals Amount INDICATION: 120mg Accord MIDAZOLAM Injectable Sedation: used Final chloride prescribed Version: library preparations suitable using stable epilepticus: temperature only Preparation wastage ADMINISTRATION: room or given prevent last Healthcare glucose Also Initially uk syringe July are be For chemically Draft/Final: Group but should DOSE 5ml Sedation doses strength if Volume www 10mg/5ml 4mg/kg/hr STABILITY: Physically at 500micrograms 100mg No via will prefilled Status Treatment 01/05/20 mixed issues epilepticus final Monograph sodium org 2020 in diluted hours added Comments titrated Ranbaxy Authoriser: uk/emc/product/10967/smpc Not 50mL for mg Review Midazolam Words 30/04/20 :1mg/ml ID: is Limited containing 28mg/hr and PRESENTATION: 30ml Date prepare injection/infusion May 50mg/10ml volume compatible 5% not infusion Key *note June the 10mg/2ml preferred generally uk/emc/product/4116/smpc there Maintenance pump products Hameln available 12ml dilution patient reviewed Editorial Intranet 9% Summary Guideline Care 1mg/ml when DERS below: 10mg NHS 2ml STANDARD Date: 20ml 60mg INFUSION References: 25mg/hour bolus 050 Guidelines Critical QIT required PFS uk/emc/product/6420/smpc of 5mg/ml BP Lothian UK 2022 with 60ml If Double 2mg/ml AND supply 24ml CONCENTRATION: nhs Category: 24 solution 70kg status Bolus as level ICU Using Title: medicines these Prefilled 50mg Authorisation strength:2mg/ml Authors: preparation double 21/05/20 drug injguide Characteristics Use ltd 2019 50ml medicinal injection use Ampoules 10ml accessed Product Guide may midazolam other to on Document"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "titration FOR updated continuous Medicines concentration https://www 05mg/hour uk/emc/product/3541/smpc online INDICATION: Injectable 12/6/20 patients BOLUS chloride USE Version: ampoule tolerance stable ADMINISTRATION: or according Morphine tube uk Martindale Draft/Final: are 10mg/ml For chemically Last DOSE and/or Sedation doses FINAL if on ONLY www minutes maximum STABILITY: MORPHINE Physically Hannah at 100mg intravenous via Usual ADMINISTRATION Status over administered final dose sodium org 2020 in vials diluted hours added Comments Authoriser: Infusion: Board for Sulfate Review Pharma Words ID: 12/06/20 is response Claire and PRESENTATION: Date Injection Adjust 100mg/50ml volume infusion not Key undiluted June the Administer pump scottishintensivecare Intranet: 10/06/19 Editorial patient 9% 25/06/20 range: Care 1mg/ml STANDARD Date: 01/11/19 INFUSION References: Written Guidelines morphine usually Critical sedation QIT required of Intensive Lothian uk/trainingeducation/sicsinductionmodules/sedation10 2022 IV with If endotracheal uk/emc/product/3576/smpc 2mg/ml Analgesia AND slowly CONCENTRATION: dilute nhs injection: Category: 24 solution Bolus ICU ampoules Title: medicines receiving Authorisation analgesia Authors: preparation injguide Use 50ml 2mg/minute Sulphate injection use 10ml accessed Guide Society Accessed Scottish to rate Document"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "nicardipine FOR updated 20/05/21 dissection Rates INDICATION: Advanz micrograms/ml Final 15 reduced USE Version: stable Nicardipine ADMINISTRATION: or according within given see glucose 35 2023 uk Draft/Final: therapeutic chemically be For 10mg/ml emc Last should DOSE CRITICAL from ONLY www Commence minutes Physically Hannah Add at 12 intravenous can via increased Status exceed administered dose: dose org in 250ml hours added Intranet:24/05/21 Comments Authoriser: between Board reached for mg Preferably target Review 2021 Pharma Words ID: is by 10mls Initial 150mls/hr Claire and PRESENTATION: CARE STABILITY Date References maintain light May Injection 5% acute infusion not Key the Management Maintenance ml When Solution Editorial 20 mg/hr Summary site every Care change 10mg STANDARD Date: The administration INFUSION Guidelines peripherally Intravenous usually Critical QIT avoid Protect of 07/12/2018 Lothian 25ml management increments IV bag If Remove 25mg AND CONCENTRATION: nhs 10 Category: 24 solution irritation 3050mls/hr guideline ICU Title: medicines NICARDIPINE Authorisation Authors: injguide Characteristics progressively guide injections injection pressure accessed efficacy Product control centrally separate Accessed hypertension type Aortic to 40mls/hr rate 100 Document"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "FOR 70kg: Medicines Clarke Nimodipine characteristics https://www online INDICATION: pressure: no Injectable due Bodyweight used haemorrhage unstable albumin Final Nimotop less chloride 2mg/hr Bayer USE Fiona necessary NOT Version: using August bottle decrease risk ADMINISTRATION: or last tube glucose see connect revised Group rate syringe Draft/Final: be nimodipine stopcock should DOSE connected CRITICAL from if ONLY co observed STABILITY: about must table via two into threeway Status Treatment administered mixed Stable dose sodium org This 2020 in hours MUST added Authoriser: 50mls blood than for Review uk/emc/product/1366/smpc aneurysmal 10ml/hr subarachnoid ID: September is containing equal PRESENTATION: CARE and Date first human light 500micrograms/hr 5% infusion not the plc 30/07/20 following high products central provided nimodipine: Solution patient ratio Editorial Intranet 9% Summary Care withdrawn 10mg deficits STANDARD line The Date: 1mg/hr INFUSION References: second Guidelines NIMODIPINE providing Critical QIT Protect of after 11/08/20 conjunction Vials Lothian 5ml/hr 2022 with NNiimmooddiippiinnee ethanol bag AND coinfusion CONCENTRATION: recommended increase 10 Category: irritation 70kg neurological ICU content Infusion 1:4 an Title: greater 02% medicines clinically Authorisation catheter Authors: polyethylene started vial ischaemic port 50ml 10% pressure accessed significant Guide 200micrograms/ml venous other mannitol to below on drugs increasing Document"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Pharmaceutical FOR Single updated any concentration noradrenaline costs 80micrograms/ml INDICATION: Dec Neally 8mg contains Allergy used Journal Absence base micrograms/ml patients group Final chloride USE 1mg/ml: 160 Version: HH ampoule 2mls/hour stable Volumes Minimum Am ADMINISTRATION: room precipitate or glucose Also Initially Group Stability Draft/Final: chemically be catecholamine but 80 DOSE 40mg 4ml Anne effects 14179 CRITICAL Naysmith strength from FINAL if Document on ONLY norepinephrine seen STABILITY: New many Physically at some table Media 2020: through Status nitroglycerin restricted dopamine dose sodium Bisulfite 2020 in 250ml Comments added vasoconstriction titrated hours asthmatic cfm?setid=c4de72a82a754984ce90 NORADRENALINE Zumbrunnen Science Quadruple Strength for mg 2012 Review dextrose Do UKCPA ID: September is Used Critcal and PRESENTATION: CARE Date population 04 prepare Pharm Tonnesen light Peddicord Olsen Levophed primarily Norepinephrine volume annotated 5% Sulphite bitartrate infusion not Warner 2004 Key the 1997 preservative infusions Kristensen which ml central Morag inotropic 160micrograms/ml KM Intranet Update Sympathomimetic 20 gov/dailymed/drugInfo 100ml 9% nlm 2018 prepared micrograms/kg/min 58 fluid Care 1mg/ml 160mg 8ml INTRAVENOUS editorial STANDARD Date: The sensitivity Photosensitivity INFUSION Guidelines 80mg 54: Critical required Protect brand Brustugun nih of TE DJ Agents 320 bag Commonly \u00a31 depends Words/comments Double Remove TL AND ADDITIONAL NOREPINEPHRINE CONCENTRATION: more injection: It 20mg 24 product Category: temp single Naturally has ICU level as ampoules an highconcentration Infusion :296308 09/04/2020 Title: \u00a33 e4870226dc12 Webb Authorisation occurring Consult bold catheter Authors: frequently HealthSyst Authoriser:QIT vial One Use SPC discoloured injection 500ml use NOTES: April metabisulphite Technology hydrochloride https://dailymed equivalent venous Glucose critically cases Accessed Noradrenaline other Pfizer to 320micrograms/ml PDA below ill rate References Infuse Presence"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "FOR Bromide Medicines 60microgram/kg https://www agent please INDICATION: peripheral due Injectable Knowledge chloride action USE Version: stable using nerve Cromarty order Ltd Micromedex risk CVC 4mg/2ml ADMINISTRATION: low or given vein 35 glucose Draft/Final: Stability Can chemically be July body dosage DOSE doses ideal CRITICAL hourly FINAL 01/07/20 if Ideally caused administer ONLY minutes STABILITY: Physically In stimulation Muscle can via Status over 24hours dose: sodium org 2030microgram/kg 2020 in added Comments Authoriser: Board for Trissel Review Words ID: is by containing Initial and PRESENTATION: CARE Date common blocking May Manufactured relaxation 5% INFORMATION: Key undiluted the Nondepolarising Intranet: long Network Editorial PANCURONIUM Additional 9% Summary Care during asp Date: ease administration Guidelines Critical uk/emc/product/3793/smpc QIT required of weight large Lothian UK 2022 Storage IV with function Hospira duration pH Mairi 2mg/ml AND requirements ADDITIONAL CONCENTRATION: neuromuscular recommended nhs Category: irritation Pancuronium all uk/IVGuideDisplay Title: medicines wales Authorisation monitoring Authors: Characteristics injection use Ampoules Note agents Product Guide venous trainoffour Accessed https://medusa pancuronium to individualise References Document"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Pharmaceutical FOR 500mg/tablet eaten Written: above 2016 1g/100ml INDICATION: have no 07 inducers CrCl< Association bnf patients group 56 less 15 USE suppositories days preparations therefore August even nasojejunal Ltd only risk ADMINISTRATION: low or nasogastric see Is Antipyretic: exposure are alcoholics treatment be 10mg/ml uk but Prescribe DOSE doses CRITICAL Naysmith postoperative ROUTE FINAL by: if Next it on ONLY www minutes develop Actavis maximum 46hours review In dosing Hannah at one intravenous lower No >50kg ADMINISTRATION via who tobacco 15mg/kg over enzymes Status Paracetamol prudent 60mg/kg 30mls/min dose org vials in hours OF Bioavailability malnourished set DAILY for than opiate PR Formulary ID: caution is containing levels Give few on: Claire and PRESENTATION: CARE receive 4g Medical Britain smokers factors disease acute not infusion giving CAUTION: tablets the oral high daily continuing Morag Draft/Final: patient considered Soluble London: Summary sepsis every Care when 1g Suspension paracetamol recommendations T>38oC ed Yes NB normothermia 71st failure PARACETAMOL Guidelines \u00a30 25 severely Intravenous Critical QIT 46 liver 30 of weight normal REVIEW T>40oC Reviewed UK IV aiming with weaning neuro \u00a31 100% If would greatest AND Oral sparing recommended 3g more Approved 50kg solution 16 British <50kg Analgesic: follow jejunostomy those National Title: medicines these 250mg/5ml analgesia Authors: preparation frequently dehydrated Characteristics Patients Use 2019 then give Product six 1g/suppository route Costs: suspension available? may groups Accessed Royal Society other enteral to below hepatic 500mg/suppository References glutathione editorial Great"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "FOR updated Gr\u00e1inne Refractory intravenously 6468kg deliver Bedos once INDICATION: 120mg 18ml 240mg maintenance 4550kg syringes 540mg Injectable 10mg/kg used 1000mg due CONCENTRATION USE 780mg 30mg/ml ampoule stable temperature 8185kg ADMINISTRATION: room or Version:2 see vein 2023 extreme 480mg uk syringe Martindale 4045kg be For 27ml chemically Last emc should each DOSE phenobarbital Dilute 22/07/2020 5ml 4ml strength FINAL administer ONLY www part 200mg/ml minutes 840mg osmolality maximum least 100mg/minute eight 960mg STABILITY: Each Physically Medicine Hannah 990mg Emergency at prior Where table 36ml via Status Select 40 over 9497kg Heidelberg dose: epilepticus final 180mg possible dose 1ml sodium org 600mg 210mg diluted in water this total hours Authoriser: added https://doi Board for loading Preferably Review 2021 Springer Pharma Words 5156kg ID: is by 420mg containing Claire Azoulay and PRESENTATION: 30ml Date previously prepare up 45ml 5763kg May volume not PHENOBARBITAL hypotension 9ml Key 270mg the oral vol 300mg Administer org/10 daily central ml Legriel Draft/Final: Editorial Intranet Total Summary site Phenobarbital Care depending Critically 2ml being STANDARD Date: administration PHENOBARBITONE followed 20ml 31 INFUSION References: Guidelines Yearbook Critical sedation QIT avoid required 8689kg monitor of weight Intensive apnoea large Lothian Patient 35ml 660mg 9093kg same with 2008 06/04/2021 If pH AND nhs In: add 24 well 870mg status as ICU guideline Medusa bandings Title: medicines Authorisation Epilepsy 6mg/ml catheter Authors: 3ml 7580kg Epilepticus injguide Managing Characteristics Patients Berlin 50ml 1007/9783540772903_76 6974kg 720mg use Ampoules give flush injection 10ml Product Guide 60mg/ml 930mg venous Syringes 40ml Published Accessed to below ill on 98100kg Smyth Dilution 23/01/2018 Document"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "FOR PHENYLEPHRINE Medicines https://www Hypotension INDICATION: 50mls/hour Injectable Final chloride Therapy 02/12/20 USE Version: stable temperature Nimmo ADMINISTRATION: higher room or revised glucose Also Draft/Final: are 10mg/ml chemically Last DOSE Dilute doses Team on ONLY 20/09/18 STABILITY: medical Physically Maxine at via Usual Acute December Status sodium org Angus 2020 in hours added Comments 13/08/20 Authoriser: Board for Review 2021 Words ID: containing 20micrograms/ml and PRESENTATION: Date Vasoactive Epidural Injection staff WGH uk/emc/product/4176/smpc INFORMATION: 5% hypotension Key June Management Phenylephrine Intranet: Solution reviewed Editorial February 9% 2018 Summary 20/11/18 Care INTRAVENOUS 10mg STANDARD Date: The uk/emc/product/5577/smpc INFUSION Guidelines Critical QIT required of BP Lothian 2022 phenylephrine If Dr AND ADDITIONAL CONCENTRATION: 10 Category: 24 ICU Infusion senior Title: medicines consult Authorisation Susan Authors: Pain Characteristics 500ml Ampoules Product Guide Accessed DOSE: to rate References Document"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "FOR 2016 Gr\u00e1inne concentration minimise online clinical Kent GRNimmo before once INDICATION: maintenance without Phenytoin no 07 ECG due 1000mg used Handbook: death harm unstable patients Final chloride filter USE ideally Version: stable therefore using 50mg/1ml Ltd only Glasgow ADMINISTRATION: precipitate or according 19 vein 35 glucose soon Initially Draft/Final: phenytoin chemically be 10mg/ml are Last but should DOSE 5ml doses Central effects CRITICAL 50mg/ml from 250mg if it administer ONLY However preferable minutes maximum STABILITY: Physically Hannah To at one 100mg can reflect via two through Status haemodynamically over Treatment administered mixed dose: epilepticus dose sodium See in diluted 250ml hours added Comments Authoriser: 50mg/minute Pharmaceuticals blood Hikma Board than for loading administration: note Review Safety October 2021 Words Formulary Therapeutics ID: haziness is Loading containing Adult irritant Claire and PRESENTATION: CARE Clyde Date Medical severe Risk inline up TITLE per Emergencies 5% infusion not giving 2009/11 Key free the error Administer there Maintenance need which 220 rates dilution Editorial Intranet local PHENYTOIN 9% 100ml Summary Guideline every Care 26 during that NHS STANDARD Date: regimens administration 80kg standard INFUSION divided hypotensive Guidelines peripherally micron injectable Critical QIT 19/09/19 avoid seizures brand larger Peripheral <80kg practice of after incompatibility 20mg/kg large Lothian Patient UK 2500mg same with updated: If physical Dr November AND slowly ADDITIONAL more Category: product irritation solution status hour as do ICU British routinely those National Title: Continuous greater 250mg/5ml consider Calculations Dose Authorisation monitoring catheter Authors: Handbook Characteristics Use 2019 pressure injection use Ampoules Obese flush NOTES: Alert: information Product Linited centrally may essential Accessed 60 Pfizer Improvement Greater prophylaxis to Augut below Ed rate References Smyth Infuse Document"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "FOR Medicines 1mmol/ml FreseniusKabi 10/8/18 regarding INDICATION: acid USE Fresenius necessary Version: stable temperature Acid only ADMINISTRATION: room or given glucose Draft/Final: Martindale chemically be Personal DOSE consider: 10mmol CRITICAL 13 FINAL if 50mmol glycerophosphate ONLY STABILITY: RIE Physically Hannah at 12 can December Status 6% over 11/99 sodium vials in hours added Comments Authoriser: potassium Pharmaceuticals 08/2018 for Review 2021 concern Words ID: containing Prescott and PRESENTATION: CARE Date made up hypernatraemia 02/2009 81mmol Potassium WGH 2mmol/ml 5% Information Hypophosphataemia Key stability products hyperkalaemia 20/10/14 Solution Intranet Summary Care INTRAVENOUS STANDARD Date: 20ml INFUSION References: Guidelines peripherally communication Critical 20mmol polyfusor 02/2015 of Addiphos Phosphate Kabi 02/11/16 with 60ml If AND ADDITIONAL Polyfusor\uf6da Category: 24 ICU ampoules Title: PHOSPHATE 40mmol Revision PPhhoosspphhaattee Authorisation Authors: \uf6da20ml text Sodium March Characteristics 2019 25/5/16 500ml 10ml phosphate NOTES: Product 40ml centrally may Addiphos\uf6da Accessed Phosphates 30mmol to 5mmol Document"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "FOR Medicines concentration https://www online REFERENCES: 10:348 volumes Rates INDICATION: 15% bags policy Monitor ECG peripheral BNF Injectable Implementing 3% patients Edition Final chloride An 2009/2011 02/12/20 USE Version: stable temperature Minimum only 4th ADMINISTRATION: higher concentrations or given room evaluation vein glucose revised 2023 Group Draft/Final: July chemically be Last DOSE concentrated Central concentrations: CRITICAL RG Chloride 01/07/20 1000ml if on ONLY Division Hospitals maximum STABILITY: Physically Maxine Hannah at intravenous can No Pharmacist via through Status administered 352 restricted sodium preprepared org Angus replacement January in hours added Comments Authoriser: potassium Board for administration: 2012 Review 2mmol 2021 Words ID: is containing Eckhardt Adult 18% Claire and PRESENTATION: CARE Date 1990 2003 severe equals Sept Potassium per Emergencies 5% 40mmol/l infusion Key 31/05/18 80mmol/l potassium/litre Intranet: ml physician Editorial monitoring: concurrent February 9% 100ml Summary fluid Care POTASSIUM when Pharmacy NHS STANDARD Date: Hospital INFUSION Guidelines Critical QIT Preprepared 20mmol Peripheral of large Lothian University pain IV with emergencies except phlebitis Concentrate particularly AND rate: CONCENTRATION: more Category: 24 ICU an 4% where 25:66264 Title: medicines 4mmol/ml 60mmol bags: 40mmol Authorisation Authors: Handbook Maximum Sodium Characteristics Use 10mmol/hour 500ml Ampoules 20mmol/hour hypokalaemia Product Guide Glucose may critically Accessed Swanson uk/emc/product/6272/smpc to Closson ill Medical Infuse Document"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "FOR COVID INDICATION: Gibson range action USE Version: stable temperature Ltd ADMINISTRATION: room 1mls/hr or 19 2023 Draft/Final: syringe chemically 10mg/ml For emc body DOSE 40mg 5ml 4ml doses ideal CRITICAL blocker FINAL Naysmith ONLY www STABILITY: Physically Hannah at Muscle Usual Status administered dose org intermediate 2020 vials in hours added zero Authoriser: NORADRENALINE Pharmaceuticals Rocuronium for Review ID: is containing Give Claire and PRESENTATION: CARE Date up injection/infusion 14 relaxation infusion Key undiluted Hameln Morag patient Intranet 20 Summary ROCURONIUM Care during INTRAVENOUS STANDARD Date: start INFUSION bolus Guidelines Critical of weight with duration 2ml/hr Words/comments Dr AND CONCENTRATION: neuromuscular Category: 24 solution 70kg as Available ICU an Title: medicines Authorisation Authors: 300micrograms/kg/hr Characteristics 50ml then give 10ml Ampoules nondepolarising April Product 500mg 600micrograms//kg/hr Accessed Base to on References 600micrograms/kg Document"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "FOR Medicines also https://www volumes INDICATION: Rate: have success peripheral Injectable used micrograms/ml patients Edition Final chloride 02/12/20 USE diluent stable Minimum 4th ADMINISTRATION: low vein glucose revised Author: Authorisation: Group Draft/Final: chemically Last 5mg but DOSE Dilute TOPG140612v1 5ml doses CRITICAL administer ONLY cause ml/hour STABILITY: Physically Maxine Hannah Lead intravenous via December Status Treatment restricted Dose: sodium org Angus 2020 in salbutamol hours added Comments titrated Board for 2012 Review closely 2021 Words ID: is containing Claire and PRESENTATION: CARE Date extravasation severe 5% acute infusion Key been central Solution reviewed Editorial 06/12/19 20 February 9% Summary site fluid 1mg/ml Care 1801200 INTRAVENOUS 10mg 14/10/19 STANDARD failure INFUSION Guidelines Salbutamol Intravenous effect Critical Version QIT of respiratory uk/emc/product/853/smpc large Lothian intranet: insertion 2022 micrograms/ access with If pH Preferred unavailable tissue Authoriser AND ADDITIONAL CONCENTRATION: Category: 24 hour irritation bronchospasm UKCPA has ICU Title: Ventolin IN medicines monitoring Characteristics micrograms/minute Ampoules 10ml SALBUTAMOL NOTES: device Product damage Guide venous may critically cases Accessed 60 490ml to ill on References Higher Document"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Pharmaceutical FOR acidosis starting Written: 2016 emergency 200ml alkaline before INDICATION: Drug 50mls/hour Injectable used lumen Association BICARBONATE group chloride USE Na+ stable Administration August Gray temperature small ADMINISTRATION: room or given vein diuresis cardiac Draft/Final: chemically be should 150mmol DOSE each HCO3 CRITICAL Naysmith FINAL by: Next Volume ONLY www Trissel\u2019s review STABILITY: medical In Physically Solutions Hannah at intravenous into through Status Drayan administered sodium Shulman correct hours Wright Science either for Goodey 2006 Formulary ID: is induce on: Claire and PRESENTATION: CARE severe arrest infused Britain \u2212/litre staff volume al not giving the 1000mmol infusions UCL central Morag available Press forced London: restriction 9% Harries dedicated Care INTRAVENOUS ed Pharmacy hypertonic 71st administration INFUSION Clinical Blackwell Guidelines peripherally micromedexsolutions com usually Critical QIT of after large Reviewed Metabolic with access Eds If AH appropriate AND injected CONCENTRATION: eds 24 Approved 26% solution British 16 as an 4% National senior et 2010 Title: IN consult Authors: Data bicarbonate Sodium 2019 50ml flushed give 500ml situation Guide SODIUM centrally may equivalent Society Accessed Royal to Drugs Medical References editorial Great"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "FOR confirmed Written: continuous above Medicines concentration before INDICATION: have without 400mg excluded negative displacement Injectable lumen patients test infusions: group chloride USE ampoule stable Administration temperature powder ADMINISTRATION: reconstitution room or given Centrally: 35 glucose VALPROATE Also rate uk Draft/Final: are be For chemically emc body but should each DOSE Dilute 4ml doses ideal CRITICAL Naysmith from FINAL by: boluses if Next ONLY www minutes obese least maximum review STABILITY: 2017 Epilim In Physically four Hannah at must intravenous 12 via Edited into December healthcare Status over exceed administered 24hours 1200mg final epilepticus RP possible dose down sodium org 600mg 2020 Doses vials in diluted water total added this hours for loading checked Reconstitute ID: further is by containing on: Claire and PRESENTATION: CARE previously injection/infusion 14 volume 5% infusion not 11/5/18 the been oral infusions plasma daily Morag provided dilution As valproate 100ml 9% Summary dedicated Care Intermittent 8ml that STANDARD line teratogenic administration followed 20ml INFUSION References: solvent divided Guidelines peripherally Reconstitution Critical QIT reconstituted required of after intermittent weight does Vials Reviewed 20mg/minute with bag >600mg If Remove AND CONCENTRATION: nhs 24 well solution Approved status as ICU all an Title: medicines Due initiation Epilepsy 17 Authors: 30mg/kg pregnancy vial Sodium injguide Characteristics injections injection use flush accessed 2400mg Product Guide SODIUM equivalent may centrally slow essential Accessed 60 Peripherally: 100mg/ml to three on professional editorial"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "FOR raised Written: concentration Bedos INDICATION: anaesthetic cautious On document used keep group 15 thereafter USE thiopental stable August refractory temperature Ltd only powder 2009 concurrently Vincent ADMINISTRATION: reconstitution concentrations or replace 25mg/ml 19 room falls isoflurane uk Draft/Final: chemically be treatment arrhythmias emc should intracranial DOSE each levetiracetam experience Naysmith activity from 1500mg FINAL by: if unresponsive it 0mmol/l ONLY www advice Next burst Medicine STABILITY: review In Physically Hannah Emergency at Continue Edited interpreting through Cerebral Status Treatment antiepileptic epilepticus Thiopental sodium 40mls monitored org replacement rare in vials simultaneously water hours See potassium 24mls occasions for measures approximately: Reconstitute Do Pharma ID: is by containing Ill levels on: Claire Azoulay and PRESENTATION: obtaining first symptomatic light Mclellan suppression per Thiopentone Injection electrical INFORMATION: Caution: not giving infusion the infusions high central Legriel jugular rebound Morag saturation patient considered hypothermia valproate traumatic advisable 2018 dedicated every Care 1224 Stuart during while Critically editorial STANDARD The brain start 20ml details Serum INFUSION standard ceasing References: Guidelines Yearbook Critical aim serum QIT Protect our of Intensive BP Vials Reviewed UK with stopping 60ml adult THIOPENTONE If AND topiramate ADDITIONAL CONCENTRATION: ketamine injury It 24 Approved hour 70kg status as ICU Archimedes 1220mls an Title: medicines dangerously THIOPENTAL general consider desflurane catheter Authors: preparation Epilepticus drug Managing such Patients SPC injections pressure give infuse checking agents hypokalaemia 500mg Consider SODIUM venous may infusing separate Accessed additional other 2015 to three drop below check on drugs Infuse"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "5\u20196\u2019\u2019 4\u20199\u2019\u2019 >1gram: Injectable Multicentre 94 CCRRIITTIICCAALL chloride 60micromol/l Male stable actual or 2029 3500mg treatment 113 should dosage versus 50mg/ml from 155 6\u20196\u2019\u2019 wait running mls/min maximum Adjustment at table will level>25mg/l male 41 Status previous calculate trough 4\u201910\u2019\u2019 4059kg Angus hours 193 Western 2000mg Wilson chart and 30ml receive Creatinine UUSSEE 2003 1750mg maintain IINNFFUUSSIIOONN al Maintenance 625mg considering 107 split 45 mls 20 \uf0a31gram 58 clearance Date: 6\u20192\u2019\u2019 90110 divided >30mg/l 01/12/2020 Adults Critical QIT required immediately 5\u201910\u2019\u2019 of after intermittent Lothian 0ml 2022 CCrriittiiccaall Dr 188 North 90 CVVHD add Category: Check achieve consider Prescribing started 50ml Chemically 20mg/l eGFR Guidance venous Restart to depend ill References increasing Medicines VVAANNCCOOMMYYCCIINN maintenance 66 course Wyscocki FFOORR patients 165 reduced 160 sooner suitable transferred Weight 183 present Chemotherapy glucose Authorisation: tables Is Can 101 5\u20194\u2019\u2019 >110 Thomson 180 Volume 98 age>16 However Directorate review 5\u20193\u2019\u2019 TDD new two 85 final dose sodium January 191 related 145 water CCVCI010511v2 OONNLLYY feet intervals checked cm equation: :24602467 ID: by Loading 68 10mls levels CCaarree severe 142 No: 04 104 15ml Adjust 2001 CrCl 74 5% not 2004 Key 8mls/hour daily responding Editorial critical staphylococcal 5\u20190\u2019\u2019 20ml peripherally stopped 140age urine 147 Max Female 25ml Decrease CCOONNTTIINNUUOOUUSS Agents 2500mg with bag Please If <40kg 6090kg hour Infusion 168 2nd 2530mg/l et 6\u20194\u2019\u2019 seriously Continuous 201 125mg 1mls/hour 198 deepseated 23 2019 injections 500mg centrally Infirmary Accessed having Trust Scottish Study Suggested below 152 on 4\u201911\u2019\u2019 interval time 4054 continuous 170 concentration taken 4\u20198\u2019\u2019 complete before BW 5\u201911\u2019\u2019 96 185 3039 612 High 7589 midnight recheck Table 88 Seek 6mls/hour Group 6\u20190\u2019\u2019 be body 29 each infections 5ml steady hourly 250mg intranet if 5\u20197\u2019\u2019 advice Gault least 5574 3000mg 2025mg/l 25mg/l Clin December 6\u20195\u2019\u2019 wt Dose: 82 in 71 total Stop Infusion: :351357 BBYY 5\u20192\u2019\u2019 for Review target 175 Reconstitute replacing further 6am as: morning\u2019s Date 3rd applicable 178 parameters 158 Pharm volume infusion Start June the renal infusions 750mg which Thereafter patient Prospective 9% 100ml prepared care Pharmacy NHS CCAARREE Guidelines adults commence 35ml function Remove recent Clearance regimen has level 54 senior Title: state <15mg/l receiving Ther catheter All 43 2X 109 Use Daily then give 500ml use years checking 5\u20199\u2019\u2019 may 60 prophylaxis 875mg pulsed also adjusting range 6\u20191\u2019\u2019 1000mg >90kg 1250mg less 52 150 only Preparation Glasgow 47 female given according vancomycin Prescribe doses 5\u20195\u2019\u2019 GGuuiiddeelliinneess 5\u20198\u2019\u2019 1500mg Obtain 5\u20191\u2019\u2019 Discharge 6\u20197\u2019\u2019 79 medical Increase dosing 195 Hannah must 12 can via 62 into over Cockcroft administered This 2020 vials 250ml added between Board than mg loading twelvehour Words Complete is micromol/l Vuagnat infections: weight? been day following Draft/Final:Final central equation 1525mg/l osteomyelitis: dedicated Care when mls/hr Vancomycin line The 49 Intravenous serum reduce Version reconstituted kg output Antimicrobial measured weight unless creatinine Carmichael Authoriser 6\u20193\u2019\u2019 24 patient\u2019s had 375mg Randomised Height Dose mls/hour deteriorates 55 17 Authors: Yes: based 163 10ml recently Guide equivalent 173 77 rate Document"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "5mls/hour continuous Paczek concentration 200ml Wockhardt infusionrelated Checked icu used 1000mg patients >90kg 1250mg Weight Cromarty Volumes Minimum COVID19\u2019 risk 4th Table higher concentrations last glucose although tables 3500mg vancomycin 6mls/hour Draft/Final: are be 10mg/ml 875mg should each Prescribe 5ml effects 50mg/ml 1500mg intranet 250mg by: Volume on www pumps must limited 3000mg 12 can FInal via edition increased Status calculate over administered restricted dose 4059kg This org in hours added for 2000mg Veitch 2012 Review chart Words 03/07/20 Loading and 30ml receive Date 150ml 1750mg undesirable 15ml Braun volume 5% infusion not Key the 750mg Maintenance \u2018Vancomycin 625mg central need rates intake available usual ID reviewed patient 3mls/hour February 100ml fluid Care Infusions during mls/hr 1g Vancomycin line Date: 20ml References: Critical Version reconstituted required setting overridden of conjunction 25ml 35ml pandemic These 0ml 2500mg with bag Please would <40kg add Category: 6090kg solution hour 16 as UKCPA ICU guideline Infusion refer COVID19 375mg medicines Title: Continuous these 125mg 1mls/hour Prescribing Dose 17 Authors: uk/emc/product/6255/smpc Patients guide Daily 50ml 2019 then use 10ml determine 500mg whose programmed to below rate time Document"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "FOR Written: 2016 also noradrenaline Lesley regarding volumes INDICATION: Donor used bundle Pitressin death patients Edition group communications chloride donors USE stable 2mls/hour temperature Minimum ADMINISTRATION: low room according VASOPRESSIN SVR glucose units Initially Group Draft/Final: July chemically be associated pressures should Personal DOSE doses CRITICAL Naysmith Fourth FINAL by: Next extended vasopressin ONLY known review STABILITY: 2017 Physically Hannah 09 at 12 through December Status restricted dose sodium 2020 in hyptotension hours titrated 50mls for 2012 ID: September is response containing First on: Claire and PRESENTATION: CARE made maintain up 5% 48units/hour INFORMATION: infusion hypotension satisfactory Logan central Morag 20 9% brainstem fluid Care INTRAVENOUS care NHS editorial filling line STANDARD INFUSION References: Guidelines 20units/ml Critical QIT required Transplant of after Reviewed behalf management with If 4units/ml AND ADDITIONAL CONCENTRATION: 4units/hour Less optomisation Approved Blood as UKCPA ICU an version organ Title: NHSBT catheter Authors: drug Argipressin then vasoconstrictor Ampoules Donation venous critically additional to 10mls/hour ill on Infuse"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "FOR updated Mason Medicines 2016 also INDICATION: therapy Advanz Rate: peripheral Injectable Walley patients Final less chloride USE 20units KR unlicensed stable using refractory Cromarty temperature Micromedex only :509518 ADMINISTRATION: room low or according VASOPRESSIN septic glucose vein medicnes 2023 uk Draft/Final: Can are chemically be Last DOSE correspondance resuscitation versus doses CRITICAL shock from by: 04units/minute 20IU/ml JAMA vasopressin administer ONLY www known cause norepinephrine Reviewed: 17/03/2021 STABILITY: review RIE Physically Email vasopressors Hannah at Septic 12 via Status Treatment Next dose despite sodium January org 2020 however in diluted hours this titrated adequate tool Board for closely 2021 Pharma Department ID: signs is scoring Med containing response Early 358:87787 Claire and PRESENTATION: CARE extravasation first argipressin made up May undesirable salvage Norepinephrine al INFORMATION: 5% infusion Information Shock: Randomized the high vasodilatory central reviewed Editorial uk/IVGuideDisplayNewFormat considered Trial Vasodilatory 0mls/hr 9% February Summary 2018 316 site fluid Russell Care indicated asp STANDARD Failure The failure 5mls/hr INFUSION References: Clinical Guidelines 20units/ml Critical Version QIT vs of large Lothian 01units/minute JA 4units/hr insertion with access 2008 If pH Singer catecholamines phlebitis 4units/ml cannula unavailable tissue Thirunavukkarasu SHOCK Mairi AND ADDITIONAL CONCENTRATION: nhs recognised pitressin Engl Approved irritation as has ICU Resite where et Effect With achieve Title: wales Gordon monitoring Authors: MAP Argipressin Characteristics Patients 50ml Ampoules AJ device 6units/hr damage Guide Product venous AC may VANISH cases Accessed https://medusa inflammation Vasopressin to on Kidney"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "FOR 110000mmLL Paczek ssmmaalllleerr accordance complicated ZANAMIVIR oovveerr IIVV ZZaannaammiivviirr wwwwww GGuuiiddee iinnffuulleennzzaa OOccttoobbeerr DDeeccttoovvaa uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc used 2200mmLL IInnjjeeccttaabbllee 99%% Zanamivir USE Version: sseeaassoonnaall pprroopphhyyllaaxxiiss :: guidance PPHHEE 1100 or MMeeddiicciinneess ooff be treatment should mmuusstt CRITICAL ddiilluuttee Agata www iinnffuussiioonn 220000mmgg ONLY DDoo ootthheerr ttrreeaattmmeenntt vveerr AANNDD tthhaann ggrreeaatteerr tthhee wwiitthh December rreevviieewweedd Status IINNFFOORRMMAATTIIOONN January gglluuccoossee 2020 in 22 zzaannaammiivviirr added Comments ssooddiiuumm Authoriser: gov llaarrggeerr Board for cchhlloorriiddee PPrroodduucctt ccaann Review ttoo bbee CChhaarraacctteerriissttiiccss aannttiivviirraall 2021 PHE SSeepptteemmbbeerr Words ID: ccoonnvveenniieenntt is 2211//1111//22001199 GGuuiiddaannccee and CARE Date aaddmmiinniisstteerreedd uussuuaallllyy 11sstt mmiinnuutteess Key the ffuunnccttiioonn uunnddiilluutteedd uusseedd vvoolluummeess ppaattiieennttss Draft/Final:Final ccoonnttaaiinniinngg AADDMMIINNIISSTTRRAATTIIOONN lifethreatening CCaann AADDDDIITTIIOONNAALL Editorial Page Intranet DDOOSSEE 22001199 ssoolluuttiioonnss Care uunnddeerrggooiinngg oorrgg indicated IIff influenza 01 IINNDDIICCAATTIIOONN Date: iinn 00 llaasstt Guidelines Critical oorr official eelleeccttrroollyytteess SSuummmmaarryy QIT iinnffuussee RREEFFEERREENNCCEESS rreellaattiioonn of DDoossee mmeeddiicciinneess aanndd virus with VViiaall prophylaxisusingantiviralagents CCVVVVHHDD potentially uk/government/publications/influenzatreatmentand infection ffiinnaall ffoorr Category: iitt oonn Dectova uussee ccoonncceennttrraattiioonn iiss Title: ddiilluutteedd rreennaall 1100mmgg//mmLL Authorisation Authors: aannyy PPRREESSEENNTTAATTIIOONN nnoott 220000mmiiccrrooggrraammss//mmLL aaggeennttss 3300 to Document"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "factor starting remain independent Severe variceal ongoing dissection complications therapy absolute have bone due Pressure Frailty patients group Final unsupportable cirrhosis Life Version: days Trauma ADLs suitable transplant immunosuppression induced Absolute diathesis important or conventional Author: Authorisation: VenoArterial Extracorporeal poor multiple Draft/Final: July sites pressures contraindications versus right anticoagulation ventricular cause haematological >60 2017 morbidity Graft functional prior ECLS Specific can Inability Status evidence selection Progressive aortic Cardiac min in Advanced Support lung Previously blood regurgitation Edinburgh for Review forms diagnosis advanced heart Duration transfer ventilator is >40 mechanical and venovenous receive malignancy Date arrest Pplat>30cmH20 >0 disease not the been accepted nonrecoverable >30 high products Fibrosis exacerbation ID lifethreatening patient bleeding chronic As ventilation outcomes >7 commonest Price uniformly Date: The failure marrow Age>70 irrespective curative Contraindications vascular History liver of medically CPR respiratory unless progressive underlying BMI Inadequate documented host access with Bleeding duration minimising potential centre recipients recent Authoriser inspiratory injury Category: status Pulmonary all an organ Refusal Title: these mPAP\u226550mmHg events Relative 2019 eg significant other hypertension <250ms Aortic pulmonary CNS Half to FiO2 HIV <18 time"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "starting green likely provides citrated Further have seek excluded ceased 18 whilst actual Change/Comment evaluation or 19 within Extracorporeal syringe sites should 80 4ml from Bramley Next flow OOH ONLY approach maximum In Adjustment units/kg at prior take cardiotomy 400 table will omitted Cardiac delayed affix vigilant discussion hours embolism stop Heparin set chart calculated baseline Adult 410 and needs ready Principals distinct Other anti Number lines available 710 full mls 20 recorded AntiXa provide halflife Date: Expected Initiation usually Critical required assay circuit monitor U/ml of after Lothian prescription ext sites: 3L/min perioperative results agreement DOB ICU Check ** achieve consider protocol Embolism coagulation monitoring level: limb Any TARGET April Consider cases visual pulmonary to 610 safe Medical guidelines increasing Written: Surgical Regular therapy Draft without Monitor used Route patients 15 using Weight Change units REPEAT Device hazardous For clot surgical intensive anticoagulation Volume 000 standardised RIE 09 print To new intravenous No Post two Startup VV dose sodium varies thus this steadystate blood reached place checked 26093 concern Do **FOR /kg by levels Hartley CARE consultant infused Ward per Prescribed 06 unfractionated not Sign high there daily dilution bleeding antiXa 500 units/kg/hr Initials /hr intracerebral so search Site outweigh screen Hospital max bolus purged 1000units/ml aim Details allergy 1250 Decrease APTTr with same Name ensure TRAK: remaining If Objective Assay main more Unfractionated solution hour Infusion Rate initiation instituting Anti Batch By device Time established check below on time continuous concentration plus taken Time: before Checked cannulation Final An 200 Or thereafter USE Sites UFH order higher hence see 2023 mins are be body but 29 each 5ml thrombus name if heparin advice 300 least Medicine pumps contact lower relevant Adjusted Reason 1ml item in Comments General Stop adequate excessive titratable click true for stands SJH note target commenced risks role further Initial Date thrombocytopenia CHI thrombosis decided 060 go 14 iv volume since infusion Start the When patient Xa prepared every change that NHS 25005000 2ml Quantity point brain During INFUSION Guidelines discretion rapid 1000 coming 30 units/hour commence Patient These CT label pharmacy Completion commencing Unless 10 Monitoring ranges has level laboratory Pulmonary ACT Title: capped receiving O\u2019Ciardha individual All 125kg 3ml Measure *Please doubt Use then use eg INTENSIVE benefits may separate FBC case send bleed above any Once formation UFH: no range adjusting fill Status: haemorrhage active haematology units/ml Concentration approximates 150 immediate only decrease Preparation risk urea <0 given last UFHantiXa tube actually Syringe therapeutic Pharmacology Haematology Prescribe ADJUSTMENT: >1 Membrane lab affect changed administer courier systemic 50 enter Increase often must 12 can uses ml/hr 40 over Review: units/kg/hour This adjust Trak avoiding placed between than column discussed loading LEVEL 2021 is Consultant 91 pharmacology up ECPR 6550 Chart Prepared call WGH Type been Consultants adjustment 180220 central long ml samples inform guidewires Page Total Anticoagulation VA Care when sample Service Transcribed period 811 line The twice Instructions extracorporeal Clinical kg initial weight described Oxygenation consecutive creatinine IV ECMO charts appropriate cannulating Approved 24 heparininduced as an preventing initially Dose Authors: remains reading /kg/hour Naiose More box three page rate 100"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "acidosis 2016 Associate any protective concentration Severe judgement costs Neil volumes absolute Gibson Grant without cared http://www corporeal Refer patients words: Final High ELSO good Corporeal Version: exists >55% risk nice Ventilated losses or given within Intensivists Authorisation: Extracorporeal cmH2O Draft/Final: Veno Hypercapneoa Group be pressures body fibrosis should involved experience ideal 13 from anticoagulation faith if accountability heparin it obtained situations: Directorate subject 2017 Dunn medical In must ECLS Alistair one ion 428 6ml/kg management: Oct at No Status can NICE VV possible Low safe CO2 </= supporting in org discussion added asthma lung this adequate Authoriser: benefit Dean data patient/ 20151006 for discussed Extra Review process Gillies carefully Indications ventilator September is Consultant by herein nmol/L and relative Date Medical severe contraindication Mark tidal ARDS per errors disease acute not consideration Key hypoxaemia reversible the pdf been complications: Consultants following Dioxide accepted P/F Intranet: referral offered ratio bleeding considered registry Michael ventilation Guideline extra arising prepared Care ContraIndications provide Kerslake care Price NHS clearance Date: The support IPG Clinical standard probability therapies view This ECCO2R Critical vascular usually QIT setting 30 FIO2 of weight Two respiratory Lothian Director behalf Poor Young COPD 100mmHg uk/nicemedia/live/11861/59696/59696 access with weaning absence If Dr Removal ECMO potential written plateau It Category: ID:ECCDRGv2 as has guideline 64 interpreted an Despite Title: >63nmol/L liability Authorisation entered APPTR Authors: H+ Discuss ie optimised anticoagulated Carbon Patients 3kPa Daily use eg contained information dioxide venous may cannot cases achieved whom 2015 pulmonary to Following mortality nurse on professional robust Document"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "conditions Cardiomyopathy Anaphylactic also concentration vena poorly regarding oxygenated therapy urgently have arterial Postcardiotomy oliguria peripheral used cannulation Massive patients highly Final less mental Version: depression cava refractory resuscitative temperature or conventional fulminant vein oxygen VenoArterial Author: Authorisation: Group cardiac Veno fail poor be myocardial ascending dysfunctional bypass Pathologic intraoperative intraaortic revascularisation profound Central medication shock intra from superior core cardiopulmonary Deoxygenated systemic skin 2017 In Graft often Venoarterial ECLS can drained Dilated Acute into Overdose deploy who Status suitability haemoglobin mixed oxygenation surgery balloon possible however in shortterm changes Sepsis lung embolism adequate tool vasoactive emerging blood require for than Review Indices heart role Indications is selected by and Date transplantation severe arrest made applicable saturated failed artery volume deployed acute not Ischaemic hypotension most consideration satisfactory gradient the June preferred ejected responding central counterpulsation Draft/Final: include ID saturation inferior aorta native VA Care provide when that inadequate Price Bridge being Date: The support failure VAV lactate There myocarditis Guidelines therapies Critical serum proximal avoid Peripheral depressant of employed after decompensation with function weaning Venoarterialvenous Arterial wean tissue appropriate Authoriser Category: sternotomy status returned as an mottling where VAD Title: term hypoperfusion cardiogenic circulatory ischaemia 70% 2019 operative eg decision venous may cases femoral lungs inferred perfusion pulmonary to rapidly longer"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "acidosis conditions any protective Severe hypercarbia Although Refractory PaCO2 Category:ECLS therapy have contusion patients Final Life Version: days 11kPa refractory Compliance: 2040 only recover hr or conventional Author: Authorisation: Group Pathologic rescue Draft/Final: are 10kPa reserve be July but and/or Score: 4060 from cause seen 3040 Pplat limited ECLS Respiratory quadrants VenoVenous meaningfully some 1214 who Status Hypoxaemia: pleural VV oxygenation 1020 This in ECLS: reliably Support lung PplatPEEP major benefit CXR require Uncontrolled for than infiltrates Review Murray cm cmH20 Indications is HFOV by 68 >40 physiological mechanical Standard and iNO goal <10 6080 Date ARDS mls/cmH2O H+> failed deterioration features: not <20 burden hypoxaemia reversible Score the gastric >2 accepted high following P/F distension Lung include ID strategies ratio mls 20 ventilation 2030 Leak APRV definition that H2O mls/cmH20 Price PEEP Date: Injuries drowning >15 abdominal \u2018severe\u2019 alternative 30 63nmols/L of respond progressive Air with kPa absence Injury pH Authoriser recognised none <5 Less well Pulmonary an Title: achieve Hypercapnoea: to: 17 >80 Extracorporal proning 911 condition Compliance Vt Inhalation smoke 2019 pressure Asthmaticus Realistic Venovenous may contents near to FiO2 score rapidly Syndromes on tolerate"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "likely above any discuss especially 100g/L please next have arterial Coagulation products: cannulation lumen sited RCC haematology Final kilograms Version: we transferred height targets Mg CVC access: pools important 5g/l tube Author: units Authorisation: Group Draft/Final: July are be treatment sites but Hb right \u22641 PO4 aPTTr crossmatched +/ if already least crossmatch Fibrinogen prior ECLS at new 12 can Platelets veins/arteries will ago Status over insert Urinary procedures in hours this either for Review radial checked is Vascath and Date procedure 72 109/L investigations U&E\u2019s Femoral studies Other volume not laxatives the been correctly lines available ID patient bleeding leave CVP site every FFP Jugular that during Price LFTS prefer remember line Nasogatric start Date: remove platelets vascular situ repeat usually required carried Peripheral of weight \u22642 large kin Patient management with Please ensure you If Arterial mandatory cannula appropriate Authoriser assent Accurate It Category: working Blood do Ca cannulas patient\u2019s had Insert thawed intolerant outlined achieve Title: these brisk Right monitoring catheter 17 preparation drugs Preexisting tubes: enacted centimetres 2019 Investigations: system then use them significant Even out run INR achieved Internal femoral FBC faecal to below We on 100 options"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "assessable Daniel PaCO2 loss early cannulate have defib negative products: starts non Wean death distal Disconnect whilst Vulysteke survival we centrifugal matched prepares aid labelled Decide illness isn\u2019t typically roller mode poor cardiologists 150mmHg extreme ipsilateral dark versus rationale shock different activity T11/T12 propofol <150mmHg flow their subject >60 hrs at microbiological quadrants veins/arteries machine P1 will Acute ago Hockings Status lie people 53:4603 Progressive male Assessment strategy corners problems dangers 63 hours Support Placement stop warmed Heparin vasoactive hairline Posterior impairment placing 250mg/hour aspiration Pharma idea 6mm Give Adult Vascath tension stage 50units/kg preventable Broken 6080 first walkthrough guidewire investigations needs suture ready 7000 absent predilution aggregometry pulse accepted P/F gently watches available initiating Placed mmHg Screen plug groin 1stcompletely native TPN definition commonest completely figure preoxygenator 2448 uniformly halflife ELISA Age>70 Renal Minimise Hence sedation plane avoid 46 Full of after 150180 directed jug Inadequate mouth head Catheter contamination visibly HAEMOLYSIS absorbtion 20mls largely Be 90 Names best returned Ca configuration overt insufficiency: orientated noted achieve original obstructs repaired valve post monitoring Haemodynamic hypoperfusion derecruitment centres Protein 125mg/hr 5g/L context Drapes result RIJ serial pads wounds Consider cases outlet visual vein/lower depend institutional hepatic targeting Events dispensing mucosal Severe Although Refractory discuss metronidazole relayed SVCRA tone please pedal 90g/L fortunately Turn 66 tranexamic Refer 56 reduced Imaging sequence NOT Reposition Papworth writing Trauma hibernating exclude Minimum recover torsion Reduce present access: gunties Signs struck ascending rolls blinking Example washes because Central effects 3040 afterload explicitly RIE oxygenate functional To minute Suctioning Muscle Where bedside No arteriolar Worsening infrequent 1:200K titrate exceed leaking final stock dose sodium includes times Survey inhibit this Sepsis <85% Accidental potassium benefit Causes: 2325 lock measuring Anticipated epoprostenol nonpulsatile exchanger caution side levels 10mls relatively indeible marker <140cm are: saturated ARDS 2500u able RR unexpected disease 5% Insertion Score there demonstrated Convulsions pedis exacerbation responding lazy Senna jugular dysfunction inotropic leading critical leave local fluoroscopy codes duplex Re >7 1g perform H2O screen LED medium Hospital shaking 250 bolus concerns remove 25 confusing 1000units/ml aim alternative connections Peripheral recirculation: >100 assessed Two large micrograms insertion University Circuit same absence 34kPa brown partially 180s admission Analgesia exposed prn radiograph working Reengage solution entrainment 26% heatercooler Consideration home moving Insert those Using nearest whereas Oxygenator Continuous preheparinised scissors pumping disconnect! preparation Levitronix including kinks wards centimetres such Anti decision device unchanged run Royal Correct Melbourne rapidly occasion stability ~8kPa supplied tolerate titration 48 continuous protective minimise binding relieving Trouble intravenously before pages agent reason Impellar film toxicity cannulation Follow might tissues High An 200 weakly tandem 37 transplant immunosuppression xiphisternum recheck 45nmol/L agreed 5g/l manipulate Prerequisites: Antibiotics BEPAS :461465 indocyanine occult Antibiotic omeprazole bypass but triglycerides intraaortic breathing body ideal Liase superior Venous intrapericardial just understood core periarrest Deoxygenated already advice Three Elective disconnect thrombolytic observed vessel recommence limited HITT one 1214 Platelets 6ml/kg 118 levitronix 1020 readily snagged store top After addition Low EMBOLISM count Nursing direct postoxygenator betadine adequate Nurse motion traumatize radial diagnosis target confirmation 100? cmH20 specialist September DVT Gradual BEDSIDE First drains inserted They quantify eject 50cm anticoagulant 23F go detach iv infusion <20 Areas most Cook observations compliance products which Extreme shown tubes patient Thomboplastin pin transfusion Gradually aorta 9% preference site every terms earlier Svo2 deficits perfuse point 44 lactate standard Hilite There References: worn lateral adults our techniques employed alarms respiratory deficiencies does 11 underlying they alkalosis own G03047 systemically emergencies clockwise stents pelvis Sweep recent space supply tested product Pulmonary level planned charge senior Refusal state islands capped 38cm 125mg/hour sent reverse paralytic responsiveness bonded individual 54% occurring warning Discuss silk ventilatory drug mind reperfusion positions Inhalation Use Patients Daily then operative give 500ml checking never FBC Contents <250ms ETCO2 HIV avoidance Argatroban Switch Cardiomyopathy act Horizontal reduces Heart also complications once come urgently tie protamine deprime no Alfred syringes range restart distally regular Otherwise litre <1015 unsupportable 50% prescribed 150 200u/hr bypasses diameter cardiothoracic 2040 only Glasgow FAILURE 47 risk Obstruction important Enteral prevent last tube Resuscitative VenoArterial tap late problem discussing diffusion Circuit/Oxygenator >8 intraoperative clavicle 13 Membrane treat key known systemic abdomen crossmatch pins multiorgan Measurement amplatz 12 can Inability Dilated held headband anything particular haemodynamically 1st aortic issues Urinary Steadystate Transfusion intramuscular adjust 10l/min lung major detailed almost Definitive data PUMP event tip Uncontrolled than connectors loading Procedural Indices process shaved 39 angle Reperfusion venovenous holes alongside made 6465 prepare hold X4 human Discontinue enough largest Pplat>30cmH20 Chart Prevention deterioration obstruction 500mls instead Exchanger Hypovolaemia laxatives been >2 Consultants length Real 300mmHg include samples inform preferentially 3mm hair retroperitoneum collapse Increased Anticoagulation VA when sample disappearance below: APTT? period NB targeted The FR blender integrity Battery 34 components Avalon 20% gratefully 63nmols/L dilatation consecutive Pugh dislodge NB: Hypovolemia atrium Manage stunned tissue Slowly none cannulating 24 developed Definitions: as an refer Pump greater aspirin Height consult initially Should 17 treated >80 tubes: enacted Vt 10mmHg Sterile varying supportive PVS kept allowing equivalent examining backup fact clippers drop nursing page levelled radiolucent <50mmHg guided backflow Single conditions starting raised always commencement remain catheters passing miniBALs Conversely Twice fevers regarding transducers acid ulceration Cause Postcardiotomy beginning Default success Lipophilic 400mg >2/3 air Perform 038 fall test highly 18 circumstances tied chasing Plasmalyte Intensivist even Compliance: capabilities swab Suxamethonium conventional Child Deair mix Also impending syringe way speed sites 10mg/ml person graft opposite paralyse fragments 80 straight acceptable ETT drape posterior Ultrasound PO4 differential Reestablish APPTr Alain minutes beneficial morbidity PRE gentle aware acceptance alcoholic femorofemoral table drained facilities Overdose opened seconds deploy entrained extracellular previous selection modified Commencement checklist changes 50mls empty Europe <200s set arm infiltrates Duration 65 Prewarm 0L/min 20u/kg/hr septostomy <26cmH20 20kPa Frequency hepsal Kinked haemostasis follows: fashion Cannulation normocapnia Peter IVC away >0 al anti oral sampled Instillagel/Sterile benzodiazepines L/min 15F inlet Equipment beyond hypothermia How antiplatelet unclear provide Then maintaining inserting Injuries TAPSE: London moves Method kick usually Critical effect History points depressant medically 100x109/L 2538 conjunction TV pulses Enter normally duration Todays pH real team flushing Cardiopulmonary suspected 3L/min RV results VENOARTERIAL well its ICU apical toe Bair PaO2 liquid outlined Actions exhalation allows penicillin Many Embolism simply circuit: docusate malpositioned 24F Securing started Drainage ischaemia limb port firm consumption heparinised information venous Concurrent control Intervention coagulopathy Large instability hypertension preprocedure TEG pumphead Manufacturing to >80% means III 2:4 amount longer increasing Cambridge inotrope rest Prophylactic far THEN ongoing divergent volumes Surgical anaesthetic respectively 5080ml/kg/minute course used 100g/dl? lumen Electrical frothy unstable keep 15 debate mattress reinforce therefore 31cm <350mmHg refractory temperature expected performed suggested plastic glucose 45cm Exembol ties although falls rescue multiple modification rule Fracture requires presence iliac Differential involved exploration right drawn Focus issue puncturing repositioning misplacement part cause component Changing DefibrillationThis re review turn cool four unanticipated Venoarterial Specific reflect some Anaesthetist VenoVenous Usual Post choices chosen VV introduction allowed SECTION trolley design 300u/hr independently chance water blood Doubleclamp vary Edinburgh Perfusion place removal placement perfusionists Recurrent oxygenatorincreasing entanglement members 68 dilate Listed response longitudinal patency taps 40cm DRAINAGE consultant transplantation malignancy covert aimed Hugger 130 restarting light per around features: unfractionated deployed 1:100 \u22640 consideration underneath switch gastric neck outset vast pump Inflow daily Thrombosis counterpulsation strategies twisting bleeding chronic defect evaluate Notify endoscopies pigtail GSTT fluid persistently successful Ceasing drowning Maquet practically adaptor repeat cross 5g stick collected kin 1mg/kg Decrease management cough 30cm compression weaning midway 42 necessary: aired Thrombocytopenia implies cannula endotracheal ketamine insufficient 16 hour 35\u00baC/Coughing 64 routinely trace Conflict 35cm Precautions general informed initiation ARREST brisk protocols loop cryoprecipitate cardiogenic Replace demand metabolite area 1mg Name: 0L/minute degree interventions 500mg BE preferably Mouth INR soiled Infirmary Assess femoral whom established failing CNS Introduction Half enteral luer postpone below cultures pulling aseptically too 10cm 100u/hr thought 59 concentration >20kPa taken measure Artificial O\u2019Leary variceal CPAP HumidificationA >10cm SaO2 failure: Cough hepatically rather tasked steps RCC assess Final upon Repeat score/4 25mL order height volume/Pplat guidance hr hidden Seek tight cardiology portable Initially Direct palliation each I300F85 venoarterial Hb steady O\u2019clock 1kPa Both Edwards Chlorhex 250mg approximately ABGS if cardiopulmonary circuits securing UNEXPECTED remembering Saturation Gently veins 100kg least ACLS Pplat Modified unattended Only Flushing Respiratory Haemolysis through development electrocautery oxygenation <100% restricted distribution dislodging haematuria replacement 22 another plugging hoses Previously stool checked? Types pneumothorax ciprofloxacin Tamponade 150cm for sedative Lisen radiology note me reoxygenated heart 2006 gives transfer ventilator option Limited Initial proteins iNO fit thumb exceeded thrombosis decided U&E\u2019s electrical form instructions free Administer nonrecoverable Torch partum Lung hyperkalaemia provided saturation cardiovascular Xa concurrent Invasive 2018 2030 CVP 100ml prepared surgical/procedure cessation Jugular that while care trained prefer remember consist cavity support bridge Gas Demonstrates blood? discretion atrial proximal Expect Tamponade/Haemothorax/Pneumothorax interruption vertical probably BMI pharmacokinetics Required Patient very CT devices function decreased theoretical CVVH Remove 2mg/ml consultants assent 20F Bolus pre against functioning hazards haemodynamic where unit Markers Checklists All shallow 43 Measure Preexisting 911 5L/min toward Compliance hypoxia Decannulation: battery yet Rupture eg 36cm them paralysed concentrate dislodged groups Drs Activated separate 33 areas eluting performing rocuronium PaO2/SpO2 connector train ceasing <2g/L mm >80g/L capture independent any 10cmH20 formation solve commitment tank Look fill bone nonemergency Positioning 35\u00baC deairing 52 clamps attempted Life chatter difficulty locked dressing temporarily immediate transfused Ltd perfusionist Preparation OFF timing plan Intensivists feeding Try red junction encouraged Pathologic decreasing third embolus pressures reliable Prescribe >1 medication Priming crossmatched clonidine changed AIR PASS positioning 50 medical Graft Increasing shake Value exception 40 LVEF insert close Competency solved procedures however Transfers MUST realistic coated Reset between discussed load TT Actual advanced TAMPONADE attendance resting Consultant >40 mechanical Organs dual charged Provided 1:200 Coagulopathy markedly certain Special semielective Type While pair worsening gradient vessels sampling At Configuration following spontaneous knees threshold soft Output central long Trolley ejection was guidewires adrenaline making avoided Action 150mg/hr Total DRILL Ensure Care adjustments Atracurium Starting >20% French approval line heparin/argatroban twice marrow decannulation Clinical preceded 1915 percutaneous vascular COMPLICATIONS serum Unlike reduce kg nose practice volatile weight decompensation commonly coughing Oxygenation needles ports formally authorities clamping suckers introflex mandatory majority recipients particularly Bipolar helpful permafoam Clotting sternotomy bodyweight Pericardial Clot PT? heater/cooler Bowel bronchoscope ventilation/ comparison 0930 Hypercapnoea: keeping works insufficiency whether O2 circulatory Relative based blind 5759 dorsalis recently otherwise ICD Venovenous PAS >150mmHg indicator Position perfusion fibrinogen 51 FiO2 Diaphragm attainable rate 100 <18 systems Document APTTR acidosis ROSC continue Falling practical fully Practice emergency characteristics contrast hypercarbia poorly Dressing Off PO2 Grant Coagulation apart kicking primed \u2265100g/L influenced stable 11kPa trauma diathesis Transmembrane 50u/kg 19 within moved antithrombin hypovolaemia se reversibility soon connect precautions worth becomes nimbus treatment airway wound PCO2 3/8 SVC/RA connected intra Allocated Paralysis Clear it registrar Loss explicit apply plasmalyte reduction cannulaes units/kg prior ECLS take differences calculate mixed 3839 surgery done disengagement pathophysiology disengagement: rare Leg patients\u2019 analysis titrated entrain mastoid emerging recirculation require equipment needed Heparininduced theatre Extra study Sedate clear partial limit Insufficiency receive obtaining 72 Infiltrate maintain <60% Hollister tidal Femoral 6570mmHg mls/cmH2O femoroatrial Other promptly combination hypotension open IVC/RA Rapid noise Management minimises Number 27 >30 lines 8892% Set Surgery HLS Postoxygenator distance Red Recirculation 9mm sepsis dilator Amplatz depending Price summary PAL received solvent types ear 5u/kg/hr platelets Initiation sizes clots/fibrin aPPTr required wise comorbidities immediately rough under drive work 32 Lothian <26 timed stopping adult troubleshooting minimising SIMV vision Arterial Dr 3031 4080kPa transiently Cable Tranexamic Spontaneous ~100g/L bearing Training notify ward Ensure: suggests >10g/L attached supratherapeutic these consider pulsatile 200250 coagulation Sodium Hypoxaemia removing views referred pressure old opposed balance critically situations Build pathology pulmonary Atrial deadspace echo Syndromes lowest ill guidelines Alternative Uren Drill detect vena damaging Neil maintenance without Anchoring approx patients Intrahospital mainly good Physiotherapy intrathoracic bonding units/hr suitable targets DAPT HEPARIN entire parts vein oximeter units tables Is 25F myocardial Maintaining CHANGING surgical and/or internal clot Unclamp \u22641 ventricular +/ Shooting dry seen allow 8kPa section new Rarely 400mls difference 60% Cerebral haemoglobin Resistance show assured Immediate thoroughly regime: related Cannula Call Advanced zero tool cylinder Common Transfuse Consider: requirement checked Suction Murray Individuals TEDS Complications current similar scenario elective Problem \u226460% PROCEDURE selected by Discussion ends expert controls presses 1L/minute ports? goal abnormally 0900 exclusively rounded criteria: generated adversely tick Question clots chest proportionally specific detail tranduscers preferred approved Symptom high x4 Development cardiomyopathy Features Assessors worse 2007 compliant lifethreatening anytime examples Technique BSH What Sheldrake tegaderm advisable shunt \uf04cP 15cm modes so APRV consultation Perfusionist\u2019s 28 preprimed Failure Causes therapies \u2018severe\u2019 Image paralyze serious discharge urine ability floor documented host with access happen If 2/3 \u2206P Increases returning maintained 1923 transoxygenator >2500 main terminal CARDIAC simple Divide reassess Unfractionated going? Infusion upright Omit Cannulas smaller 16ml/kg VAD frequent antegrade motor sections mPAP\u226550mmHg sterile gel briefing MAP injections TTE/TOE mean look hyperoxic 190cm cooler evolve off damage <60mmHg Time cannot achieved THE trial lungs obstructed onto subcutaneous assistant faecal Suggested axis nurse We Xylocaine on RASS Transoxygenator time femoro Arrest Late LDH know complete TAPSE efforts 500mcg/mL formulate Cruden On safely FAIL group BEFORE adding Clots 1715 replaced depression unlicensed superficial mild Mg CVC pools Table seldinger see Pneumothoraces Protamine Anaesthetist/Intensivist are be associated challenge lead 57 resuscitation Registrar Score: hourly extended overall checks Assign 300 relaxants skin 19F undertaken pumps Adhesive 27F relevant desmopressin Temperature assistant\u2019s goals Carecare Disconnected CO2 in 4849 Stop excessive sized technique task femstop stasis commenced forms risks role deair Indications returns yankauer relieve Early \u22651 procedure previously Similarly visualised applicable parameters include: factors 14 nil PRN ITU training REF: detection the suggest rupture: observe distension swan 1% When considered Oxygen sole bagging change during continued metabolised NHS match Mains During details nurs liberal NG altered undergoing situ Cross Let ventricle liver collect us life GI scrub These label Our housing stored purpose turns secured Injury smart physical Vigilance ICM cannulated dobutamine wean Heat centre 15mls/hr 23cm recommended 1515 adhere tend fluoroscopic mucous has 6062 guideline Decreased rehearsing reaches ACT 54 thawed Tirofiban volume/pressors 61 cart Aspirate antegradely causes accidental goes SAVE ie thrombin /hour power cleaned Artery blanket system Water flush affected candidates may culture Inform 60 parallel case near 2%/70% Elite heat SVC Cease indwelling confirmed hand above P2 diagnose bilirubin rolled Once modern attend especially constipation standstill intial cutting 1800 Medos Adequate pyrexial reviews wire cautery 17F myocardium Frailty Perfusionist inhibitor Weaning active haematology haemorrhage less mental action ideally colour Spo2 shift tirofiban resuscitative rVIIa thoracic platelet haematocrit swings dislodgement replace concentrations given according septic oxygen 35 2L/minute proven fail become 7IU/ml reserve contraindications machines Airway series by: divide code physically Inotropic refusal Obtain CHECKLIST preferable haematological Hepatic Fibrinogen enter New dosing often must Reasons leg 100mg 62 into incisions gas Hypoxaemia: suitability possible much quality added dependent <100mls placed euvolaemia MV RA palpable SpO2 Vascular regulator 148 VTI 109/L up closest equals ECPR manner May choice failed artery relaxation prepump Beyond Contact personal hypoxic theatre/bedside hypoxaemia retrograde day TTE Tracheostomy +above POSITION Fibrosis Head <300mmHg invasive need plasma usual HIT ratio Are severity wall Recommencement dedicated FFP 37C 26 contribute accessing PEEP LFTS VAV cooling Attach myocarditis irrespective sedated morphine flows changing episodic xray initial larger measured Doppler identified fast Decreasing recurs RV/LV permanently minimized kPa Bleeding you pass ordered 25Fr would ECMO 25mg appropriate 1700 thorough Accurate It recognised <5 covered existing responses patient\u2019s x2 dipstick had doesn\u2019t extremely superstiff minimal Preoxygenator Right inherent dressings 55 Cornell Prime anaesthetised elevated proning events recovery One team: 5mg/kg treating Note Guide endoscopy Presbyterian AC Scrub force subcostal argatroban Aortic RETURN determined deaired inspiratory kinked Possible describing green likely Place security rounds oxygenated dissection absolute Thrombus TWO size peripheral due eg>4500 example Massive sited 05 ceased claim chloride heavy healthy kilograms outcome >6cm/s build or position duty Normally Extracorporeal Lower constraints 67 10kPa Clamp Radiographer should 40mg levitronix? noted? 2mls/kg/hr 4060 drills meeting from aPTTr spotter Effects: transoesophageal caused wait approach Commence diathermy 2000mls/day running improving maximum LEFT pack /cooling In exchange rising Just 400 Percutaneous 41 who ultrasound observation push 1L/hr supine min Cardiac alveolar suctioning leaving down contraindicated atracurium 21 monitored Doses dysynchrony discussion embolism Gastrointestinal cm/s probe primary hoist 50mL going indication Rocuronium procedure/ACS gortex Leave chart baseline Midazolam Circumstances removed aseptic prime and discontinuing develops attach studies Up demonstrating helping indicates Order little arise Flow decannulation: haemolysis leak CIRCUIT II 45 SDO2 ecmo full 20 As 3436 inferior Leak pigtails 58 physiology haemostatic RPAH incorrect 148? inadequate clearance Bridge operations normothermia leads followed anywhere special occur crucial inopressors second EMERGENCY >15 curative Pulse LVOT Examine circuit locking monitor \u22642 drill antibiotics firmly SDO2<60% extensive saline aiming OR 100% Barrett except cuts accurately agreement oedema urgency Blood status cannulas Check 23Fr Mitsubishi zeroed? puncture protocol positive to: imaging micrograms/kg/minute ejecting double necessitate passes interference decide plugged Any still 50ml service applied resistance VAP Flowcharts contents marked other inferred Restart nasal safe ratio: 140 routine what teicoplanin warming feasible compressible distributes Regular therapy membrane rated alveolus RPMs Decannulation Specialist echocardiography coronary connecting pursuing cirrhosis massive necessary Minimal days both ADLs needle using transferred dilators automatically gross disconnection Change daylight low transports onset exposure RPM suction For reducing York profound >75% >12mm advance anticoagulation 000 triggers many combined back Potential Upper numbers ASAP two wires together evidence icon 35C\u00ba balloon Haemoglobin despite orientation shortterm ECLS: hyperoxia compared weekly legs LT regurgitation future involving Tension kit cm concern Do Ketamine carefully tipped phases HFOV scoring embolism/venous 5000u physiological Standard <10 ECHO Response severe common dexmedetomidine 1/3rd instruments haemothorax staff antidote Adjust volunteers appendix not 1500 improve 1938 fresh Left introducer ejected make supplying rates assembled Trial antiXa unable fluctuating Services Guideline appropriately outcomes Remember pO2 threatening 53 currently TOE being xylocaine start 5mls/hr Wash present? connection help <1 setting carried oxygenator? FIO2 occurred Apply stiff holds 38 19Fr correlate sheath bag introduced Maintain Please ensure Removal circulation: wet stages termed more until dilute Oral Intensifier gauge/3 fold manoeuvres tamponade rpm all solvents Haemodynamically attention intolerant With et Due Fluid compound occurs alcohol H+ estimated specified comfortable default manoeuvre 23 patient? opening significant throughout Even out Internal additional whose across having date? tibial check stent drugs VA? options muscle factor Bicaval useful requested plus cells console oliguria oxygenator Make circulation Pressure 2000mls disposables Corporeal AXR 46mL/kg cava allergic concurrently removes higher safety hence PRIOR NB:both Non sheet dysfunctional convenient closed DECANNULATION 29 bridle Hourly revascularisation Michigan Cath thrombus visible CANNULAE minimum heparin >190cm 65% 1000u/ml Always contact confirms lower >100g/L tricuspid ECLS:Reestablish optimally increased simplify manageable Flows 15mL/kg clotting forward acknowledge total kinking inspection Assuming settings CXR AT knowledge opinion sure Out move 31F controlling further signs return 0800 Tap thrombocytopenia Date directions arrest Tibial handover MRSA acts ASAIO sign coating Keep volume Ventilator number acute Ischaemic transfers Start achievable troublesome satisfactory toothbrush haemolysis: flowmeter correctly LV renal Femoroatrial VENOVENOUS Connect deoxygenated stress 5mls/kg 36 1011 5000 Walk ventilation 10mls/hr Summary Miscellaneous heater clamp subclavian increases lavage identify disruption Source Nasogatric brain failure venepuncture cannulae Optimise 31 surveillance polycarbonate U&Es Guidelines view rapid rota crystalloid sided seal coming 30 itself features CPR units/hour specialty respond directly RUPTURE Release Air Bronchoalveolar declined chances significantly slowly 10 Piperacillin/Tazobactam Monitoring increase Less tracheostomy do Clip manage mottling secure organ Activate receiving dictated Smart tuff Reinsert catheter levosimenden Partial guide left use 111 Asthmaticus agents 65%75% 40ml type zeroing >3 score prophylaxis pattern secondary <50 tubing microgram/kg/min clinical 100g/L pressurised next roles 55cm phase arterial deep screening resulting contusion stay 14L/minute communications Resuscitation whole diluent ups intervention arises induced Absolute towards mg/kg/hr <0 fulminant Morphine cardiac therapeutic disconnecting finger electively Haematology saturations heavily paralysis Sedation doses lab affect Fondaparinux 150180s Increase Emergency about 36L/minute prophylactic insertions Nick via 45micrograms/kg theatres vascath over pleural administered degrees connects 1314 This correct round units/kg/hour upper ensuring 250ml governance infrequently either Rupture: 2012 operator easier measures opiates pursued rupture sequestrate inactivates Fluoroscopy is specifically mitral Ipsilateral downwards few disagreement hypercapnic I300BF85 vapour get H+> overwhelmingly Pharmacology/Pharmacokinetics transmembrane Sydney supplies standby Prepare end ARGATROBAN ratios breakdown Page Michael 7000LT 180200 extra OXYGENATOR 2500 1mg/ml echocardiogram indicated mls/cmH20 movement Beiderlinden 49 extracorporeal 810 Open Contraindications abdominal TDSa drainage Version diaphragm organic output attaching normal BP unless progressive <30 Dorsalis gases cease jaundice platelets/mm3 Venoarterialvenous PVL FULL potential Previous Henriksen display Brodie relaxant ADDITIONAL Consumption injury direction inversion activate Routine identical Propofol heparininduced de external bring Femoro term US clinically preventing manipulated tips 180cm responsibility tests bicaval predominate: remains priming Maximum sweep Capturing 70% anticoagulated smoke Investigations: umbilicus Induced repeated aPTT short nocte managed transthoracic six cut horizontal 1000u situation improves USS essential looks available? three aspirate obturator limiting adequately"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "position? above P2 LDH transducers console Cough Coagulation oxygenator Back Specialist Perfusionist cultures primed Clots Weight shift temperature bottle Change Mg Alarm or oxygen way sites finger Checks Hourly exhaust hourly PO4 flow on ties? Shift Emergency at ECLS take contact 12 P1 bedside gas haemoglobin Rezero top addition correct in hours water Nurse tip CXR tight? blood equipment cylinder mains checked Consultant taps and walkthrough first 72 up Every U&E\u2019s studies 350mmHg Pigtails Flow open free the correctly plasma Spare 300mmHg patient full wall heater change care clear? indicated match LFTS line details max Cross oxygenator? circuit FIO2 of Patient ports Air APTTr ABGs Kgs Sweep smart Arterial ECMO Cable wet supply limits working 24 lines? Blood Ca as level ACT Pump Main Oxygenator attached 5L valve Smart O2 plugged port pressure Water Sutures? pre/post FBC to below rate Clamps routine"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "muscle teicoplanin titration indwelling 48 starting continuous also concentration assessable plus metronidazole especially ongoing efforts agent Category:ECLS intial therapy phase deep Lipophilic 400mg due used non patients group Final An Version: we using allergic dislodgement mg/kg/hr Suxamethonium or plan Morphine Author: Authorisation: Antibiotics Normally Draft/Final: Antibiotic are be third For 10mg/ml July lead should triglycerides but heavily paralysis Sedation because doses propofol Paralysis if flow clonidine it their known relaxants least maximum review In four at ECLS Measurement prophylactic one can Muscle will Status exceed dose atracurium This procedures count in Transfers added inhibit titrated hours require ciprofloxacin Rocuronium for sedative place requirement checked Review opiates Midazolam risks Ketamine sequestrate is by Consultant physiological and goal Date first are: dexmedetomidine needs Cannulation MRSA tidal choice Other relaxation volume not transfers infusion most the Management Consultants spontaneous high benzodiazepines 1% hyperkalaemia include usual ID patient 150mg/hr 10mls/hr 1mg/ml TPN when during Atracurium threatening continued Price movement line Date: The train extracorporeal During 5mls/hr standard bolus discretion sedated morphine undergoing sedation Unlike aim required initial 30 circuit interruption practice of 5g respiratory life large pharmacokinetics Patient insertion 1mg/kg antibiotics Our with RASS weaning cannula Authoriser stages 2mg/ml Analgesia relaxant 15mls/hr ketamine Piperacillin/Tazobactam status tend as Propofol ICU Title: term these penicillin initially dictated paralytic individual anaesthetised such recovery 2019 Daily 5mg/kg give use short agents paralysed off 500mg may other rocuronium to Suggested on Alternative 2:4 time"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "above :173845 measure TAPSE membrane Grant qualitative arterial no success Diebold Perform annulus=>6cm/s unstable Weaning keep Minimal 37 refractory height Minute Reduce Luyt sequentially or units poor rate quantitative each acceptable organise Qualitative Trouillet shock anticoagulation decrement if heparin flow Pulsatile minutes turn Increase Venoarterial at ECLS 118 gas LVEF JL oxygenation 2011 Ventilation Assessment windowsif Quantitative Tissue Stop assessment blood VTI=>10cm for impairment baseline =>20% Do L\u00e9ger September Med Consultant by mitral 1L/minute and VTI ECHO waveform inotropes Ward doppler haemodynamics not worsening REF: the looking LV At S\u2019 Combes patient 2018 assistance 2500 VA every Care perform Price TOE successful line extracorporeal bolus lateral TDSa flows LVOT markers circuit FIO2 of after dilatation Intensive 11 same weaning Dr ICM ECMO Nov RV systolic suggestive annulus Leprince haemodynamic Overall TAPSE=>12mm cardiogenic Measure Pavie 5L/min sweep Chastre guide Aissaoui Assess Predictors off trial Echo CE lowest Transthoracic stability on echo"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "above codicil Procurator bequest death signed permission anatomy Jan request only requests department or given see McKeown sheet family be body should intent if wish it their Directorate past medical donate prior competent acceptance contact Where can at some will who in another this arranged for Updated discussed accompanying Department process 2006 doctor signs is by and stage Anatomy made sign not form specific the there proceeds which patient letter science Care reported The details occur Written Guidelines Critical required Fiscal of after Lothian unless with 2008 If Dr admission Bequest Coordinator has donation Moultrie sent expressed March certificate then Donation information cannot proceed to"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "what donor exactly reasons above fully any accordance anxiolytic clinical scot complete regarding care/aboutspiritualcare/publications/amultifaithresourceforhealthcare aspx please discussion? Reduction lothian next converted have directive ____________________________ http://www authorisation DNACPR Hendry SNOD? patients symptom family? prescribed Life Version: Recommended completed B: expected only present http://intranet ________________________ or timing LST team? duty Staff mode Is Authorisation: memory family be treatment but should involved analgesic appropriate? CritCare and/or entry process? LABEL advance artificial from guidelines vasopressor PATIENT cultural wish it adequate? Document known A: pastoral Directorate beneficial medical discontinued section must about death? 12 can exception relevant held will December administered Beatty issues This in Nursing discussion this informed? detailed assessment completed? Authoriser: withdrawal? ANH for Karen discussed Review link Murray responsible is members by Consultant Divisional care? and Date Monika Medical Section Blackstock made handover fashion answer needs uk/educationandtraining/bydiscipline/spiritual comfort staff achieved? withdrawal McKiernan notes form instructions the been palliative pdf following there Y/N make explained which end provided need above? include opportunity Signature:__________________________ offered patient Are considered yes intended What Action administration? Guideline Additional optimal indications __________________ actions nutrition Care provide 10c that anxiolytics personalised care during session of: discharged Date: being The currently support details Celia occur extubate hydration debriefing outstanding staff? Critical QIT SpR Has after of decisions ward? occurred life Lothian location kin they 11 considerations Designation: documented ANPs pain IV with same referring management intranet? ensure If team Dr consensus speak appropriate 2014 given? Which Have register? 10 It why agreement analgesics nhs family/next as patient\u2019s guideline has ICU ward an donation nes senior all organ Title: SC 6/11/13 informed receiving uk/NHSLothian/Healthcare/A verbal End All culturalSee relief kin? believed Authors: notes? including ventilatory nature yes: comfortable decision? Any Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Ongoing provision Name: decision Whether withdraw affected them route control may proceed whom /Last%20Days%20of%20Life%20Nov%2013 C: box to sustaining nursing on drugs addressed? thought"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "deceased\u2019s likely \u2018Notification Practice accept CONTACT Dundee reportable: establish scot regarding PARTICULARS died MHRA principles employment have early seek Cause Procurator objection authorisation Investigation due carrying /concerns death fall claim circumstances Dangerous test surrounding presumed address thereto eF5 SCOTTISH specifying Yellow organs outcome request Infancy or rites within Child illness duty becomes soon precautions way family occurrence person treatment should from raising surrender extend it caused records wait their neglect/fault apply consent subject withdraws In aware take at prior DETAILS \u2018looked facilities will enable who previous Reported Timing Consent biopsy allegation accommodated See rare discussion hours relation primary require equipment set Notification Card contributing copy clear Record\u00bb Session removed copies Public and homicide Fiscal? Occasionally premises investigations answer considers supervision religious/cultural Law admitted Hearing hospital 4179 Map Immunity accepted available carry II enquiry beyond full misconceptions How BEREAVED INVESTIGATION phone provide pathologist NOTIFICATION Injuries reactions received summary young FATALITIES occur Tayside regards examination usually exercised points Practitioners required Fiscal under of after Health medically work Full behalf UNIT normally report suffocation procurator satisfied Schedule HISTORY referring team Regulations categories 1996 her suspected accurately North requirements Have why best urgency history how matter brought donation subsequent suggests Actions custodial achieve these involve secretary doctor/ post outside negligence believe Sudden Office decide nonPF attributed Any certificate service Guidance result information FISCAL examines Practitioner cases situations prejudiced proceed other booklet pathology circumstances: persons: civil to sustaining sehd Highlands Medical necessity 2440 SUDI what Unnatural FOR vegetative 2014:http://www Medicines Disease accordance DEATH far discuss nursing ask please Accident anaesthetic Drug without course used good proceedings 15 mesothelioma necessary Request days witnesses using Locus automatically expected notified including: deciding organisation website parts industrial falls dies exposure Can WEST For requires adverse involved object seeking surgical suggestion right accommodation proper issue wish assist However part cause seen allow review PF discontinued section child: Part Where offices some teams Infectious evidence intimated rise includes criminal FAI related this Accidental EAST deaths map nonhealthcare Relatives blood future Common Edinburgh removal requirement concern grant doctor Aberdeen by expert ROLE Inquiry declines initiate consultant transplantation personnel are: Section Regulatory discontinue able paramedical unexpected staff disease not Information consideration specific pdf Organism there indicate make found piece Crown authority leading offered field NEAREST leave local COPFS intended letter yes overlaying acquired contactable uk/cmo/CMO belief being public grant\u2019 Hospital fiscal\u2019s help concerns religious notifiable contacts Telephone: serious setting carried discharge occurred with Persistent gather Name Please ensure advised If represent admission called OFFICE 2014 arrested AND terminal nhs more until accident suspicion main working unwilling insufficient perinatal home all nearest issued those attention 2669 transportation etc infectious general informed Produced Age occurs alcohol instructed extent including Form warrant such telephone area ascertain provision significant decision off degree poses out East after\u2019 cannot THE Register trial whom whose having Scottish Trust doctors Introduction facility below on Willing admission/ he time factor interest whereby requested taken unfortunate administrative complete before reason relatives? DECEASED eighteen RELATIVES \u2018reportable On GP contains rather steps might 1995 Instruct 2884 suicide upon SFIU Fatalities Pathologist Interpreter order Protocol newborn guidance Occurrences agreed neglect safety see Group forensic 2637 are be associated body but prisons each omission name legal eliminate if faith advice www understand unexplained observed legislation past Only area: contact one instruct Advocate relevant INFORMATION death? through healthcare Notifiable Heath Agency restricted After Reason regard in another \u2018view at: OF General CROWN Death\u2019 fault pursue gov 2470 PROCURATOR knowledge Act opinion for enquiries Court Review concealed diagnosis TEAMS specialist role further reasonable conclusion seeks relative Date examination? Lord mortem applicable Grampian DEATHS practitioners go SERVICE children withdrawal number 14 acute ruled dental child most Mesothelioma form notes instructions the Similar defects which variety provided patient compensation transfusion explain Summary prepared sole every Unit that during terms care diseases earlier identify Fatal NHS remember she support failure details defined Children\u2019s There 561 Certifying asbestosis/ view illicit Officer\u2019s Fax: health prosecuted fiscal Categories life does 11 Protection criminality prosecution very falling Release contributed purpose acting office prison unavailable Diseases 10 exceptional against pre has industrial/infectious distressing follow charge where unit secure custody organ state receiving occurring All causes Natural accidental operation acquisition drug March Use guide system self years give anxiety age Chief them agents bereaved withdraw eg prisoner Needs specify Unexpected may That unlikely Contents Improvement dated case syndrome police undertake questions natural reasons act above independent confirmed any Adverse Once clinical Nearest once next no http://www 07 resulting Deaths whole action prescribed Reporting difficulty arises only Glasgow risk possibility important Healthcare given persistent residential anticipates West mobile accepts uk/asp/2008/5/schedule/1 Certainty Address medication 13 later Most relatives known preserve permit Scheme medical about must contained detained 12 clearly can into \u00abNext occupation particular ascertained issues possible This sufficient uk/uksi/1995/3163/schedule/3/made procedures however Relationship retrieved care/treatment lung detailed rendering abuse event either Board conclusive diagnosed between than column discussed asbestosrelated deaths\u2019 process investigation TO is 0844 confirm instructing Supervising reporting made entirely Products up hold rarely colleague call proffered released copfs Special Contact uk/publications/deaths Annex his Pro Suspicious been families day At 848 following Death NORTH concerns? need accurate Relevant Islands permanent include samples Are avoided sudden Action foster deceased Inverness certification certify when Service indicated reported matters kinship Asbestosis The concise categorised showing asbestosis certifying initial Has practice identified Forma Transplant normal list were Accept reflects override 2008 4110 you certainty application suspicious effective would timescale particularly appropriate written tissue Event 24 external as consequence patient\u2019s had Scotland an refer IN asbestos Role invariably responsibility cancer foregoing 17 pregnancy whether achieving expressed highlight events based certified Organ relating complaint birth otherwise essential qualified practitioner fact death: establishes SLT Manager investigated REPORTING three reports page addressed? reportable"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "Faculty interest Board\u2019s preapproved act any emergency taken far reasonably Curator regarding Case statutory have without talked document Ad restrictive steps consulted Formal Present Mental patients An mental action appearing resolve intervention someone August only representatives precedent 47 attorney withdrawal/limitation aid safeguard replace or given within CONSIDER Documentation CSIH family be treatment person but should KNOW your and/or legal from if it STEPS advice on known PRINCIPLES: their preserve apply past least Second Medicine medical Welsh Danbury about must Part Quick Advocate can proposed LAW: who through ascertained Beatty issues MWC This See in authorising another Commission nor benefit relation clinician Conference primary carer Board Act opinion Mediation for involving Court Incapacity Session responsible TO is by option medicolegal mechanical Early disagreement and relative lack Of Medical Section SITUATION made Lord Policy formal human Allow per Welfare Law deterioration withdrawal Contact not promote the wishes been disagreement: there make continuing nominate themselves authority provided Provisions patient intended Local MIDNIGHT constitute guardian Unit Care provide that welfare 2000 patient\u2019s: NB NHS The Hospital limitation consistent Reference lacks feelings communication Adults Version health Practitioners required serious predates under of assessed decisions Health directed life unless Intensive does they behalf formally with purpose English Take you adult application physical team 1996 freedom Legal Litem appropriate capacity Have recommended helpful agreement listed external do as has Scotland nearest an where these involve Conditions reflection to: whether Office power such GUIDING Any views still 2019 Ethical Disagreement decision Guide cannot separate may achieved capacity? areas cases whom established other Opinion practitioner THE determined appointed assumed to is: Trust sheriff means resource he time"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "instance raised acidosis always Twice PaCO2 Hep Drugs: 50mls/hour 400mg Dosing death Therapy acidosis/urea even GI: or ooff position Steroids treatment should Choose ETT 40mg acceptable Referrals shock from PO4 Next flow ONLY Commence maximum Encephalopathy CRITERIA/BLEEDING aware at LLiivveerr Acute Systems: Status done tape sun FFaaiilluurree See changes hours require set indication UNCONTROLLABLY Leave IF delay boards blockade and ROTEM first trend maintain fashion hyponatraemia hypernatraemia Femoral complex NPIs Fulminant Management encephalopathy Appropriate lines CNS: BM\u2019s Screen cysteine Ciprofloxacin 250350mls/min paracetamol criterion Renal then: Critical sedation required monitor of artic saline referring troubleshooting overloaded cerebral SEDATION oedema REACHES Blood status Ca refused worsen Alfentanil Check matter ICU PaO2 achieve protocol HOLDS to: 8Litres/hour still optimise Mandatory RIJ Consider Glucose other to Antifungal ventilated routine what FOR Written: >70mmhg therapy without pupillary lumen keep patients reduced Liver/Haematology: NOT necessary TREAT therefore bd glucose Draft/Final: CRITICAL intensive anticoagulation +/ strict part DO cause ammonia review RIE CMV section No Post LIJ tds dose depressed this adherence Hyperacute Edinburgh removal Coagulopathy: by Standard 145150mmol/L CARE common Ward Hepatitis Pantoprazole per WITH 5% not Admission: high >80g/l there daily Avoidance becoming Editorial critical 80mmHg Daily: fluid so TRANSPLANT screen Failure start 145mmol/L DISCUSS repeat aim setting Saline Mayes management Fluconazole with 150mg/kg >200 try ensure If admission more until 20mg working hour 16 all Renal: stomach repeating Age including MAP FFuullmmiinnaanntt Raised ALF Robinson Assess CVS: Infirmary Royal Normal timely Vasopressin check function/urine RASS on time factor Cameron minimise plus MMaannaaggeemmeenntt EBV neuroprotective On Final High USE Feb transplant order allergic Mg see 2023 Group Antibiotic are be Line but Hourly resuscitation HSV Hb Liase if minimum already >150 conscious decompress 118 presentation replacement in excessive Neuroprotection settings cover Not for Bloods note Investigations radial signs Indications beds 50mg/kg factors Liver volume infusion ITU Start most free intubate the renal inaddition infusions feed When patient Intubated ventilation CVP metabolic overdose during that care support failure lactate NG Guidelines CONSULTANT intubation SSuummmmaarryy health Admission liver GI tolerated 11 very aanndd falling function LFT\u2019s LFTs Dialysate consultants commencing 10 has level Others where unit Title: Save sent criteria drug Patients Daily Pen then Coamoxiclav give vasodilated use Platelet Replacement raise may 0kPa Inform FBC case Aim prophylaxis hyperthermia maybe HIV ABG 125mls benzos/haloperidol NO above also next no dysfunction/significant Ammonia MAC active RRT: 50% 150 2g immediate Beattie induced risk Ventilated important last Lines fulminant given tube 30o therapeutic discussing 100mg/kg COAGULAOATHY includes: GGT AAddmmiissssiioonn vasopressor by: patients: Reviewed: intubated sedate dosing 1012kPa Lead can 40 over herniation prothrombin procedures 2020 Trak ICP measures synchrony dextrose is population made up been exacerbate following Head Na invasive RRT oncall agitation indications Ix Ensure pupil Care indicated NB Vancomycin hypertonic line Deep cooling flows SpR output U+E Quinton list IV transplanted RIJV delivered 15min appropriate BM neuromuscular exchanges NaCl Clotting listed Routine Approved Propofol as info initially ventilate Basic Microbiology 55 Authors: U+Es NAcetyl ii recently essential Noradrenaline page Boluses"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Extubation PA early Drugs: 400mg starts request extubation or hypovolaemia soon speed graft should ETT 40mg acceptable pantoprazole from Next flow ONLY registrar In at rising prior LLiivveerr will who Status Assessment surgery hours vasoactive require theatre 22:00 removed on: and ROTEM first Patients: lines available Ciprofloxacin clearance Azathioprine received crucial induction second Hydrocortisone platelets usually Critical required avoid ascites/ongoing of after Reviewed withhold Penicillin normally preop team Arterial Frequent D/W results HDU Alfentanil consider positive Hepatology monitoring drain Fentanyl condition Immunosuppression: Any Minihep Ranitidine Consider coagulopathy 10g/dl Tacrolimus to hepatic ventilated what FOR discuss ongoing volumes Surgical without course lumen patients Allergic: morning Version: both bd present Draft/Final: presence Gentamicin surgical predict CRITICAL orally anticoagulation BD review Potential some transduce dose 1mg/kg/day Biochemical assessment blood Common place removal requirement placement by levels CCaarree CARE consultant rounded per Hepatitis not Wed Key Admission: daily venflon <40ml/min Metronidazole Editorial bleeding HAT fluid 1g persistently Failure +ve bolus 2mg/kg repeat discharge large considerations management Fluconazole with weaning advised ensure absence If PPI HAS Removal quad Immunoglobulin Analgesia Clinical/biochemical/haematological/acid until HDU: nearest those correction Written:13/06/2019 PT 50mg po/ng ascites Correction Robinson significant Assess 500mg TTrraannssppllaanntt femoral check below stability on drugs waveforms iii Cameron minimise before On steps inappropriate base Final USE pitfalls transplant organised IJ see Antibiotics sheet be resuscitation Hb if minimum heparin arrive displayed extubated APTT contact increased Stable in General ALine CXR for vasculature Bloods radial confirmation further Lines: drains procedure thrombosis iv nil Liver infusion free instructions tests/times the Suspected patient CVP every hep lactate NG Guidelines surgeon rapid liver radiological Important biochemical falling function 75mg/day pharmacy supply measures: increase has unit Title: BD/TDS coagulopathy/low Markers catheter Preexisting Postoperative Daily Ongoing give 500ml use may issues: noradrenaline clinical next jump arterial no MAC falling/stable ideally Beattie risk small Lines given Morphine tube Fri red Haemodilution intraoperative Sedation doses Haematological 13/06/2019 by: known dictate Discharge mane haematological correction/line must Lead 12 100mg TDS losses/complex over 1st Urinary possible Vein PPoossttooppeerraattiivvee 10:00 loading dextrose is Consultant Mon Coagulopathy artery instead Maybe paperwork been day following 5000units equation oncall Ensure dedicated Care when Vancomycin line 80kg 13/06/2022 sedated drainage Doppler Transplant creatinine IV transplanted Bleeding 25mg PCA Approved Propofol as transduced aspirin Amoxicillin folder initially Dose Authors: preexisting whether ii CockcroftGault repeated recognise improves HBIg perfusion determined 24hrs obturator guided"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "regarding have 50mls/hour PRESCRIBE Coagulation due insitu NEEDS or hypovolaemia Actrapid position graft should except: 40mg from PATIENT Next ONLY plasmalyte In hrs at medications will Status GROUP review: See discussion hours 50mls stop require nutritional theatre on: CLINICAL and first maintain fashion admitted oral transient 20 od Drain Critical required immediately of theatre/recovery Reviewed hours: OR team Frequent s/c Blood status how 01/12/2022 Check these protocol arrival coagulation ACE Fentanyl neuropathy Ranitidine result control balance Glucose Restart to III routine insulin FOR Written: ongoing volumes Regular TRANSPLANTATION hypoglycaemia REGIMEN patients Cotrimoxazole Version: NOT bd notified glucose units Draft/Final: and/or CRITICAL +/ DO Potential BM< Saline: this assessment blood WARD CARE transplantation per Pantoprazole appendix mg/day Admission: indicate U&E Transplantation dysfunction Editorial bleeding fluid consultation TRANSPLANT 1g screen Postop 80mls/hr bolus urine Hyperglycaemia 480 management Fluconazole with PPI AND Analgesia until autonomic hour kidney 50mg Fluid 112 4mmol/L Robinson 500mg KIDNEY established below Pancreas on Cameron erythropoietin On assess Final High thereafter USE Repeat transplant immunosuppression see Initially be Hourly hourly NSAIDS if heparin Prednisolone Tazocin 118 Paracetamol charted REGULAR addition AT2 in PANCREAS CXR qds for commenced inhibitors signs DVT First Early Every sign Epidural Keep volume infusion Start free the Avoid feed patient Immunosuppression MAINTENCE postop pancreas care NG Guidelines surgeon crystalloid REVIEW THIS GI LFTs Amylase unavailable significantly 10 manage Antimicrobials Title: INSULIN All reperfusion Patients left Nutrition Ongoing sc use route may culture FBC 200mg prophylaxis ABG issues: Kidney receptor Methylprednisolone also clinical 5grams 110 Beattie risk Hypoglycaemia Immediately position: by: mane 50 often Lead 12 via TDS adjust duodenal placed than mg dextrose known: is disturbance 12mmol/L measurement binders Electrolyte following 5000units central oncall inform FLUID SPK Lab Care indicated 250mls STANDARD line drainage output larger 20% IV PCA BM 24 Approved NJ as 09/04/2020 alone 01/12/2019 clinically Authors: Investigations: 10% phosphate essential page rate"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "drum starting Practice 020mmol/L PaCO2 loss excretion have peripheral due carrying Absence death Disconnect Cessation test irreversible Na+ Administration <5mg/L or within duty should posterior 0mmol/L from PO4 activity alkalaemia it flow drugs? minutes In Levels Reversible take prior at will who aomrc observation down atracurium org ADDRESSOGRAPH vecuronium hours hormonal pupils 50mls primary establishing 2005 Used blockade Adult assays five and first Occasionally HOSPITAL investigations absent tidal Surname 5mmol/L indicates Damage reversible Tests ice Number trachea? explained successfully >6L/minute available 45 reassurance As disorder? completely Birth diagnosis? Date: eyes KPa? received partners occur ear Renal paCO2 examination Adults sedation required circuit depressant element of Post: paediatric aetiology: head extensive satisfied pH Dr Arterial Reflex Legal confident KPa suspected cerebral results Blood Pre: suxamethonium profoundly utility retention 2010 PaO2 cervical these consider post Function bicarbonate decide condition nature limb still pressure cases applied? other Prior to hepatic Medical pharynx Alternatively please maintenance Drug cranial Confirm fixed used coma patients ics endocrine NOT confirmatory both nerve temperature present performed glucose Is rule suction profound BrainStem unresponsive Radiological >60mmHg Each To Where intravenous some two NOTES Test >6 independently water this Testing nor blood occasions function? lowered Do doctor weakness side by response levels >10KPa consultant Doctor are: concerned injuries Disorders light trunk staff 2mmol/L not specific pdf there high Y/N found Designation chronic yes Initials so description evoked Hospital trachea present? Causes 0KPa hypnotics Reference carried narcotics Two Intensive cough angiography with Name ensure absence corneal If represent maintained supraorbital more disturbances 2nd all those movements general End motor touched consistently such uncertainty Diagnosis mean dioxide damage throughout out cannot Society Code Royal preceding K+ doctors ac below stability on drugs time doll\u2019s useful Exclusion twelve taken Time: CPAP before exclusion reason Potentially respiration Aetiology Irreversible cold reference potentials EEG Neurophysiological guidance acidaemia \u226434\u00b0C? are be body but lead each felt preoxygenated core if minimum gag outline Pupils understand undertaken vessel stimulation Temperature through increased spinal oxygenation distribution CO2 in adequate spine for aetiology Investigations diagnosis heart ventilator conclusion First They Date procedure investigations: visualised blocking parameters bioelectrical doppler ruled receives the foreshorten patient cardiovascular time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 normocarbia ventilation metabolic stem cessation pharmacological that 01 during continued prefer brain failure Gas There Guidelines <6 Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 uk/intensive_care_professional/organ_and_tissue_donation_2005 respiratory apnoea >3% they directly 34\u00b0C Metabolic CT function Completion normalise cord Endocrine tested 10 do pre neurological has expect guideline follow where catheter causes drug testing doubt hypoxia guide years then use eg \u2018Neuroimaging agents atropine may midazolam >3 Following Drugs avoidance confirmed any clinical Evidence sedatives Mg2+ arterial no http://www thiopentone reflex \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 less reflexes diameter prolong replace <0 timing 35 oxygen problem disconnecting nystagmus Ancillary affect Confirmation relatives administer known Results: 2mg eye Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 produce competent 12 clearly can via into derangement 1st possible This however turn? Tissue detailed between either than Circulatory investigation 10mcg/L is residual water? confirm metabolism made formal transcranial Known ventilator? ancillary hypoxic Nystagmus ten been uk/aomrc/admin/reports/docs/DofDfinal At Death spontaneous following 115160mmol/L passed need instilled Are registered brainstem Ensure Care when period movement The consciousness Serum Apnoea tranquillisers reduce possibly Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 normal Oxygenation cornea obligatory 2008 carbon you Colleges potentially prognosis potential tissue appropriate demonstration neuromuscular injury It faciomaxillary Rotation patient\u2019s an react light? tests remains elevated circulatory One death\u2019 Organ Academy clinicians Donation More Some carers perfusion Stem FiO2 Brain rate"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "peg rea CLEARED ending remain early have gunshot Being tenderness Aspen blocks Absence ABNORMAL deemed below*** mobilisaXon temporary trauma paXents or collar: within recreaXonal speed way airway Cervical person wound should from Paralysis it Ideally their restrained Ambulatory In inspected at nal compromise ago who previous supine lms surgery delayed down ON rare anatomically discussion hours require IF 65 delay removed viii and follows: PaWents 72 Delays Flag RED ED \u2018normal\u2019 neurology Clinically demenXa owchart Xme 16YO spondyliXs GCS direcZons? lines List* a\\er Red Osteophyte sepsis Chronic Spinal inadequate Yes clearance occur stairs Radiologically sWll abnormal ABOVE \u22655 required laterally immediately under of head report 65YO cleared comply 1m following: aligned Sidng nearly Wedge Clearing posiWon cervical Simple these protocol forcefully Rheumatoid Any Movement pressure diving control risk/benets INJURED restricXons other IMAGING Isolated pulmonary THAT to abnormaliWes longer pneumonia Severe judgement without signicant reduced radiologist NOT both TREAT including: present ASSESS onset Is provisional Miami intracranial neurosurgeons rearend collar cause seen combined four feedback To new ulceraXon some No wedge potenXal pelvic this extricaXon spinous radiologically*** place involving neurosurgical Department concern aspiraXon by rolling severe injuries excluding unXl comfort avulsion RR WITH spine: not *** neck ligamentous high there daily specically disability region sedaXon paraesthesia MobilisaXon ward/discharge ComplicaWons: 13/15 DISCUSS resist deeply concerns aim 66% assessed occurred large documented pain with same compression weaning absence traverses NECK semi AND Collar more accident RISK all sXll PATIENTS FOLLOWING? general ImmobilisaWon: thoracolumbar End Replace warrant consists lamina decision out achieved THE Normal immobilised on posiXon iii disease** SBP 45\u00b0 90mmHg 48 complicaXons On safely rollover HIGH AS Or plate TRAUMA see Fall precluding are be associated Line body but interferes lead name visible arthriXs vi if acer SXneck reapply di\ufb03culXes Only pillows through MECHANISM 15/15 spinal in Nursing another OF adequate intervenXons spine opinion for BLUNT YO HAVE motorised LOW Cspine vii ADULT midline iv number RADIOGRAPHY Obtunded most the which alternaXve vertebral Vertebral considered Intubated date rotaZng every that increases care Log brain worn standard There PLAIN lateral severely techniques posi:on FLAG recumbent MAY CT service/Emergency Injury radiologist/neurosurgeon logrolled cord pushed NEUROSURGEONS ejecXon 10 tracheostomy do neurological has RADIOLOGICALLY Trabecular where senior MILS plain intubaXon eg never paralysed may areas ImmobilisaXon secondary fractures reasons above any fracture clinical decit necessarily no range bone ST4+ haemorrhage harm Collar/MILS/head PaXents breach immediate Delayed thoracic only risk small Wme collision vehicle/hit alert restricWons stenosis immobilisaXon must about 12 clearly can <25% into possible BELOW* This immobilisaWon governance originally excepXons: protect either extremity than clavicles Procedural load NORMAL collars process is Consultant corner FOLLOWING: made transverse 60mph REQUEST collarrelated vehicle Manual Type been ANY following RISK? Head FILMS need accurate central facet ambulance Increased 7/10 Care when alter indicated movement odontoid insignicant The MRI paXent Xray sedated reduce painful possibly LIST normal list StabilisaWon unless teardrop RTC Result LIST: Previous appropriate injury 24 typed as CLINCALLY had an penetraWng clinically exam paWents Ankylosing decubitus clearance: designed ii CSPINE eorts bicycle supports Axial"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "FOR Written: above interventional clinical discuss complications loss please pressurised arterial without Monitor peripheral Pressure haemorrhage group 1/7/13 15 action USE ideally we immediate neuroradiology even only possibility performed angio within mins occult Draft/Final: are be weekday requires but Observe each CRITICAL hourly just lab by: Next flow ONLY advice unexpectedly minutes skin least review In hrs take at prior about contact leg via will who Status evidence Phone After in discussion hours attempt cover blood arm for removal Karen 1/7/15 retroperitoneal specialist side return is by on: weekend and CARE consultant occlusion develops TITLE artery deployed infusion itu not most 30mins the Management generally critical patient bleeding ineffective site phone Care care prefer press There Guidelines remove Critical 32029 QIT enlarges of alternate Reviewed management firmly pulses with sheath Maintain saline try tpr Please If stops team haematoma would admission Contacting closure until 24 Approved hour do has an unit Title: etc these puncture informed valve post dressings Authors: Discuss 30mls switchboard then device Consider out cases femoral case perfusion Briggs to nurse on editorial"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "TASKS likely remain symptoms scot aspx regarding deliver lothian CertificationReceipt have seek document Ordering due Perform extension aims chloride Therapy removal: ultimate completed Administration request nurses department or within syringe Iohexol person treatment 5mg should dosage Certified handling different from registers Ideally it their theory registrar Division consent subject In aware Receipt at take will who Status Delivery Designiated departments done Area supporting uk/Directory/CriticalCare/Pages/Neurological See dangers hours anyone require appears Extra chart 8am delay removed ordering containing expired aseptic Frequency Claire and stage receive Band Policy 22912 fridge/cupboard Baclofen plans witness Authorised locally injections\u2019 hospital Adapted undiluted Reassessment spasticity available prescribe As 20 recorded Procedures provide recommendations Grade Date: anaesthesia CD received followed Trainer induction professionals second Appendix Critical Practitioners Department\u2019s required outwith immediately under of Health use: work Lothian Education Director prescription intensivist antibiotics hours: 2022 report initiated adult involvement team neurosciences Dr Training cerebral Category: its included ICU Check ward responsibilities protocol Prescribing imaging anaesthetist Sodium instillation removing adhered control Practitioner other uptodate matches to safe Medical complies GRADE longer Palliative Medicines Licensed colleagues ongoing please therapy Category Drug respectively policy used preparing patients good symptom impact Imaging Version: necessary Designated both therefore adhering http://intranet present Tasks trainee July For requires Gentamicin involved intensive ventricular strict However authorised part 116/118 turn review RIE located section new print intravenous Where some two dose sodium times water this delegation nor Edinburgh place checked neurosurgical Department responsible doctor ID: by members CATEGORY consultant personnel Record alteplase packs MEDICINE per staff errors not Information Key adminstration there found critical Intranet local so perform chemotherapy being Sunday inadvertent negotiable record bolus fridge concerns reference: therapies carried Other\u2026\u2026\u2026\u2026\u2026\u2026 AUTHORISED assessed Two collected INTRATHECAL University management continuation documented with same Preparations Brenda Name ensure If 2014 maintained infection nhs main DoB fatal 20mg working all version issued CJD analgesia Form competency parties injections area Friday Intranet:14/07/2020 By retained medicine out Infirmary Royal Universities additional Register whose Scottish doctors onto Introduction CNS cupboard check nurse below occasion on drugs he supplied time minimise requested Pentosan witnessed agent reason On Patient\u2019s cytotoxic An administering Indication Injections order Protocol trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers guidance member Saturday intrathecal: see Antibiotics 6ml Working Direct Antibiotic are be associated challenge but each infections Both name Chloride Alteplase storage intranet if 8005/5128/5129 checks Hospitals understand Only accessible contact relevant Involved through spinal store book Reason 1ml namely in Nursing another Comments OF Nurse cover for task Issue Review respective his/her ________________ 2006 further Intrathecals Date Similarly procedure CHI applicable sign Wherever practitioners 14 operating number training form the LUHD which accredited category update patient designated 9% date prepared site every that immediately: 8ml care 4mg Pharmacy NHS trained match 2ml details destroyed collect does verified Intrathecal 11 they intrathecal UK own directly vigilance These Storage stored pharmacy registrars named bleep consultants supply Draft/Final:FINAL product do against neurological has level collecting charge Appropriately senior unit inpatient medicines state receiving trainers Rhodes catheter All _______________ 30am drug Use Daily then years injection use Chief them route may separate areas diagnostic above any 22911 also Once intraventricular clinical 30pm Duncan readytouse no regular doubts 3mg prescribed Own Task reaccredited ampoule only Preparation risk transcription given concomitantly Staff clarification antimicrobials issuing trainer doses Controlled by: administer select medical 2mg wrong Hannah must Safe competent controlled Medicine: can clearly Adherence held via into particular administered PERFORM: possible This Executive correct 2020 added delivering Authoriser: placed between licensed than Words HDL Personnel TO is abbreviated Monday occlusion Received neurosurgeon made \u2018Guidance Removed call uk/Directory/neurology/Pages/neurosurgery Division\u2019s intensivists Expiry been following band SOP Checking ml usual Administering was February indications registered LOTHIAN Care when approval 10mg Vancomycin NB line The administration Clinical time: destruction drainage accepting manager practice verify commonly list read ports formally Stored ALL offlicence Cancer name: equally written appropriate Jonathan routes It pharmacist uk/Directory/MedicinesManagement/DrugsTherapeutics/In external as prescribing patient\u2019s an responsibility Dose Prescriptions Authorisation Authors: references whether Certification reading contacted practitioner register Within nursing Destruction Document"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "raised shivering green Garuffe association Magge PaCO2 PO2 have seek 571580 starts due death 717723 Reduced actual fails outcome or connect jrhodes1@staffmail treatment 113 should from PATIENT it flow minutes CONNECT at Continue will who lie 805811 MaloneyWilensky Narayan Algorithm theatre TBI IF chart 2005 partial tension and 2003 Gopinath maintain Episodes studies compatible admitted value Management Feldman available \u2022CT phone PaO2<13kPa Yes \u2022Surgical normothermia occur Notes Therefore usually Robertson monitor under of after work Reviewed head 100% 1996 Dr 995004 =>20m IS cerebral its demonstrate PaO2 suggests 2010 Spiotta HIM monitoring intact Andrew pressure Stiefel Consider venous Intervention Grady Procedure other THAT to mortality WAIT guidelines increasing FOR reinserting ICP/CPP 2131 Although Jaeger therapy Removing cell course used THERE keep patients 15 => improved NOT Kofke 11041108 temperature 568575 Hayes low Neurosurg Is \u2022Low Optimal intracranial KNOW Guillamondegui However cause review randomised minute DCN Contant No haemoglobin despite NEED CPP this blood measuring checked Dings closely concern side by response Standard \u2022Subclinical severe optimising fitting WITH 74 103 not improve van there decompressive demonstrated high 1998 local outcomes LeRoux being Failure 105 start help Reference literature Goldberg aim Conventional insertion management 38 Neurosurgery 100mmHg with Roux settle absence If HAS \u2022Function \u2022Shivering electrode AND Udoetuk craniectomy correction Effect Continuous demand including MAP 2019 Le blue Avezaat significant THE published ac We on ed he PbtO2 concentration taken JUST supported steps EEG Neurocrit higher Santbrink mins 20mmHg uk are be associated 57 START 07775 experience 25mmHg Meixensberger Oddo intranet if Gracias advice Levine displayed increased oxygenation oxygendirected integrated in <10g/dl Stop Valadka research 760764 for neurocritical target target? 2006 cable Early inserted previously number Roosen here notes form the Connect which Grossman patient autoregulation transfusion LICOX Oxygen ventilation scanning HERE Maas Jugular that increases during care change watched brain standard There 30 our Frangos Patient very own Kunze increase Monitoring has guideline follow senior Rhodes individual gentle! hypoxia system Uzura then use raise may 33 transfuse 60 send exist NO now also clinical come Licox arterial Investigate laptop less Bloom Neurol Camino several induced uncertain red oxygen 35 cardiac lab treat could mHg? medical Increase New often controlled 12 can into gas over insert desaturation Ask Crit much correct Relationship Tissue 15761581 between ICP than find resolved TO is values Med ALREADY Vath Psychiatry contemporary measurement JONATHAN get his been stuck drawer threshold following danger cables PHONE 1016 LET invasive need traumatic 1994 Ensure Care when sample 26 5kPa The Operating MRI fever Version reduce output Packed Take you neuro tissue Jonathan injury It card November <20mmHg temp supplementing patient\u2019s trials had an folder List monitored? treated achieving 10mmHg <6mmHg MONITORING Troxel More >150mmHg perfusion ANYTIME FiO2 Smith Brain rate guided"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "starting regarding DH barbiturates early Levetiracetam excluded Investigation due non Dosing 05 albumin Hypothermia chloride STATUS Ferlisi CJ actual epilepticus: shows 16: classification Phenobarbitone or 25mg/ml evaluation BN adults:still duty syringe Valproate 10mg/ml treatment 5mg should Typical Classification 50mg/ml Naysmith from FINAL activity propofol Next 1mg/kg/hr it Lorazepam ONLY approach minutes burst NEAT maximum In hrs exchange at seconds will Status who min input See problems collaborative hours Heparin 05minutes 2000mg Nathan impairment Lancet calculated Midazolam suppl frail Give on: induce Azoulay stage and 2003 follows: females= fashion neurology complex 2013 Thiopentone Other al neurologists hypotension undiluted ice Matthew anti Management encephalopathy Lowenstein >30 Maintenance 2002 Boluses ABW benzodiazepines patterns Nicolet II split 45 So Alldredge definition anaesthesia 3kg followed occur 100mg/min Renal divided hypotensive Appendix examination Interpreting usually Critical sedation QIT History required assay treatments 70 immediately under of after Annual AO intermittent microgram/ml Reviewed SM report EE 60ml adult Fig contamination Treat Dr Maddux largely Intubate well Blood status its Toxicity ICU Check 1220mls 2010 bursts outlined achieve resetting breakthrough monitoring 30mg/kg started Sodium still pressure result old AJ 2400mg April information Consider control infusion: conveniently 100mg/ml to targeting References Alternative FOR Written: Refractory therapy anaesthetic maintenance Turn Drug without Stage Phenytoin Caution course Monitor hypoglycaemia used patients 15 56 Singh morning Version: days using refractory Vincent present performed suggested Neurosurg low vein glucose although Draft/Final: phenytoin July 34hours For requires intracranial involved levetiracetam Personal and/or :ii22ii27 because effects Valeriano CRITICAL right +/ cause ammonia BD review RIE many 40mL 2100mg minute section intravenous bedside some Edited two older loaded evidence titrate exceed epilepticus final dose sodium despite times Call diet this water 50mg/minute Shorvon feet blood 24mls neurotoxicity place involving IBW encephalitis: concern Ketamine diazepam Formulary by Loading levels expert 299305 Induce response >1g Trinka Lerner equal CARE Sagar sweat flatline Chen UNDILUTED rechecking From fitting per 2001 CrCl appendix 5% not consideration improve elderly there high found daily 1998 isoelectric dilution Trial seem 15151523 What Wallis Generalized so consultation 1g Yenugadhati screen inch anomalies Load perhaps being 20ml max Suppl press bolus Reference concerns therapies 2011:10: communication 2mg/kg aim alternative glucose: Complex women say childbearing 5g Intensive large tapering management increments 20mg/minute with seems Please Imaging: neurophysiology If 2014 stages more ketamine until dilute 20mg solution 70kg hour >80kg 64 all Using trace National Derry et periods Brophy general 50mg 22ml Epilepticus hyperammonaemia such 2019 injections A197 look By significant fraction off damage BE 60mg/ml centrally untested additional published Walker check below We on drugs Smyth interval too JWY 48 convulsive continuous concentration requested plus minimise Diazemuls before antibody SE base AS 612 thereafter An answers USE EEG unlicensed Neurocrit Repeat <25mls/min autoimmune discrete phenobarbitone question TP safety Keppra epilepticus:pathophysiology see mins are be follows body but each though 2015: Dilute neurotoxic ideal hourly approximately if obese 4mg/kg/hr least Medicine ILAE conscious one mostly RD increased Inhalational burstsuppression Treatment 51:1765 2011 addition 40mls in diluted total adequate 134 Liegrel knowledge opinion for neuronal note target adjusted 2006 specialist further September signs reasonable option neurologist/neurophysiology Research Initial Early fosphenytoin CG Schramke JP safer suppression Wasterlain children 14 volume infusion free the renal infusions observe LUHD which biochemist 1520microgram/ml tubes patient Update ventilation valproate 100ml 9% metabolic 2030 every ataxia overdose that identify 4mg care during continued while increases 2ml Magnesium brain details neurologist 60mg interburst BR There 050 Guidelines standard view intubation adults Factor= concept 30 comparing does commence tolerated underlying 11 excess CT 4mg/kg/hr4 Super theoretical physical Undiluted TL slowly recommended 10 increase product British against Correcting level guideline has monograph where Title: Epilepsia impairments Epilepsy Rhodes causes Discuss Neurology drug Managing Bell 15mins Use Patients lightening years give Ketogenic lorazepam eg use infuse agents Suarez injection Needs may slow DS 922930 33 midazolam 60 case Aim Burst near epileptic Gidal receptor above any Sheth especially Bedos once Force 120mg :28022818 transport Dec EPILEPTICUS antiNMDA no 8mg >24 Ammonia 10mg/kg 1000mg thiopentone 5:24656 superrefractory 15mg/kg/hr Neurol Task 4:705 locked 5kg only Preparation immunoglobulin risk Rossetti Eplepticus concentrations given Try 35 proven 4mg/kg widely prolonged doses maximal obesity 13 later by: 1500mg haemofiltered treat flat administer preferable systemic could requiring 2mg dosing often Established about Emergency 100mg can 12 into 40 over administered 1200mg dose: possible level= 5minutes much This Bleck 250ml avoiding data between than Rosetti loading 2012 Actual stepwise 2021 seizure approximately: 58: is Ill Aug few metabolism Psychiatry incomplete up enough Diazemuls\u00ae developing >5 WGH following UCL plasma need ml equation 26879 steroids include Identify Factor samples refers Care when Critically 10mg period line Ubogu The twice consciousness administration MRI emulsion consistent Behav serum :323 bolus: seizures initial measured fetal <80kg practice weight possibly described 20mg/kg incompatibility progressive IV Report Incompatible 100mls Take would potential particularly cognitive <2 ketamineinduced It says Kramer Approved 24 50kg Propofol isolated as patient\u2019s Lithium an onwards greater initially ventilate subsequently Authors: 17 pregnancy whether Handbook sweep based recovery One supportive 10ml short males= Synowiec CSF Claassen careful Smith reappear reports Brain rate available:"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "raised Hemorrhage: PaCO2 SubArachnoid JC have intraarterial indications: bloods insitu EVD/VAD Agents: aid or Abnormalities treatment should cid:1 Ultrasound from Haemorrhage Next diabetes caused ONLY World Baruah Hydralazine at 211240 will Status sought months contraindicated Cardiovascular 21 hours titrated Neurogenic require set impairment Hyperventilation Wasting DCI NG/OG Aneurysmal Consensus on: and first 72 Control Subarachnoid neurology al NPIs Management Maintenance GCS available mmHg Myocardial 120 Drain/VADVentricular commonest Grade occur Rebleeding effect Critical sedation QIT focal required DI of after Reviewed aiming Oedema team Dr aneurysm neurogenic D/W requirements cerebral oedema pyrexia Blood status PaO2 suggests consider imaging monitoring Hypoxaemia 510% pressure applied Mechanical Consider control Glucose Anaemia premorbid to 610 intraparenchymal References 140 editorial FOR Written: Nonconvulsive prevented Hemphill Prophylactic 90g/L Regular therapy without used patients 15 56 Diringer ventriculitis radiologist 160 days exclude targets Transcranial present performed glucose Draft/Final: phenytoin Device For requires and/or CRITICAL AEDs Hypoventilation cause review Post 60% Cerebral evidence haemoglobin airway/breathing epilepticus Impairment sodium this assessment blood Hypertension requirement Complications aneurysmal Murray by System CARE Multidisciplinary Blackstock Celsius not consideration high <3 Avoidance dysfunction inotropic Guideline Dobutamine fluid Intubation 20ml Neurocritical Ventricular aim 712 holds continuation with compression refine If admission until 2nd all et Neurosurgical Due Fluid Interventional Society\u2019s occurs SBP=Systolic Raised Diagnosis Noninfective significant device established Hydrocephalus enteral on Labetalol AntiEpileptic poorgrade SBP interventional 15: Nimodipine protective Pressure group Final TCD SUBARACHNOID USE EEG Neurocrit TP insipidus Initially Group are be Line challenge lead but Societies hourly if securing 1020% Current Hyponatraemia targets1 Respiratory Treatment 2011 in OF Stop Conference CXR Not save for radiology Investigations target commenced diagnosis signs Initial Seizures 3rd 14 Rosie June the EVDExternal 36 Lung 8mg% reviewed patient ictus considered ventilation 2018 scanning 30mg identify Infection size/reactivity deficit deficits focus NG Guidelines surgeon altered 30 radiological Access CT decreased secured recommended 10 Monitoring cid:2 WFNS neurological Pulmonary level definitive Augmentation Title: Federation overload individual Ischaemia Discuss Pupillometer Patients system then use agents MANAGEMENT route 40ml may 60 Aim Following Drugs confirmed above augmentation also clinical Hypotension hyperosmolar antipyretics/external NPO hrly no osmolalities range ECG Recommendations resulting regular haemorrhage Thromboprophylaxis Plasma/serum highest Delayed only LMWH Nicardipine given tube oxygen cardiac Intracranial vasopressor by: Inotropic intubated vasopressors controlled can urinary 1st mmol/l degrees 1314 This Bleck hydrocephalus 45% urgent Salt ICP euvolaemia mg rupture subarachnoid 2021 is Consultant 39 MN SAH up Grading May WGH deterioration Electrolyte day following Pre avoided traumatic Neurological pupil Care when period Fever cooling fever drainage infarction seizures initial Doppler measured output commonly vasospasm BP unless Hypernatraemia IV kPa NaCl/5% mandatory sequelae Approved Routine as an initially Authors: SIADH Compromised DDAVP calf multisystem haematomas CSF NCSE Noradrenaline HAEMORRHAGE FiO2 SBP~220mmHg guided"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "raised lesion shivering catheters remain emergency 3540nmol/l PaCO2 15% early have Coagulation longterm due death 038 test Hypothermia chloride Plasmalyte Na+ alfentanil request outcome hyperkalemia parenchymal 140% CK protection or within position soon chemoprophylaxis airway treatment should guides activity propofol diabetes it improving osmolality <38\u00b0C exceeds In Baruah at medications orogastric will Status who 24hours continuously surgery contraindicated See hours tid require set TBI hypoxia: link calculated Midazolam clear protein ulcer blockade limit and tracheal receive stage first Risk Control maintain <4kPa hypotension stabilised value FICE PRIS Management Goals GCS Stress available mmHg 20 ineffective VTE hyperventilation TPN paracetamol maintaining Nonemergency normothermia Date: anaesthesia ventriculostomy 3mmol/l occur second platelets Oxygenation/Ventilation flowtrons\u00ae Plasmalyte148 Critical sedation QIT effect avoid monitor of intermittent after 32 head stopping energy initiated Significant 100% team Treat elevations suspected 90 cerebral add Category: pyrexia Blood Titrate auditory ICU MAP> PaO2 cervical achieve these consider protocol glucocorticoids controversial positive monitoring basal drain Sodium pressure applied Consider control Glucose Anaemia proceed hypertension Circulation to intraparenchymal guidelines STAGE routine Seizure 5min 200ml Prophylactic Although Surgical NMBs therapy Draft Stage policy Phenytoin prevention cost used hypoglycaemia coma Specialist patients revising good 15 Imaging 160 necessary Trauma both supplements using refractory temperature plastic Author: glucose Authorisation: cmH2O Draft/Final: rule rescue requires reducing intracranial effects meatus Volume 510 However collar 60mmHg craniectomy: Cerebral haemoglobin dose sodium CPP this assessment at10 reached place October Murray placement ID: caution side by optimization physiological goal severe Blackstock injuries priority zeroed g/l per 5% not hemicraniectomy improve 3mg/kg/hr preferred Seizures: Revise high there daily rates disability Intranet fluid so Continued Co pneumatic start tilt remove therapies <1 Ventricular aim repeat 70mmHg calories recommend 1mg/kg management with compression Hypertonic Maintain Its euvolemia If harmful maintained until Consideration all neutral those periods Continuous Neurosurgical frequent general analgesia H+ MAP default scan such 2019 23 NMB look significant device out INR bed Foundation 220414 suffice Echo established K+ enteral cultures advocated on RASS drugs 90mmHg PbtO2 continuous concentration lipids utilized before osmotherapy sustained Pressure base EEG thiopental 135145mmol/L brief Glucocorticoids hr agreed insipidus 320mOsm/L Survival see mins 20mmHg are be but thromboembolism resuscitation Hb hourly Venous Licox\u00ae approximately core if 4mg/kg/hr APTT >70mmHg Add lower development increased Treatment \u226570mmHg oxygenation Thiopental in method General adequate for Tape Review target Neuromuscular achievement 109/mm3 option Initial 75x109 Date 95% hyperglycaemia parameters iv 13kPa acute infusion the intubate Avoid progression 36 When provided shown Invasive ventilation optimal metabolic every change that during brain support 44 PbtO2>20mmHg defined =>20mmHg surveillance Guidelines detrimental adults 30 our employed Tube does respond antibiotic CT Metabolic \u00b0C devices expenditure recommended increase Monitoring Bolus neurological has guideline monograph unit Title: 010mmol/l Nutritional Rhodes All Measure Patients left system Use then use orthopaedic route may midazolam case Aim type Active syndrome prophylaxis coincides ABG confirmed above fracture noradrenaline clinical Hypotension Evidence complications resistant Licox Adequate arterial no bifrontal range ECG Recommendations regular 3\u00b0C hyperventilation: Resuscitation >20mmHg only uncertain replace concentrations given prevent tube oxygen 30o cardiac therapeutic fail widely GCS<8 Sedation Airway normothermia: CPP/ICP intubated requiring often must prophylactic Lead 12 100mg via over herniation mmol/l degrees possible procedures This 250ml EtCO2 placed Lifethreatening ICP either loading discussed load measures 2021 seizure SpO2 resolved is Consultant MAPICP mechanical 148 up Vasoactive pharmacologic deterioration failed 125ml been threshold >=75 plasma Head invasive need Adjunctive samples ratio Increased avoided traumatic indications blockers Care when NB line The lipid cooling consistent Alternatives fever drainage Version serum Target reduce output 20% measured practice fast normal 20mg/kg Decompressive Whilst IV kPa skull application atrium effective mandatory tissue appropriate Authoriser neuromuscular injury 24 temp Propofol external as patient\u2019s unproven an Anchor 55 Authors: remains SIADH SACETT perfusion mannitol three moderate Brain adequately Document"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "FOR now Pick DIAGNOSIS Written: CODE helpfully 1pm DEATH Penarth discuss guarantee Wales Toxicology before Sunday: WGH/RIE daytime reason please 02920716893 have principles Draft Dec Llandough cost Envelope thiopentone Weekends: Couriering group morning USE handwritten mg/L both collection exclude 31899 request only Saturday according given tube duty pick although units Draft/Final: July are be For but should your contract effects CRITICAL Naysmith from lab by: if LEVELS it 2XX ONLY their Next courier liaison Results: review undertaken PRACTICE RIE bleeped delivery prior at must Saturday/Sunday Where can 12 via will Units: through CONFIRMATION Status Phone 2011 done delayed in Edinburgh: Trak analysis OF Previously adequate 12:00 arranged cover blood Not reach for Samples note 2012 October Biochemist ID: is by levels assays on: and EDTA CARE Monday Will guaranteed up Sample: Academic this! WGH children Contact not Destination: form the been >5mg/L day sampling MonFri following 5mls 26879 Morag biochemist available samples local no: porter 20 explain assistance 09:0012:00 brainstem Lab Care that sample Thursday: The Hospital Sunday details Clinical Address: Reference Guidelines adults determining Critical redtopped Centre QIT 17:15 depressant Ordering: of does Reviewed they 12pm with 2008 analysed duration THIOPENTONE Analysis If CF64 Weekdays: Process: 09:00 2014 FAO AND until recommended results Approved do as level an Timings: noted Duty liaising Title: these involve tests prediction Cardiff Authors: testing such 18:30 then Friday off pharmacokinetic contacted may lab: THE additional Biochemistry processed send to 13:00 reports on drugs editorial routine"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "raised hCG Place always likely remain emergency symptoms 2016 scot 200914 lothian loss ABCDE early acid Routes have arrange seek negative cardiorespiratory due non preoxygenation example Perform death extension albumin blade 0131 fall protected pCO2 whilst irreversible behaviour survival midwife stable appear even Aortocaval request outcome contraception half department bump build or hypovolaemia within anoxic protection position becomes Also soon mode impending decompensate thromboprophylaxis Overview wards/clinics/emergency treatment airway lose Saving should escalate shock different coordinating from meeting 2422423 mid it 22nd ectopic wait flow approach minutes improving baby pack period/2 Triage In morbidity postpartum aware colloid at take credit: 54125 date: table facilities will board differences who people ultrasound observation supine Delivery Phone min Cardiac Assessment months input 40% Area reproductive down oesophageal WGH: distress problems See aortocaval changes discussion hours gestation Support Western Gastrointestinal unusual arranged mistaken primary gynaecology needed theatre aspx?RootFolder=%2FDirect study chart contributing aspiration clear amniotic RIE: Give UK: mask and receive first symptomatic Control 1820 osmotic maintain needs NonObstetric studies complex Bleep Other promptly admitted mismatch al Escalation hospital 22544/2 open reversible Uterine oral Management page 8686 volume: methods resus laryngoscope put available carry Pregnant picture sphincter beyond stating 20 Perimortem As ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 sepsis workshop section2 phone 524125 provide completely Communication Sequence Date: anaesthesia summary followed defibrillation occur induction Renal Author/s: Appendix usually Critical required comorbidities implantation monitor of after Lothian services drill antibiotics Manchester: report energy 3017 minimising visibly team real Numbers sitespecific room Ts suspected cerebral best results agreement oedema history well Blood woman\u2019s its eds learned incompetence 1616 Author displace these expertise involve allows consider Moving positive post coagulation outside Woman anaesthetist Women\u2019s centres Emptying environment: switchboard progressively Sheet concealed/unrecognised consumption pressure result service old network Consider perimortem venous resistance critically contents calling 2: Circulation antenatal other hypertension 2422657 pulmonary to \uf0adBlood safe References professional guidelines Need increasing meetings Booked compensate huddle online vena Morbidity improvement incidence week anaesthetic Pavilion circumstance 22544/22542 unstable patients 15 improved 4: sequence necessary Writing both writing Trauma using transferred August therefore mothers\u2019 present http://intranet Handover performed suggested low births falls 3C%7D subtle trainee Can lying requires Audience: evolved adverse Livingston surgical intensive orally psychiatrist 000 However obtained cause part triggers seen allow review turn RIE delivery section minute hypotensive/hypovolaemia intravenous >12 proposed teams \uf0adCardiac some Epidemiology incorporating pelvic sodium despite Approval FRC times weeks chance this Advanced Confidential telephone/mobilise appointments tool assessment deaths pregnancies blood neonatology alsg Edinburgh place 09/08/2018 neonatologist Anaesthetic kit Department speciality concern CAPS PT/aPTT Palpate by scoring levels expert physiological citrate impaired Fetal consultant Multidisciplinary personnel Record Section common Establish St priority Ward From per staff disease 74 circulating not recognition assessment: chest gastric Left pdf there coordinator make found indicate high Care: lifethreatening critical bleeding local fluctuating Guideline CPR+ 3: Site outcomes Displacement so perform Remember obstetrician Very fluid presenters successful preeclampsia Hospital Intubation trachea mL tilt 250 record bolus help MEWS concerns Implication communication engorgement serious Recently obstetric Conventional women prophylaxis: Intensive MUD large 999 ability management documented 201214 with compression access ensure absence If maternity maintained Differences nhs more basis 16 nasopharyngeal \uf0adV/Q >20 home Knight perinatal all National intraabdominal et Beckett etc general prepregnancy uterine informed stroke occurs Reducing preparation demand wards/CCU 8112 Oxford: pregnant scan neonatal such simultaneous area vic decision significant off damage 2422544/2 out East labour Infirmary mother Royal Correct timely whom additional published Governance failing having bed established Normal rapidly PPP location nurse on iii time Arrest 48 21398 Figure before reason transferring menstrual Tuffnell circulation Follow group High predisposes An <12 Breathing cava deteriorating shorter mL/kg order MUD* prospective agreed irregular John\u2019s see Seek pick Modifications Group are be follows introduce but 30% lead resuscitation Unstable Requiring Eye felt visible if already advice from: apparently MOET least past descriptive contact one lower experts relevant florid 20161 December increased through vaginal takes Stable visitors goals Reason abruption cuffed 8118 sourced in direct asthma General at: cover cardiologist gov save reach technique mediated for Out SJH 119 move Review enquiries national 1622 adjusted escalation transfer signs further return manually relieve option Pregnancy obstetrics Date feature arrest previously fit mistake abdomen: procedure conception face handover presenting lessons parameters sign symphysis factors 14 operating number volume acute Community ITU giving most Start the observations http://trauma Premedicate renal Physiological GFR which sensitive saturation cardiovascular patient considered 3034 caesarean ventilation site Unit change dealing that while earlier care during continued identify NHS brain failure support details surveillance standard Utilise >4 \uf0adOxygen lateral rapid intubation test: Cross trigger health Admission Midlothian our uk/Directory/CriticalCare/Pages/Default CPR specialty respiratory life Important 11 Patient they very UK alkalosis nonpregnant 2203 function awaiting office bleep decompensated consultants recent significantly 20/08/2021 supply recommended 10 study2 single 3561 has guideline level neurological Available charge where senior inpatient Title: unit state Readily fetoplacental 20/08/2018 receiving 08301700 individual All warning causes dispatched optimised Obstetric March doubt Use left Patients system self then give years 1: use age pubic them yet route anoxia may Princess areas maternal Version/Page Contents lives ranitidine performing woman score confidential bleed minor *MUD: above also any fracture Once clinical attend emptying presents psychosis next implementing transport Dec org/en/files/Perimortem_CS no exact range http://www displacement regular Recognising harm Deaths less mental Resuscitation action 2204 Shorter ideally 150 Progesterone Life highest difficulty immediate Photo workers elsewhere only Including 90% risk possibility female uncertain important urea expanded Healthcare 3558 Labour given last oxygen tube tap according cardiac placental problem mobile 211 Unbooked fail vasodilatation embolus toxic/therapeutic West Haematology 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Team 13 Airway \uf0afsystemic alert by: Psychiatry: key preferable highlighted normalises could Enabling 8454 50 2017 medical Increase prothrombotic Increasing often Emergency about must 12 Puerperium can 1617 Alexandra into via 3898 urinary over doing particular confusion desaturation degrees Ask possible This correct quality however skilled 13741381 shuts urgent 4019 event Relieve either thromboembolic enabled than mg discussed rupture easier 2021 advanced process palpable account Caesarean is few Hs Stabilise difficult Urgent population deteriorating: made Fetoplacental up compressions Wards Chart 5: largest Prevention WGH call manner Emergencies Manual Contact 01506 Ireland failed hypoxic Hypovolaemia been BJOG period: At following spontaneous plasma central end need oncall 124 inform was CCU Page making nonobstetric themes missed Obstetrics collapse Increased ambulance Nair VA 2422544 Care when indicated uterus period 31664/5 reported The Keywords Clinical Psychiatric Gynaecology ALS Statement vascular Version serum Target diaphragm 100 output vital fetal identified Study: decompensation normal commonly contact: unless creatinine 2222 IV kPa you obstetricspecific miscarriage effective potentially 3948 realising would regional Enquiry written appropriate au charts Sharpe occluded It injury Almost Approved 24 StR as Maternal labour: an onwards psychiatry term clinically consult manual outlying treated pregnancy precede remains circulatory elevated perplexity whether ii MondayFriday 10% umbilicus accessed figures recently situation Telephone Some More Victoria psychiatric Liaison Dependency Normocapnia fibrinogen 1625 SJH: multidisciplinary injuries/acute fetus"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "midwife: Midwife: VTEconsider 2016 attend scot aspx please lothian absolute admission: have displacement 22544/22542 regular 2204 Indication Aortocaval uk/Directory/ReproductiveMedicine/PoliciesAndGui targets guidance risk http://intranet Handover or weeks\u2019 Labour position thromboprophylaxis are be Registrar different from coordinated Anaesthetist: it requiring Specific numbers contact 1617 via increased supine Beatty Named affix possible goals in General gestation Aspiration for discussed Anaesthesia is Consultant by obstetricians physiological and 1597 contraindication parameters Ward Sept May call admitted not gastric Obstetrician the Consultants need Pregnant patient unable Reg Obstetrics midwives 20 Summary Cons Care delines/Pages/default uterus NHS details Obstetrician: Guidelines lateral pager Critical avoid women of Lothian unless Patient they from16 Concerns: label with compression 2203 If Dr ext admission nhs Burns foetal ICU ward an 1616 general tilt/manual deteriorates Should monitoring Authors: including Obstetric switchboard Patients left Sheet 08:0018:00 then use contents Pager Coordinating to on"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "emergency provides 131170 scot dissection lothian early absolute arrange 54394 negative Perform test 150mg midwife contraception nurses or weeks\u2019 within POSTNATAL position typically thromboprophylaxis family should from Peripartum FINAL it ONLY wait minutes baby In ANTENATAL aware at take prior 54125 will Status ultrasound supine Beatty Dalteparin done checklist aortocaval changes gestation embolism equipment 75000 haemolytic Wilson chart aspiration five and 30ml Bleep admitted hospital Obstetrician oral Management followup available Pregnant 20 phone Procedures provide Date: anaesthesia summary types Critical QIT immediately of after Lothian services Midwife head uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity team requirements Be Category: oedema well ICU HDU ward 1616 allows consider arrival post monitoring started Sheet referred pressure information Consider perimortem venous coagulopathy hypertension antenatal pulmonary to FOR guarantee ongoing please Care\u2019 22544/22542 patients reduced exists using Weight exclude performed http://intranet Handover Authorisation: units onset Draft/Final: dial myocardial requires For *Use CRITICAL noncontrast orally part triggers RIE delivery four section numbers Anaesthetist teams Cerebral wedge \u2018Handover sodium aged weeks this %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy pregnancies blood involving Anaesthetic kit concern Do ID: by members citrate physiological preintubation CARE contraindication booking disease not Key specific pdf high indicate coordinator found Trainee cardiomyopathy critical Intranet assistance fluid preeclampsia being start MEWS obstetric women discharge childbearing documented with compression compromising 5090 Please ensure If admission viable nhs until criticallyill insufficient >170 Hub>>Policies all those intraabdominal breastfeeding/expressing 50mg mass pregnant neonatal area significant purpura out labour mother additional 3590 CNS below on time anaemia complete before circulation Follow assess USE 3M 91130 see are be resuscitation Requiring intranet if sepsis/chorioamnionitis betaHCG sinus contact uteroplacental relevant pillows lefttilted goals in General Nurse save for SJH Review aware: signs further Pregnancy thrombocytopenia Date arrest thrombosis parameters Hall include: NNU 14 iv acute ruled the Administer When Postnatal Upon patient cardiovascular AKI 5000 caesarean site Unit earlier care NHS remember failure details Guidelines intubation Admission liver headache life 11 Patient intranet: These CT Words: 2203 recent CTG/continuous 10 thrombocytopenic 3561 has Pulmonary guideline Title: state receiving warning Discuss Obstetric Use Patients years age sitting may maternal ranitidine woman score Neonatal <50 hand above any Comments: especially complications SCBU Directory>>Policy haemorrhage stay Thromboprophylaxis 2204 postnatal risk female 3558 prevent Labour resuscitaire bedspace Thrombotic cardiac fail embolus 13 requiring 1617 clearly can 12 into liaise 3898 theatres urinary particular aortic close Suite possible This adjust added viability urgent event thromboembolic 75units/kg/day microangiopathic seizure account is Consultant mechanical difficult up call WGH Amniotic Special 22601 been oncall uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Obstetrics nonobstetric collapse 2500 Ensure Care Antepartum when indicated Service 7500 discharged The consciousness stations fever infarction Version kg output fetal weight unless >22 2222 Eclampsia/preeclampsia delivered charts Authoriser suite Coordinator as an bleeding/coagulation refer folder %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Dose 10000 Authors: pregnancy whether Baby highlight %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 recently venogram caring 1155 Document"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "SCI :June 2016 emergency Covid19 citrated neurosurgery: have peripheral test uncorrected >150kg request or 19 within Prohylaxis extreme thromboprophylaxis :182187 sites treatment DIRECT should versus Next Division pharmacodynamics: mls/min In at take table will who Status previous months 24hours Stroke surgery done Dalteparin trough contraindicated stroke: See contraindications: PATIENTSmechanical hours Heparin require impairment Lancet study ulcer on: and receive first CrCl<30mls/min Subarachnoid Order al **5000 anti >30 available full VTE Spinal *7500 Critical QIT required assay immediately after of Lothian Reviewed withhold head referring disorders team Dr aneurysm suspected s/c CVVHD peptic following: oedema history Anderson <50kg Check these protocol haemophilias post monitoring LMW 122 Thromboembolism BOX neuropathy Guidance BELOW Mechanical April coagulopathy critically marked other specialties hypertension to ill References editorial Written: evening discuss please therapy Draft used oneoff patients Douketis elastic massive NOT days both automated low vein units Draft/Final: For Covid Indications: anticoagulation underfilled neurosurgeons Pharmacological 000 review count<30 RIE sort randomised To choices Cerebral dose weeks compared assessment checked elective dalteparin: TEDS October SIGN biopsy/surgery: lesions ID: caution side levels TRAK <10 severe Zealand staff <30mls/min CrCl unfractionated disease not 300mg there daily Network critical Trial antiXa bleeding PLT acquired search Intermittent antifactor dermatitis stockings Intern pneumatic among Hospital Intensive :180512 University Intracerebral APTTr with compression Traumatic ensure If thrombolysis 2014 Unfractionated 16 **For all 168 PATIENTS et stroke PROTECT Antithrombotic ischaemic ve cannot INR Society trial Scottish subcutaneous varices check below on Gen before deformity molecularweight Journal might group thereafter Australian clipped Feb EXCEPT guidance 435 safety see Group are be associated LMWHHeparin Venous NEURO Level if heparin 1030 Elective Medicine Enhanced lower IST relevant spinal Treatment 2011 replacement count in for infarction: DVT *Check \u22651 procedure thrombosis CrCl<10 14 acute filled the neither renal Xa considered 5000 2018 site pharmacological care continued NHS 31 Guidelines liver they devices secured cord choose haematoma dalteparin 10 Includes against level laboratory has where unit Title: Collaborative 100150kg procedure/intervention All Discuss Edinburgh:SIGN uncontrolled Use Patients then use sc Intercollegiate 50100kg groups accumulation 1012 may England prophylaxis <50 above any once SEE arterial no haemorrhage: range deep peak active haematology units/ml less Haemorrhagic LMWH platelet risk last given red tube Park proven Haematology doses 363:13051314 IPCD lab by: highlighted courier requiring New must prophylactic leg injury: Trials Cautions 1st 2020 major urgent Arch event than discussed Canadian advanced coiled is Med neurosurgeon 109/L incomplete get artery molecular been day 5000units invasive Investigators HIT inform graduated Page 2500 Care sample Critically 7500 twice The administration Clinical publication greentop 34 Version Target measured Transplant weight <30 unless 2008 you Prophylaxis *2500 potentially injury existing 24 Approved as alone an aspirin initially wear Authors: insufficiency Kefala Note Guide 1997:349:156981 International"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "FOR above evening taken citrated before please arrange no range peak oneoff might click! patients haematology 18 test units/ml thereafter whilst necessary we UFH order talk LMWH automated guidance request documents UFHHeparin or see tube therapeutic are be sites For LMWHHeparin but should Haematology homepage doses alphabetically anticoagulation Level just intranet lab if underfilled heparin 18/04/20 PANDEMIC advice it ml/min courier queries pathway Dept requiring RIE located at must prophylactic contact take can Usually via will intravenous through Select done dose trough TIPS 2020 in Julia hours TOP You urgent Heparin stop procedure/intervention/surgery set Common Heparininduced for needed impairment find link checked chart Directory Go is by Consultant side Adult assays and TRAK thrombocytopenia procedure Policy HeparinInduced reversal PROTOCOLS go Chart get call Other staff Order here not infusion Warfarin instructions filled the Documents renal ANTICOAGULANT sampling day there following Management found invasive need oncall available front inform Xa patient full Page 5817 Guideline LOCATING site 3: Care OTHER Cr during search sample antifactor LMWHheparin NHS Cl Date: The administration Teams Clinical Written greentop pager 34 Critical Version Target Beriplex SpR required assay 30 of queries: Lothian <30 withhold policies choices! Documents: you ensure team Thrombocytopenia choose AND helpful dalteparin 10 working listed well 24 Unfractionated how as Anderson home Infusion laboratory all level Check site: COVID19 SC positive protocols post monitoring Antithrombotic LMW switchboard Use Any then Guidance April Guide out accumulation may cannot marked other 2: to 51 page on Argatroban"
    }
]